id	sid	tid	token	lemma	pos
cuesj-1047	1	1	tx_1	tx_1	PROPN
cuesj-1047	1	2	~	~	X
cuesj-1047	1	3	abs	ab	NOUN
cuesj-1047	1	4	:	:	PUNCT
cuesj-1047	1	5	at	at	ADP
cuesj-1047	1	6	/	/	SYM
cuesj-1047	1	7	add	add	VERB
cuesj-1047	1	8	:	:	PUNCT
cuesj-1047	1	9	tx_2	tx_2	PROPN
cuesj-1047	1	10	~	~	NOUN
cuesj-1047	1	11	abs	ab	NOUN
cuesj-1047	1	12	:	:	PUNCT
cuesj-1047	1	13	at	at	ADP
cuesj-1047	1	14	8	8	NUM
cuesj-1047	1	15	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	1	16	cuesj	cuesj	ADJ
cuesj-1047	1	17	2024	2024	NUM
cuesj-1047	1	18	,	,	PUNCT
cuesj-1047	1	19	8	8	NUM
cuesj-1047	1	20	(	(	PUNCT
cuesj-1047	1	21	1	1	NUM
cuesj-1047	1	22	):	):	PUNCT
cuesj-1047	1	23	8	8	NUM
cuesj-1047	1	24	-	-	SYM
cuesj-1047	1	25	17	17	NUM
cuesj-1047	1	26	research	research	NOUN
cuesj-1047	1	27	article	article	NOUN
cuesj-1047	1	28	an	an	DET
cuesj-1047	1	29	overview	overview	NOUN
cuesj-1047	1	30	of	of	ADP
cuesj-1047	1	31	signs	sign	NOUN
cuesj-1047	1	32	and	and	CCONJ
cuesj-1047	1	33	symptoms	symptom	NOUN
cuesj-1047	1	34	to	to	PART
cuesj-1047	1	35	determine	determine	VERB
cuesj-1047	1	36	coronavirus	coronavirus	NOUN
cuesj-1047	1	37	and	and	CCONJ
cuesj-1047	1	38	omicron	omicron	PROPN
cuesj-1047	1	39	patients	patient	NOUN
cuesj-1047	1	40	in	in	ADP
cuesj-1047	1	41	primary	primary	ADJ
cuesj-1047	1	42	care	care	NOUN
cuesj-1047	1	43	and	and	CCONJ
cuesj-1047	1	44	hospitals	hospital	NOUN
cuesj-1047	1	45	ali	ali	PROPN
cuesj-1047	1	46	m.	m.	PROPN
cuesj-1047	1	47	hussein1	hussein1	PROPN
cuesj-1047	1	48	,	,	PUNCT
cuesj-1047	1	49	hawry	hawry	NOUN
cuesj-1047	1	50	a.	a.	NOUN
cuesj-1047	1	51	majeed1	majeed1	PROPN
cuesj-1047	1	52	,	,	PUNCT
cuesj-1047	1	53	naz	naz	PROPN
cuesj-1047	1	54	r.	r.	PROPN
cuesj-1047	1	55	majeed1	majeed1	PROPN
cuesj-1047	1	56	,	,	PUNCT
cuesj-1047	1	57	nza	nza	PROPN
cuesj-1047	1	58	h.	h.	PROPN
cuesj-1047	1	59	m.	m.	PROPN
cuesj-1047	1	60	ali1	ali1	PROPN
cuesj-1047	1	61	,	,	PUNCT
cuesj-1047	1	62	dashne	dashne	PROPN
cuesj-1047	1	63	a.	a.	NOUN
cuesj-1047	1	64	saeed2	saeed2	NOUN
cuesj-1047	1	65	,	,	PUNCT
cuesj-1047	1	66	narmin	narmin	PROPN
cuesj-1047	1	67	a.	a.	PROPN
cuesj-1047	1	68	ali3	ali3	PROPN
cuesj-1047	1	69	1department	1department	NUM
cuesj-1047	1	70	of	of	ADP
cuesj-1047	1	71	biomedical	biomedical	ADJ
cuesj-1047	1	72	sciences	science	NOUN
cuesj-1047	1	73	,	,	PUNCT
cuesj-1047	1	74	college	college	NOUN
cuesj-1047	1	75	of	of	ADP
cuesj-1047	1	76	science	science	NOUN
cuesj-1047	1	77	,	,	PUNCT
cuesj-1047	1	78	cihan	cihan	VERB
cuesj-1047	1	79	university	university	NOUN
cuesj-1047	1	80	-	-	PUNCT
cuesj-1047	1	81	erbil	erbil	PROPN
cuesj-1047	1	82	,	,	PUNCT
cuesj-1047	1	83	kurdistan	kurdistan	PROPN
cuesj-1047	1	84	region	region	NOUN
cuesj-1047	1	85	,	,	PUNCT
cuesj-1047	1	86	iraq	iraq	PROPN
cuesj-1047	1	87	,	,	PUNCT
cuesj-1047	1	88	2department	2department	NUM
cuesj-1047	1	89	of	of	ADP
cuesj-1047	1	90	general	general	ADJ
cuesj-1047	1	91	education	education	NOUN
cuesj-1047	1	92	,	,	PUNCT
cuesj-1047	1	93	college	college	NOUN
cuesj-1047	1	94	of	of	ADP
cuesj-1047	1	95	education	education	NOUN
cuesj-1047	1	96	,	,	PUNCT
cuesj-1047	1	97	cihan	cihan	VERB
cuesj-1047	1	98	university	university	NOUN
cuesj-1047	1	99	-	-	PUNCT
cuesj-1047	1	100	erbil	erbil	PROPN
cuesj-1047	1	101	,	,	PUNCT
cuesj-1047	1	102	kurdistan	kurdistan	PROPN
cuesj-1047	1	103	region	region	NOUN
cuesj-1047	1	104	,	,	PUNCT
cuesj-1047	1	105	iraq	iraq	PROPN
cuesj-1047	1	106	,	,	PUNCT
cuesj-1047	1	107	3department	3department	NUM
cuesj-1047	1	108	of	of	ADP
cuesj-1047	1	109	community	community	NOUN
cuesj-1047	1	110	health	health	NOUN
cuesj-1047	1	111	nursing	nursing	NOUN
cuesj-1047	1	112	,	,	PUNCT
cuesj-1047	1	113	college	college	NOUN
cuesj-1047	1	114	of	of	ADP
cuesj-1047	1	115	health	health	PROPN
cuesj-1047	1	116	technology	technology	NOUN
cuesj-1047	1	117	,	,	PUNCT
cuesj-1047	1	118	cihan	cihan	VERB
cuesj-1047	1	119	university	university	NOUN
cuesj-1047	1	120	-	-	PUNCT
cuesj-1047	1	121	erbil	erbil	PROPN
cuesj-1047	1	122	,	,	PUNCT
cuesj-1047	1	123	kurdistan	kurdistan	ADJ
cuesj-1047	1	124	region	region	NOUN
cuesj-1047	1	125	,	,	PUNCT
cuesj-1047	1	126	iraq	iraq	PROPN
cuesj-1047	1	127	abstract	abstract	ADJ
cuesj-1047	1	128	coronaviruses	coronaviruse	NOUN
cuesj-1047	1	129	,	,	PUNCT
cuesj-1047	1	130	a	a	DET
cuesj-1047	1	131	type	type	NOUN
cuesj-1047	1	132	of	of	ADP
cuesj-1047	1	133	virus	virus	NOUN
cuesj-1047	1	134	family	family	NOUN
cuesj-1047	1	135	,	,	PUNCT
cuesj-1047	1	136	cause	cause	VERB
cuesj-1047	1	137	severe	severe	ADJ
cuesj-1047	1	138	respiratory	respiratory	ADJ
cuesj-1047	1	139	diseases	disease	NOUN
cuesj-1047	1	140	in	in	ADP
cuesj-1047	1	141	people	people	NOUN
cuesj-1047	1	142	.	.	PUNCT
cuesj-1047	2	1	the	the	DET
cuesj-1047	2	2	coronavirus	coronavirus	NOUN
cuesj-1047	2	3	is	be	AUX
cuesj-1047	2	4	most	most	ADV
cuesj-1047	2	5	frequently	frequently	ADV
cuesj-1047	2	6	linked	link	VERB
cuesj-1047	2	7	to	to	ADP
cuesj-1047	2	8	the	the	DET
cuesj-1047	2	9	common	common	ADJ
cuesj-1047	2	10	cold	cold	NOUN
cuesj-1047	2	11	,	,	PUNCT
cuesj-1047	2	12	but	but	CCONJ
cuesj-1047	2	13	in	in	ADP
cuesj-1047	2	14	persons	person	NOUN
cuesj-1047	2	15	with	with	ADP
cuesj-1047	2	16	severe	severe	ADJ
cuesj-1047	2	17	acute	acute	ADJ
cuesj-1047	2	18	respiratory	respiratory	ADJ
cuesj-1047	2	19	syndrome	syndrome	NOUN
cuesj-1047	2	20	virus	virus	NOUN
cuesj-1047	2	21	infection	infection	NOUN
cuesj-1047	2	22	,	,	PUNCT
cuesj-1047	2	23	it	it	PRON
cuesj-1047	2	24	can	can	AUX
cuesj-1047	2	25	also	also	ADV
cuesj-1047	2	26	lead	lead	VERB
cuesj-1047	2	27	to	to	ADP
cuesj-1047	2	28	serious	serious	ADJ
cuesj-1047	2	29	respiratory	respiratory	ADJ
cuesj-1047	2	30	sickness	sickness	NOUN
cuesj-1047	2	31	.	.	PUNCT
cuesj-1047	3	1	the	the	DET
cuesj-1047	3	2	spread	spread	NOUN
cuesj-1047	3	3	of	of	ADP
cuesj-1047	3	4	the	the	DET
cuesj-1047	3	5	coronavirus	coronavirus	NOUN
cuesj-1047	3	6	is	be	AUX
cuesj-1047	3	7	by	by	ADP
cuesj-1047	3	8	having	have	VERB
cuesj-1047	3	9	direct	direct	ADJ
cuesj-1047	3	10	contact	contact	NOUN
cuesj-1047	3	11	with	with	ADP
cuesj-1047	3	12	infected	infected	ADJ
cuesj-1047	3	13	saliva	saliva	NOUN
cuesj-1047	3	14	,	,	PUNCT
cuesj-1047	3	15	mucus	mucus	NOUN
cuesj-1047	3	16	,	,	PUNCT
cuesj-1047	3	17	or	or	CCONJ
cuesj-1047	3	18	blood	blood	NOUN
cuesj-1047	3	19	.	.	PUNCT
cuesj-1047	4	1	infected	infected	ADJ
cuesj-1047	4	2	surfaces	surface	NOUN
cuesj-1047	4	3	,	,	PUNCT
cuesj-1047	4	4	such	such	ADJ
cuesj-1047	4	5	as	as	ADP
cuesj-1047	4	6	those	those	PRON
cuesj-1047	4	7	in	in	ADP
cuesj-1047	4	8	hospitals	hospital	NOUN
cuesj-1047	4	9	or	or	CCONJ
cuesj-1047	4	10	other	other	ADJ
cuesj-1047	4	11	health	health	NOUN
cuesj-1047	4	12	-	-	PUNCT
cuesj-1047	4	13	care	care	NOUN
cuesj-1047	4	14	facilities	facility	NOUN
cuesj-1047	4	15	,	,	PUNCT
cuesj-1047	4	16	can	can	AUX
cuesj-1047	4	17	potentially	potentially	ADV
cuesj-1047	4	18	spread	spread	VERB
cuesj-1047	4	19	the	the	DET
cuesj-1047	4	20	infection	infection	NOUN
cuesj-1047	4	21	when	when	SCONJ
cuesj-1047	4	22	touched	touch	VERB
cuesj-1047	4	23	.	.	PUNCT
cuesj-1047	5	1	now	now	ADV
cuesj-1047	5	2	,	,	PUNCT
cuesj-1047	5	3	spreading	spread	VERB
cuesj-1047	5	4	globally	globally	ADV
cuesj-1047	5	5	is	be	AUX
cuesj-1047	5	6	the	the	DET
cuesj-1047	5	7	omicron	omicron	PROPN
cuesj-1047	5	8	version	version	NOUN
cuesj-1047	5	9	of	of	ADP
cuesj-1047	5	10	the	the	DET
cuesj-1047	5	11	severe	severe	ADJ
cuesj-1047	5	12	acute	acute	ADJ
cuesj-1047	5	13	respiratory	respiratory	ADJ
cuesj-1047	5	14	syndrome	syndrome	NOUN
cuesj-1047	5	15	coronavirus	coronavirus	NOUN
cuesj-1047	5	16	2	2	NUM
cuesj-1047	5	17	(	(	PUNCT
cuesj-1047	5	18	sars	sar	NOUN
cuesj-1047	5	19	-	-	PUNCT
cuesj-1047	5	20	cov-2	cov-2	NOUN
cuesj-1047	5	21	)	)	PUNCT
cuesj-1047	5	22	.	.	PUNCT
cuesj-1047	6	1	according	accord	VERB
cuesj-1047	6	2	to	to	ADP
cuesj-1047	6	3	preliminary	preliminary	ADJ
cuesj-1047	6	4	studies	study	NOUN
cuesj-1047	6	5	,	,	PUNCT
cuesj-1047	6	6	the	the	DET
cuesj-1047	6	7	omicron	omicron	PROPN
cuesj-1047	6	8	variant	variant	NOUN
cuesj-1047	6	9	of	of	ADP
cuesj-1047	6	10	sars	sar	NOUN
cuesj-1047	6	11	-	-	PUNCT
cuesj-1047	6	12	cov-2	cov-2	PART
cuesj-1047	6	13	has	have	VERB
cuesj-1047	6	14	a	a	DET
cuesj-1047	6	15	higher	high	ADJ
cuesj-1047	6	16	probability	probability	NOUN
cuesj-1047	6	17	of	of	ADP
cuesj-1047	6	18	re	re	NOUN
cuesj-1047	6	19	-	-	NOUN
cuesj-1047	6	20	infection	infection	NOUN
cuesj-1047	6	21	.	.	PUNCT
cuesj-1047	7	1	to	to	PART
cuesj-1047	7	2	recognize	recognize	VERB
cuesj-1047	7	3	coronavirus	coronavirus	NOUN
cuesj-1047	7	4	disease	disease	NOUN
cuesj-1047	7	5	19	19	NUM
cuesj-1047	7	6	as	as	ADV
cuesj-1047	7	7	well	well	ADV
cuesj-1047	7	8	as	as	ADP
cuesj-1047	7	9	omicron	omicron	PROPN
cuesj-1047	7	10	people	people	NOUN
cuesj-1047	7	11	in	in	ADP
cuesj-1047	7	12	hospitals	hospital	NOUN
cuesj-1047	7	13	and	and	CCONJ
cuesj-1047	7	14	primary	primary	ADJ
cuesj-1047	7	15	health	health	NOUN
cuesj-1047	7	16	care	care	NOUN
cuesj-1047	7	17	,	,	PUNCT
cuesj-1047	7	18	this	this	DET
cuesj-1047	7	19	review	review	NOUN
cuesj-1047	7	20	study	study	NOUN
cuesj-1047	7	21	focuses	focus	VERB
cuesj-1047	7	22	on	on	ADP
cuesj-1047	7	23	the	the	DET
cuesj-1047	7	24	symptoms	symptom	NOUN
cuesj-1047	7	25	and	and	CCONJ
cuesj-1047	7	26	indications	indication	NOUN
cuesj-1047	7	27	.	.	PUNCT
cuesj-1047	8	1	the	the	DET
cuesj-1047	8	2	data	datum	NOUN
cuesj-1047	8	3	were	be	AUX
cuesj-1047	8	4	collected	collect	VERB
cuesj-1047	8	5	and	and	CCONJ
cuesj-1047	8	6	analyzed	analyze	VERB
cuesj-1047	8	7	from	from	ADP
cuesj-1047	8	8	more	more	ADJ
cuesj-1047	8	9	than	than	ADP
cuesj-1047	8	10	100	100	NUM
cuesj-1047	8	11	high	high	ADJ
cuesj-1047	8	12	-	-	PUNCT
cuesj-1047	8	13	impact	impact	NOUN
cuesj-1047	8	14	original	original	ADJ
cuesj-1047	8	15	research	research	NOUN
cuesj-1047	8	16	papers	paper	NOUN
cuesj-1047	8	17	to	to	PART
cuesj-1047	8	18	conclude	conclude	VERB
cuesj-1047	8	19	their	their	PRON
cuesj-1047	8	20	results	result	NOUN
cuesj-1047	8	21	and	and	CCONJ
cuesj-1047	8	22	make	make	VERB
cuesj-1047	8	23	a	a	DET
cuesj-1047	8	24	comparison	comparison	NOUN
cuesj-1047	8	25	between	between	ADP
cuesj-1047	8	26	methods	method	NOUN
cuesj-1047	8	27	and	and	CCONJ
cuesj-1047	8	28	findings	finding	NOUN
cuesj-1047	8	29	.	.	PUNCT
cuesj-1047	9	1	keywords	keyword	NOUN
cuesj-1047	9	2	:	:	PUNCT
cuesj-1047	9	3	coronavirus	coronavirus	NOUN
cuesj-1047	9	4	disease	disease	NOUN
cuesj-1047	9	5	19	19	NUM
cuesj-1047	9	6	,	,	PUNCT
cuesj-1047	9	7	omicron	omicron	PROPN
cuesj-1047	9	8	,	,	PUNCT
cuesj-1047	9	9	health	health	NOUN
cuesj-1047	9	10	care	care	NOUN
cuesj-1047	9	11	,	,	PUNCT
cuesj-1047	9	12	signs	sign	NOUN
cuesj-1047	9	13	,	,	PUNCT
cuesj-1047	9	14	symptoms	symptom	NOUN
cuesj-1047	9	15	introduction	introduction	VERB
cuesj-1047	9	16	the	the	DET
cuesj-1047	9	17	first	first	ADJ
cuesj-1047	9	18	report	report	NOUN
cuesj-1047	9	19	of	of	ADP
cuesj-1047	9	20	the	the	DET
cuesj-1047	9	21	coronavirus	coronavirus	NOUN
cuesj-1047	9	22	infection	infection	NOUN
cuesj-1047	9	23	came	come	VERB
cuesj-1047	9	24	from	from	ADP
cuesj-1047	9	25	wuhan	wuhan	PROPN
cuesj-1047	9	26	which	which	PRON
cuesj-1047	9	27	is	be	AUX
cuesj-1047	9	28	a	a	DET
cuesj-1047	9	29	city	city	NOUN
cuesj-1047	9	30	in	in	ADP
cuesj-1047	9	31	china	china	PROPN
cuesj-1047	9	32	,	,	PUNCT
cuesj-1047	9	33	in	in	ADP
cuesj-1047	9	34	december	december	PROPN
cuesj-1047	9	35	2019	2019	NUM
cuesj-1047	9	36	.	.	PUNCT
cuesj-1047	10	1	this	this	DET
cuesj-1047	10	2	infection	infection	NOUN
cuesj-1047	10	3	is	be	AUX
cuesj-1047	10	4	life	life	NOUN
cuesj-1047	10	5	threatening	threaten	VERB
cuesj-1047	10	6	which	which	PRON
cuesj-1047	10	7	is	be	AUX
cuesj-1047	10	8	endangering	endanger	VERB
cuesj-1047	10	9	people	people	NOUN
cuesj-1047	10	10	’s	’s	PART
cuesj-1047	10	11	health	health	NOUN
cuesj-1047	10	12	and	and	CCONJ
cuesj-1047	10	13	well	well	ADV
cuesj-1047	10	14	-	-	PUNCT
cuesj-1047	10	15	being.[1	being.[1	NOUN
cuesj-1047	10	16	]	]	X
cuesj-1047	10	17	global	global	ADJ
cuesj-1047	10	18	coronavirus	coronavirus	NOUN
cuesj-1047	10	19	disease	disease	NOUN
cuesj-1047	10	20	19	19	NUM
cuesj-1047	10	21	(	(	PUNCT
cuesj-1047	10	22	covid-19	covid-19	PROPN
cuesj-1047	10	23	)	)	PUNCT
cuesj-1047	10	24	mass	mass	NOUN
cuesj-1047	10	25	immunization	immunization	NOUN
cuesj-1047	10	26	programs	program	NOUN
cuesj-1047	10	27	have	have	AUX
cuesj-1047	10	28	demonstrated	demonstrate	VERB
cuesj-1047	10	29	the	the	DET
cuesj-1047	10	30	efficacy	efficacy	NOUN
cuesj-1047	10	31	of	of	ADP
cuesj-1047	10	32	this	this	DET
cuesj-1047	10	33	strategy	strategy	NOUN
cuesj-1047	10	34	.	.	PUNCT
cuesj-1047	11	1	influenza	influenza	NOUN
cuesj-1047	11	2	and	and	CCONJ
cuesj-1047	11	3	covid-19	covid-19	PROPN
cuesj-1047	11	4	infections	infection	NOUN
cuesj-1047	11	5	weaken	weaken	VERB
cuesj-1047	11	6	the	the	DET
cuesj-1047	11	7	host	host	NOUN
cuesj-1047	11	8	’s	’s	PART
cuesj-1047	11	9	immune	immune	ADJ
cuesj-1047	11	10	system	system	NOUN
cuesj-1047	11	11	,	,	PUNCT
cuesj-1047	11	12	which	which	PRON
cuesj-1047	11	13	provides	provide	VERB
cuesj-1047	11	14	an	an	DET
cuesj-1047	11	15	ideal	ideal	ADJ
cuesj-1047	11	16	setting	setting	NOUN
cuesj-1047	11	17	for	for	ADP
cuesj-1047	11	18	bacterial	bacterial	ADJ
cuesj-1047	11	19	and	and	CCONJ
cuesj-1047	11	20	viral	viral	ADJ
cuesj-1047	11	21	pathogens	pathogen	NOUN
cuesj-1047	11	22	to	to	PART
cuesj-1047	11	23	exploit	exploit	VERB
cuesj-1047	11	24	and	and	CCONJ
cuesj-1047	11	25	produce	produce	VERB
cuesj-1047	11	26	secondary	secondary	ADJ
cuesj-1047	11	27	infectious	infectious	ADJ
cuesj-1047	11	28	diseases.[2	diseases.[2	NOUN
cuesj-1047	11	29	]	]	X
cuesj-1047	11	30	covid-19	covid-19	PROPN
cuesj-1047	11	31	(	(	PUNCT
cuesj-1047	11	32	severe	severe	ADJ
cuesj-1047	11	33	acute	acute	ADJ
cuesj-1047	11	34	respiratory	respiratory	ADJ
cuesj-1047	11	35	syndrome	syndrome	NOUN
cuesj-1047	11	36	coronavirus	coronavirus	NOUN
cuesj-1047	11	37	2	2	NUM
cuesj-1047	12	1	[	[	X
cuesj-1047	12	2	sars	sar	NOUN
cuesj-1047	12	3	-	-	PUNCT
cuesj-1047	12	4	cov-2	cov-2	NOUN
cuesj-1047	12	5	]	]	PUNCT
cuesj-1047	12	6	)	)	PUNCT
cuesj-1047	12	7	and	and	CCONJ
cuesj-1047	12	8	other	other	ADJ
cuesj-1047	12	9	coronavirus	coronavirus	NOUN
cuesj-1047	12	10	infections	infection	NOUN
cuesj-1047	12	11	can	can	AUX
cuesj-1047	12	12	cause	cause	VERB
cuesj-1047	12	13	mild	mild	ADJ
cuesj-1047	12	14	respiratory	respiratory	ADJ
cuesj-1047	12	15	symptoms	symptom	NOUN
cuesj-1047	12	16	up	up	ADP
cuesj-1047	12	17	to	to	ADP
cuesj-1047	12	18	severe	severe	ADJ
cuesj-1047	12	19	pneumonia.[3	pneumonia.[3	NOUN
cuesj-1047	12	20	]	]	PUNCT
cuesj-1047	12	21	the	the	DET
cuesj-1047	12	22	world	world	PROPN
cuesj-1047	12	23	health	health	PROPN
cuesj-1047	12	24	organization	organization	NOUN
cuesj-1047	12	25	stated	state	VERB
cuesj-1047	12	26	(	(	PUNCT
cuesj-1047	12	27	covid-19	covid-19	PROPN
cuesj-1047	12	28	)	)	PUNCT
cuesj-1047	12	29	was	be	AUX
cuesj-1047	12	30	a	a	DET
cuesj-1047	12	31	worldwide	worldwide	ADJ
cuesj-1047	12	32	pandemic	pandemic	NOUN
cuesj-1047	12	33	on	on	ADP
cuesj-1047	12	34	the	the	DET
cuesj-1047	12	35	11th	11th	NOUN
cuesj-1047	12	36	of	of	ADP
cuesj-1047	12	37	march	march	PROPN
cuesj-1047	12	38	,	,	PUNCT
cuesj-1047	12	39	2020	2020	NUM
cuesj-1047	12	40	.	.	PUNCT
cuesj-1047	13	1	evaluation	evaluation	NOUN
cuesj-1047	13	2	of	of	ADP
cuesj-1047	13	3	symptoms	symptom	NOUN
cuesj-1047	13	4	and	and	CCONJ
cuesj-1047	13	5	signs	sign	NOUN
cuesj-1047	13	6	has	have	AUX
cuesj-1047	13	7	been	be	AUX
cuesj-1047	13	8	proposed	propose	VERB
cuesj-1047	13	9	as	as	ADP
cuesj-1047	13	10	a	a	DET
cuesj-1047	13	11	viable	viable	ADJ
cuesj-1047	13	12	method.[4	method.[4	NOUN
cuesj-1047	13	13	]	]	X
cuesj-1047	13	14	significant	significant	ADJ
cuesj-1047	13	15	advancements	advancement	NOUN
cuesj-1047	13	16	in	in	ADP
cuesj-1047	13	17	covid-19	covid-19	PROPN
cuesj-1047	13	18	testing	testing	NOUN
cuesj-1047	13	19	,	,	PUNCT
cuesj-1047	13	20	prevention	prevention	NOUN
cuesj-1047	13	21	,	,	PUNCT
cuesj-1047	13	22	and	and	CCONJ
cuesj-1047	13	23	treatment	treatment	NOUN
cuesj-1047	13	24	have	have	AUX
cuesj-1047	13	25	been	be	AUX
cuesj-1047	13	26	accomplished	accomplish	VERB
cuesj-1047	13	27	2	2	NUM
cuesj-1047	13	28	years	year	NOUN
cuesj-1047	13	29	after	after	SCONJ
cuesj-1047	13	30	it	it	PRON
cuesj-1047	13	31	was	be	AUX
cuesj-1047	13	32	recognized	recognize	VERB
cuesj-1047	13	33	as	as	ADP
cuesj-1047	13	34	a	a	DET
cuesj-1047	13	35	global	global	ADJ
cuesj-1047	13	36	epidemic.[5	epidemic.[5	NOUN
cuesj-1047	13	37	]	]	PUNCT
cuesj-1047	13	38	because	because	SCONJ
cuesj-1047	13	39	there	there	PRON
cuesj-1047	13	40	is	be	VERB
cuesj-1047	13	41	no	no	DET
cuesj-1047	13	42	approved	approved	ADJ
cuesj-1047	13	43	immunization	immunization	NOUN
cuesj-1047	13	44	for	for	ADP
cuesj-1047	13	45	children	child	NOUN
cuesj-1047	13	46	aged	aged	ADJ
cuesj-1047	13	47	0–4	0–4	NUM
cuesj-1047	13	48	years	year	NOUN
cuesj-1047	13	49	old	old	ADJ
cuesj-1047	13	50	,	,	PUNCT
cuesj-1047	13	51	children	child	NOUN
cuesj-1047	13	52	everywhere	everywhere	ADV
cuesj-1047	13	53	are	be	AUX
cuesj-1047	13	54	in	in	ADP
cuesj-1047	13	55	danger	danger	NOUN
cuesj-1047	13	56	of	of	ADP
cuesj-1047	13	57	contracting	contract	VERB
cuesj-1047	13	58	sars	sar	NOUN
cuesj-1047	13	59	-	-	PUNCT
cuesj-1047	13	60	cov-2	cov-2	NOUN
cuesj-1047	13	61	infection1.[6	infection1.[6	PROPN
cuesj-1047	13	62	]	]	X
cuesj-1047	13	63	the	the	DET
cuesj-1047	13	64	two	two	NUM
cuesj-1047	13	65	companies	company	NOUN
cuesj-1047	13	66	authorized	authorize	VERB
cuesj-1047	13	67	to	to	PART
cuesj-1047	13	68	produce	produce	VERB
cuesj-1047	13	69	messenger	messenger	NOUN
cuesj-1047	13	70	ribonucleic	ribonucleic	NOUN
cuesj-1047	13	71	(	(	PUNCT
cuesj-1047	13	72	mrna	mrna	PROPN
cuesj-1047	13	73	)	)	PUNCT
cuesj-1047	13	74	covid-19	covid-19	PROPN
cuesj-1047	13	75	vaccines	vaccine	NOUN
cuesj-1047	13	76	,	,	PUNCT
cuesj-1047	13	77	pfizerbiontech	pfizerbiontech	NOUN
cuesj-1047	13	78	and	and	CCONJ
cuesj-1047	13	79	moderna	moderna	NOUN
cuesj-1047	13	80	,	,	PUNCT
cuesj-1047	13	81	have	have	AUX
cuesj-1047	13	82	indicated	indicate	VERB
cuesj-1047	13	83	their	their	PRON
cuesj-1047	13	84	capability	capability	NOUN
cuesj-1047	13	85	to	to	PART
cuesj-1047	13	86	develop	develop	VERB
cuesj-1047	13	87	vaccinations	vaccination	NOUN
cuesj-1047	13	88	tailored	tailor	VERB
cuesj-1047	13	89	specifically	specifically	ADV
cuesj-1047	13	90	for	for	ADP
cuesj-1047	13	91	the	the	DET
cuesj-1047	13	92	omicron	omicron	PROPN
cuesj-1047	13	93	variant	variant	NOUN
cuesj-1047	13	94	in	in	ADP
cuesj-1047	13	95	100	100	NUM
cuesj-1047	13	96	days.[7	days.[7	NOUN
cuesj-1047	13	97	]	]	X
cuesj-1047	13	98	there	there	PRON
cuesj-1047	13	99	are	be	VERB
cuesj-1047	13	100	more	more	ADJ
cuesj-1047	13	101	than	than	ADP
cuesj-1047	13	102	50	50	NUM
cuesj-1047	13	103	known	know	VERB
cuesj-1047	13	104	variants	variant	NOUN
cuesj-1047	13	105	of	of	ADP
cuesj-1047	13	106	the	the	DET
cuesj-1047	13	107	omicron	omicron	PROPN
cuesj-1047	13	108	variant	variant	NOUN
cuesj-1047	13	109	,	,	PUNCT
cuesj-1047	13	110	32	32	NUM
cuesj-1047	13	111	of	of	ADP
cuesj-1047	13	112	which	which	PRON
cuesj-1047	13	113	are	be	AUX
cuesj-1047	13	114	found	find	VERB
cuesj-1047	13	115	in	in	ADP
cuesj-1047	13	116	the	the	DET
cuesj-1047	13	117	spike	spike	ADJ
cuesj-1047	13	118	protein.[8	protein.[8	NOUN
cuesj-1047	13	119	]	]	PUNCT
cuesj-1047	13	120	during	during	ADP
cuesj-1047	13	121	the	the	DET
cuesj-1047	13	122	peak	peak	NOUN
cuesj-1047	13	123	of	of	ADP
cuesj-1047	13	124	omicron	omicron	PROPN
cuesj-1047	13	125	’s	’s	PART
cuesj-1047	13	126	prevalence	prevalence	NOUN
cuesj-1047	13	127	in	in	ADP
cuesj-1047	13	128	january	january	PROPN
cuesj-1047	13	129	2022	2022	NUM
cuesj-1047	13	130	,	,	PUNCT
cuesj-1047	13	131	unvaccinated	unvaccinate	VERB
cuesj-1047	13	132	adults	adult	NOUN
cuesj-1047	13	133	had	have	VERB
cuesj-1047	13	134	hospitalization	hospitalization	NOUN
cuesj-1047	13	135	rates	rate	NOUN
cuesj-1047	13	136	that	that	PRON
cuesj-1047	13	137	were	be	AUX
cuesj-1047	13	138	12	12	NUM
cuesj-1047	13	139	times	time	NOUN
cuesj-1047	13	140	higher	high	ADJ
cuesj-1047	13	141	than	than	ADP
cuesj-1047	13	142	individuals	individual	NOUN
cuesj-1047	13	143	who	who	PRON
cuesj-1047	13	144	had	have	AUX
cuesj-1047	13	145	received	receive	VERB
cuesj-1047	13	146	booster	booster	NOUN
cuesj-1047	13	147	or	or	CCONJ
cuesj-1047	13	148	additional	additional	ADJ
cuesj-1047	13	149	vaccinations.[9	vaccinations.[9	NOUN
cuesj-1047	13	150	]	]	PUNCT
cuesj-1047	13	151	the	the	DET
cuesj-1047	13	152	omicron	omicron	PROPN
cuesj-1047	13	153	variety	variety	NOUN
cuesj-1047	13	154	was	be	AUX
cuesj-1047	13	155	recognized	recognize	VERB
cuesj-1047	13	156	on	on	ADP
cuesj-1047	13	157	the	the	DET
cuesj-1047	13	158	9th	9th	NOUN
cuesj-1047	13	159	of	of	ADP
cuesj-1047	13	160	november	november	PROPN
cuesj-1047	13	161	,	,	PUNCT
cuesj-1047	13	162	2021	2021	NUM
cuesj-1047	13	163	,	,	PUNCT
cuesj-1047	13	164	in	in	ADP
cuesj-1047	13	165	south	south	PROPN
cuesj-1047	13	166	africa	africa	PROPN
cuesj-1047	13	167	’s	’s	PART
cuesj-1047	13	168	city	city	NOUN
cuesj-1047	13	169	of	of	ADP
cuesj-1047	13	170	tshwane	tshwane	NOUN
cuesj-1047	13	171	,	,	PUNCT
cuesj-1047	13	172	gauteng	gauteng	PROPN
cuesj-1047	13	173	province	province	PROPN
cuesj-1047	13	174	,	,	PUNCT
cuesj-1047	13	175	resulting	result	VERB
cuesj-1047	13	176	in	in	ADP
cuesj-1047	13	177	a	a	DET
cuesj-1047	13	178	dramatic	dramatic	ADJ
cuesj-1047	13	179	spike	spike	NOUN
cuesj-1047	13	180	in	in	ADP
cuesj-1047	13	181	hospital	hospital	NOUN
cuesj-1047	13	182	admissions	admission	NOUN
cuesj-1047	13	183	as	as	ADV
cuesj-1047	13	184	well	well	ADV
cuesj-1047	13	185	as	as	ADP
cuesj-1047	13	186	exponential	exponential	ADJ
cuesj-1047	13	187	growth	growth	NOUN
cuesj-1047	13	188	in	in	ADP
cuesj-1047	13	189	the	the	DET
cuesj-1047	13	190	number	number	NOUN
cuesj-1047	13	191	of	of	ADP
cuesj-1047	13	192	incidents.[1	incidents.[1	NOUN
cuesj-1047	13	193	]	]	X
cuesj-1047	13	194	the	the	DET
cuesj-1047	13	195	omicron	omicron	PROPN
cuesj-1047	13	196	form	form	NOUN
cuesj-1047	13	197	(	(	PUNCT
cuesj-1047	13	198	b.1.1.529	b.1.1.529	ADV
cuesj-1047	13	199	)	)	PUNCT
cuesj-1047	13	200	of	of	ADP
cuesj-1047	13	201	the	the	DET
cuesj-1047	13	202	sars	sar	NOUN
cuesj-1047	13	203	-	-	PUNCT
cuesj-1047	13	204	cov-2	cov-2	PART
cuesj-1047	13	205	virus	virus	NOUN
cuesj-1047	13	206	,	,	PUNCT
cuesj-1047	13	207	which	which	PRON
cuesj-1047	13	208	results	result	VERB
cuesj-1047	13	209	in	in	ADP
cuesj-1047	13	210	covid-19	covid-19	PROPN
cuesj-1047	13	211	,	,	PUNCT
cuesj-1047	13	212	was	be	AUX
cuesj-1047	13	213	found	find	VERB
cuesj-1047	13	214	in	in	ADP
cuesj-1047	13	215	the	the	DET
cuesj-1047	13	216	united	united	PROPN
cuesj-1047	13	217	states	states	PROPN
cuesj-1047	13	218	for	for	ADP
cuesj-1047	13	219	the	the	DET
cuesj-1047	13	220	1st	1st	ADJ
cuesj-1047	13	221	time.[10	time.[10	NOUN
cuesj-1047	13	222	]	]	PUNCT
cuesj-1047	13	223	compared	compare	VERB
cuesj-1047	13	224	to	to	ADP
cuesj-1047	13	225	earlier	early	ADJ
cuesj-1047	13	226	variations	variation	NOUN
cuesj-1047	13	227	,	,	PUNCT
cuesj-1047	13	228	omicron	omicron	PROPN
cuesj-1047	13	229	seems	seem	VERB
cuesj-1047	13	230	to	to	PART
cuesj-1047	13	231	cause	cause	VERB
cuesj-1047	13	232	less	less	ADV
cuesj-1047	13	233	severe	severe	ADJ
cuesj-1047	13	234	acute	acute	ADJ
cuesj-1047	13	235	sickness	sickness	NOUN
cuesj-1047	13	236	,	,	PUNCT
cuesj-1047	13	237	at	at	ADP
cuesj-1047	13	238	least	least	ADJ
cuesj-1047	13	239	in	in	ADP
cuesj-1047	13	240	people	people	NOUN
cuesj-1047	13	241	immunized.[11	immunized.[11	PROPN
cuesj-1047	13	242	]	]	X
cuesj-1047	13	243	omicron	omicron	PROPN
cuesj-1047	13	244	-	-	PUNCT
cuesj-1047	13	245	affected	affect	VERB
cuesj-1047	13	246	corresponding	corresponding	ADJ
cuesj-1047	13	247	author	author	NOUN
cuesj-1047	13	248	:	:	PUNCT
cuesj-1047	13	249	ali	ali	PROPN
cuesj-1047	13	250	m.	m.	PROPN
cuesj-1047	13	251	hussein	hussein	PROPN
cuesj-1047	13	252	,	,	PUNCT
cuesj-1047	13	253	department	department	NOUN
cuesj-1047	13	254	of	of	ADP
cuesj-1047	13	255	biomedical	biomedical	ADJ
cuesj-1047	13	256	sciences	sciences	PROPN
cuesj-1047	13	257	,	,	PUNCT
cuesj-1047	13	258	college	college	NOUN
cuesj-1047	13	259	of	of	ADP
cuesj-1047	13	260	science	science	NOUN
cuesj-1047	13	261	,	,	PUNCT
cuesj-1047	13	262	cihan	cihan	VERB
cuesj-1047	13	263	university	university	NOUN
cuesj-1047	13	264	-	-	PUNCT
cuesj-1047	13	265	erbil	erbil	PROPN
cuesj-1047	13	266	,	,	PUNCT
cuesj-1047	13	267	kurdistan	kurdistan	PROPN
cuesj-1047	13	268	region	region	NOUN
cuesj-1047	13	269	,	,	PUNCT
cuesj-1047	13	270	iraq	iraq	PROPN
cuesj-1047	13	271	.	.	PUNCT
cuesj-1047	14	1	e	e	X
cuesj-1047	14	2	-	-	NOUN
cuesj-1047	14	3	mail	mail	NOUN
cuesj-1047	14	4	:	:	PUNCT
cuesj-1047	14	5	ali.m.hussein@cihanuniversity.edu.iq	ali.m.hussein@cihanuniversity.edu.iq	NOUN
cuesj-1047	14	6	received	receive	VERB
cuesj-1047	14	7	:	:	PUNCT
cuesj-1047	14	8	october	october	PROPN
cuesj-1047	14	9	19	19	NUM
cuesj-1047	14	10	,	,	PUNCT
cuesj-1047	14	11	2023	2023	NUM
cuesj-1047	14	12	accepted	accept	VERB
cuesj-1047	14	13	:	:	PUNCT
cuesj-1047	14	14	january	january	PROPN
cuesj-1047	14	15	01	01	NUM
cuesj-1047	14	16	,	,	PUNCT
cuesj-1047	14	17	2024	2024	NUM
cuesj-1047	14	18	published	publish	VERB
cuesj-1047	14	19	:	:	PUNCT
cuesj-1047	14	20	february	february	PROPN
cuesj-1047	14	21	05	05	NUM
cuesj-1047	14	22	,	,	PUNCT
cuesj-1047	14	23	2024	2024	NUM
cuesj-1047	14	24	doi	doi	NOUN
cuesj-1047	14	25	:	:	PUNCT
cuesj-1047	14	26	10.24086	10.24086	NUM
cuesj-1047	14	27	/	/	SYM
cuesj-1047	14	28	cuesj.v8n1y2024.pp8	cuesj.v8n1y2024.pp8	NOUN
cuesj-1047	14	29	-	-	PUNCT
cuesj-1047	14	30	17	17	NUM
cuesj-1047	14	31	copyright	copyright	NOUN
cuesj-1047	14	32	©	©	PROPN
cuesj-1047	14	33	2024	2024	NUM
cuesj-1047	14	34	ali	ali	PROPN
cuesj-1047	14	35	m.	m.	PROPN
cuesj-1047	14	36	hussein	hussein	PROPN
cuesj-1047	14	37	,	,	PUNCT
cuesj-1047	14	38	hawry	hawry	NOUN
cuesj-1047	14	39	a.	a.	NOUN
cuesj-1047	14	40	majeed	majeed	PROPN
cuesj-1047	14	41	,	,	PUNCT
cuesj-1047	14	42	naz	naz	PROPN
cuesj-1047	14	43	r.	r.	PROPN
cuesj-1047	14	44	majeed	majeed	PROPN
cuesj-1047	14	45	,	,	PUNCT
cuesj-1047	14	46	nza	nza	PROPN
cuesj-1047	14	47	h.	h.	PROPN
cuesj-1047	14	48	m.	m.	PROPN
cuesj-1047	14	49	ali	ali	PROPN
cuesj-1047	14	50	,	,	PUNCT
cuesj-1047	14	51	dashne	dashne	PROPN
cuesj-1047	14	52	a.	a.	PROPN
cuesj-1047	14	53	saeed	saeed	PROPN
cuesj-1047	14	54	,	,	PUNCT
cuesj-1047	14	55	narmin	narmin	PROPN
cuesj-1047	14	56	a.	a.	PROPN
cuesj-1047	14	57	ali	ali	PROPN
cuesj-1047	14	58	.	.	PUNCT
cuesj-1047	15	1	this	this	PRON
cuesj-1047	15	2	is	be	AUX
cuesj-1047	15	3	an	an	DET
cuesj-1047	15	4	open	open	ADJ
cuesj-1047	15	5	-	-	PUNCT
cuesj-1047	15	6	access	access	NOUN
cuesj-1047	15	7	article	article	NOUN
cuesj-1047	15	8	distributed	distribute	VERB
cuesj-1047	15	9	under	under	ADP
cuesj-1047	15	10	the	the	DET
cuesj-1047	15	11	creative	creative	ADJ
cuesj-1047	15	12	commons	common	NOUN
cuesj-1047	15	13	attribution	attribution	NOUN
cuesj-1047	15	14	license	license	NOUN
cuesj-1047	15	15	.	.	PUNCT
cuesj-1047	16	1	cihan	cihan	VERB
cuesj-1047	16	2	university	university	NOUN
cuesj-1047	16	3	-	-	PUNCT
cuesj-1047	16	4	erbil	erbil	PROPN
cuesj-1047	16	5	scientific	scientific	ADJ
cuesj-1047	16	6	journal	journal	NOUN
cuesj-1047	16	7	(	(	PUNCT
cuesj-1047	16	8	cuesj	cuesj	PROPN
cuesj-1047	16	9	)	)	PUNCT
cuesj-1047	16	10	hussein	hussein	PROPN
cuesj-1047	16	11	,	,	PUNCT
cuesj-1047	16	12	et	et	PROPN
cuesj-1047	16	13	al	al	PROPN
cuesj-1047	16	14	.	.	PUNCT
cuesj-1047	16	15	:	:	PUNCT
cuesj-1047	17	1	a	a	DET
cuesj-1047	17	2	review	review	NOUN
cuesj-1047	17	3	on	on	ADP
cuesj-1047	17	4	coronavirus	coronavirus	NOUN
cuesj-1047	17	5	and	and	CCONJ
cuesj-1047	17	6	omicron	omicron	PROPN
cuesj-1047	17	7	patients	patient	NOUN
cuesj-1047	17	8	9	9	NUM
cuesj-1047	17	9	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	17	10	cuesj	cuesj	NOUN
cuesj-1047	17	11	2024	2024	NUM
cuesj-1047	17	12	,	,	PUNCT
cuesj-1047	17	13	8	8	NUM
cuesj-1047	17	14	(	(	PUNCT
cuesj-1047	17	15	1	1	NUM
cuesj-1047	17	16	):	):	PUNCT
cuesj-1047	17	17	8	8	NUM
cuesj-1047	17	18	-	-	SYM
cuesj-1047	17	19	17	17	NUM
cuesj-1047	17	20	patients	patient	NOUN
cuesj-1047	17	21	most	most	ADV
cuesj-1047	17	22	frequently	frequently	ADV
cuesj-1047	17	23	displayed	display	VERB
cuesj-1047	17	24	fever	fever	NOUN
cuesj-1047	17	25	,	,	PUNCT
cuesj-1047	17	26	extreme	extreme	ADJ
cuesj-1047	17	27	weariness	weariness	NOUN
cuesj-1047	17	28	,	,	PUNCT
cuesj-1047	17	29	a	a	DET
cuesj-1047	17	30	moist	moist	ADJ
cuesj-1047	17	31	cough	cough	NOUN
cuesj-1047	17	32	,	,	PUNCT
cuesj-1047	17	33	a	a	DET
cuesj-1047	17	34	stuffy	stuffy	ADJ
cuesj-1047	17	35	nose	nose	NOUN
cuesj-1047	17	36	,	,	PUNCT
cuesj-1047	17	37	diarrhea	diarrhea	PROPN
cuesj-1047	17	38	,	,	PUNCT
cuesj-1047	17	39	head	head	NOUN
cuesj-1047	17	40	pain	pain	NOUN
cuesj-1047	17	41	,	,	PUNCT
cuesj-1047	17	42	and	and	CCONJ
cuesj-1047	17	43	other	other	ADJ
cuesj-1047	17	44	pains	pain	NOUN
cuesj-1047	17	45	in	in	ADP
cuesj-1047	17	46	the	the	DET
cuesj-1047	17	47	body.[12	body.[12	NOUN
cuesj-1047	17	48	]	]	X
cuesj-1047	17	49	early	early	ADV
cuesj-1047	17	50	in	in	ADP
cuesj-1047	17	51	2022	2022	NUM
cuesj-1047	17	52	,	,	PUNCT
cuesj-1047	17	53	omicron	omicron	PROPN
cuesj-1047	17	54	took	take	VERB
cuesj-1047	17	55	over	over	ADP
cuesj-1047	17	56	as	as	ADP
cuesj-1047	17	57	the	the	DET
cuesj-1047	17	58	predominant	predominant	ADJ
cuesj-1047	17	59	version	version	NOUN
cuesj-1047	17	60	in	in	ADP
cuesj-1047	17	61	some	some	DET
cuesj-1047	17	62	parts	part	NOUN
cuesj-1047	17	63	of	of	ADP
cuesj-1047	17	64	europe.[13	europe.[13	NOUN
cuesj-1047	17	65	]	]	PUNCT
cuesj-1047	17	66	in	in	ADP
cuesj-1047	17	67	2021	2021	NUM
cuesj-1047	17	68	and	and	CCONJ
cuesj-1047	17	69	2022	2022	NUM
cuesj-1047	17	70	,	,	PUNCT
cuesj-1047	17	71	most	most	ADJ
cuesj-1047	17	72	of	of	ADP
cuesj-1047	17	73	the	the	DET
cuesj-1047	17	74	covid-19	covid-19	PROPN
cuesj-1047	17	75	crises	crisis	NOUN
cuesj-1047	17	76	were	be	AUX
cuesj-1047	17	77	brought	bring	VERB
cuesj-1047	17	78	on	on	ADP
cuesj-1047	17	79	by	by	ADP
cuesj-1047	17	80	omicron	omicron	PROPN
cuesj-1047	17	81	and	and	CCONJ
cuesj-1047	17	82	delta	delta	PROPN
cuesj-1047	17	83	variants.[14	variants.[14	PROPN
cuesj-1047	17	84	]	]	PUNCT
cuesj-1047	17	85	despite	despite	SCONJ
cuesj-1047	17	86	the	the	DET
cuesj-1047	17	87	little	little	ADJ
cuesj-1047	17	88	improvement	improvement	NOUN
cuesj-1047	17	89	after	after	ADP
cuesj-1047	17	90	the	the	DET
cuesj-1047	17	91	booster	booster	NOUN
cuesj-1047	17	92	dosage	dosage	NOUN
cuesj-1047	17	93	,	,	PUNCT
cuesj-1047	17	94	vaccines	vaccine	NOUN
cuesj-1047	17	95	give	give	VERB
cuesj-1047	17	96	less	less	ADJ
cuesj-1047	17	97	protection	protection	NOUN
cuesj-1047	17	98	against	against	ADP
cuesj-1047	17	99	symptomatic	symptomatic	ADJ
cuesj-1047	17	100	omicron	omicron	NOUN
cuesj-1047	17	101	infection	infection	NOUN
cuesj-1047	17	102	than	than	SCONJ
cuesj-1047	17	103	they	they	PRON
cuesj-1047	17	104	do	do	VERB
cuesj-1047	17	105	against	against	ADP
cuesj-1047	17	106	the	the	DET
cuesj-1047	17	107	delta	delta	NOUN
cuesj-1047	17	108	form	form	NOUN
cuesj-1047	17	109	,	,	PUNCT
cuesj-1047	17	110	according	accord	VERB
cuesj-1047	17	111	to	to	ADP
cuesj-1047	17	112	observational	observational	ADJ
cuesj-1047	17	113	studies	study	NOUN
cuesj-1047	17	114	in	in	ADP
cuesj-1047	17	115	the	the	DET
cuesj-1047	17	116	general	general	ADJ
cuesj-1047	17	117	population.[14	population.[14	PROPN
cuesj-1047	17	118	]	]	PUNCT
cuesj-1047	17	119	anxiety	anxiety	NOUN
cuesj-1047	17	120	and	and	CCONJ
cuesj-1047	17	121	despair	despair	NOUN
cuesj-1047	17	122	have	have	AUX
cuesj-1047	17	123	increased	increase	VERB
cuesj-1047	17	124	significantly	significantly	ADV
cuesj-1047	17	125	since	since	SCONJ
cuesj-1047	17	126	the	the	DET
cuesj-1047	17	127	covid-19	covid-19	PROPN
cuesj-1047	17	128	pandemic	pandemic	NOUN
cuesj-1047	17	129	,	,	PUNCT
cuesj-1047	17	130	particularly	particularly	ADV
cuesj-1047	17	131	after	after	ADP
cuesj-1047	17	132	the	the	DET
cuesj-1047	17	133	omicron	omicron	PROPN
cuesj-1047	17	134	wave.[15	wave.[15	PROPN
cuesj-1047	17	135	]	]	PUNCT
cuesj-1047	17	136	the	the	DET
cuesj-1047	17	137	omicron	omicron	PROPN
cuesj-1047	17	138	version	version	NOUN
cuesj-1047	17	139	is	be	AUX
cuesj-1047	17	140	resistant	resistant	ADJ
cuesj-1047	17	141	to	to	ADP
cuesj-1047	17	142	modern	modern	ADJ
cuesj-1047	17	143	vaccines	vaccine	NOUN
cuesj-1047	17	144	more	more	ADJ
cuesj-1047	17	145	than	than	ADP
cuesj-1047	17	146	previous	previous	ADJ
cuesj-1047	17	147	variants.[16	variants.[16	NOUN
cuesj-1047	17	148	]	]	PUNCT
cuesj-1047	17	149	by	by	ADP
cuesj-1047	17	150	the	the	DET
cuesj-1047	17	151	end	end	NOUN
cuesj-1047	17	152	of	of	ADP
cuesj-1047	17	153	december	december	PROPN
cuesj-1047	17	154	2021	2021	NUM
cuesj-1047	17	155	,	,	PUNCT
cuesj-1047	17	156	the	the	DET
cuesj-1047	17	157	extremely	extremely	ADV
cuesj-1047	17	158	contagious	contagious	ADJ
cuesj-1047	17	159	sars	sar	NOUN
cuesj-1047	17	160	-	-	PUNCT
cuesj-1047	17	161	cov-2	cov-2	NOUN
cuesj-1047	17	162	omicron	omicron	NOUN
cuesj-1047	17	163	variant	variant	NOUN
cuesj-1047	17	164	,	,	PUNCT
cuesj-1047	17	165	which	which	PRON
cuesj-1047	17	166	was	be	AUX
cuesj-1047	17	167	first	first	ADV
cuesj-1047	17	168	discovered	discover	VERB
cuesj-1047	17	169	in	in	ADP
cuesj-1047	17	170	november	november	PROPN
cuesj-1047	17	171	2021	2021	NUM
cuesj-1047	17	172	in	in	ADP
cuesj-1047	17	173	southern	southern	PROPN
cuesj-1047	17	174	africa	africa	PROPN
cuesj-1047	17	175	,	,	PUNCT
cuesj-1047	17	176	had	have	AUX
cuesj-1047	17	177	taken	take	VERB
cuesj-1047	17	178	over	over	ADP
cuesj-1047	17	179	in	in	ADP
cuesj-1047	17	180	the	the	DET
cuesj-1047	17	181	united	united	PROPN
cuesj-1047	17	182	states.[10	states.[10	PROPN
cuesj-1047	17	183	]	]	PUNCT
cuesj-1047	17	184	a	a	PRON
cuesj-1047	17	185	coronavirus	coronavirus	NOUN
cuesj-1047	17	186	outbreak	outbreak	NOUN
cuesj-1047	17	187	(	(	PUNCT
cuesj-1047	17	188	covid-19	covid-19	PROPN
cuesj-1047	17	189	)	)	PUNCT
cuesj-1047	17	190	which	which	PRON
cuesj-1047	17	191	occurred	occur	VERB
cuesj-1047	17	192	in	in	ADP
cuesj-1047	17	193	china	china	PROPN
cuesj-1047	17	194	in	in	ADP
cuesj-1047	17	195	the	the	DET
cuesj-1047	17	196	city	city	NOUN
cuesj-1047	17	197	of	of	ADP
cuesj-1047	17	198	shanghai	shanghai	PROPN
cuesj-1047	17	199	from	from	ADP
cuesj-1047	17	200	february	february	PROPN
cuesj-1047	17	201	to	to	ADP
cuesj-1047	17	202	june	june	PROPN
cuesj-1047	17	203	of	of	ADP
cuesj-1047	17	204	2022	2022	NUM
cuesj-1047	17	205	was	be	AUX
cuesj-1047	17	206	brought	bring	VERB
cuesj-1047	17	207	on	on	ADP
cuesj-1047	17	208	by	by	ADP
cuesj-1047	17	209	sars	sar	NOUN
cuesj-1047	17	210	-	-	PUNCT
cuesj-1047	17	211	cov-2	cov-2	NOUN
cuesj-1047	17	212	omicron	omicron	PROPN
cuesj-1047	17	213	ba.2	ba.2	PROPN
cuesj-1047	17	214	sub	sub	PROPN
cuesj-1047	17	215	-	-	ADJ
cuesj-1047	17	216	lineage.[17	lineage.[17	ADJ
cuesj-1047	17	217	]	]	PUNCT
cuesj-1047	17	218	however	however	ADV
cuesj-1047	17	219	,	,	PUNCT
cuesj-1047	17	220	it	it	PRON
cuesj-1047	17	221	revealed	reveal	VERB
cuesj-1047	17	222	that	that	SCONJ
cuesj-1047	17	223	omicron	omicron	PROPN
cuesj-1047	17	224	infections	infection	NOUN
cuesj-1047	17	225	resulted	result	VERB
cuesj-1047	17	226	in	in	ADP
cuesj-1047	17	227	significantly	significantly	ADV
cuesj-1047	17	228	fewer	few	ADJ
cuesj-1047	17	229	hospitalizations	hospitalization	NOUN
cuesj-1047	17	230	than	than	ADP
cuesj-1047	17	231	delta	delta	NOUN
cuesj-1047	17	232	infections	infection	NOUN
cuesj-1047	17	233	because	because	SCONJ
cuesj-1047	17	234	the	the	DET
cuesj-1047	17	235	cases	case	NOUN
cuesj-1047	17	236	of	of	ADP
cuesj-1047	17	237	omicron	omicron	PROPN
cuesj-1047	17	238	covid-19	covid-19	PROPN
cuesj-1047	17	239	in	in	ADP
cuesj-1047	17	240	south	south	PROPN
cuesj-1047	17	241	africa	africa	PROPN
cuesj-1047	17	242	climbed	climb	VERB
cuesj-1047	17	243	quickly.[18	quickly.[18	NOUN
cuesj-1047	17	244	]	]	PUNCT
cuesj-1047	17	245	there	there	PRON
cuesj-1047	17	246	have	have	AUX
cuesj-1047	17	247	been	be	AUX
cuesj-1047	17	248	waves	wave	NOUN
cuesj-1047	17	249	of	of	ADP
cuesj-1047	17	250	hospitalonset	hospitalonset	ADJ
cuesj-1047	17	251	covid-19	covid-19	PROPN
cuesj-1047	17	252	infections	infection	NOUN
cuesj-1047	17	253	(	(	PUNCT
cuesj-1047	17	254	hoci	hoci	PROPN
cuesj-1047	17	255	)	)	PUNCT
cuesj-1047	17	256	during	during	ADP
cuesj-1047	17	257	the	the	DET
cuesj-1047	17	258	covid-19	covid-19	PROPN
cuesj-1047	17	259	epidemic.[19	epidemic.[19	NOUN
cuesj-1047	17	260	]	]	PUNCT
cuesj-1047	17	261	globally	globally	ADV
cuesj-1047	17	262	,	,	PUNCT
cuesj-1047	17	263	covid-19	covid-19	PROPN
cuesj-1047	17	264	has	have	AUX
cuesj-1047	17	265	resulted	result	VERB
cuesj-1047	17	266	in	in	ADP
cuesj-1047	17	267	543	543	NUM
cuesj-1047	17	268	million	million	NUM
cuesj-1047	17	269	illnesses	illness	NOUN
cuesj-1047	17	270	and	and	CCONJ
cuesj-1047	17	271	6.3	6.3	NUM
cuesj-1047	17	272	million	million	NUM
cuesj-1047	17	273	fatalities	fatality	NOUN
cuesj-1047	17	274	as	as	ADP
cuesj-1047	17	275	of	of	ADP
cuesj-1047	17	276	june	june	PROPN
cuesj-1047	17	277	2022.[20	2022.[20	NUM
cuesj-1047	17	278	]	]	PUNCT
cuesj-1047	17	279	furthermore	furthermore	ADV
cuesj-1047	17	280	,	,	PUNCT
cuesj-1047	17	281	to	to	PART
cuesj-1047	17	282	assume	assume	VERB
cuesj-1047	17	283	the	the	DET
cuesj-1047	17	284	risk	risk	NOUN
cuesj-1047	17	285	of	of	ADP
cuesj-1047	17	286	hospitalization	hospitalization	NOUN
cuesj-1047	17	287	among	among	ADP
cuesj-1047	17	288	outpatients	outpatient	NOUN
cuesj-1047	17	289	,	,	PUNCT
cuesj-1047	17	290	the	the	DET
cuesj-1047	17	291	out	out	ADJ
cuesj-1047	17	292	cov	cov	NOUN
cuesj-1047	17	293	rating	rating	NOUN
cuesj-1047	17	294	was	be	AUX
cuesj-1047	17	295	created	create	VERB
cuesj-1047	17	296	and	and	CCONJ
cuesj-1047	17	297	internally	internally	ADV
cuesj-1047	17	298	verified	verify	VERB
cuesj-1047	17	299	in	in	ADP
cuesj-1047	17	300	switzerland	switzerland	PROPN
cuesj-1047	17	301	without	without	ADP
cuesj-1047	17	302	needing	need	VERB
cuesj-1047	17	303	laboratory	laboratory	NOUN
cuesj-1047	17	304	tests.[21	tests.[21	PROPN
cuesj-1047	17	305	]	]	PUNCT
cuesj-1047	17	306	in	in	ADP
cuesj-1047	17	307	south	south	PROPN
cuesj-1047	17	308	africa	africa	PROPN
cuesj-1047	17	309	,	,	PUNCT
cuesj-1047	17	310	europe	europe	PROPN
cuesj-1047	17	311	,	,	PUNCT
cuesj-1047	17	312	and	and	CCONJ
cuesj-1047	17	313	canada	canada	PROPN
cuesj-1047	17	314	,	,	PUNCT
cuesj-1047	17	315	omicron	omicron	PROPN
cuesj-1047	17	316	(	(	PUNCT
cuesj-1047	17	317	b.1.1.529	b.1.1.529	ADV
cuesj-1047	17	318	and	and	CCONJ
cuesj-1047	17	319	ba	ba	NOUN
cuesj-1047	17	320	lineages	lineage	NOUN
cuesj-1047	17	321	)	)	PUNCT
cuesj-1047	17	322	has	have	AUX
cuesj-1047	17	323	created	create	VERB
cuesj-1047	17	324	less	less	ADV
cuesj-1047	17	325	serious	serious	ADJ
cuesj-1047	17	326	illnesses	illness	NOUN
cuesj-1047	17	327	than	than	ADP
cuesj-1047	17	328	previous	previous	ADJ
cuesj-1047	17	329	variants.[22	variants.[22	PROPN
cuesj-1047	17	330	]	]	PUNCT
cuesj-1047	17	331	in	in	ADP
cuesj-1047	17	332	early	early	ADJ
cuesj-1047	17	333	2022	2022	NUM
cuesj-1047	17	334	,	,	PUNCT
cuesj-1047	17	335	omicron	omicron	PROPN
cuesj-1047	17	336	took	take	VERB
cuesj-1047	17	337	over	over	ADP
cuesj-1047	17	338	as	as	ADP
cuesj-1047	17	339	the	the	DET
cuesj-1047	17	340	predominant	predominant	ADJ
cuesj-1047	17	341	version	version	NOUN
cuesj-1047	17	342	in	in	ADP
cuesj-1047	17	343	some	some	DET
cuesj-1047	17	344	parts	part	NOUN
cuesj-1047	17	345	of	of	ADP
cuesj-1047	17	346	europe.[13	europe.[13	NOUN
cuesj-1047	17	347	]	]	PUNCT
cuesj-1047	17	348	during	during	ADP
cuesj-1047	17	349	the	the	DET
cuesj-1047	17	350	omicron	omicron	PROPN
cuesj-1047	17	351	pandemic	pandemic	NOUN
cuesj-1047	17	352	in	in	ADP
cuesj-1047	17	353	hong	hong	PROPN
cuesj-1047	17	354	kong	kong	PROPN
cuesj-1047	17	355	,	,	PUNCT
cuesj-1047	17	356	elderly	elderly	ADJ
cuesj-1047	17	357	people	people	NOUN
cuesj-1047	17	358	60	60	NUM
cuesj-1047	17	359	years	year	NOUN
cuesj-1047	17	360	of	of	ADP
cuesj-1047	17	361	age	age	NOUN
cuesj-1047	17	362	or	or	CCONJ
cuesj-1047	17	363	over	over	ADV
cuesj-1047	17	364	made	make	VERB
cuesj-1047	17	365	up	up	ADP
cuesj-1047	17	366	more	more	ADJ
cuesj-1047	17	367	than	than	ADP
cuesj-1047	17	368	95	95	NUM
cuesj-1047	17	369	%	%	NOUN
cuesj-1047	17	370	of	of	ADP
cuesj-1047	17	371	the	the	DET
cuesj-1047	17	372	fatal	fatal	ADJ
cuesj-1047	17	373	cases.[23	cases.[23	PROPN
cuesj-1047	17	374	]	]	PUNCT
cuesj-1047	17	375	omicron	omicron	PROPN
cuesj-1047	17	376	has	have	AUX
cuesj-1047	17	377	expanded	expand	VERB
cuesj-1047	17	378	quickly	quickly	ADV
cuesj-1047	17	379	,	,	PUNCT
cuesj-1047	17	380	and	and	CCONJ
cuesj-1047	17	381	as	as	ADP
cuesj-1047	17	382	of	of	ADP
cuesj-1047	17	383	january	january	PROPN
cuesj-1047	17	384	6	6	NUM
cuesj-1047	17	385	,	,	PUNCT
cuesj-1047	17	386	2022	2022	NUM
cuesj-1047	17	387	,	,	PUNCT
cuesj-1047	17	388	149	149	NUM
cuesj-1047	17	389	countries	country	NOUN
cuesj-1047	17	390	across	across	ADP
cuesj-1047	17	391	all	all	DET
cuesj-1047	17	392	six	six	NUM
cuesj-1047	17	393	world	world	NOUN
cuesj-1047	17	394	health	health	NOUN
cuesj-1047	17	395	organizations	organization	NOUN
cuesj-1047	17	396	had	have	AUX
cuesj-1047	17	397	been	be	AUX
cuesj-1047	17	398	confirmed	confirm	VERB
cuesj-1047	17	399	to	to	PART
cuesj-1047	17	400	have	have	VERB
cuesj-1047	17	401	it.[24	it.[24	NOUN
cuesj-1047	17	402	]	]	PUNCT
cuesj-1047	17	403	when	when	SCONJ
cuesj-1047	17	404	the	the	DET
cuesj-1047	17	405	omicron	omicron	PROPN
cuesj-1047	17	406	variety	variety	NOUN
cuesj-1047	17	407	was	be	AUX
cuesj-1047	17	408	more	more	ADV
cuesj-1047	17	409	common	common	ADJ
cuesj-1047	17	410	,	,	PUNCT
cuesj-1047	17	411	a	a	DET
cuesj-1047	17	412	child	child	NOUN
cuesj-1047	17	413	infected	infect	VERB
cuesj-1047	17	414	with	with	ADP
cuesj-1047	17	415	it	it	PRON
cuesj-1047	17	416	had	have	VERB
cuesj-1047	17	417	a	a	DET
cuesj-1047	17	418	lower	low	ADJ
cuesj-1047	17	419	possibility	possibility	NOUN
cuesj-1047	17	420	of	of	ADP
cuesj-1047	17	421	hospitalization	hospitalization	NOUN
cuesj-1047	17	422	–	–	PUNCT
cuesj-1047	17	423	between	between	ADP
cuesj-1047	17	424	a	a	DET
cuesj-1047	17	425	quarter	quarter	NOUN
cuesj-1047	17	426	and	and	CCONJ
cuesj-1047	17	427	a	a	DET
cuesj-1047	17	428	half	half	NOUN
cuesj-1047	17	429	–	–	PUNCT
cuesj-1047	17	430	than	than	ADP
cuesj-1047	17	431	when	when	SCONJ
cuesj-1047	17	432	the	the	DET
cuesj-1047	17	433	delta	delta	NOUN
cuesj-1047	17	434	variant	variant	NOUN
cuesj-1047	17	435	was	be	AUX
cuesj-1047	17	436	more	more	ADJ
cuesj-1047	17	437	common.[25	common.[25	NOUN
cuesj-1047	17	438	]	]	X
cuesj-1047	17	439	in	in	ADP
cuesj-1047	17	440	qatar	qatar	PROPN
cuesj-1047	17	441	,	,	PUNCT
cuesj-1047	17	442	a	a	DET
cuesj-1047	17	443	wave	wave	NOUN
cuesj-1047	17	444	of	of	ADP
cuesj-1047	17	445	sars	sar	NOUN
cuesj-1047	17	446	-	-	PUNCT
cuesj-1047	17	447	cov-2	cov-2	NOUN
cuesj-1047	17	448	omicron	omicron	NOUN
cuesj-1047	17	449	(	(	PUNCT
cuesj-1047	17	450	b.1.1.529)1	b.1.1.529)1	PROPN
cuesj-1047	17	451	coronavirus	coronavirus	NOUN
cuesj-1047	17	452	caused	cause	VERB
cuesj-1047	17	453	severe	severe	ADJ
cuesj-1047	17	454	acute	acute	ADJ
cuesj-1047	17	455	respiratory	respiratory	ADJ
cuesj-1047	17	456	syndrome	syndrome	NOUN
cuesj-1047	17	457	topped	top	VERB
cuesj-1047	17	458	in	in	ADP
cuesj-1047	17	459	mid	mid	PROPN
cuesj-1047	17	460	-	-	PROPN
cuesj-1047	17	461	january	january	NOUN
cuesj-1047	17	462	2022.[26	2022.[26	NUM
cuesj-1047	17	463	]	]	PUNCT
cuesj-1047	17	464	in	in	ADP
cuesj-1047	17	465	south	south	PROPN
cuesj-1047	17	466	africa	africa	PROPN
cuesj-1047	17	467	’s	’s	PART
cuesj-1047	17	468	initial	initial	ADJ
cuesj-1047	17	469	three	three	NUM
cuesj-1047	17	470	covid-19	covid-19	PROPN
cuesj-1047	17	471	waves	wave	NOUN
cuesj-1047	17	472	,	,	PUNCT
cuesj-1047	17	473	the	the	DET
cuesj-1047	17	474	pediatric	pediatric	ADJ
cuesj-1047	17	475	disease	disease	NOUN
cuesj-1047	17	476	burden	burden	NOUN
cuesj-1047	17	477	was	be	AUX
cuesj-1047	17	478	not	not	PART
cuesj-1047	17	479	very	very	ADV
cuesj-1047	17	480	severe	severe	ADJ
cuesj-1047	17	481	,	,	PUNCT
cuesj-1047	17	482	with	with	ADP
cuesj-1047	17	483	most	most	ADJ
cuesj-1047	17	484	children	child	NOUN
cuesj-1047	17	485	exhibiting	exhibit	VERB
cuesj-1047	17	486	asymptomatic	asymptomatic	ADJ
cuesj-1047	17	487	or	or	CCONJ
cuesj-1047	17	488	mild	mild	ADJ
cuesj-1047	17	489	-	-	PUNCT
cuesj-1047	17	490	to	to	ADP
cuesj-1047	17	491	-	-	PUNCT
cuesj-1047	17	492	moderate	moderate	ADJ
cuesj-1047	17	493	disease.[27	disease.[27	PROPN
cuesj-1047	17	494	]	]	PUNCT
cuesj-1047	17	495	methods	method	NOUN
cuesj-1047	17	496	search	search	NOUN
cuesj-1047	17	497	methodologies	methodology	NOUN
cuesj-1047	17	498	and	and	CCONJ
cuesj-1047	17	499	criteria	criterion	NOUN
cuesj-1047	17	500	selection	selection	NOUN
cuesj-1047	17	501	in	in	ADP
cuesj-1047	17	502	conducting	conduct	VERB
cuesj-1047	17	503	this	this	DET
cuesj-1047	17	504	systematic	systematic	ADJ
cuesj-1047	17	505	review	review	NOUN
cuesj-1047	17	506	,	,	PUNCT
cuesj-1047	17	507	the	the	DET
cuesj-1047	17	508	recommended	recommend	VERB
cuesj-1047	17	509	reporting	reporting	NOUN
cuesj-1047	17	510	elements	element	NOUN
cuesj-1047	17	511	for	for	ADP
cuesj-1047	17	512	systematic	systematic	ADJ
cuesj-1047	17	513	reviews	review	NOUN
cuesj-1047	17	514	and	and	CCONJ
cuesj-1047	17	515	meta	meta	NOUN
cuesj-1047	17	516	-	-	PUNCT
cuesj-1047	17	517	analyses	analysis	NOUN
cuesj-1047	17	518	(	(	PUNCT
cuesj-1047	17	519	prisma	prisma	NOUN
cuesj-1047	17	520	)	)	PUNCT
cuesj-1047	17	521	criteria	criterion	NOUN
cuesj-1047	17	522	were	be	AUX
cuesj-1047	17	523	followed	follow	VERB
cuesj-1047	17	524	.	.	PUNCT
cuesj-1047	18	1	the	the	DET
cuesj-1047	18	2	question	question	NOUN
cuesj-1047	18	3	of	of	ADP
cuesj-1047	18	4	the	the	DET
cuesj-1047	18	5	study	study	NOUN
cuesj-1047	18	6	was	be	AUX
cuesj-1047	18	7	:	:	PUNCT
cuesj-1047	18	8	what	what	PRON
cuesj-1047	18	9	clinical	clinical	ADJ
cuesj-1047	18	10	signs	sign	NOUN
cuesj-1047	18	11	are	be	AUX
cuesj-1047	18	12	most	most	ADV
cuesj-1047	18	13	prevalent	prevalent	ADJ
cuesj-1047	18	14	in	in	ADP
cuesj-1047	18	15	covid-19	covid-19	PROPN
cuesj-1047	18	16	and	and	CCONJ
cuesj-1047	18	17	omicron	omicron	PROPN
cuesj-1047	18	18	patients	patient	NOUN
cuesj-1047	18	19	?	?	PUNCT
cuesj-1047	19	1	we	we	PRON
cuesj-1047	19	2	chose	choose	VERB
cuesj-1047	19	3	studies	study	NOUN
cuesj-1047	19	4	that	that	PRON
cuesj-1047	19	5	research	research	VERB
cuesj-1047	19	6	the	the	DET
cuesj-1047	19	7	epidemiological	epidemiological	ADJ
cuesj-1047	19	8	characteristics	characteristic	NOUN
cuesj-1047	19	9	of	of	ADP
cuesj-1047	19	10	covid-19	covid-19	PROPN
cuesj-1047	19	11	patients	patient	NOUN
cuesj-1047	19	12	hospitalized	hospitalize	VERB
cuesj-1047	19	13	in	in	ADP
cuesj-1047	19	14	pubmed	pubmed	PROPN
cuesj-1047	19	15	,	,	PUNCT
cuesj-1047	19	16	bmc	bmc	PROPN
cuesj-1047	19	17	,	,	PUNCT
cuesj-1047	19	18	medline	medline	NOUN
cuesj-1047	19	19	,	,	PUNCT
cuesj-1047	19	20	and	and	CCONJ
cuesj-1047	19	21	scopus	scopus	NOUN
cuesj-1047	19	22	databases	database	NOUN
cuesj-1047	19	23	between	between	ADP
cuesj-1047	19	24	january	january	PROPN
cuesj-1047	19	25	1st	1st	NOUN
cuesj-1047	19	26	,	,	PUNCT
cuesj-1047	19	27	2021	2021	NUM
cuesj-1047	19	28	,	,	PUNCT
cuesj-1047	19	29	and	and	CCONJ
cuesj-1047	19	30	december	december	PROPN
cuesj-1047	19	31	1st	1st	NOUN
cuesj-1047	19	32	,	,	PUNCT
cuesj-1047	19	33	2022	2022	NUM
cuesj-1047	19	34	,	,	PUNCT
cuesj-1047	19	35	using	use	VERB
cuesj-1047	19	36	the	the	DET
cuesj-1047	19	37	descriptors	descriptor	NOUN
cuesj-1047	19	38	covid-19	covid-19	PROPN
cuesj-1047	19	39	,	,	PUNCT
cuesj-1047	19	40	sars	sar	NOUN
cuesj-1047	19	41	-	-	PUNCT
cuesj-1047	19	42	cov2	cov2	PROPN
cuesj-1047	19	43	,	,	PUNCT
cuesj-1047	19	44	2019	2019	NUM
cuesj-1047	19	45	-	-	PUNCT
cuesj-1047	19	46	ncov	ncov	NOUN
cuesj-1047	19	47	,	,	PUNCT
cuesj-1047	19	48	n	n	CCONJ
cuesj-1047	19	49	-	-	PUNCT
cuesj-1047	19	50	cov	cov	NOUN
cuesj-1047	19	51	,	,	PUNCT
cuesj-1047	19	52	and	and	CCONJ
cuesj-1047	19	53	coronavirus	coronavirus	NOUN
cuesj-1047	19	54	merged	merge	VERB
cuesj-1047	19	55	with	with	ADP
cuesj-1047	19	56	“	"	PUNCT
cuesj-1047	19	57	clinical	clinical	ADJ
cuesj-1047	19	58	profile	profile	NOUN
cuesj-1047	19	59	”	"	PUNCT
cuesj-1047	19	60	or	or	CCONJ
cuesj-1047	19	61	“	"	PUNCT
cuesj-1047	19	62	epidemiological	epidemiological	ADJ
cuesj-1047	19	63	profile	profile	NOUN
cuesj-1047	19	64	.	.	PUNCT
cuesj-1047	19	65	”	"	PUNCT
cuesj-1047	20	1	we	we	PRON
cuesj-1047	20	2	wanted	want	VERB
cuesj-1047	20	3	to	to	PART
cuesj-1047	20	4	find	find	VERB
cuesj-1047	20	5	whether	whether	SCONJ
cuesj-1047	20	6	covid-19	covid-19	PROPN
cuesj-1047	20	7	and	and	CCONJ
cuesj-1047	20	8	omicron	omicron	PROPN
cuesj-1047	20	9	patients	patient	NOUN
cuesj-1047	20	10	shared	share	VERB
cuesj-1047	20	11	any	any	DET
cuesj-1047	20	12	common	common	ADJ
cuesj-1047	20	13	clinical	clinical	ADJ
cuesj-1047	20	14	symptoms	symptom	NOUN
cuesj-1047	20	15	studies	study	NOUN
cuesj-1047	20	16	although	although	SCONJ
cuesj-1047	20	17	which	which	DET
cuesj-1047	20	18	primary	primary	ADJ
cuesj-1047	20	19	care	care	NOUN
cuesj-1047	20	20	and	and	CCONJ
cuesj-1047	20	21	hospitality	hospitality	NOUN
cuesj-1047	20	22	were	be	AUX
cuesj-1047	20	23	followed	follow	VERB
cuesj-1047	20	24	for	for	ADP
cuesj-1047	20	25	these	these	DET
cuesj-1047	20	26	patients	patient	NOUN
cuesj-1047	20	27	(	(	PUNCT
cuesj-1047	20	28	figure	figure	NOUN
cuesj-1047	20	29	1	1	NUM
cuesj-1047	20	30	)	)	PUNCT
cuesj-1047	20	31	.	.	PUNCT
cuesj-1047	21	1	the	the	DET
cuesj-1047	21	2	boolean	boolean	ADJ
cuesj-1047	21	3	operators	operator	NOUN
cuesj-1047	21	4	“	"	PUNCT
cuesj-1047	21	5	and	and	CCONJ
cuesj-1047	21	6	”	"	PUNCT
cuesj-1047	21	7	and	and	CCONJ
cuesj-1047	21	8	“	"	PUNCT
cuesj-1047	21	9	or	or	CCONJ
cuesj-1047	21	10	”	"	PUNCT
cuesj-1047	21	11	were	be	AUX
cuesj-1047	21	12	used	use	VERB
cuesj-1047	21	13	for	for	ADP
cuesj-1047	21	14	the	the	DET
cuesj-1047	21	15	search	search	NOUN
cuesj-1047	21	16	strategy	strategy	NOUN
cuesj-1047	21	17	.	.	PUNCT
cuesj-1047	22	1	a	a	DET
cuesj-1047	22	2	manual	manual	ADJ
cuesj-1047	22	3	search	search	NOUN
cuesj-1047	22	4	for	for	ADP
cuesj-1047	22	5	references	reference	NOUN
cuesj-1047	22	6	listed	list	VERB
cuesj-1047	22	7	in	in	ADP
cuesj-1047	22	8	the	the	DET
cuesj-1047	22	9	papers	paper	NOUN
cuesj-1047	22	10	was	be	AUX
cuesj-1047	22	11	also	also	ADV
cuesj-1047	22	12	done	do	VERB
cuesj-1047	22	13	.	.	PUNCT
cuesj-1047	23	1	requirements	requirement	NOUN
cuesj-1047	23	2	for	for	ADP
cuesj-1047	23	3	eligibility	eligibility	NOUN
cuesj-1047	23	4	in	in	ADP
cuesj-1047	23	5	addition	addition	NOUN
cuesj-1047	23	6	,	,	PUNCT
cuesj-1047	23	7	investigated	investigate	VERB
cuesj-1047	23	8	were	be	AUX
cuesj-1047	23	9	clinical	clinical	ADJ
cuesj-1047	23	10	trials	trial	NOUN
cuesj-1047	23	11	,	,	PUNCT
cuesj-1047	23	12	cohorts	cohort	NOUN
cuesj-1047	23	13	,	,	PUNCT
cuesj-1047	23	14	crosssectional	crosssectional	ADJ
cuesj-1047	23	15	data	datum	NOUN
cuesj-1047	23	16	,	,	PUNCT
cuesj-1047	23	17	clinical	clinical	ADJ
cuesj-1047	23	18	case	case	NOUN
cuesj-1047	23	19	studies	study	NOUN
cuesj-1047	23	20	,	,	PUNCT
cuesj-1047	23	21	and	and	CCONJ
cuesj-1047	23	22	case	case	NOUN
cuesj-1047	23	23	series	series	NOUN
cuesj-1047	23	24	published	publish	VERB
cuesj-1047	23	25	worldwide	worldwide	ADV
cuesj-1047	23	26	in	in	ADP
cuesj-1047	23	27	different	different	ADJ
cuesj-1047	23	28	languages	language	NOUN
cuesj-1047	23	29	.	.	PUNCT
cuesj-1047	24	1	official	official	ADJ
cuesj-1047	24	2	diagnostic	diagnostic	ADJ
cuesj-1047	24	3	reports	report	NOUN
cuesj-1047	24	4	,	,	PUNCT
cuesj-1047	24	5	remarks	remark	NOUN
cuesj-1047	24	6	,	,	PUNCT
cuesj-1047	24	7	evaluations	evaluation	NOUN
cuesj-1047	24	8	of	of	ADP
cuesj-1047	24	9	literature	literature	NOUN
cuesj-1047	24	10	,	,	PUNCT
cuesj-1047	24	11	papers	paper	NOUN
cuesj-1047	24	12	with	with	ADP
cuesj-1047	24	13	restricted	restricted	ADJ
cuesj-1047	24	14	access	access	NOUN
cuesj-1047	24	15	to	to	ADP
cuesj-1047	24	16	the	the	DET
cuesj-1047	24	17	material	material	NOUN
cuesj-1047	24	18	,	,	PUNCT
cuesj-1047	24	19	and	and	CCONJ
cuesj-1047	24	20	animal	animal	NOUN
cuesj-1047	24	21	experimentation	experimentation	NOUN
cuesj-1047	24	22	were	be	AUX
cuesj-1047	24	23	removed	remove	VERB
cuesj-1047	24	24	.	.	PUNCT
cuesj-1047	25	1	variables	variable	NOUN
cuesj-1047	25	2	for	for	ADP
cuesj-1047	25	3	investigation	investigation	NOUN
cuesj-1047	25	4	this	this	DET
cuesj-1047	25	5	study	study	NOUN
cuesj-1047	25	6	’s	’s	PART
cuesj-1047	25	7	goal	goal	NOUN
cuesj-1047	25	8	was	be	AUX
cuesj-1047	25	9	to	to	PART
cuesj-1047	25	10	find	find	VERB
cuesj-1047	25	11	clinical	clinical	ADJ
cuesj-1047	25	12	manifestation	manifestation	NOUN
cuesj-1047	25	13	features	feature	NOUN
cuesj-1047	25	14	in	in	ADP
cuesj-1047	25	15	covid-19	covid-19	PROPN
cuesj-1047	25	16	and	and	CCONJ
cuesj-1047	25	17	omicron	omicron	PROPN
cuesj-1047	25	18	individuals	individual	NOUN
cuesj-1047	25	19	.	.	PUNCT
cuesj-1047	26	1	the	the	DET
cuesj-1047	26	2	resulting	result	VERB
cuesj-1047	26	3	features	feature	NOUN
cuesj-1047	26	4	were	be	AUX
cuesj-1047	26	5	investigated	investigate	VERB
cuesj-1047	26	6	:	:	PUNCT
cuesj-1047	26	7	study	study	NOUN
cuesj-1047	26	8	nation	nation	NOUN
cuesj-1047	26	9	,	,	PUNCT
cuesj-1047	26	10	study	study	NOUN
cuesj-1047	26	11	population	population	NOUN
cuesj-1047	26	12	,	,	PUNCT
cuesj-1047	26	13	gender	gender	NOUN
cuesj-1047	26	14	(	(	PUNCT
cuesj-1047	26	15	male	male	ADJ
cuesj-1047	26	16	and	and	CCONJ
cuesj-1047	26	17	female	female	NOUN
cuesj-1047	26	18	)	)	PUNCT
cuesj-1047	26	19	,	,	PUNCT
cuesj-1047	26	20	age	age	NOUN
cuesj-1047	26	21	,	,	PUNCT
cuesj-1047	26	22	and	and	CCONJ
cuesj-1047	26	23	clinical	clinical	ADJ
cuesj-1047	26	24	symptoms	symptom	NOUN
cuesj-1047	26	25	.	.	PUNCT
cuesj-1047	27	1	preference	preference	NOUN
cuesj-1047	27	2	of	of	ADP
cuesj-1047	27	3	studies	study	NOUN
cuesj-1047	27	4	two	two	NUM
cuesj-1047	27	5	separate	separate	ADJ
cuesj-1047	27	6	researchers	researcher	NOUN
cuesj-1047	27	7	conducted	conduct	VERB
cuesj-1047	27	8	the	the	DET
cuesj-1047	27	9	search	search	NOUN
cuesj-1047	27	10	.	.	PUNCT
cuesj-1047	28	1	following	follow	VERB
cuesj-1047	28	2	this	this	DET
cuesj-1047	28	3	action	action	NOUN
cuesj-1047	28	4	,	,	PUNCT
cuesj-1047	28	5	they	they	PRON
cuesj-1047	28	6	independently	independently	ADV
cuesj-1047	28	7	carried	carry	VERB
cuesj-1047	28	8	out	out	ADP
cuesj-1047	28	9	the	the	DET
cuesj-1047	28	10	subsequent	subsequent	ADJ
cuesj-1047	28	11	procedures	procedure	NOUN
cuesj-1047	28	12	:	:	PUNCT
cuesj-1047	28	13	reading	read	VERB
cuesj-1047	28	14	the	the	DET
cuesj-1047	28	15	title	title	NOUN
cuesj-1047	28	16	and	and	CCONJ
cuesj-1047	28	17	synopsis	synopsis	NOUN
cuesj-1047	28	18	to	to	PART
cuesj-1047	28	19	identify	identify	VERB
cuesj-1047	28	20	possibly	possibly	ADV
cuesj-1047	28	21	relevant	relevant	ADJ
cuesj-1047	28	22	research	research	NOUN
cuesj-1047	28	23	,	,	PUNCT
cuesj-1047	28	24	reading	read	VERB
cuesj-1047	28	25	the	the	DET
cuesj-1047	28	26	entire	entire	ADJ
cuesj-1047	28	27	article	article	NOUN
cuesj-1047	28	28	,	,	PUNCT
cuesj-1047	28	29	gathering	gather	VERB
cuesj-1047	28	30	variables	variable	NOUN
cuesj-1047	28	31	,	,	PUNCT
cuesj-1047	28	32	and	and	CCONJ
cuesj-1047	28	33	building	build	VERB
cuesj-1047	28	34	the	the	DET
cuesj-1047	28	35	database	database	NOUN
cuesj-1047	28	36	are	be	AUX
cuesj-1047	28	37	the	the	DET
cuesj-1047	28	38	first	first	ADJ
cuesj-1047	28	39	three	three	NUM
cuesj-1047	28	40	steps	step	NOUN
cuesj-1047	28	41	.	.	PUNCT
cuesj-1047	29	1	the	the	DET
cuesj-1047	29	2	differences	difference	NOUN
cuesj-1047	29	3	were	be	AUX
cuesj-1047	29	4	discussed	discuss	VERB
cuesj-1047	29	5	among	among	ADP
cuesj-1047	29	6	the	the	DET
cuesj-1047	29	7	researchers	researcher	NOUN
cuesj-1047	29	8	and	and	CCONJ
cuesj-1047	29	9	then	then	ADV
cuesj-1047	29	10	resolved	resolve	VERB
cuesj-1047	29	11	.	.	PUNCT
cuesj-1047	30	1	data	datum	NOUN
cuesj-1047	30	2	analysis	analysis	NOUN
cuesj-1047	30	3	both	both	DET
cuesj-1047	30	4	authors	author	NOUN
cuesj-1047	30	5	utilized	utilize	VERB
cuesj-1047	30	6	a	a	DET
cuesj-1047	30	7	systematic	systematic	ADJ
cuesj-1047	30	8	data	data	NOUN
cuesj-1047	30	9	extraction	extraction	NOUN
cuesj-1047	30	10	form	form	NOUN
cuesj-1047	30	11	to	to	PART
cuesj-1047	30	12	independently	independently	ADV
cuesj-1047	30	13	and	and	CCONJ
cuesj-1047	30	14	twice	twice	ADV
cuesj-1047	30	15	extract	extract	VERB
cuesj-1047	30	16	data	datum	NOUN
cuesj-1047	30	17	from	from	ADP
cuesj-1047	30	18	the	the	DET
cuesj-1047	30	19	reports	report	NOUN
cuesj-1047	30	20	of	of	ADP
cuesj-1047	30	21	all	all	DET
cuesj-1047	30	22	included	include	VERB
cuesj-1047	30	23	studies	study	NOUN
cuesj-1047	30	24	.	.	PUNCT
cuesj-1047	31	1	discussion	discussion	NOUN
cuesj-1047	31	2	was	be	AUX
cuesj-1047	31	3	used	use	VERB
cuesj-1047	31	4	to	to	PART
cuesj-1047	31	5	settle	settle	VERB
cuesj-1047	31	6	differences	difference	NOUN
cuesj-1047	31	7	in	in	ADP
cuesj-1047	31	8	the	the	DET
cuesj-1047	31	9	retrieved	retrieve	VERB
cuesj-1047	31	10	data	datum	NOUN
cuesj-1047	31	11	.	.	PUNCT
cuesj-1047	32	1	when	when	SCONJ
cuesj-1047	32	2	possible	possible	ADJ
cuesj-1047	32	3	,	,	PUNCT
cuesj-1047	32	4	the	the	DET
cuesj-1047	32	5	following	follow	VERB
cuesj-1047	32	6	data	datum	NOUN
cuesj-1047	32	7	have	have	AUX
cuesj-1047	32	8	been	be	AUX
cuesj-1047	32	9	gathered	gather	VERB
cuesj-1047	32	10	from	from	ADP
cuesj-1047	32	11	each	each	DET
cuesj-1047	32	12	chosen	choose	VERB
cuesj-1047	32	13	article	article	NOUN
cuesj-1047	32	14	:	:	PUNCT
cuesj-1047	32	15	the	the	DET
cuesj-1047	32	16	initial	initial	ADJ
cuesj-1047	32	17	author	author	NOUN
cuesj-1047	32	18	,	,	PUNCT
cuesj-1047	32	19	the	the	DET
cuesj-1047	32	20	publishing	publishing	NOUN
cuesj-1047	32	21	year	year	NOUN
cuesj-1047	32	22	,	,	PUNCT
cuesj-1047	32	23	the	the	DET
cuesj-1047	32	24	study	study	NOUN
cuesj-1047	32	25	’s	’s	PART
cuesj-1047	32	26	design	design	NOUN
cuesj-1047	32	27	,	,	PUNCT
cuesj-1047	32	28	the	the	DET
cuesj-1047	32	29	number	number	NOUN
cuesj-1047	32	30	of	of	ADP
cuesj-1047	32	31	cases	case	NOUN
cuesj-1047	32	32	,	,	PUNCT
cuesj-1047	32	33	gender	gender	NOUN
cuesj-1047	32	34	,	,	PUNCT
cuesj-1047	32	35	age	age	NOUN
cuesj-1047	32	36	,	,	PUNCT
cuesj-1047	32	37	clinical	clinical	ADJ
cuesj-1047	32	38	symptoms	symptom	NOUN
cuesj-1047	32	39	,	,	PUNCT
cuesj-1047	32	40	laboratory	laboratory	NOUN
cuesj-1047	32	41	tests	test	NOUN
cuesj-1047	32	42	,	,	PUNCT
cuesj-1047	32	43	radiological	radiological	ADJ
cuesj-1047	32	44	examinations	examination	NOUN
cuesj-1047	32	45	,	,	PUNCT
cuesj-1047	32	46	and	and	CCONJ
cuesj-1047	32	47	the	the	DET
cuesj-1047	32	48	results	result	NOUN
cuesj-1047	32	49	(	(	PUNCT
cuesj-1047	32	50	discharged	discharge	VERB
cuesj-1047	32	51	,	,	PUNCT
cuesj-1047	32	52	still	still	ADV
cuesj-1047	32	53	hospitalized	hospitalize	VERB
cuesj-1047	32	54	,	,	PUNCT
cuesj-1047	32	55	or	or	CCONJ
cuesj-1047	32	56	death	death	NOUN
cuesj-1047	32	57	)	)	PUNCT
cuesj-1047	32	58	.	.	PUNCT
cuesj-1047	33	1	results	result	VERB
cuesj-1047	33	2	covid-19	covid-19	PROPN
cuesj-1047	33	3	predictors	predictor	NOUN
cuesj-1047	33	4	in	in	ADP
cuesj-1047	33	5	outpatient	outpatient	NOUN
cuesj-1047	33	6	and	and	CCONJ
cuesj-1047	33	7	children	child	NOUN
cuesj-1047	33	8	with	with	ADP
cuesj-1047	33	9	symptoms	symptom	NOUN
cuesj-1047	33	10	a	a	DET
cuesj-1047	33	11	total	total	NOUN
cuesj-1047	33	12	of	of	ADP
cuesj-1047	33	13	5336	5336	NUM
cuesj-1047	33	14	children	child	NOUN
cuesj-1047	33	15	had	have	VERB
cuesj-1047	33	16	signs	sign	NOUN
cuesj-1047	33	17	or	or	CCONJ
cuesj-1047	33	18	symptoms	symptom	NOUN
cuesj-1047	33	19	that	that	PRON
cuesj-1047	33	20	were	be	AUX
cuesj-1047	33	21	consistent	consistent	ADJ
cuesj-1047	33	22	with	with	ADP
cuesj-1047	33	23	covid-19	covid-19	PROPN
cuesj-1047	33	24	but	but	CCONJ
cuesj-1047	33	25	did	do	AUX
cuesj-1047	33	26	not	not	PART
cuesj-1047	33	27	require	require	VERB
cuesj-1047	33	28	hospitalization	hospitalization	NOUN
cuesj-1047	33	29	;	;	PUNCT
cuesj-1047	33	30	about	about	ADP
cuesj-1047	33	31	4166	4166	NUM
cuesj-1047	33	32	were	be	AUX
cuesj-1047	33	33	in	in	ADP
cuesj-1047	33	34	secret	secret	ADJ
cuesj-1047	33	35	practice	practice	NOUN
cuesj-1047	33	36	(	(	PUNCT
cuesj-1047	33	37	including	include	VERB
cuesj-1047	33	38	80	80	NUM
cuesj-1047	33	39	pediatricians	pediatrician	NOUN
cuesj-1047	33	40	)	)	PUNCT
cuesj-1047	33	41	,	,	PUNCT
cuesj-1047	33	42	while	while	SCONJ
cuesj-1047	33	43	1170	1170	NUM
cuesj-1047	33	44	were	be	AUX
cuesj-1047	33	45	in	in	ADP
cuesj-1047	33	46	hospital	hospital	NOUN
cuesj-1047	33	47	emergency	emergency	NOUN
cuesj-1047	33	48	rooms	room	NOUN
cuesj-1047	33	49	(	(	PUNCT
cuesj-1047	33	50	13	13	NUM
cuesj-1047	33	51	hospitals	hospital	NOUN
cuesj-1047	33	52	)	)	PUNCT
cuesj-1047	33	53	.	.	PUNCT
cuesj-1047	34	1	the	the	DET
cuesj-1047	34	2	majority	majority	NOUN
cuesj-1047	34	3	(	(	PUNCT
cuesj-1047	34	4	53.5	53.5	NUM
cuesj-1047	34	5	%	%	NOUN
cuesj-1047	34	6	)	)	PUNCT
cuesj-1047	34	7	of	of	ADP
cuesj-1047	34	8	them	they	PRON
cuesj-1047	34	9	were	be	AUX
cuesj-1047	34	10	men	man	NOUN
cuesj-1047	34	11	,	,	PUNCT
cuesj-1047	34	12	with	with	ADP
cuesj-1047	34	13	a	a	DET
cuesj-1047	34	14	median	median	ADJ
cuesj-1047	34	15	age	age	NOUN
cuesj-1047	34	16	of	of	ADP
cuesj-1047	34	17	3.0	3.0	NUM
cuesj-1047	34	18	years	year	NOUN
cuesj-1047	34	19	.	.	PUNCT
cuesj-1047	35	1	the	the	DET
cuesj-1047	35	2	percentage	percentage	NOUN
cuesj-1047	35	3	of	of	ADP
cuesj-1047	35	4	positive	positive	ADJ
cuesj-1047	35	5	test	test	NOUN
cuesj-1047	35	6	results	result	NOUN
cuesj-1047	35	7	(	(	PUNCT
cuesj-1047	35	8	sc2	sc2	NOUN
cuesj-1047	35	9	-	-	PUNCT
cuesj-1047	35	10	rtpcr	rtpcr	ADJ
cuesj-1047	35	11	and/or	and/or	CCONJ
cuesj-1047	35	12	sc2	sc2	ADJ
cuesj-1047	35	13	-	-	PUNCT
cuesj-1047	35	14	rat	rat	NOUN
cuesj-1047	35	15	)	)	PUNCT
cuesj-1047	35	16	over	over	ADP
cuesj-1047	35	17	the	the	DET
cuesj-1047	35	18	course	course	NOUN
cuesj-1047	35	19	of	of	ADP
cuesj-1047	35	20	the	the	DET
cuesj-1047	35	21	entire	entire	ADJ
cuesj-1047	35	22	trial	trial	NOUN
cuesj-1047	35	23	was	be	AUX
cuesj-1047	35	24	13.9	13.9	NUM
cuesj-1047	35	25	%	%	NOUN
cuesj-1047	35	26	(	(	PUNCT
cuesj-1047	35	27	741/5	741/5	NUM
cuesj-1047	35	28	,	,	PUNCT
cuesj-1047	35	29	336	336	NUM
cuesj-1047	35	30	;	;	PUNCT
cuesj-1047	35	31	95	95	NUM
cuesj-1047	35	32	confidence	confidence	NOUN
cuesj-1047	35	33	interval	interval	NOUN
cuesj-1047	35	34	[	[	X
cuesj-1047	35	35	ci	ci	X
cuesj-1047	35	36	]	]	X
cuesj-1047	35	37	13.0–14.8	13.0–14.8	NUM
cuesj-1047	35	38	)	)	PUNCT
cuesj-1047	35	39	and	and	CCONJ
cuesj-1047	35	40	was	be	AUX
cuesj-1047	35	41	5.6	5.6	NUM
cuesj-1047	35	42	%	%	NOUN
cuesj-1047	35	43	(	(	PUNCT
cuesj-1047	35	44	102/1	102/1	PROPN
cuesj-1047	35	45	,	,	PUNCT
cuesj-1047	35	46	825	825	NUM
cuesj-1047	35	47	;	;	PUNCT
cuesj-1047	35	48	95	95	NUM
cuesj-1047	35	49	ci	ci	NOUN
cuesj-1047	35	50	4.6–6.7	4.6–6.7	NUM
cuesj-1047	35	51	)	)	PUNCT
cuesj-1047	35	52	for	for	ADP
cuesj-1047	35	53	period	period	NOUN
cuesj-1047	35	54	1	1	NUM
cuesj-1047	35	55	;	;	PUNCT
cuesj-1047	35	56	7.4	7.4	NUM
cuesj-1047	35	57	%	%	NOUN
cuesj-1047	35	58	(	(	PUNCT
cuesj-1047	35	59	107/1	107/1	PROPN
cuesj-1047	35	60	,	,	PUNCT
cuesj-1047	35	61	453	453	NUM
cuesj-1047	35	62	;	;	PUNCT
cuesj-1047	35	63	95	95	NUM
cuesj-1047	35	64	ci	ci	NOUN
cuesj-1047	35	65	6.1–8.8	6.1–8.8	NOUN
cuesj-1047	35	66	)	)	PUNCT
cuesj-1047	35	67	for	for	ADP
cuesj-1047	35	68	period	period	NOUN
cuesj-1047	35	69	2	2	NUM
cuesj-1047	35	70	;	;	PUNCT
cuesj-1047	35	71	12.6	12.6	NUM
cuesj-1047	35	72	%	%	NOUN
cuesj-1047	35	73	(	(	PUNCT
cuesj-1047	35	74	156/1	156/1	NUM
cuesj-1047	35	75	,	,	PUNCT
cuesj-1047	35	76	236	236	NUM
cuesj-1047	35	77	;	;	PUNCT
cuesj-1047	35	78	95	95	NUM
cuesj-1047	35	79	ci	ci	NOUN
cuesj-1047	35	80	10.8–14.6	10.8–14.6	NUM
cuesj-1047	35	81	)	)	PUNCT
cuesj-1047	35	82	for	for	ADP
cuesj-1047	35	83	period	period	NOUN
cuesj-1047	35	84	3	3	NUM
cuesj-1047	35	85	;	;	PUNCT
cuesj-1047	35	86	and	and	CCONJ
cuesj-1047	35	87	45.7	45.7	NUM
cuesj-1047	35	88	%	%	NOUN
cuesj-1047	35	89	(	(	PUNCT
cuesj-1047	35	90	376/822	376/822	NUM
cuesj-1047	35	91	;	;	PUNCT
cuesj-1047	35	92	hussein	hussein	PROPN
cuesj-1047	35	93	,	,	PUNCT
cuesj-1047	35	94	et	et	PROPN
cuesj-1047	35	95	al	al	PROPN
cuesj-1047	35	96	.	.	PUNCT
cuesj-1047	35	97	:	:	PUNCT
cuesj-1047	36	1	a	a	DET
cuesj-1047	36	2	review	review	NOUN
cuesj-1047	36	3	on	on	ADP
cuesj-1047	36	4	coronavirus	coronavirus	NOUN
cuesj-1047	36	5	and	and	CCONJ
cuesj-1047	36	6	omicron	omicron	PROPN
cuesj-1047	36	7	patients	patient	NOUN
cuesj-1047	36	8	10	10	NUM
cuesj-1047	36	9	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	36	10	cuesj	cuesj	ADJ
cuesj-1047	36	11	2024	2024	NUM
cuesj-1047	36	12	,	,	PUNCT
cuesj-1047	36	13	8	8	NUM
cuesj-1047	36	14	(	(	PUNCT
cuesj-1047	36	15	1	1	NUM
cuesj-1047	36	16	):	):	PUNCT
cuesj-1047	36	17	8	8	NUM
cuesj-1047	36	18	-	-	SYM
cuesj-1047	36	19	17	17	NUM
cuesj-1047	36	20	95	95	NUM
cuesj-1047	36	21	ci	ci	PROPN
cuesj-1047	36	22	42.3–49.2	42.3–49.2	NUM
cuesj-1047	36	23	)	)	PUNCT
cuesj-1047	36	24	for	for	ADP
cuesj-1047	36	25	period	period	NOUN
cuesj-1047	36	26	4	4	NUM
cuesj-1047	36	27	(	(	PUNCT
cuesj-1047	36	28	p	p	X
cuesj-1047	36	29	<	<	X
cuesj-1047	36	30	0.001	0.001	NUM
cuesj-1047	36	31	between	between	ADP
cuesj-1047	36	32	the	the	DET
cuesj-1047	36	33	four	four	NUM
cuesj-1047	36	34	periods	period	NOUN
cuesj-1047	36	35	)	)	PUNCT
cuesj-1047	36	36	.	.	PUNCT
cuesj-1047	37	1	throughout	throughout	ADP
cuesj-1047	37	2	the	the	DET
cuesj-1047	37	3	study	study	NOUN
cuesj-1047	37	4	of	of	ADP
cuesj-1047	37	5	the	the	DET
cuesj-1047	37	6	course	course	NOUN
cuesj-1047	37	7	,	,	PUNCT
cuesj-1047	37	8	the	the	DET
cuesj-1047	37	9	percentage	percentage	NOUN
cuesj-1047	37	10	of	of	ADP
cuesj-1047	37	11	positive	positive	ADJ
cuesj-1047	37	12	test	test	NOUN
cuesj-1047	37	13	results	result	NOUN
cuesj-1047	37	14	for	for	ADP
cuesj-1047	37	15	children	child	NOUN
cuesj-1047	37	16	who	who	PRON
cuesj-1047	37	17	had	have	VERB
cuesj-1047	37	18	a	a	DET
cuesj-1047	37	19	confirmed	confirm	VERB
cuesj-1047	37	20	covid-19	covid-19	PROPN
cuesj-1047	37	21	contact	contact	NOUN
cuesj-1047	37	22	was	be	AUX
cuesj-1047	37	23	38.9	38.9	NUM
cuesj-1047	37	24	%	%	NOUN
cuesj-1047	37	25	(	(	PUNCT
cuesj-1047	37	26	95	95	NUM
cuesj-1047	37	27	ci	ci	NOUN
cuesj-1047	37	28	36.3–41.6	36.3–41.6	NUM
cuesj-1047	37	29	)	)	PUNCT
cuesj-1047	37	30	,	,	PUNCT
cuesj-1047	37	31	which	which	PRON
cuesj-1047	37	32	was	be	AUX
cuesj-1047	37	33	7.0	7.0	NUM
cuesj-1047	37	34	times	time	NOUN
cuesj-1047	37	35	higher	high	ADJ
cuesj-1047	37	36	than	than	ADP
cuesj-1047	37	37	the	the	DET
cuesj-1047	37	38	percentage	percentage	NOUN
cuesj-1047	37	39	for	for	ADP
cuesj-1047	37	40	children	child	NOUN
cuesj-1047	37	41	who	who	PRON
cuesj-1047	37	42	had	have	VERB
cuesj-1047	37	43	no	no	DET
cuesj-1047	37	44	confirmed	confirm	VERB
cuesj-1047	37	45	covid-19	covid-19	PROPN
cuesj-1047	37	46	contacts	contact	NOUN
cuesj-1047	37	47	(	(	PUNCT
cuesj-1047	37	48	5.6	5.6	NUM
cuesj-1047	37	49	%	%	NOUN
cuesj-1047	37	50	,	,	PUNCT
cuesj-1047	37	51	95	95	NUM
cuesj-1047	37	52	ci	ci	NOUN
cuesj-1047	37	53	4.9–6.3	4.9–6.3	NOUN
cuesj-1047	37	54	,	,	PUNCT
cuesj-1047	37	55	chi	chi	ADJ
cuesj-1047	37	56	-	-	PUNCT
cuesj-1047	37	57	square	square	ADJ
cuesj-1047	37	58	test	test	NOUN
cuesj-1047	37	59	p	p	NOUN
cuesj-1047	37	60	=	=	PUNCT
cuesj-1047	37	61	0.001).[25	0.001).[25	PROPN
cuesj-1047	37	62	]	]	X
cuesj-1047	37	63	the	the	DET
cuesj-1047	37	64	most	most	ADV
cuesj-1047	37	65	commonly	commonly	ADV
cuesj-1047	37	66	reported	report	VERB
cuesj-1047	37	67	symptoms	symptom	NOUN
cuesj-1047	37	68	included	include	VERB
cuesj-1047	37	69	mood	mood	NOUN
cuesj-1047	37	70	fluctuations	fluctuation	NOUN
cuesj-1047	37	71	,	,	PUNCT
cuesj-1047	37	72	rashes	rash	NOUN
cuesj-1047	37	73	,	,	PUNCT
cuesj-1047	37	74	gastrointestinal	gastrointestinal	ADJ
cuesj-1047	37	75	problems	problem	NOUN
cuesj-1047	37	76	,	,	PUNCT
cuesj-1047	37	77	coughing	cough	VERB
cuesj-1047	37	78	,	,	PUNCT
cuesj-1047	37	79	and	and	CCONJ
cuesj-1047	37	80	lack	lack	NOUN
cuesj-1047	37	81	of	of	ADP
cuesj-1047	37	82	appetite	appetite	NOUN
cuesj-1047	37	83	among	among	ADP
cuesj-1047	37	84	children	child	NOUN
cuesj-1047	37	85	aged	age	VERB
cuesj-1047	37	86	0–3	0–3	NUM
cuesj-1047	37	87	years	year	NOUN
cuesj-1047	37	88	old	old	ADJ
cuesj-1047	37	89	while	while	SCONJ
cuesj-1047	37	90	children	child	NOUN
cuesj-1047	37	91	between	between	ADP
cuesj-1047	37	92	the	the	DET
cuesj-1047	37	93	ages	age	NOUN
cuesj-1047	37	94	of	of	ADP
cuesj-1047	37	95	4	4	NUM
cuesj-1047	37	96	and	and	CCONJ
cuesj-1047	37	97	11	11	NUM
cuesj-1047	37	98	years	year	NOUN
cuesj-1047	37	99	most	most	ADV
cuesj-1047	37	100	frequently	frequently	ADV
cuesj-1047	37	101	had	have	VERB
cuesj-1047	37	102	mood	mood	NOUN
cuesj-1047	37	103	fluctuations	fluctuation	NOUN
cuesj-1047	37	104	,	,	PUNCT
cuesj-1047	37	105	memory	memory	NOUN
cuesj-1047	37	106	loss	loss	NOUN
cuesj-1047	37	107	,	,	PUNCT
cuesj-1047	37	108	attention	attention	NOUN
cuesj-1047	37	109	issues	issue	NOUN
cuesj-1047	37	110	,	,	PUNCT
cuesj-1047	37	111	and	and	CCONJ
cuesj-1047	37	112	rashes	rash	NOUN
cuesj-1047	37	113	.	.	PUNCT
cuesj-1047	38	1	the	the	DET
cuesj-1047	38	2	symptoms	symptom	NOUN
cuesj-1047	38	3	of	of	ADP
cuesj-1047	38	4	long	long	ADJ
cuesj-1047	38	5	covid	covid	NOUN
cuesj-1047	38	6	are	be	AUX
cuesj-1047	38	7	described	describe	VERB
cuesj-1047	38	8	as	as	ADP
cuesj-1047	38	9	new	new	ADJ
cuesj-1047	38	10	symptoms	symptom	NOUN
cuesj-1047	38	11	that	that	PRON
cuesj-1047	38	12	appeared	appear	VERB
cuesj-1047	38	13	with	with	ADP
cuesj-1047	38	14	sars	sar	NOUN
cuesj-1047	38	15	-	-	PUNCT
cuesj-1047	38	16	cov-2	cov-2	PART
cuesj-1047	38	17	infection	infection	NOUN
cuesj-1047	38	18	and	and	CCONJ
cuesj-1047	38	19	persisted	persist	VERB
cuesj-1047	38	20	for	for	ADP
cuesj-1047	38	21	8	8	NUM
cuesj-1047	38	22	weeks	week	NOUN
cuesj-1047	38	23	following	follow	VERB
cuesj-1047	38	24	the	the	DET
cuesj-1047	38	25	discovery	discovery	NOUN
cuesj-1047	38	26	of	of	ADP
cuesj-1047	38	27	a	a	DET
cuesj-1047	38	28	positive	positive	ADJ
cuesj-1047	38	29	sars	sar	NOUN
cuesj-1047	38	30	-	-	PUNCT
cuesj-1047	38	31	cov-2	cov-2	NOUN
cuesj-1047	38	32	examination	examination	NOUN
cuesj-1047	38	33	result.[6	result.[6	NUM
cuesj-1047	38	34	]	]	X
cuesj-1047	38	35	omicron	omicron	PROPN
cuesj-1047	38	36	-	-	PUNCT
cuesj-1047	38	37	caused	cause	VERB
cuesj-1047	38	38	disease	disease	NOUN
cuesj-1047	38	39	burden	burden	NOUN
cuesj-1047	38	40	from	from	ADP
cuesj-1047	38	41	covid-19	covid-19	PROPN
cuesj-1047	38	42	from	from	ADP
cuesj-1047	38	43	february	february	PROPN
cuesj-1047	38	44	26	26	NUM
cuesj-1047	38	45	to	to	ADP
cuesj-1047	38	46	june	june	PROPN
cuesj-1047	38	47	30	30	NUM
cuesj-1047	38	48	,	,	PUNCT
cuesj-1047	38	49	2022	2022	NUM
cuesj-1047	38	50	,	,	PUNCT
cuesj-1047	38	51	there	there	PRON
cuesj-1047	38	52	were	be	VERB
cuesj-1047	38	53	9	9	NUM
cuesj-1047	38	54	%	%	NOUN
cuesj-1047	38	55	symptomatic	symptomatic	ADJ
cuesj-1047	38	56	cases	case	NOUN
cuesj-1047	38	57	,	,	PUNCT
cuesj-1047	38	58	91.00	91.00	NUM
cuesj-1047	38	59	%	%	NOUN
cuesj-1047	38	60	cases	case	NOUN
cuesj-1047	38	61	that	that	PRON
cuesj-1047	38	62	were	be	AUX
cuesj-1047	38	63	asymptomatic	asymptomatic	ADJ
cuesj-1047	38	64	,	,	PUNCT
cuesj-1047	38	65	and	and	CCONJ
cuesj-1047	38	66	1	1	NUM
cuesj-1047	38	67	%	%	NOUN
cuesj-1047	38	68	death	death	NOUN
cuesj-1047	38	69	situations	situation	NOUN
cuesj-1047	38	70	.	.	PUNCT
cuesj-1047	39	1	the	the	DET
cuesj-1047	39	2	total	total	ADJ
cuesj-1047	39	3	rate	rate	NOUN
cuesj-1047	39	4	of	of	ADP
cuesj-1047	39	5	infection	infection	NOUN
cuesj-1047	39	6	was	be	AUX
cuesj-1047	39	7	2.74	2.74	NUM
cuesj-1047	39	8	%	%	NOUN
cuesj-1047	39	9	.	.	PUNCT
cuesj-1047	40	1	children	child	NOUN
cuesj-1047	40	2	aged	age	VERB
cuesj-1047	40	3	3–17	3–17	PROPN
cuesj-1047	40	4	had	have	VERB
cuesj-1047	40	5	the	the	DET
cuesj-1047	40	6	lowest	low	ADJ
cuesj-1047	40	7	infection	infection	NOUN
cuesj-1047	40	8	rates	rate	NOUN
cuesj-1047	40	9	,	,	PUNCT
cuesj-1047	40	10	and	and	CCONJ
cuesj-1047	40	11	the	the	DET
cuesj-1047	40	12	highest	high	ADJ
cuesj-1047	40	13	were	be	AUX
cuesj-1047	40	14	in	in	ADP
cuesj-1047	40	15	those	those	PRON
cuesj-1047	40	16	60–79	60–79	NUM
cuesj-1047	40	17	years	year	NOUN
cuesj-1047	40	18	old	old	ADJ
cuesj-1047	40	19	.	.	PUNCT
cuesj-1047	41	1	with	with	ADP
cuesj-1047	41	2	age	age	NOUN
cuesj-1047	41	3	,	,	PUNCT
cuesj-1047	41	4	the	the	DET
cuesj-1047	41	5	incidence	incidence	NOUN
cuesj-1047	41	6	of	of	ADP
cuesj-1047	41	7	severe	severe	ADJ
cuesj-1047	41	8	/	/	SYM
cuesj-1047	41	9	critical	critical	ADJ
cuesj-1047	41	10	infection	infection	NOUN
cuesj-1047	41	11	rose	rise	VERB
cuesj-1047	41	12	.	.	PUNCT
cuesj-1047	42	1	individuals	individual	NOUN
cuesj-1047	42	2	aged	age	VERB
cuesj-1047	42	3	80	80	NUM
cuesj-1047	42	4	and	and	CCONJ
cuesj-1047	42	5	up	up	ADV
cuesj-1047	42	6	had	have	VERB
cuesj-1047	42	7	the	the	DET
cuesj-1047	42	8	highest	high	ADJ
cuesj-1047	42	9	rate	rate	NOUN
cuesj-1047	42	10	of	of	ADP
cuesj-1047	42	11	12.5	12.5	NUM
cuesj-1047	42	12	%	%	NOUN
cuesj-1047	42	13	people	people	NOUN
cuesj-1047	42	14	,	,	PUNCT
cuesj-1047	42	15	which	which	PRON
cuesj-1047	42	16	was	be	AUX
cuesj-1047	42	17	substantially	substantially	ADV
cuesj-1047	42	18	greater	great	ADJ
cuesj-1047	42	19	than	than	ADP
cuesj-1047	42	20	the	the	DET
cuesj-1047	42	21	rate	rate	NOUN
cuesj-1047	42	22	of	of	ADP
cuesj-1047	42	23	0.001	0.001	NUM
cuesj-1047	42	24	%	%	NOUN
cuesj-1047	42	25	people	people	NOUN
cuesj-1047	42	26	aged	age	VERB
cuesj-1047	42	27	3–17	3–17	PROPN
cuesj-1047	42	28	years	year	NOUN
cuesj-1047	42	29	.	.	PUNCT
cuesj-1047	43	1	the	the	DET
cuesj-1047	43	2	mortality	mortality	NOUN
cuesj-1047	43	3	rate	rate	NOUN
cuesj-1047	43	4	for	for	ADP
cuesj-1047	43	5	all	all	DET
cuesj-1047	43	6	people	people	NOUN
cuesj-1047	43	7	was	be	AUX
cuesj-1047	43	8	2.42	2.42	NUM
cuesj-1047	43	9	%	%	NOUN
cuesj-1047	43	10	people	people	NOUN
cuesj-1047	43	11	.	.	PUNCT
cuesj-1047	44	1	in	in	ADP
cuesj-1047	44	2	terms	term	NOUN
cuesj-1047	44	3	of	of	ADP
cuesj-1047	44	4	age	age	NOUN
cuesj-1047	44	5	categories	category	NOUN
cuesj-1047	44	6	,	,	PUNCT
cuesj-1047	44	7	those	those	DET
cuesj-1047	44	8	aged	age	VERB
cuesj-1047	44	9	3–17	3–17	PROPN
cuesj-1047	44	10	years	year	NOUN
cuesj-1047	44	11	had	have	VERB
cuesj-1047	44	12	a	a	DET
cuesj-1047	44	13	0	0	NUM
cuesj-1047	44	14	%	%	NOUN
cuesj-1047	44	15	death	death	NOUN
cuesj-1047	44	16	rate	rate	NOUN
cuesj-1047	44	17	,	,	PUNCT
cuesj-1047	44	18	0.02	0.02	NUM
cuesj-1047	44	19	%	%	NOUN
cuesj-1047	44	20	people	people	NOUN
cuesj-1047	44	21	aged	age	VERB
cuesj-1047	44	22	18–39	18–39	NUM
cuesj-1047	44	23	years	year	NOUN
cuesj-1047	44	24	,	,	PUNCT
cuesj-1047	44	25	0.32	0.32	NUM
cuesj-1047	44	26	%	%	NOUN
cuesj-1047	44	27	aged	aged	ADJ
cuesj-1047	44	28	40–59	40–59	NUM
cuesj-1047	44	29	years	year	NOUN
cuesj-1047	44	30	,	,	PUNCT
cuesj-1047	44	31	4.60	4.60	NUM
cuesj-1047	44	32	%	%	NOUN
cuesj-1047	44	33	aged	aged	ADJ
cuesj-1047	44	34	60–79	60–79	ADJ
cuesj-1047	44	35	years	year	NOUN
cuesj-1047	44	36	,	,	PUNCT
cuesj-1047	44	37	and	and	CCONJ
cuesj-1047	44	38	57.17	57.17	NUM
cuesj-1047	44	39	%	%	NOUN
cuesj-1047	44	40	people	people	NOUN
cuesj-1047	44	41	aged	age	VERB
cuesj-1047	44	42	80	80	NUM
cuesj-1047	44	43	years	year	NOUN
cuesj-1047	44	44	or	or	CCONJ
cuesj-1047	44	45	older.[17	older.[17	PROPN
cuesj-1047	44	46	]	]	PUNCT
cuesj-1047	44	47	hospitalizations	hospitalization	NOUN
cuesj-1047	44	48	for	for	ADP
cuesj-1047	44	49	children	child	NOUN
cuesj-1047	44	50	that	that	PRON
cuesj-1047	44	51	had	have	VERB
cuesj-1047	44	52	covid-19	covid-19	PROPN
cuesj-1047	44	53	during	during	ADP
cuesj-1047	44	54	the	the	DET
cuesj-1047	44	55	initial	initial	ADJ
cuesj-1047	44	56	omicron	omicron	NOUN
cuesj-1047	44	57	of	of	ADP
cuesj-1047	44	58	sars	sars	PROPN
cuesj-1047	44	59	-	-	PUNCT
cuesj-1047	44	60	cov2	cov2	PROPN
cuesj-1047	44	61	the	the	DET
cuesj-1047	44	62	sars	sar	NOUN
cuesj-1047	44	63	-	-	PUNCT
cuesj-1047	44	64	cov-2	cov-2	NOUN
cuesj-1047	44	65	omicron	omicron	NOUN
cuesj-1047	44	66	form	form	NOUN
cuesj-1047	44	67	is	be	AUX
cuesj-1047	44	68	highly	highly	ADV
cuesj-1047	44	69	contagious	contagious	ADJ
cuesj-1047	44	70	in	in	ADP
cuesj-1047	44	71	south	south	PROPN
cuesj-1047	44	72	africa	africa	PROPN
cuesj-1047	44	73	in	in	ADP
cuesj-1047	44	74	the	the	DET
cuesj-1047	44	75	tshwane	tshwane	NOUN
cuesj-1047	44	76	district	district	NOUN
cuesj-1047	44	77	,	,	PUNCT
cuesj-1047	44	78	as	as	SCONJ
cuesj-1047	44	79	indicated	indicate	VERB
cuesj-1047	44	80	by	by	ADP
cuesj-1047	44	81	the	the	DET
cuesj-1047	44	82	sharp	sharp	ADJ
cuesj-1047	44	83	rise	rise	NOUN
cuesj-1047	44	84	in	in	ADP
cuesj-1047	44	85	pediatric	pediatric	ADJ
cuesj-1047	44	86	covid-19	covid-19	PROPN
cuesj-1047	44	87	cases	case	NOUN
cuesj-1047	44	88	and	and	CCONJ
cuesj-1047	44	89	hospitalizations	hospitalization	NOUN
cuesj-1047	44	90	.	.	PUNCT
cuesj-1047	45	1	a	a	DET
cuesj-1047	45	2	continuous	continuous	ADJ
cuesj-1047	45	3	observational	observational	ADJ
cuesj-1047	45	4	study	study	NOUN
cuesj-1047	45	5	is	be	AUX
cuesj-1047	45	6	required	require	VERB
cuesj-1047	45	7	to	to	PART
cuesj-1047	45	8	determine	determine	VERB
cuesj-1047	45	9	the	the	DET
cuesj-1047	45	10	omicron	omicron	PROPN
cuesj-1047	45	11	variation	variation	NOUN
cuesj-1047	45	12	’s	’s	PART
cuesj-1047	45	13	long	long	ADJ
cuesj-1047	45	14	-	-	PUNCT
cuesj-1047	45	15	term	term	NOUN
cuesj-1047	45	16	effects	effect	NOUN
cuesj-1047	45	17	on	on	ADP
cuesj-1047	45	18	kids	kid	NOUN
cuesj-1047	45	19	and	and	CCONJ
cuesj-1047	45	20	teenagers.[28	teenagers.[28	NUM
cuesj-1047	45	21	]	]	PUNCT
cuesj-1047	45	22	of	of	ADP
cuesj-1047	45	23	the	the	DET
cuesj-1047	45	24	2550	2550	NUM
cuesj-1047	45	25	covid-19	covid-19	PROPN
cuesj-1047	45	26	patients	patient	NOUN
cuesj-1047	45	27	hospitalized	hospitalize	VERB
cuesj-1047	45	28	during	during	ADP
cuesj-1047	45	29	this	this	DET
cuesj-1047	45	30	time	time	NOUN
cuesj-1047	45	31	,	,	PUNCT
cuesj-1047	45	32	462	462	NUM
cuesj-1047	45	33	(	(	PUNCT
cuesj-1047	45	34	18	18	NUM
cuesj-1047	45	35	%	%	NOUN
cuesj-1047	45	36	)	)	PUNCT
cuesj-1047	45	37	were	be	AUX
cuesj-1047	45	38	under	under	ADP
cuesj-1047	45	39	the	the	DET
cuesj-1047	45	40	age	age	NOUN
cuesj-1047	45	41	of	of	ADP
cuesj-1047	45	42	19	19	NUM
cuesj-1047	45	43	(	(	PUNCT
cuesj-1047	45	44	figure	figure	NOUN
cuesj-1047	45	45	2	2	NUM
cuesj-1047	45	46	)	)	PUNCT
cuesj-1047	45	47	.	.	PUNCT
cuesj-1047	46	1	comparatively	comparatively	ADV
cuesj-1047	46	2	speaking	speak	VERB
cuesj-1047	46	3	to	to	ADP
cuesj-1047	46	4	the	the	DET
cuesj-1047	46	5	three	three	NUM
cuesj-1047	46	6	prior	prior	ADJ
cuesj-1047	46	7	sars	sar	NOUN
cuesj-1047	46	8	-	-	PUNCT
cuesj-1047	46	9	cov-2	cov-2	NOUN
cuesj-1047	46	10	waves	wave	NOUN
cuesj-1047	46	11	,	,	PUNCT
cuesj-1047	46	12	there	there	PRON
cuesj-1047	46	13	were	be	VERB
cuesj-1047	46	14	more	more	ADJ
cuesj-1047	46	15	pediatric	pediatric	ADJ
cuesj-1047	46	16	cases	case	NOUN
cuesj-1047	46	17	.	.	PUNCT
cuesj-1047	47	1	unusually	unusually	ADV
cuesj-1047	47	2	rising	rise	VERB
cuesj-1047	47	3	ahead	ahead	ADV
cuesj-1047	47	4	of	of	ADP
cuesj-1047	47	5	adult	adult	NOUN
cuesj-1047	47	6	hospital	hospital	NOUN
cuesj-1047	47	7	admissions	admission	NOUN
cuesj-1047	47	8	.	.	PUNCT
cuesj-1047	48	1	in	in	ADP
cuesj-1047	48	2	the	the	DET
cuesj-1047	48	3	district	district	NOUN
cuesj-1047	48	4	,	,	PUNCT
cuesj-1047	48	5	sequencing	sequencing	NOUN
cuesj-1047	48	6	was	be	AUX
cuesj-1047	48	7	done	do	VERB
cuesj-1047	48	8	on	on	ADP
cuesj-1047	48	9	75	75	NUM
cuesj-1047	48	10	viral	viral	ADJ
cuesj-1047	48	11	samples	sample	NOUN
cuesj-1047	48	12	from	from	ADP
cuesj-1047	48	13	adults	adult	NOUN
cuesj-1047	48	14	and	and	CCONJ
cuesj-1047	48	15	children	child	NOUN
cuesj-1047	48	16	,	,	PUNCT
cuesj-1047	48	17	and	and	CCONJ
cuesj-1047	48	18	74	74	NUM
cuesj-1047	48	19	(	(	PUNCT
cuesj-1047	48	20	99	99	NUM
cuesj-1047	48	21	%	%	NOUN
cuesj-1047	48	22	)	)	PUNCT
cuesj-1047	48	23	of	of	ADP
cuesj-1047	48	24	those	those	DET
cuesj-1047	48	25	samples	sample	NOUN
cuesj-1047	48	26	were	be	AUX
cuesj-1047	48	27	the	the	DET
cuesj-1047	48	28	omicron	omicron	PROPN
cuesj-1047	48	29	variety	variety	PROPN
cuesj-1047	48	30	.	.	PUNCT
cuesj-1047	49	1	out	out	ADP
cuesj-1047	49	2	of	of	ADP
cuesj-1047	49	3	183	183	NUM
cuesj-1047	49	4	hospitalized	hospitalize	VERB
cuesj-1047	49	5	children	child	NOUN
cuesj-1047	49	6	with	with	ADP
cuesj-1047	49	7	covid-19	covid-19	PROPN
cuesj-1047	49	8	,	,	PUNCT
cuesj-1047	49	9	138	138	NUM
cuesj-1047	49	10	(	(	PUNCT
cuesj-1047	49	11	75	75	NUM
cuesj-1047	49	12	%	%	NOUN
cuesj-1047	49	13	)	)	PUNCT
cuesj-1047	49	14	had	have	VERB
cuesj-1047	49	15	comprehensive	comprehensive	ADJ
cuesj-1047	49	16	clinical	clinical	ADJ
cuesj-1047	49	17	records	record	NOUN
cuesj-1047	49	18	available	available	ADJ
cuesj-1047	49	19	.	.	PUNCT
cuesj-1047	50	1	eighty	eighty	NUM
cuesj-1047	50	2	-	-	PUNCT
cuesj-1047	50	3	seven	seven	NUM
cuesj-1047	50	4	(	(	PUNCT
cuesj-1047	50	5	or	or	CCONJ
cuesj-1047	50	6	63	63	NUM
cuesj-1047	50	7	%	%	NOUN
cuesj-1047	50	8	)	)	PUNCT
cuesj-1047	50	9	of	of	ADP
cuesj-1047	50	10	the	the	DET
cuesj-1047	50	11	138	138	NUM
cuesj-1047	50	12	kids	kid	NOUN
cuesj-1047	50	13	were	be	AUX
cuesj-1047	50	14	under	under	ADP
cuesj-1047	50	15	4	4	NUM
cuesj-1047	50	16	years	year	NOUN
cuesj-1047	50	17	old.[29	old.[29	NOUN
cuesj-1047	50	18	]	]	PUNCT
cuesj-1047	50	19	the	the	DET
cuesj-1047	50	20	cases	case	NOUN
cuesj-1047	50	21	included	include	VERB
cuesj-1047	50	22	symptoms	symptom	NOUN
cuesj-1047	50	23	such	such	ADJ
cuesj-1047	50	24	as	as	ADP
cuesj-1047	50	25	fever	fever	NOUN
cuesj-1047	50	26	(	(	PUNCT
cuesj-1047	50	27	61	61	NUM
cuesj-1047	50	28	%	%	NOUN
cuesj-1047	50	29	)	)	PUNCT
cuesj-1047	50	30	,	,	PUNCT
cuesj-1047	50	31	cough	cough	NOUN
cuesj-1047	50	32	(	(	PUNCT
cuesj-1047	50	33	57	57	NUM
cuesj-1047	50	34	%	%	NOUN
cuesj-1047	50	35	)	)	PUNCT
cuesj-1047	50	36	,	,	PUNCT
cuesj-1047	50	37	shortness	shortness	NOUN
cuesj-1047	50	38	of	of	ADP
cuesj-1047	50	39	breath	breath	NOUN
cuesj-1047	50	40	(	(	PUNCT
cuesj-1047	50	41	31	31	NUM
cuesj-1047	50	42	%	%	NOUN
cuesj-1047	50	43	)	)	PUNCT
cuesj-1047	50	44	,	,	PUNCT
cuesj-1047	50	45	seizures	seizure	NOUN
cuesj-1047	50	46	(	(	PUNCT
cuesj-1047	50	47	31	31	NUM
cuesj-1047	50	48	%	%	NOUN
cuesj-1047	50	49	)	)	PUNCT
cuesj-1047	50	50	,	,	PUNCT
cuesj-1047	50	51	vomiting	vomiting	NOUN
cuesj-1047	50	52	(	(	PUNCT
cuesj-1047	50	53	26	26	NUM
cuesj-1047	50	54	%	%	NOUN
cuesj-1047	50	55	)	)	PUNCT
cuesj-1047	50	56	,	,	PUNCT
cuesj-1047	50	57	and	and	CCONJ
cuesj-1047	50	58	diarrhea	diarrhea	NOUN
cuesj-1047	50	59	(	(	PUNCT
cuesj-1047	50	60	25	25	NUM
cuesj-1047	50	61	%	%	NOUN
cuesj-1047	50	62	)	)	PUNCT
cuesj-1047	50	63	.	.	PUNCT
cuesj-1047	51	1	covid-19	covid-19	PROPN
cuesj-1047	51	2	was	be	AUX
cuesj-1047	51	3	the	the	DET
cuesj-1047	51	4	main	main	ADJ
cuesj-1047	51	5	diagnosis	diagnosis	NOUN
cuesj-1047	51	6	in	in	ADP
cuesj-1047	51	7	61	61	NUM
cuesj-1047	51	8	(	(	PUNCT
cuesj-1047	51	9	44	44	NUM
cuesj-1047	51	10	%	%	NOUN
cuesj-1047	51	11	)	)	PUNCT
cuesj-1047	51	12	of	of	ADP
cuesj-1047	51	13	the	the	DET
cuesj-1047	51	14	138	138	NUM
cuesj-1047	51	15	cases	case	NOUN
cuesj-1047	51	16	(	(	PUNCT
cuesj-1047	51	17	figure	figure	NOUN
cuesj-1047	51	18	3	3	NUM
cuesj-1047	51	19	)	)	PUNCT
cuesj-1047	51	20	.	.	PUNCT
cuesj-1047	52	1	two	two	NUM
cuesj-1047	52	2	days	day	NOUN
cuesj-1047	52	3	on	on	ADP
cuesj-1047	52	4	average	average	ADJ
cuesj-1047	52	5	were	be	AUX
cuesj-1047	52	6	spent	spend	VERB
cuesj-1047	52	7	in	in	ADP
cuesj-1047	52	8	the	the	DET
cuesj-1047	52	9	hospital	hospital	NOUN
cuesj-1047	52	10	(	(	PUNCT
cuesj-1047	52	11	range	range	NOUN
cuesj-1047	52	12	,	,	PUNCT
cuesj-1047	52	13	1–3	1–3	NOUN
cuesj-1047	52	14	)	)	PUNCT
cuesj-1047	52	15	.	.	PUNCT
cuesj-1047	53	1	of	of	ADP
cuesj-1047	53	2	the	the	DET
cuesj-1047	53	3	138	138	NUM
cuesj-1047	53	4	kids	kid	NOUN
cuesj-1047	53	5	for	for	ADP
cuesj-1047	53	6	whom	whom	PRON
cuesj-1047	53	7	data	datum	NOUN
cuesj-1047	53	8	were	be	AUX
cuesj-1047	53	9	available	available	ADJ
cuesj-1047	53	10	,	,	PUNCT
cuesj-1047	53	11	122	122	NUM
cuesj-1047	53	12	(	(	PUNCT
cuesj-1047	53	13	88	88	NUM
cuesj-1047	53	14	%	%	NOUN
cuesj-1047	53	15	)	)	PUNCT
cuesj-1047	53	16	required	require	VERB
cuesj-1047	53	17	routine	routine	ADJ
cuesj-1047	53	18	care	care	NOUN
cuesj-1047	53	19	in	in	ADP
cuesj-1047	53	20	hospital	hospital	NOUN
cuesj-1047	53	21	and	and	CCONJ
cuesj-1047	53	22	27	27	NUM
cuesj-1047	53	23	(	(	PUNCT
cuesj-1047	53	24	20	20	NUM
cuesj-1047	53	25	%	%	NOUN
cuesj-1047	53	26	)	)	PUNCT
cuesj-1047	53	27	required	require	VERB
cuesj-1047	53	28	oxygen	oxygen	NOUN
cuesj-1047	53	29	treatment	treatment	NOUN
cuesj-1047	53	30	.	.	PUNCT
cuesj-1047	54	1	four	four	NUM
cuesj-1047	54	2	(	(	PUNCT
cuesj-1047	54	3	33	33	NUM
cuesj-1047	54	4	%	%	NOUN
cuesj-1047	54	5	)	)	PUNCT
cuesj-1047	54	6	out	out	ADP
cuesj-1047	54	7	of	of	ADP
cuesj-1047	54	8	138	138	NUM
cuesj-1047	54	9	children	child	NOUN
cuesj-1047	54	10	who	who	PRON
cuesj-1047	54	11	participated	participate	VERB
cuesj-1047	54	12	in	in	ADP
cuesj-1047	54	13	the	the	DET
cuesj-1047	54	14	trial	trial	NOUN
cuesj-1047	54	15	died	die	VERB
cuesj-1047	54	16	,	,	PUNCT
cuesj-1047	54	17	and	and	CCONJ
cuesj-1047	54	18	7	7	NUM
cuesj-1047	54	19	(	(	PUNCT
cuesj-1047	54	20	5	5	NUM
cuesj-1047	54	21	%	%	NOUN
cuesj-1047	54	22	)	)	PUNCT
cuesj-1047	54	23	of	of	ADP
cuesj-1047	54	24	them	they	PRON
cuesj-1047	54	25	required	require	VERB
cuesj-1047	54	26	ventilation	ventilation	NOUN
cuesj-1047	54	27	due	due	ADP
cuesj-1047	54	28	to	to	ADP
cuesj-1047	54	29	complicated	complicated	ADJ
cuesj-1047	54	30	underlying	underlie	VERB
cuesj-1047	54	31	pathologies	pathology	NOUN
cuesj-1047	54	32	(	(	PUNCT
cuesj-1047	54	33	figure	figure	NOUN
cuesj-1047	54	34	4	4	NUM
cuesj-1047	54	35	)	)	PUNCT
cuesj-1047	54	36	.	.	PUNCT
cuesj-1047	55	1	with	with	ADP
cuesj-1047	55	2	data	datum	NOUN
cuesj-1047	55	3	from	from	ADP
cuesj-1047	55	4	84	84	NUM
cuesj-1047	55	5	parents	parent	NOUN
cuesj-1047	55	6	or	or	CCONJ
cuesj-1047	55	7	guardians	guardian	NOUN
cuesj-1047	55	8	,	,	PUNCT
cuesj-1047	55	9	77	77	NUM
cuesj-1047	55	10	(	(	PUNCT
cuesj-1047	55	11	92	92	NUM
cuesj-1047	55	12	%	%	NOUN
cuesj-1047	55	13	)	)	PUNCT
cuesj-1047	55	14	were	be	AUX
cuesj-1047	55	15	covid-19	covid-19	PROPN
cuesj-1047	55	16	not	not	PART
cuesj-1047	55	17	vaccinated	vaccinate	VERB
cuesj-1047	55	18	,	,	PUNCT
cuesj-1047	55	19	as	as	SCONJ
cuesj-1047	55	20	were	be	AUX
cuesj-1047	55	21	all	all	DET
cuesj-1047	55	22	the	the	DET
cuesj-1047	55	23	children.[30	children.[30	ADJ
cuesj-1047	55	24	]	]	PUNCT
cuesj-1047	55	25	omicron	omicron	PROPN
cuesj-1047	55	26	ba.1	ba.1	PROPN
cuesj-1047	55	27	and	and	CCONJ
cuesj-1047	55	28	ba.2	ba.2	PROPN
cuesj-1047	55	29	sars	sar	NOUN
cuesj-1047	55	30	-	-	PUNCT
cuesj-1047	55	31	cov-2	cov-2	NOUN
cuesj-1047	55	32	infections	infection	NOUN
cuesj-1047	55	33	and	and	CCONJ
cuesj-1047	55	34	hospitalizations	hospitalization	NOUN
cuesj-1047	55	35	figure	figure	VERB
cuesj-1047	55	36	5	5	NUM
cuesj-1047	55	37	shows	show	VERB
cuesj-1047	55	38	that	that	SCONJ
cuesj-1047	55	39	from	from	ADP
cuesj-1047	55	40	333	333	NUM
cuesj-1047	55	41	adult	adult	NOUN
cuesj-1047	55	42	patients	patient	NOUN
cuesj-1047	55	43	diagnosed	diagnose	VERB
cuesj-1047	55	44	with	with	ADP
cuesj-1047	55	45	the	the	DET
cuesj-1047	55	46	omicron	omicron	PROPN
cuesj-1047	55	47	variation	variation	NOUN
cuesj-1047	55	48	,	,	PUNCT
cuesj-1047	55	49	86.1	86.1	NUM
cuesj-1047	55	50	%	%	NOUN
cuesj-1047	55	51	had	have	VERB
cuesj-1047	55	52	ba.1	ba.1	NOUN
cuesj-1047	55	53	,	,	PUNCT
cuesj-1047	55	54	4.8	4.8	NUM
cuesj-1047	55	55	%	%	NOUN
cuesj-1047	55	56	had	have	VERB
cuesj-1047	55	57	ba.2	ba.2	NOUN
cuesj-1047	55	58	,	,	PUNCT
cuesj-1047	55	59	and	and	CCONJ
cuesj-1047	55	60	5.4	5.4	NUM
cuesj-1047	55	61	%	%	NOUN
cuesj-1047	55	62	had	have	VERB
cuesj-1047	55	63	both	both	DET
cuesj-1047	55	64	ba.1	ba.1	NOUN
cuesj-1047	55	65	and	and	CCONJ
cuesj-1047	55	66	ba.2	ba.2	PROPN
cuesj-1047	55	67	.	.	PUNCT
cuesj-1047	56	1	patients	patient	NOUN
cuesj-1047	56	2	with	with	ADP
cuesj-1047	56	3	ba.1	ba.1	NOUN
cuesj-1047	56	4	had	have	VERB
cuesj-1047	56	5	clinical	clinical	ADJ
cuesj-1047	56	6	hospitalizations	hospitalization	NOUN
cuesj-1047	56	7	lasting	last	VERB
cuesj-1047	56	8	longer	long	ADV
cuesj-1047	56	9	than	than	ADP
cuesj-1047	56	10	24	24	NUM
cuesj-1047	56	11	h	h	NOUN
cuesj-1047	56	12	in	in	ADP
cuesj-1047	56	13	39.4	39.4	NUM
cuesj-1047	56	14	%	%	NOUN
cuesj-1047	56	15	of	of	ADP
cuesj-1047	56	16	cases	case	NOUN
cuesj-1047	56	17	,	,	PUNCT
cuesj-1047	56	18	<	<	X
cuesj-1047	56	19	24	24	NUM
cuesj-1047	56	20	h	h	NOUN
cuesj-1047	56	21	in	in	ADP
cuesj-1047	56	22	9.8	9.8	NUM
cuesj-1047	56	23	%	%	NOUN
cuesj-1047	56	24	of	of	ADP
cuesj-1047	56	25	cases	case	NOUN
cuesj-1047	56	26	,	,	PUNCT
cuesj-1047	56	27	and	and	CCONJ
cuesj-1047	56	28	only	only	ADV
cuesj-1047	56	29	outpatient	outpatient	NOUN
cuesj-1047	56	30	visits	visit	NOUN
cuesj-1047	56	31	in	in	ADP
cuesj-1047	56	32	50.9	50.9	NUM
cuesj-1047	56	33	%	%	NOUN
cuesj-1047	56	34	of	of	ADP
cuesj-1047	56	35	cases	case	NOUN
cuesj-1047	56	36	.	.	PUNCT
cuesj-1047	57	1	clinical	clinical	ADJ
cuesj-1047	57	2	hospital	hospital	NOUN
cuesj-1047	57	3	admission	admission	NOUN
cuesj-1047	57	4	rates	rate	NOUN
cuesj-1047	57	5	for	for	ADP
cuesj-1047	57	6	adult	adult	NOUN
cuesj-1047	57	7	ba.2	ba.2	NOUN
cuesj-1047	57	8	patients	patient	NOUN
cuesj-1047	57	9	were	be	AUX
cuesj-1047	57	10	50	50	NUM
cuesj-1047	57	11	%	%	NOUN
cuesj-1047	57	12	for	for	ADP
cuesj-1047	57	13	inpatient	inpatient	NOUN
cuesj-1047	57	14	stays	stay	VERB
cuesj-1047	57	15	and	and	CCONJ
cuesj-1047	57	16	50	50	NUM
cuesj-1047	57	17	%	%	NOUN
cuesj-1047	57	18	for	for	ADP
cuesj-1047	57	19	outpatient	outpatient	NOUN
cuesj-1047	57	20	visits	visit	NOUN
cuesj-1047	57	21	.	.	PUNCT
cuesj-1047	58	1	the	the	DET
cuesj-1047	58	2	omicron	omicron	PROPN
cuesj-1047	58	3	variation	variation	NOUN
cuesj-1047	58	4	was	be	AUX
cuesj-1047	58	5	discovered	discover	VERB
cuesj-1047	58	6	in	in	ADP
cuesj-1047	58	7	96	96	NUM
cuesj-1047	58	8	pediatric	pediatric	ADJ
cuesj-1047	58	9	patients	patient	NOUN
cuesj-1047	58	10	.	.	PUNCT
cuesj-1047	59	1	one	one	NUM
cuesj-1047	59	2	child	child	NOUN
cuesj-1047	59	3	was	be	AUX
cuesj-1047	59	4	found	find	VERB
cuesj-1047	59	5	to	to	PART
cuesj-1047	59	6	have	have	VERB
cuesj-1047	59	7	either	either	CCONJ
cuesj-1047	59	8	ba.1	ba.1	NOUN
cuesj-1047	59	9	or	or	CCONJ
cuesj-1047	59	10	ba.2	ba.2	PROPN
cuesj-1047	59	11	(	(	PUNCT
cuesj-1047	59	12	1.4	1.4	NUM
cuesj-1047	59	13	%	%	NOUN
cuesj-1047	59	14	)	)	PUNCT
cuesj-1047	59	15	,	,	PUNCT
cuesj-1047	59	16	whereas	whereas	SCONJ
cuesj-1047	59	17	ba.2	ba.2	PROPN
cuesj-1047	59	18	was	be	AUX
cuesj-1047	59	19	found	find	VERB
cuesj-1047	59	20	in	in	ADP
cuesj-1047	59	21	15.9	15.9	NUM
cuesj-1047	59	22	%	%	NOUN
cuesj-1047	59	23	of	of	ADP
cuesj-1047	59	24	the	the	DET
cuesj-1047	59	25	kids	kid	NOUN
cuesj-1047	59	26	and	and	CCONJ
cuesj-1047	59	27	ba.1	ba.1	NOUN
cuesj-1047	59	28	in	in	ADP
cuesj-1047	59	29	82.6	82.6	NUM
cuesj-1047	59	30	%	%	NOUN
cuesj-1047	59	31	of	of	ADP
cuesj-1047	59	32	the	the	DET
cuesj-1047	59	33	kids	kid	NOUN
cuesj-1047	59	34	.	.	PUNCT
cuesj-1047	60	1	the	the	DET
cuesj-1047	60	2	average	average	ADJ
cuesj-1047	60	3	amount	amount	NOUN
cuesj-1047	60	4	of	of	ADP
cuesj-1047	60	5	time	time	NOUN
cuesj-1047	60	6	spent	spend	VERB
cuesj-1047	60	7	in	in	ADP
cuesj-1047	60	8	clinical	clinical	ADJ
cuesj-1047	60	9	hospitals	hospital	NOUN
cuesj-1047	60	10	by	by	ADP
cuesj-1047	60	11	ba.1	ba.1	NOUN
cuesj-1047	60	12	patients	patient	NOUN
cuesj-1047	60	13	was	be	AUX
cuesj-1047	60	14	26.3	26.3	NUM
cuesj-1047	60	15	%	%	NOUN
cuesj-1047	60	16	,	,	PUNCT
cuesj-1047	60	17	1.8	1.8	NUM
cuesj-1047	60	18	%	%	NOUN
cuesj-1047	60	19	for	for	ADP
cuesj-1047	60	20	stays	stay	NOUN
cuesj-1047	60	21	of	of	ADP
cuesj-1047	60	22	<	<	X
cuesj-1047	60	23	24	24	NUM
cuesj-1047	60	24	h	h	NOUN
cuesj-1047	60	25	,	,	PUNCT
cuesj-1047	60	26	and	and	CCONJ
cuesj-1047	60	27	71.9	71.9	NUM
cuesj-1047	60	28	%	%	NOUN
cuesj-1047	60	29	for	for	ADP
cuesj-1047	60	30	outpatient	outpatient	NOUN
cuesj-1047	60	31	visits	visit	NOUN
cuesj-1047	60	32	exclusively	exclusively	ADV
cuesj-1047	60	33	.	.	PUNCT
cuesj-1047	61	1	meanwhile	meanwhile	ADV
cuesj-1047	61	2	,	,	PUNCT
cuesj-1047	61	3	36.4	36.4	NUM
cuesj-1047	61	4	%	%	NOUN
cuesj-1047	61	5	with	with	ADP
cuesj-1047	61	6	ba.2	ba.2	PROPN
cuesj-1047	61	7	had	have	VERB
cuesj-1047	61	8	clinical	clinical	ADJ
cuesj-1047	61	9	hospitalization	hospitalization	NOUN
cuesj-1047	61	10	extended	extend	VERB
cuesj-1047	61	11	beyond	beyond	ADP
cuesj-1047	61	12	24	24	NUM
cuesj-1047	61	13	h	h	NOUN
cuesj-1047	61	14	and	and	CCONJ
cuesj-1047	61	15	63.6	63.6	NUM
cuesj-1047	61	16	%	%	NOUN
cuesj-1047	61	17	of	of	ADP
cuesj-1047	61	18	them	they	PRON
cuesj-1047	61	19	just	just	ADV
cuesj-1047	61	20	required	require	VERB
cuesj-1047	61	21	an	an	DET
cuesj-1047	61	22	outpatient	outpatient	NOUN
cuesj-1047	61	23	visit	visit	NOUN
cuesj-1047	61	24	.	.	PUNCT
cuesj-1047	62	1	according	accord	VERB
cuesj-1047	62	2	to	to	ADP
cuesj-1047	62	3	the	the	DET
cuesj-1047	62	4	study	study	NOUN
cuesj-1047	62	5	,	,	PUNCT
cuesj-1047	62	6	only	only	ADV
cuesj-1047	62	7	19	19	NUM
cuesj-1047	62	8	%	%	NOUN
cuesj-1047	62	9	of	of	ADP
cuesj-1047	62	10	pediatric	pediatric	ADJ
cuesj-1047	62	11	patients	patient	NOUN
cuesj-1047	62	12	and	and	CCONJ
cuesj-1047	62	13	45	45	NUM
cuesj-1047	62	14	%	%	NOUN
cuesj-1047	62	15	of	of	ADP
cuesj-1047	62	16	hospitalized	hospitalize	VERB
cuesj-1047	62	17	adult	adult	NOUN
cuesj-1047	62	18	ba.1	ba.1	NOUN
cuesj-1047	62	19	or	or	CCONJ
cuesj-1047	62	20	ba.2	ba.2	PROPN
cuesj-1047	62	21	patients	patient	NOUN
cuesj-1047	62	22	were	be	AUX
cuesj-1047	62	23	first	first	ADJ
cuesj-1047	62	24	covid-19	covid-19	PROPN
cuesj-1047	62	25	instances.[31	instances.[31	PROPN
cuesj-1047	62	26	]	]	PUNCT
cuesj-1047	62	27	perspectives	perspective	NOUN
cuesj-1047	62	28	pertaining	pertain	VERB
cuesj-1047	62	29	to	to	ADP
cuesj-1047	62	30	pneumonia	pneumonia	NOUN
cuesj-1047	62	31	along	along	ADP
cuesj-1047	62	32	with	with	ADP
cuesj-1047	62	33	covid-19	covid-19	PROPN
cuesj-1047	62	34	signs	sign	NOUN
cuesj-1047	62	35	such	such	ADJ
cuesj-1047	62	36	as	as	ADP
cuesj-1047	62	37	high	high	ADJ
cuesj-1047	62	38	body	body	NOUN
cuesj-1047	62	39	temperature	temperature	NOUN
cuesj-1047	62	40	,	,	PUNCT
cuesj-1047	62	41	cough	cough	NOUN
cuesj-1047	62	42	,	,	PUNCT
cuesj-1047	62	43	or	or	CCONJ
cuesj-1047	62	44	other	other	ADJ
cuesj-1047	62	45	respiratory	respiratory	ADJ
cuesj-1047	62	46	symptoms	symptom	NOUN
cuesj-1047	62	47	,	,	PUNCT
cuesj-1047	62	48	moderate	moderate	ADJ
cuesj-1047	62	49	individuals	individual	NOUN
cuesj-1047	62	50	also	also	ADV
cuesj-1047	62	51	had	have	VERB
cuesj-1047	62	52	pneumonia	pneumonia	NOUN
cuesj-1047	62	53	symptoms	symptom	NOUN
cuesj-1047	62	54	.	.	PUNCT
cuesj-1047	63	1	in	in	ADP
cuesj-1047	63	2	pulmonary	pulmonary	ADJ
cuesj-1047	63	3	imaging	imaging	NOUN
cuesj-1047	63	4	,	,	PUNCT
cuesj-1047	63	5	the	the	DET
cuesj-1047	63	6	individuals	individual	NOUN
cuesj-1047	63	7	with	with	ADP
cuesj-1047	63	8	pneumonia	pneumonia	NOUN
cuesj-1047	63	9	revealed	reveal	VERB
cuesj-1047	63	10	>	>	PUNCT
cuesj-1047	63	11	50	50	NUM
cuesj-1047	63	12	%	%	NOUN
cuesj-1047	63	13	lesion	lesion	NOUN
cuesj-1047	63	14	development	development	NOUN
cuesj-1047	63	15	within	within	ADP
cuesj-1047	63	16	24–48	24–48	PROPN
cuesj-1047	63	17	h.	h.	NOUN
cuesj-1047	63	18	pneumonia	pneumonia	NOUN
cuesj-1047	63	19	is	be	AUX
cuesj-1047	63	20	less	less	ADV
cuesj-1047	63	21	likely	likely	ADJ
cuesj-1047	63	22	to	to	PART
cuesj-1047	63	23	develop	develop	VERB
cuesj-1047	63	24	from	from	ADP
cuesj-1047	63	25	an	an	DET
cuesj-1047	63	26	omicron	omicron	NOUN
cuesj-1047	63	27	infection	infection	NOUN
cuesj-1047	63	28	than	than	ADP
cuesj-1047	63	29	a	a	DET
cuesj-1047	63	30	delta	delta	NOUN
cuesj-1047	63	31	infection	infection	NOUN
cuesj-1047	63	32	.	.	PUNCT
cuesj-1047	64	1	both	both	CCONJ
cuesj-1047	64	2	the	the	DET
cuesj-1047	64	3	administration	administration	NOUN
cuesj-1047	64	4	of	of	ADP
cuesj-1047	64	5	booster	booster	NOUN
cuesj-1047	64	6	doses	dose	NOUN
cuesj-1047	64	7	6	6	NUM
cuesj-1047	64	8	months	month	NOUN
cuesj-1047	64	9	after	after	ADP
cuesj-1047	64	10	receiving	receive	VERB
cuesj-1047	64	11	the	the	DET
cuesj-1047	64	12	initial	initial	ADJ
cuesj-1047	64	13	vaccines	vaccine	NOUN
cuesj-1047	64	14	and	and	CCONJ
cuesj-1047	64	15	the	the	DET
cuesj-1047	64	16	first	first	ADJ
cuesj-1047	64	17	6	6	NUM
cuesj-1047	64	18	months	month	NOUN
cuesj-1047	64	19	afterward	afterward	ADV
cuesj-1047	64	20	were	be	AUX
cuesj-1047	64	21	linked	link	VERB
cuesj-1047	64	22	to	to	ADP
cuesj-1047	64	23	a	a	DET
cuesj-1047	64	24	significantly	significantly	ADV
cuesj-1047	64	25	decreased	decrease	VERB
cuesj-1047	64	26	incidence	incidence	NOUN
cuesj-1047	64	27	of	of	ADP
cuesj-1047	64	28	pneumonia	pneumonia	NOUN
cuesj-1047	64	29	.	.	PUNCT
cuesj-1047	65	1	age	age	NOUN
cuesj-1047	65	2	range	range	NOUN
cuesj-1047	65	3	,	,	PUNCT
cuesj-1047	65	4	kind	kind	NOUN
cuesj-1047	65	5	,	,	PUNCT
cuesj-1047	65	6	and	and	CCONJ
cuesj-1047	65	7	immunization	immunization	NOUN
cuesj-1047	65	8	status	status	NOUN
cuesj-1047	65	9	were	be	AUX
cuesj-1047	65	10	all	all	PRON
cuesj-1047	65	11	significant	significant	ADJ
cuesj-1047	65	12	predictors	predictor	NOUN
cuesj-1047	65	13	of	of	ADP
cuesj-1047	65	14	pneumonia	pneumonia	NOUN
cuesj-1047	65	15	,	,	PUNCT
cuesj-1047	65	16	according	accord	VERB
cuesj-1047	65	17	to	to	ADP
cuesj-1047	65	18	univariate	univariate	ADJ
cuesj-1047	65	19	and	and	CCONJ
cuesj-1047	65	20	multivariate	multivariate	NOUN
cuesj-1047	65	21	investigations	investigation	NOUN
cuesj-1047	65	22	.	.	PUNCT
cuesj-1047	66	1	variations	variation	NOUN
cuesj-1047	66	2	of	of	ADP
cuesj-1047	66	3	pneumonia	pneumonia	NOUN
cuesj-1047	66	4	and	and	CCONJ
cuesj-1047	66	5	immunization	immunization	NOUN
cuesj-1047	66	6	status	status	NOUN
cuesj-1047	66	7	by	by	ADP
cuesj-1047	66	8	an	an	DET
cuesj-1047	66	9	immunization	immunization	NOUN
cuesj-1047	66	10	group	group	NOUN
cuesj-1047	66	11	,	,	PUNCT
cuesj-1047	66	12	figure	figure	VERB
cuesj-1047	66	13	6	6	NUM
cuesj-1047	66	14	shows	show	VERB
cuesj-1047	66	15	the	the	DET
cuesj-1047	66	16	proportion	proportion	NOUN
cuesj-1047	66	17	of	of	ADP
cuesj-1047	66	18	pneumonia	pneumonia	NOUN
cuesj-1047	66	19	-	-	PUNCT
cuesj-1047	66	20	related	relate	VERB
cuesj-1047	66	21	delta	delta	NOUN
cuesj-1047	66	22	variant	variant	NOUN
cuesj-1047	66	23	infections	infection	NOUN
cuesj-1047	66	24	ranged	range	VERB
cuesj-1047	66	25	from	from	ADP
cuesj-1047	66	26	30.77	30.77	NUM
cuesj-1047	66	27	%	%	NOUN
cuesj-1047	66	28	to	to	ADP
cuesj-1047	66	29	69.17	69.17	NUM
cuesj-1047	66	30	%	%	NOUN
cuesj-1047	66	31	,	,	PUNCT
cuesj-1047	66	32	whereas	whereas	SCONJ
cuesj-1047	66	33	the	the	DET
cuesj-1047	66	34	proportion	proportion	NOUN
cuesj-1047	66	35	of	of	ADP
cuesj-1047	66	36	pneumoniarelated	pneumoniarelated	ADJ
cuesj-1047	66	37	omicron	omicron	NOUN
cuesj-1047	66	38	infections	infection	NOUN
cuesj-1047	66	39	ranged	range	VERB
cuesj-1047	66	40	from	from	ADP
cuesj-1047	66	41	14.76	14.76	NUM
cuesj-1047	66	42	%	%	NOUN
cuesj-1047	66	43	to	to	ADP
cuesj-1047	66	44	36.71	36.71	NUM
cuesj-1047	66	45	%	%	NOUN
cuesj-1047	66	46	.	.	PUNCT
cuesj-1047	67	1	only	only	ADV
cuesj-1047	67	2	42.31	42.31	NUM
cuesj-1047	67	3	%	%	NOUN
cuesj-1047	67	4	of	of	ADP
cuesj-1047	67	5	individuals	individual	NOUN
cuesj-1047	67	6	who	who	PRON
cuesj-1047	67	7	had	have	VERB
cuesj-1047	67	8	all	all	DET
cuesj-1047	67	9	their	their	PRON
cuesj-1047	67	10	main	main	ADJ
cuesj-1047	67	11	immunizations	immunization	NOUN
cuesj-1047	67	12	before	before	ADP
cuesj-1047	67	13	an	an	DET
cuesj-1047	67	14	omicron	omicron	PROPN
cuesj-1047	67	15	infection	infection	NOUN
cuesj-1047	67	16	developed	develop	VERB
cuesj-1047	67	17	pneumonia	pneumonia	NOUN
cuesj-1047	67	18	,	,	PUNCT
cuesj-1047	67	19	in	in	ADP
cuesj-1047	67	20	contrast	contrast	NOUN
cuesj-1047	67	21	to	to	ADP
cuesj-1047	67	22	80.77	80.77	NUM
cuesj-1047	67	23	%	%	NOUN
cuesj-1047	67	24	of	of	ADP
cuesj-1047	67	25	those	those	PRON
cuesj-1047	67	26	over	over	ADP
cuesj-1047	67	27	50	50	NUM
cuesj-1047	67	28	before	before	ADP
cuesj-1047	67	29	the	the	DET
cuesj-1047	67	30	delta	delta	NOUN
cuesj-1047	67	31	infection	infection	NOUN
cuesj-1047	67	32	.	.	PUNCT
cuesj-1047	68	1	patients	patient	NOUN
cuesj-1047	68	2	with	with	ADP
cuesj-1047	68	3	the	the	DET
cuesj-1047	68	4	omicron	omicron	PROPN
cuesj-1047	68	5	variant	variant	NOUN
cuesj-1047	68	6	infection	infection	NOUN
cuesj-1047	68	7	had	have	VERB
cuesj-1047	68	8	a	a	DET
cuesj-1047	68	9	66	66	NUM
cuesj-1047	68	10	%	%	NOUN
cuesj-1047	68	11	lower	low	ADJ
cuesj-1047	68	12	chance	chance	NOUN
cuesj-1047	68	13	of	of	ADP
cuesj-1047	68	14	getting	get	VERB
cuesj-1047	68	15	pneumonia	pneumonia	NOUN
cuesj-1047	68	16	than	than	ADP
cuesj-1047	68	17	those	those	PRON
cuesj-1047	68	18	with	with	ADP
cuesj-1047	68	19	the	the	DET
cuesj-1047	68	20	delta	delta	NOUN
cuesj-1047	68	21	variant	variant	NOUN
cuesj-1047	68	22	sickness	sickness	NOUN
cuesj-1047	68	23	.	.	PUNCT
cuesj-1047	69	1	greater	great	ADJ
cuesj-1047	69	2	neutralizing	neutralize	VERB
cuesj-1047	69	3	antibody	antibody	NOUN
cuesj-1047	69	4	titers	titer	NOUN
cuesj-1047	69	5	(	(	PUNCT
cuesj-1047	69	6	hybrid	hybrid	ADJ
cuesj-1047	69	7	immunity	immunity	NOUN
cuesj-1047	69	8	)	)	PUNCT
cuesj-1047	69	9	following	follow	VERB
cuesj-1047	69	10	a	a	DET
cuesj-1047	69	11	natural	natural	ADJ
cuesj-1047	69	12	infection	infection	NOUN
cuesj-1047	69	13	may	may	AUX
cuesj-1047	69	14	occur	occur	VERB
cuesj-1047	69	15	compared	compare	VERB
cuesj-1047	69	16	to	to	ADP
cuesj-1047	69	17	primary	primary	ADJ
cuesj-1047	69	18	and	and	CCONJ
cuesj-1047	69	19	booster	booster	NOUN
cuesj-1047	69	20	immunity	immunity	NOUN
cuesj-1047	69	21	,	,	PUNCT
cuesj-1047	69	22	as	as	ADV
cuesj-1047	69	23	well	well	ADV
cuesj-1047	69	24	as	as	ADP
cuesj-1047	69	25	viral	viral	ADJ
cuesj-1047	69	26	hussein	hussein	NOUN
cuesj-1047	69	27	,	,	PUNCT
cuesj-1047	69	28	et	et	PROPN
cuesj-1047	69	29	al	al	PROPN
cuesj-1047	69	30	.	.	PUNCT
cuesj-1047	69	31	:	:	PUNCT
cuesj-1047	70	1	a	a	DET
cuesj-1047	70	2	review	review	NOUN
cuesj-1047	70	3	on	on	ADP
cuesj-1047	70	4	coronavirus	coronavirus	NOUN
cuesj-1047	70	5	and	and	CCONJ
cuesj-1047	70	6	omicron	omicron	PROPN
cuesj-1047	70	7	patients	patient	NOUN
cuesj-1047	70	8	11	11	NUM
cuesj-1047	70	9	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	70	10	cuesj	cuesj	ADJ
cuesj-1047	70	11	2024	2024	NUM
cuesj-1047	70	12	,	,	PUNCT
cuesj-1047	70	13	8	8	NUM
cuesj-1047	70	14	(	(	PUNCT
cuesj-1047	70	15	1	1	NUM
cuesj-1047	70	16	):	):	PUNCT
cuesj-1047	70	17	8	8	NUM
cuesj-1047	70	18	-	-	SYM
cuesj-1047	70	19	17	17	NUM
cuesj-1047	70	20	load	load	NOUN
cuesj-1047	70	21	disparities	disparity	NOUN
cuesj-1047	70	22	by	by	ADP
cuesj-1047	70	23	variant	variant	NOUN
cuesj-1047	70	24	.	.	PUNCT
cuesj-1047	71	1	individuals	individual	NOUN
cuesj-1047	71	2	were	be	AUX
cuesj-1047	71	3	divided	divide	VERB
cuesj-1047	71	4	based	base	VERB
cuesj-1047	71	5	on	on	ADP
cuesj-1047	71	6	their	their	PRON
cuesj-1047	71	7	vaccination	vaccination	NOUN
cuesj-1047	71	8	history	history	NOUN
cuesj-1047	71	9	:	:	PUNCT
cuesj-1047	71	10	those	those	PRON
cuesj-1047	71	11	who	who	PRON
cuesj-1047	71	12	received	receive	VERB
cuesj-1047	71	13	a	a	DET
cuesj-1047	71	14	booster	booster	NOUN
cuesj-1047	71	15	dose	dose	NOUN
cuesj-1047	71	16	,	,	PUNCT
cuesj-1047	71	17	total	total	ADJ
cuesj-1047	71	18	main	main	ADJ
cuesj-1047	71	19	immunization	immunization	NOUN
cuesj-1047	71	20	after	after	ADP
cuesj-1047	71	21	180	180	NUM
cuesj-1047	71	22	days	day	NOUN
cuesj-1047	71	23	of	of	ADP
cuesj-1047	71	24	diagnosis	diagnosis	NOUN
cuesj-1047	71	25	,	,	PUNCT
cuesj-1047	71	26	and	and	CCONJ
cuesj-1047	71	27	total	total	ADJ
cuesj-1047	71	28	main	main	ADJ
cuesj-1047	71	29	immunization	immunization	NOUN
cuesj-1047	71	30	before	before	ADP
cuesj-1047	71	31	180	180	NUM
cuesj-1047	71	32	days	day	NOUN
cuesj-1047	71	33	of	of	ADP
cuesj-1047	71	34	diagnosis	diagnosis	NOUN
cuesj-1047	71	35	.	.	PUNCT
cuesj-1047	72	1	in	in	ADP
cuesj-1047	72	2	the	the	DET
cuesj-1047	72	3	case	case	NOUN
cuesj-1047	72	4	of	of	ADP
cuesj-1047	72	5	delta	delta	NOUN
cuesj-1047	72	6	variant	variant	NOUN
cuesj-1047	72	7	infections	infection	NOUN
cuesj-1047	72	8	,	,	PUNCT
cuesj-1047	72	9	complete	complete	ADJ
cuesj-1047	72	10	main	main	ADJ
cuesj-1047	72	11	immunization	immunization	NOUN
cuesj-1047	72	12	6	6	NUM
cuesj-1047	72	13	months	month	NOUN
cuesj-1047	72	14	after	after	SCONJ
cuesj-1047	72	15	the	the	DET
cuesj-1047	72	16	illness	illness	NOUN
cuesj-1047	72	17	decreased	decrease	VERB
cuesj-1047	72	18	the	the	DET
cuesj-1047	72	19	chance	chance	NOUN
cuesj-1047	72	20	of	of	ADP
cuesj-1047	72	21	pneumonia	pneumonia	NOUN
cuesj-1047	72	22	to	to	ADP
cuesj-1047	72	23	52	52	NUM
cuesj-1047	72	24	%	%	NOUN
cuesj-1047	72	25	.	.	PUNCT
cuesj-1047	73	1	in	in	ADP
cuesj-1047	73	2	contrast	contrast	NOUN
cuesj-1047	73	3	,	,	PUNCT
cuesj-1047	73	4	immunization	immunization	NOUN
cuesj-1047	73	5	at	at	ADV
cuesj-1047	73	6	least	least	ADV
cuesj-1047	73	7	6	6	NUM
cuesj-1047	73	8	months	month	NOUN
cuesj-1047	73	9	before	before	ADP
cuesj-1047	73	10	infection	infection	NOUN
cuesj-1047	73	11	,	,	PUNCT
cuesj-1047	73	12	and	and	CCONJ
cuesj-1047	73	13	receipt	receipt	NOUN
cuesj-1047	73	14	of	of	ADP
cuesj-1047	73	15	booster	booster	NOUN
cuesj-1047	73	16	injections	injection	NOUN
cuesj-1047	73	17	lessened	lessen	VERB
cuesj-1047	73	18	the	the	DET
cuesj-1047	73	19	chance	chance	NOUN
cuesj-1047	73	20	of	of	ADP
cuesj-1047	73	21	pneumonia	pneumonia	NOUN
cuesj-1047	73	22	by	by	ADP
cuesj-1047	73	23	82	82	NUM
cuesj-1047	73	24	%	%	NOUN
cuesj-1047	73	25	.	.	PUNCT
cuesj-1047	74	1	complete	complete	ADJ
cuesj-1047	74	2	main	main	ADJ
cuesj-1047	74	3	immunization	immunization	NOUN
cuesj-1047	74	4	around	around	ADP
cuesj-1047	74	5	6	6	NUM
cuesj-1047	74	6	months	month	NOUN
cuesj-1047	74	7	lowered	lower	VERB
cuesj-1047	74	8	the	the	DET
cuesj-1047	74	9	occurrence	occurrence	NOUN
cuesj-1047	74	10	of	of	ADP
cuesj-1047	74	11	pneumonia	pneumonia	NOUN
cuesj-1047	74	12	in	in	ADP
cuesj-1047	74	13	cases	case	NOUN
cuesj-1047	74	14	of	of	ADP
cuesj-1047	74	15	omicron	omicron	PROPN
cuesj-1047	74	16	infections	infection	NOUN
cuesj-1047	74	17	by	by	ADP
cuesj-1047	74	18	66	66	NUM
cuesj-1047	74	19	%	%	NOUN
cuesj-1047	74	20	.	.	PUNCT
cuesj-1047	75	1	in	in	ADP
cuesj-1047	75	2	the	the	DET
cuesj-1047	75	3	case	case	NOUN
cuesj-1047	75	4	of	of	ADP
cuesj-1047	75	5	those	those	PRON
cuesj-1047	75	6	who	who	PRON
cuesj-1047	75	7	received	receive	VERB
cuesj-1047	75	8	booster	booster	NOUN
cuesj-1047	75	9	injections	injection	NOUN
cuesj-1047	75	10	,	,	PUNCT
cuesj-1047	75	11	there	there	PRON
cuesj-1047	75	12	were	be	VERB
cuesj-1047	75	13	too	too	ADV
cuesj-1047	75	14	few	few	ADJ
cuesj-1047	75	15	omicron	omicron	NOUN
cuesj-1047	75	16	cases	case	NOUN
cuesj-1047	75	17	to	to	PART
cuesj-1047	75	18	establish	establish	VERB
cuesj-1047	75	19	a	a	DET
cuesj-1047	75	20	reliable	reliable	ADJ
cuesj-1047	75	21	odds	odd	NOUN
cuesj-1047	75	22	ratio	ratio	NOUN
cuesj-1047	75	23	of	of	ADP
cuesj-1047	75	24	pneumonia	pneumonia	NOUN
cuesj-1047	75	25	.	.	PUNCT
cuesj-1047	76	1	there	there	PRON
cuesj-1047	76	2	were	be	VERB
cuesj-1047	76	3	no	no	DET
cuesj-1047	76	4	significant	significant	ADJ
cuesj-1047	76	5	or	or	CCONJ
cuesj-1047	76	6	extremely	extremely	ADV
cuesj-1047	76	7	serious	serious	ADJ
cuesj-1047	76	8	omicron	omicron	PROPN
cuesj-1047	76	9	infections	infection	NOUN
cuesj-1047	76	10	,	,	PUNCT
cuesj-1047	76	11	and	and	CCONJ
cuesj-1047	76	12	the	the	DET
cuesj-1047	76	13	incidence	incidence	NOUN
cuesj-1047	76	14	of	of	ADP
cuesj-1047	76	15	pneumonia	pneumonia	NOUN
cuesj-1047	76	16	was	be	AUX
cuesj-1047	76	17	improved	improve	VERB
cuesj-1047	76	18	among	among	ADP
cuesj-1047	76	19	omicron	omicron	PROPN
cuesj-1047	76	20	infections	infection	NOUN
cuesj-1047	76	21	rather	rather	ADV
cuesj-1047	76	22	than	than	ADP
cuesj-1047	76	23	delta	delta	NOUN
cuesj-1047	76	24	infections	infection	NOUN
cuesj-1047	76	25	across	across	ADP
cuesj-1047	76	26	all	all	DET
cuesj-1047	76	27	age	age	NOUN
cuesj-1047	76	28	groups	group	NOUN
cuesj-1047	76	29	and	and	CCONJ
cuesj-1047	76	30	immunization	immunization	NOUN
cuesj-1047	76	31	status	status	NOUN
cuesj-1047	76	32	.	.	PUNCT
cuesj-1047	77	1	the	the	DET
cuesj-1047	77	2	results	result	NOUN
cuesj-1047	77	3	provide	provide	VERB
cuesj-1047	77	4	an	an	DET
cuesj-1047	77	5	estimate	estimate	NOUN
cuesj-1047	77	6	of	of	ADP
cuesj-1047	77	7	the	the	DET
cuesj-1047	77	8	connection	connection	NOUN
cuesj-1047	77	9	between	between	ADP
cuesj-1047	77	10	immunization	immunization	NOUN
cuesj-1047	77	11	status	status	NOUN
cuesj-1047	77	12	and	and	CCONJ
cuesj-1047	77	13	pneumonia	pneumonia	NOUN
cuesj-1047	77	14	rather	rather	ADV
cuesj-1047	77	15	than	than	ADP
cuesj-1047	77	16	an	an	DET
cuesj-1047	77	17	indication	indication	NOUN
cuesj-1047	77	18	of	of	ADP
cuesj-1047	77	19	the	the	DET
cuesj-1047	77	20	effectiveness	effectiveness	NOUN
cuesj-1047	77	21	of	of	ADP
cuesj-1047	77	22	the	the	DET
cuesj-1047	77	23	vaccine	vaccine	NOUN
cuesj-1047	77	24	against	against	ADP
cuesj-1047	77	25	pneumonia.[14	pneumonia.[14	PROPN
cuesj-1047	77	26	]	]	PUNCT
cuesj-1047	77	27	effectiveness	effectiveness	NOUN
cuesj-1047	77	28	of	of	ADP
cuesj-1047	77	29	covid-19	covid-19	PROPN
cuesj-1047	77	30	mrna	mrna	NOUN
cuesj-1047	77	31	vaccination	vaccination	NOUN
cuesj-1047	77	32	doses	dose	NOUN
cuesj-1047	77	33	toward	toward	ADP
cuesj-1047	77	34	the	the	DET
cuesj-1047	77	35	omicron	omicron	PROPN
cuesj-1047	77	36	variant	variant	NOUN
cuesj-1047	77	37	residents	resident	NOUN
cuesj-1047	77	38	of	of	ADP
cuesj-1047	77	39	continuing	continue	VERB
cuesj-1047	77	40	concern	concern	NOUN
cuesj-1047	77	41	during	during	ADP
cuesj-1047	77	42	an	an	DET
cuesj-1047	77	43	omicron	omicron	PROPN
cuesj-1047	77	44	dominant	dominant	ADJ
cuesj-1047	77	45	phase	phase	NOUN
cuesj-1047	77	46	although	although	SCONJ
cuesj-1047	77	47	doses	dose	NOUN
cuesj-1047	77	48	of	of	ADP
cuesj-1047	77	49	covid-19	covid-19	PROPN
cuesj-1047	77	50	mrna	mrna	NOUN
cuesj-1047	77	51	vaccine	vaccine	NOUN
cuesj-1047	77	52	(	(	PUNCT
cuesj-1047	77	53	95	95	NUM
cuesj-1047	77	54	%	%	NOUN
cuesj-1047	77	55	of	of	ADP
cuesj-1047	77	56	study	study	NOUN
cuesj-1047	77	57	subjects	subject	NOUN
cuesj-1047	77	58	acquired	acquire	VERB
cuesj-1047	77	59	mrna-1273	mrna-1273	ADV
cuesj-1047	77	60	)	)	PUNCT
cuesj-1047	77	61	raised	raise	VERB
cuesj-1047	77	62	safety	safety	NOUN
cuesj-1047	77	63	toward	toward	ADP
cuesj-1047	77	64	any	any	DET
cuesj-1047	77	65	sars	sar	NOUN
cuesj-1047	77	66	-	-	PUNCT
cuesj-1047	77	67	cov-2	cov-2	NOUN
cuesj-1047	77	68	infection	infection	NOUN
cuesj-1047	77	69	,	,	PUNCT
cuesj-1047	77	70	symptoms	symptom	NOUN
cuesj-1047	77	71	of	of	ADP
cuesj-1047	77	72	disease	disease	NOUN
cuesj-1047	77	73	,	,	PUNCT
cuesj-1047	77	74	and	and	CCONJ
cuesj-1047	77	75	also	also	ADV
cuesj-1047	77	76	poor	poor	ADJ
cuesj-1047	77	77	results	result	NOUN
cuesj-1047	77	78	.	.	PUNCT
cuesj-1047	78	1	however	however	ADV
cuesj-1047	78	2	,	,	PUNCT
cuesj-1047	78	3	there	there	PRON
cuesj-1047	78	4	are	be	VERB
cuesj-1047	78	5	still	still	ADV
cuesj-1047	78	6	numerous	numerous	ADJ
cuesj-1047	78	7	unanswered	unanswered	ADJ
cuesj-1047	78	8	questions	question	NOUN
cuesj-1047	78	9	regarding	regard	VERB
cuesj-1047	78	10	the	the	DET
cuesj-1047	78	11	fourth	fourth	ADJ
cuesj-1047	78	12	dose	dose	NOUN
cuesj-1047	78	13	in	in	ADP
cuesj-1047	78	14	this	this	DET
cuesj-1047	78	15	cohort	cohort	NOUN
cuesj-1047	78	16	,	,	PUNCT
cuesj-1047	78	17	including	include	VERB
cuesj-1047	78	18	the	the	DET
cuesj-1047	78	19	prevention	prevention	NOUN
cuesj-1047	78	20	length	length	NOUN
cuesj-1047	78	21	,	,	PUNCT
cuesj-1047	78	22	for	for	ADP
cuesj-1047	78	23	the	the	DET
cuesj-1047	78	24	mrna-1273	mrna-1273	ADJ
cuesj-1047	78	25	vaccination	vaccination	NOUN
cuesj-1047	78	26	in	in	ADP
cuesj-1047	78	27	particular	particular	ADJ
cuesj-1047	78	28	.	.	PUNCT
cuesj-1047	79	1	in	in	ADP
cuesj-1047	79	2	long	long	ADJ
cuesj-1047	79	3	-	-	PUNCT
cuesj-1047	79	4	term	term	NOUN
cuesj-1047	79	5	care	care	NOUN
cuesj-1047	79	6	services	service	NOUN
cuesj-1047	79	7	,	,	PUNCT
cuesj-1047	79	8	combining	combine	VERB
cuesj-1047	79	9	vaccination	vaccination	NOUN
cuesj-1047	79	10	with	with	ADP
cuesj-1047	79	11	additional	additional	ADJ
cuesj-1047	79	12	precautions	precaution	NOUN
cuesj-1047	79	13	for	for	ADP
cuesj-1047	79	14	public	public	ADJ
cuesj-1047	79	15	health	health	NOUN
cuesj-1047	79	16	such	such	ADJ
cuesj-1047	79	17	as	as	ADP
cuesj-1047	79	18	mask	mask	NOUN
cuesj-1047	79	19	use	use	NOUN
cuesj-1047	79	20	,	,	PUNCT
cuesj-1047	79	21	better	well	ADJ
cuesj-1047	79	22	ventilation	ventilation	NOUN
cuesj-1047	79	23	,	,	PUNCT
cuesj-1047	79	24	and	and	CCONJ
cuesj-1047	79	25	physical	physical	ADJ
cuesj-1047	79	26	separation	separation	NOUN
cuesj-1047	79	27	may	may	AUX
cuesj-1047	79	28	enable	enable	VERB
cuesj-1047	79	29	this	this	DET
cuesj-1047	79	30	extremely	extremely	ADV
cuesj-1047	79	31	susceptible	susceptible	ADJ
cuesj-1047	79	32	group	group	NOUN
cuesj-1047	79	33	to	to	PART
cuesj-1047	79	34	receive	receive	VERB
cuesj-1047	79	35	the	the	DET
cuesj-1047	79	36	best	good	ADJ
cuesj-1047	79	37	possible	possible	ADJ
cuesj-1047	79	38	protection	protection	NOUN
cuesj-1047	79	39	from	from	ADP
cuesj-1047	79	40	sars	sar	NOUN
cuesj-1047	79	41	-	-	PUNCT
cuesj-1047	79	42	cov-2.[32	cov-2.[32	PROPN
cuesj-1047	79	43	]	]	PUNCT
cuesj-1047	79	44	impact	impact	NOUN
cuesj-1047	79	45	of	of	ADP
cuesj-1047	79	46	vaccination	vaccination	NOUN
cuesj-1047	79	47	on	on	ADP
cuesj-1047	79	48	clinical	clinical	ADJ
cuesj-1047	79	49	treatment	treatment	NOUN
cuesj-1047	79	50	outcomes	outcome	NOUN
cuesj-1047	79	51	during	during	ADP
cuesj-1047	79	52	the	the	DET
cuesj-1047	79	53	omicron	omicron	NOUN
cuesj-1047	79	54	before	before	ADP
cuesj-1047	79	55	contracting	contract	VERB
cuesj-1047	79	56	sars	sar	NOUN
cuesj-1047	79	57	-	-	PUNCT
cuesj-1047	79	58	cov-2	cov-2	NOUN
cuesj-1047	79	59	,	,	PUNCT
cuesj-1047	79	60	190	190	NUM
cuesj-1047	79	61	patients	patient	NOUN
cuesj-1047	79	62	had	have	AUX
cuesj-1047	79	63	gotten	get	VERB
cuesj-1047	79	64	the	the	DET
cuesj-1047	79	65	covid-19	covid-19	PROPN
cuesj-1047	79	66	vaccine	vaccine	NOUN
cuesj-1047	79	67	3	3	NUM
cuesj-1047	79	68	times	time	NOUN
cuesj-1047	79	69	or	or	CCONJ
cuesj-1047	79	70	more	more	ADJ
cuesj-1047	79	71	.	.	PUNCT
cuesj-1047	80	1	of	of	ADP
cuesj-1047	80	2	those	those	PRON
cuesj-1047	80	3	,	,	PUNCT
cuesj-1047	80	4	30.2	30.2	NUM
cuesj-1047	80	5	%	%	NOUN
cuesj-1047	80	6	of	of	ADP
cuesj-1047	80	7	the	the	DET
cuesj-1047	80	8	patients	patient	NOUN
cuesj-1047	80	9	received	receive	VERB
cuesj-1047	80	10	two	two	NUM
cuesj-1047	80	11	doses	dose	NOUN
cuesj-1047	80	12	,	,	PUNCT
cuesj-1047	80	13	7.9	7.9	NUM
cuesj-1047	80	14	%	%	NOUN
cuesj-1047	80	15	of	of	ADP
cuesj-1047	80	16	individuals	individual	NOUN
cuesj-1047	80	17	receiving	receive	VERB
cuesj-1047	80	18	three	three	NUM
cuesj-1047	80	19	dosages	dosage	NOUN
cuesj-1047	80	20	of	of	ADP
cuesj-1047	80	21	mrna	mrna	PROPN
cuesj-1047	80	22	vaccination	vaccination	NOUN
cuesj-1047	80	23	,	,	PUNCT
cuesj-1047	80	24	and	and	CCONJ
cuesj-1047	80	25	26.2	26.2	NUM
cuesj-1047	80	26	%	%	NOUN
cuesj-1047	80	27	of	of	ADP
cuesj-1047	80	28	patients	patient	NOUN
cuesj-1047	80	29	with	with	ADP
cuesj-1047	80	30	three	three	NUM
cuesj-1047	80	31	dosages	dosage	NOUN
cuesj-1047	80	32	required	require	VERB
cuesj-1047	80	33	additional	additional	ADJ
cuesj-1047	80	34	oxygen	oxygen	NOUN
cuesj-1047	80	35	(	(	PUNCT
cuesj-1047	80	36	figure	figure	NOUN
cuesj-1047	80	37	7	7	NUM
cuesj-1047	80	38	)	)	PUNCT
cuesj-1047	80	39	.	.	PUNCT
cuesj-1047	81	1	even	even	ADV
cuesj-1047	81	2	after	after	ADP
cuesj-1047	81	3	adjusting	adjust	VERB
cuesj-1047	81	4	for	for	ADP
cuesj-1047	81	5	age	age	NOUN
cuesj-1047	81	6	,	,	PUNCT
cuesj-1047	81	7	the	the	DET
cuesj-1047	81	8	three	three	NUM
cuesj-1047	81	9	doses	dose	NOUN
cuesj-1047	81	10	of	of	ADP
cuesj-1047	81	11	mrna	mrna	PROPN
cuesj-1047	81	12	vaccination	vaccination	NOUN
cuesj-1047	81	13	had	have	VERB
cuesj-1047	81	14	a	a	DET
cuesj-1047	81	15	continuing	continue	VERB
cuesj-1047	81	16	effect	effect	NOUN
cuesj-1047	81	17	on	on	ADP
cuesj-1047	81	18	the	the	DET
cuesj-1047	81	19	demand	demand	NOUN
cuesj-1047	81	20	for	for	ADP
cuesj-1047	81	21	oxygen	oxygen	NOUN
cuesj-1047	81	22	and	and	CCONJ
cuesj-1047	81	23	hospitalization	hospitalization	NOUN
cuesj-1047	81	24	rate	rate	NOUN
cuesj-1047	81	25	,	,	PUNCT
cuesj-1047	81	26	having	having	AUX
cuesj-1047	81	27	undergone	undergo	VERB
cuesj-1047	81	28	a	a	DET
cuesj-1047	81	29	liver	liver	NOUN
cuesj-1047	81	30	transplant	transplant	NOUN
cuesj-1047	81	31	,	,	PUNCT
cuesj-1047	81	32	the	the	DET
cuesj-1047	81	33	number	number	NOUN
cuesj-1047	81	34	of	of	ADP
cuesj-1047	81	35	coexisting	coexist	VERB
cuesj-1047	81	36	conditions	condition	NOUN
cuesj-1047	81	37	,	,	PUNCT
cuesj-1047	81	38	and	and	CCONJ
cuesj-1047	81	39	storm	storm	NOUN
cuesj-1047	81	40	medication	medication	NOUN
cuesj-1047	81	41	.	.	PUNCT
cuesj-1047	82	1	the	the	DET
cuesj-1047	82	2	results	result	NOUN
cuesj-1047	82	3	remained	remain	VERB
cuesj-1047	82	4	unchanged	unchanged	ADJ
cuesj-1047	82	5	between	between	ADP
cuesj-1047	82	6	patients	patient	NOUN
cuesj-1047	82	7	who	who	PRON
cuesj-1047	82	8	received	receive	VERB
cuesj-1047	82	9	the	the	DET
cuesj-1047	82	10	mrna1273	mrna1273	PROPN
cuesj-1047	82	11	vaccine	vaccine	NOUN
cuesj-1047	82	12	and	and	CCONJ
cuesj-1047	82	13	those	those	PRON
cuesj-1047	82	14	who	who	PRON
cuesj-1047	82	15	got	get	VERB
cuesj-1047	82	16	the	the	DET
cuesj-1047	82	17	bnt162b2	bnt162b2	NOUN
cuesj-1047	82	18	vaccine.[33	vaccine.[33	NOUN
cuesj-1047	82	19	]	]	X
cuesj-1047	82	20	pathological	pathological	ADJ
cuesj-1047	82	21	profiles	profile	NOUN
cuesj-1047	82	22	and	and	CCONJ
cuesj-1047	82	23	results	result	NOUN
cuesj-1047	82	24	among	among	ADP
cuesj-1047	82	25	adults	adult	NOUN
cuesj-1047	82	26	with	with	ADP
cuesj-1047	82	27	hospitalized	hospitalize	VERB
cuesj-1047	82	28	sars	sars	PROPN
cuesj-1047	82	29	-	-	PUNCT
cuesj-1047	82	30	cov-2	cov-2	PART
cuesj-1047	82	31	infection	infection	NOUN
cuesj-1047	82	32	during	during	ADP
cuesj-1047	82	33	periods	period	NOUN
cuesj-1047	82	34	of	of	ADP
cuesj-1047	82	35	b.1.617.2	b.1.617.2	PROPN
cuesj-1047	82	36	(	(	PUNCT
cuesj-1047	82	37	delta	delta	NOUN
cuesj-1047	82	38	)	)	PUNCT
cuesj-1047	82	39	and	and	CCONJ
cuesj-1047	82	40	the	the	DET
cuesj-1047	82	41	b.1.1.529	b.1.1.529	ADJ
cuesj-1047	82	42	(	(	PUNCT
cuesj-1047	82	43	omicron	omicron	PROPN
cuesj-1047	82	44	)	)	PUNCT
cuesj-1047	82	45	variant	variant	NOUN
cuesj-1047	82	46	the	the	DET
cuesj-1047	82	47	coronavirus	coronavirus	NOUN
cuesj-1047	82	48	-	-	PUNCT
cuesj-1047	82	49	causing	cause	VERB
cuesj-1047	82	50	sars	sar	NOUN
cuesj-1047	82	51	-	-	PUNCT
cuesj-1047	82	52	cov-2	cov-2	PART
cuesj-1047	82	53	virus	virus	NOUN
cuesj-1047	82	54	(	(	PUNCT
cuesj-1047	82	55	omicron	omicron	PROPN
cuesj-1047	82	56	)	)	PUNCT
cuesj-1047	82	57	form	form	NOUN
cuesj-1047	82	58	has	have	AUX
cuesj-1047	82	59	prevailed	prevail	VERB
cuesj-1047	82	60	the	the	DET
cuesj-1047	82	61	(	(	PUNCT
cuesj-1047	82	62	delta	delta	NOUN
cuesj-1047	82	63	)	)	PUNCT
cuesj-1047	82	64	variant	variant	NOUN
cuesj-1047	82	65	being	be	AUX
cuesj-1047	82	66	the	the	DET
cuesj-1047	82	67	common	common	ADJ
cuesj-1047	82	68	strain	strain	NOUN
cuesj-1047	82	69	in	in	ADP
cuesj-1047	82	70	california	california	PROPN
cuesj-1047	82	71	.	.	PUNCT
cuesj-1047	83	1	compared	compare	VERB
cuesj-1047	83	2	to	to	ADP
cuesj-1047	83	3	earlier	early	ADJ
cuesj-1047	83	4	versions	version	NOUN
cuesj-1047	83	5	,	,	PUNCT
cuesj-1047	83	6	the	the	DET
cuesj-1047	83	7	omicron	omicron	PROPN
cuesj-1047	83	8	form	form	NOUN
cuesj-1047	83	9	is	be	AUX
cuesj-1047	83	10	more	more	ADV
cuesj-1047	83	11	contagious	contagious	ADJ
cuesj-1047	83	12	and	and	CCONJ
cuesj-1047	83	13	immune	immune	ADJ
cuesj-1047	83	14	to	to	ADP
cuesj-1047	83	15	vaccination	vaccination	NOUN
cuesj-1047	83	16	neutralization	neutralization	NOUN
cuesj-1047	83	17	.	.	PUNCT
cuesj-1047	84	1	there	there	PRON
cuesj-1047	84	2	were	be	VERB
cuesj-1047	84	3	fewer	few	ADJ
cuesj-1047	84	4	hospital	hospital	NOUN
cuesj-1047	84	5	deaths	death	NOUN
cuesj-1047	84	6	among	among	ADP
cuesj-1047	84	7	fully	fully	ADV
cuesj-1047	84	8	immunized	immunize	VERB
cuesj-1047	84	9	omicron	omicron	NOUN
cuesj-1047	84	10	-	-	PUNCT
cuesj-1047	84	11	period	period	NOUN
cuesj-1047	84	12	patients	patient	NOUN
cuesj-1047	84	13	than	than	ADP
cuesj-1047	84	14	among	among	ADP
cuesj-1047	84	15	delta	delta	NOUN
cuesj-1047	84	16	-	-	PUNCT
cuesj-1047	84	17	period	period	NOUN
cuesj-1047	84	18	people	people	NOUN
cuesj-1047	84	19	.	.	PUNCT
cuesj-1047	85	1	for	for	ADP
cuesj-1047	85	2	older	old	ADJ
cuesj-1047	85	3	people	people	NOUN
cuesj-1047	85	4	with	with	ADP
cuesj-1047	85	5	sars	sar	NOUN
cuesj-1047	85	6	-	-	PUNCT
cuesj-1047	85	7	cov-2	cov-2	PART
cuesj-1047	85	8	infection	infection	NOUN
cuesj-1047	85	9	,	,	PUNCT
cuesj-1047	85	10	vaccines	vaccine	NOUN
cuesj-1047	85	11	including	include	VERB
cuesj-1047	85	12	a	a	DET
cuesj-1047	85	13	booster	booster	NOUN
cuesj-1047	85	14	shot	shot	NOUN
cuesj-1047	85	15	for	for	ADP
cuesj-1047	85	16	those	those	PRON
cuesj-1047	85	17	who	who	PRON
cuesj-1047	85	18	have	have	AUX
cuesj-1047	85	19	already	already	ADV
cuesj-1047	85	20	received	receive	VERB
cuesj-1047	85	21	the	the	DET
cuesj-1047	85	22	vaccine	vaccine	NOUN
cuesj-1047	85	23	remain	remain	VERB
cuesj-1047	85	24	essential	essential	ADJ
cuesj-1047	85	25	in	in	ADP
cuesj-1047	85	26	reducing	reduce	VERB
cuesj-1047	85	27	the	the	DET
cuesj-1047	85	28	risk	risk	NOUN
cuesj-1047	85	29	of	of	ADP
cuesj-1047	85	30	serious	serious	ADJ
cuesj-1047	85	31	health	health	NOUN
cuesj-1047	85	32	consequences	consequence	NOUN
cuesj-1047	85	33	.	.	PUNCT
cuesj-1047	86	1	more	more	ADJ
cuesj-1047	86	2	people	people	NOUN
cuesj-1047	86	3	had	have	AUX
cuesj-1047	86	4	received	receive	VERB
cuesj-1047	86	5	all	all	DET
cuesj-1047	86	6	advised	advise	VERB
cuesj-1047	86	7	immunizations	immunization	NOUN
cuesj-1047	86	8	and	and	CCONJ
cuesj-1047	86	9	fewer	few	ADJ
cuesj-1047	86	10	persons	person	NOUN
cuesj-1047	86	11	had	have	AUX
cuesj-1047	86	12	not	not	PART
cuesj-1047	86	13	been	be	AUX
cuesj-1047	86	14	among	among	ADP
cuesj-1047	86	15	737	737	NUM
cuesj-1047	86	16	adults	adult	NOUN
cuesj-1047	86	17	hospitalized	hospitalize	VERB
cuesj-1047	86	18	during	during	ADP
cuesj-1047	86	19	the	the	DET
cuesj-1047	86	20	omicron	omicron	PROPN
cuesj-1047	86	21	era	era	NOUN
cuesj-1047	86	22	.	.	PUNCT
cuesj-1047	87	1	this	this	PRON
cuesj-1047	87	2	compares	compare	VERB
cuesj-1047	87	3	to	to	ADP
cuesj-1047	87	4	the	the	DET
cuesj-1047	87	5	339	339	NUM
cuesj-1047	87	6	individuals	individual	NOUN
cuesj-1047	87	7	hospitalized	hospitalize	VERB
cuesj-1047	87	8	during	during	ADP
cuesj-1047	87	9	the	the	DET
cuesj-1047	87	10	delta	delta	NOUN
cuesj-1047	87	11	dominating	dominating	NOUN
cuesj-1047	87	12	period	period	NOUN
cuesj-1047	87	13	.	.	PUNCT
cuesj-1047	88	1	less	less	ADJ
cuesj-1047	88	2	omicron	omicron	NOUN
cuesj-1047	88	3	-	-	PUNCT
cuesj-1047	88	4	period	period	NOUN
cuesj-1047	88	5	patients	patient	NOUN
cuesj-1047	88	6	needed	need	VERB
cuesj-1047	88	7	to	to	PART
cuesj-1047	88	8	be	be	AUX
cuesj-1047	88	9	admitted	admit	VERB
cuesj-1047	88	10	to	to	ADP
cuesj-1047	88	11	the	the	DET
cuesj-1047	88	12	intensive	intensive	ADJ
cuesj-1047	88	13	care	care	NOUN
cuesj-1047	88	14	unit	unit	NOUN
cuesj-1047	88	15	(	(	PUNCT
cuesj-1047	88	16	icu	icu	PROPN
cuesj-1047	88	17	)	)	PUNCT
cuesj-1047	88	18	than	than	SCONJ
cuesj-1047	88	19	delta	delta	NOUN
cuesj-1047	88	20	-	-	PUNCT
cuesj-1047	88	21	period	period	NOUN
cuesj-1047	88	22	patients	patient	NOUN
cuesj-1047	88	23	did	do	VERB
cuesj-1047	88	24	.	.	PUNCT
cuesj-1047	89	1	adults	adult	NOUN
cuesj-1047	89	2	who	who	PRON
cuesj-1047	89	3	were	be	AUX
cuesj-1047	89	4	fully	fully	ADV
cuesj-1047	89	5	immunized	immunize	VERB
cuesj-1047	89	6	and	and	CCONJ
cuesj-1047	89	7	hospitalized	hospitalize	VERB
cuesj-1047	89	8	during	during	ADP
cuesj-1047	89	9	the	the	DET
cuesj-1047	89	10	omicron	omicron	PROPN
cuesj-1047	89	11	predominance	predominance	NOUN
cuesj-1047	89	12	period	period	NOUN
cuesj-1047	89	13	died	die	VERB
cuesj-1047	89	14	less	less	ADV
cuesj-1047	89	15	frequently	frequently	ADV
cuesj-1047	89	16	than	than	ADP
cuesj-1047	89	17	those	those	PRON
cuesj-1047	89	18	who	who	PRON
cuesj-1047	89	19	were	be	AUX
cuesj-1047	89	20	hospitalized	hospitalize	VERB
cuesj-1047	89	21	during	during	ADP
cuesj-1047	89	22	the	the	DET
cuesj-1047	89	23	delta	delta	NOUN
cuesj-1047	89	24	predominance	predominance	NOUN
cuesj-1047	89	25	period.[34	period.[34	PROPN
cuesj-1047	89	26	]	]	PUNCT
cuesj-1047	89	27	vaccinations	vaccination	NOUN
cuesj-1047	89	28	for	for	ADP
cuesj-1047	89	29	omicron	omicron	PROPN
cuesj-1047	89	30	infection	infection	NOUN
cuesj-1047	89	31	as	as	SCONJ
cuesj-1047	89	32	opposed	oppose	VERB
cuesj-1047	89	33	to	to	ADP
cuesj-1047	89	34	omicron	omicron	PROPN
cuesj-1047	89	35	sickness	sickness	PROPN
cuesj-1047	89	36	despite	despite	SCONJ
cuesj-1047	89	37	the	the	DET
cuesj-1047	89	38	fact	fact	NOUN
cuesj-1047	89	39	that	that	SCONJ
cuesj-1047	89	40	the	the	DET
cuesj-1047	89	41	vaccine	vaccine	NOUN
cuesj-1047	89	42	normally	normally	ADV
cuesj-1047	89	43	has	have	AUX
cuesj-1047	89	44	a	a	DET
cuesj-1047	89	45	higher	high	ADJ
cuesj-1047	89	46	efficiency	efficiency	NOUN
cuesj-1047	89	47	against	against	ADP
cuesj-1047	89	48	severe	severe	ADJ
cuesj-1047	89	49	omicron	omicron	PROPN
cuesj-1047	89	50	disease	disease	NOUN
cuesj-1047	89	51	,	,	PUNCT
cuesj-1047	89	52	several	several	ADJ
cuesj-1047	89	53	studies	study	NOUN
cuesj-1047	89	54	have	have	AUX
cuesj-1047	89	55	found	find	VERB
cuesj-1047	89	56	variations	variation	NOUN
cuesj-1047	89	57	,	,	PUNCT
cuesj-1047	89	58	including	include	VERB
cuesj-1047	89	59	rapid	rapid	ADJ
cuesj-1047	89	60	apparent	apparent	ADJ
cuesj-1047	89	61	waning	waning	NOUN
cuesj-1047	89	62	.	.	PUNCT
cuesj-1047	90	1	in	in	ADP
cuesj-1047	90	2	comparison	comparison	NOUN
cuesj-1047	90	3	to	to	ADP
cuesj-1047	90	4	other	other	ADJ
cuesj-1047	90	5	forms	form	NOUN
cuesj-1047	90	6	,	,	PUNCT
cuesj-1047	90	7	including	include	VERB
cuesj-1047	90	8	delta	delta	NOUN
cuesj-1047	90	9	,	,	PUNCT
cuesj-1047	90	10	the	the	DET
cuesj-1047	90	11	vaccine	vaccine	NOUN
cuesj-1047	90	12	’s	’s	PART
cuesj-1047	90	13	protection	protection	NOUN
cuesj-1047	90	14	against	against	ADP
cuesj-1047	90	15	omicron	omicron	PROPN
cuesj-1047	90	16	-	-	PUNCT
cuesj-1047	90	17	caused	cause	VERB
cuesj-1047	90	18	illness	illness	NOUN
cuesj-1047	90	19	and	and	CCONJ
cuesj-1047	90	20	infection	infection	NOUN
cuesj-1047	90	21	is	be	AUX
cuesj-1047	90	22	less	less	ADV
cuesj-1047	90	23	effective	effective	ADJ
cuesj-1047	90	24	.	.	PUNCT
cuesj-1047	91	1	the	the	DET
cuesj-1047	91	2	average	average	ADJ
cuesj-1047	91	3	effectiveness	effectiveness	NOUN
cuesj-1047	91	4	of	of	ADP
cuesj-1047	91	5	immunization	immunization	NOUN
cuesj-1047	91	6	against	against	ADP
cuesj-1047	91	7	severe	severe	ADJ
cuesj-1047	91	8	omicron	omicron	PROPN
cuesj-1047	91	9	disease	disease	NOUN
cuesj-1047	91	10	is	be	AUX
cuesj-1047	91	11	greater	great	ADJ
cuesj-1047	91	12	,	,	PUNCT
cuesj-1047	91	13	possibly	possibly	ADV
cuesj-1047	91	14	due	due	ADP
cuesj-1047	91	15	to	to	ADP
cuesj-1047	91	16	the	the	DET
cuesj-1047	91	17	continued	continued	ADJ
cuesj-1047	91	18	existence	existence	NOUN
cuesj-1047	91	19	of	of	ADP
cuesj-1047	91	20	cellular	cellular	ADJ
cuesj-1047	91	21	immunity	immunity	NOUN
cuesj-1047	91	22	.	.	PUNCT
cuesj-1047	92	1	it	it	PRON
cuesj-1047	92	2	is	be	AUX
cuesj-1047	92	3	now	now	ADV
cuesj-1047	92	4	more	more	ADV
cuesj-1047	92	5	difficult	difficult	ADJ
cuesj-1047	92	6	to	to	PART
cuesj-1047	92	7	determine	determine	VERB
cuesj-1047	92	8	the	the	DET
cuesj-1047	92	9	efficacy	efficacy	NOUN
cuesj-1047	92	10	of	of	ADP
cuesj-1047	92	11	vaccination	vaccination	NOUN
cuesj-1047	92	12	against	against	ADP
cuesj-1047	92	13	omicron	omicron	PROPN
cuesj-1047	92	14	severe	severe	ADJ
cuesj-1047	92	15	illness	illness	NOUN
cuesj-1047	92	16	,	,	PUNCT
cuesj-1047	92	17	nevertheless	nevertheless	ADV
cuesj-1047	92	18	,	,	PUNCT
cuesj-1047	92	19	due	due	ADP
cuesj-1047	92	20	to	to	ADP
cuesj-1047	92	21	the	the	DET
cuesj-1047	92	22	high	high	ADJ
cuesj-1047	92	23	incidence	incidence	NOUN
cuesj-1047	92	24	of	of	ADP
cuesj-1047	92	25	infection	infection	NOUN
cuesj-1047	92	26	.	.	PUNCT
cuesj-1047	93	1	at	at	ADV
cuesj-1047	93	2	least	least	ADV
cuesj-1047	93	3	3	3	NUM
cuesj-1047	93	4	months	month	NOUN
cuesj-1047	93	5	following	follow	VERB
cuesj-1047	93	6	the	the	DET
cuesj-1047	93	7	booster	booster	NOUN
cuesj-1047	93	8	dosage	dosage	NOUN
cuesj-1047	93	9	,	,	PUNCT
cuesj-1047	93	10	there	there	PRON
cuesj-1047	93	11	have	have	AUX
cuesj-1047	93	12	not	not	PART
cuesj-1047	93	13	been	be	AUX
cuesj-1047	93	14	many	many	ADJ
cuesj-1047	93	15	trials	trial	NOUN
cuesj-1047	93	16	evaluating	evaluate	VERB
cuesj-1047	93	17	the	the	DET
cuesj-1047	93	18	vaccine	vaccine	NOUN
cuesj-1047	93	19	’s	’s	PART
cuesj-1047	93	20	effectiveness	effectiveness	NOUN
cuesj-1047	93	21	against	against	ADP
cuesj-1047	93	22	severe	severe	ADJ
cuesj-1047	93	23	omicron	omicron	PROPN
cuesj-1047	93	24	illness	illness	NOUN
cuesj-1047	93	25	.	.	PUNCT
cuesj-1047	94	1	when	when	SCONJ
cuesj-1047	94	2	hospitalization	hospitalization	NOUN
cuesj-1047	94	3	for	for	ADP
cuesj-1047	94	4	severe	severe	ADJ
cuesj-1047	94	5	illness	illness	NOUN
cuesj-1047	94	6	is	be	AUX
cuesj-1047	94	7	regarded	regard	VERB
cuesj-1047	94	8	as	as	ADP
cuesj-1047	94	9	requiring	require	VERB
cuesj-1047	94	10	neither	neither	CCONJ
cuesj-1047	94	11	covid-19	covid-19	PROPN
cuesj-1047	94	12	clinical	clinical	ADJ
cuesj-1047	94	13	criteria	criterion	NOUN
cuesj-1047	94	14	nor	nor	CCONJ
cuesj-1047	94	15	hospitalization	hospitalization	NOUN
cuesj-1047	94	16	without	without	ADP
cuesj-1047	94	17	those	those	DET
cuesj-1047	94	18	requirements	requirement	NOUN
cuesj-1047	94	19	,	,	PUNCT
cuesj-1047	94	20	there	there	PRON
cuesj-1047	94	21	has	have	AUX
cuesj-1047	94	22	been	be	AUX
cuesj-1047	94	23	some	some	DET
cuesj-1047	94	24	evidence	evidence	NOUN
cuesj-1047	94	25	to	to	PART
cuesj-1047	94	26	suggest	suggest	VERB
cuesj-1047	94	27	that	that	SCONJ
cuesj-1047	94	28	the	the	DET
cuesj-1047	94	29	effectiveness	effectiveness	NOUN
cuesj-1047	94	30	of	of	ADP
cuesj-1047	94	31	vaccines	vaccine	NOUN
cuesj-1047	94	32	decreases	decrease	VERB
cuesj-1047	94	33	beyond	beyond	ADP
cuesj-1047	94	34	the	the	DET
cuesj-1047	94	35	first	first	ADJ
cuesj-1047	94	36	series	series	NOUN
cuesj-1047	94	37	,	,	PUNCT
cuesj-1047	94	38	especially	especially	ADV
cuesj-1047	94	39	after	after	ADP
cuesj-1047	94	40	3	3	NUM
cuesj-1047	94	41	-	-	PUNCT
cuesj-1047	94	42	month	month	NOUN
cuesj-1047	94	43	postvaccination	postvaccination	NOUN
cuesj-1047	94	44	.	.	PUNCT
cuesj-1047	95	1	in	in	ADP
cuesj-1047	95	2	comparison	comparison	NOUN
cuesj-1047	95	3	to	to	ADP
cuesj-1047	95	4	the	the	DET
cuesj-1047	95	5	delta	delta	NOUN
cuesj-1047	95	6	,	,	PUNCT
cuesj-1047	95	7	the	the	DET
cuesj-1047	95	8	omicron	omicron	NOUN
cuesj-1047	95	9	showed	show	VERB
cuesj-1047	95	10	a	a	DET
cuesj-1047	95	11	larger	large	ADJ
cuesj-1047	95	12	variation	variation	NOUN
cuesj-1047	95	13	in	in	ADP
cuesj-1047	95	14	vaccination	vaccination	NOUN
cuesj-1047	95	15	efficacy	efficacy	NOUN
cuesj-1047	95	16	among	among	ADP
cuesj-1047	95	17	hospitalized	hospitalize	VERB
cuesj-1047	95	18	cases	case	NOUN
cuesj-1047	95	19	.	.	PUNCT
cuesj-1047	96	1	in	in	ADP
cuesj-1047	96	2	addition	addition	NOUN
cuesj-1047	96	3	,	,	PUNCT
cuesj-1047	96	4	using	use	VERB
cuesj-1047	96	5	all	all	DET
cuesj-1047	96	6	admissions	admission	NOUN
cuesj-1047	96	7	caused	cause	VERB
cuesj-1047	96	8	a	a	DET
cuesj-1047	96	9	gradual	gradual	ADJ
cuesj-1047	96	10	reduction	reduction	NOUN
cuesj-1047	96	11	in	in	ADP
cuesj-1047	96	12	“	"	PUNCT
cuesj-1047	96	13	severe	severe	ADJ
cuesj-1047	96	14	”	"	PUNCT
cuesj-1047	96	15	omicron	omicron	PROPN
cuesj-1047	96	16	illness	illness	NOUN
cuesj-1047	96	17	effectiveness	effectiveness	NOUN
cuesj-1047	96	18	whereas	whereas	SCONJ
cuesj-1047	96	19	utilizing	utilize	VERB
cuesj-1047	96	20	more	more	ADV
cuesj-1047	96	21	precise	precise	ADJ
cuesj-1047	96	22	terminology	terminology	NOUN
cuesj-1047	96	23	to	to	PART
cuesj-1047	96	24	describe	describe	VERB
cuesj-1047	96	25	extreme	extreme	ADJ
cuesj-1047	96	26	covid19	covid19	NOUN
cuesj-1047	96	27	illness	illness	NOUN
cuesj-1047	96	28	caused	cause	VERB
cuesj-1047	96	29	a	a	DET
cuesj-1047	96	30	noticeably	noticeably	ADV
cuesj-1047	96	31	lower	low	ADJ
cuesj-1047	96	32	decline.[35	decline.[35	PROPN
cuesj-1047	96	33	]	]	PUNCT
cuesj-1047	96	34	covid-19	covid-19	PROPN
cuesj-1047	96	35	rapid	rapid	ADJ
cuesj-1047	96	36	antigen	antigen	ADJ
cuesj-1047	96	37	test	test	NOUN
cuesj-1047	96	38	diagnostic	diagnostic	ADJ
cuesj-1047	96	39	adequacy	adequacy	NOUN
cuesj-1047	96	40	using	use	VERB
cuesj-1047	96	41	uncontrolled	uncontrolled	ADJ
cuesj-1047	96	42	self	self	NOUN
cuesj-1047	96	43	-	-	PUNCT
cuesj-1047	96	44	sampling	sample	VERB
cuesj-1047	96	45	three	three	NUM
cuesj-1047	96	46	quick	quick	ADJ
cuesj-1047	96	47	tests	test	NOUN
cuesj-1047	96	48	for	for	ADP
cuesj-1047	96	49	antigens	antigen	NOUN
cuesj-1047	96	50	using	use	VERB
cuesj-1047	96	51	nose	nose	NOUN
cuesj-1047	96	52	self	self	NOUN
cuesj-1047	96	53	-	-	PUNCT
cuesj-1047	96	54	samples	sample	NOUN
cuesj-1047	96	55	all	all	PRON
cuesj-1047	96	56	showed	show	VERB
cuesj-1047	96	57	lower	low	ADJ
cuesj-1047	96	58	sensitivity	sensitivity	NOUN
cuesj-1047	96	59	after	after	ADP
cuesj-1047	96	60	the	the	DET
cuesj-1047	96	61	development	development	NOUN
cuesj-1047	96	62	of	of	ADP
cuesj-1047	96	63	omicron	omicron	PROPN
cuesj-1047	96	64	,	,	PUNCT
cuesj-1047	96	65	however	however	ADV
cuesj-1047	96	66	,	,	PUNCT
cuesj-1047	96	67	only	only	ADV
cuesj-1047	96	68	the	the	DET
cuesj-1047	96	69	clinical	clinical	ADJ
cuesj-1047	96	70	test	test	NOUN
cuesj-1047	96	71	showed	show	VERB
cuesj-1047	96	72	statistical	statistical	ADJ
cuesj-1047	96	73	significance	significance	NOUN
cuesj-1047	96	74	.	.	PUNCT
cuesj-1047	97	1	the	the	DET
cuesj-1047	97	2	effectiveness	effectiveness	NOUN
cuesj-1047	97	3	of	of	ADP
cuesj-1047	97	4	quick	quick	ADJ
cuesj-1047	97	5	antigen	antigen	ADJ
cuesj-1047	97	6	testing	testing	NOUN
cuesj-1047	97	7	to	to	PART
cuesj-1047	97	8	detect	detect	VERB
cuesj-1047	97	9	sars	sar	NOUN
cuesj-1047	97	10	-	-	PUNCT
cuesj-1047	97	11	cov-2	cov-2	NOUN
cuesj-1047	97	12	.	.	PUNCT
cuesj-1047	98	1	1–5	1–5	PRON
cuesj-1047	98	2	seemed	seem	VERB
cuesj-1047	98	3	promising	promise	VERB
cuesj-1047	98	4	.	.	PUNCT
cuesj-1047	99	1	the	the	DET
cuesj-1047	99	2	tests	test	NOUN
cuesj-1047	99	3	can	can	AUX
cuesj-1047	99	4	be	be	AUX
cuesj-1047	99	5	carried	carry	VERB
cuesj-1047	99	6	out	out	ADP
cuesj-1047	99	7	in	in	ADP
cuesj-1047	99	8	a	a	DET
cuesj-1047	99	9	variety	variety	NOUN
cuesj-1047	99	10	of	of	ADP
cuesj-1047	99	11	situations	situation	NOUN
cuesj-1047	99	12	without	without	ADP
cuesj-1047	99	13	laboratory	laboratory	NOUN
cuesj-1047	99	14	facilities	facility	NOUN
cuesj-1047	99	15	,	,	PUNCT
cuesj-1047	99	16	need	need	VERB
cuesj-1047	99	17	little	little	ADJ
cuesj-1047	99	18	equipment	equipment	NOUN
cuesj-1047	99	19	,	,	PUNCT
cuesj-1047	99	20	and	and	CCONJ
cuesj-1047	99	21	give	give	VERB
cuesj-1047	99	22	results	result	NOUN
cuesj-1047	99	23	in	in	ADP
cuesj-1047	99	24	15–30	15–30	NUM
cuesj-1047	99	25	min	min	NOUN
cuesj-1047	99	26	.	.	PROPN
cuesj-1047	99	27	rapid	rapid	ADJ
cuesj-1047	99	28	antigen	antigen	ADJ
cuesj-1047	99	29	tests	test	NOUN
cuesj-1047	99	30	are	be	AUX
cuesj-1047	99	31	now	now	ADV
cuesj-1047	99	32	commonly	commonly	ADV
cuesj-1047	99	33	available	available	ADJ
cuesj-1047	99	34	as	as	ADP
cuesj-1047	99	35	over	over	ADP
cuesj-1047	99	36	-	-	PUNCT
cuesj-1047	99	37	the	the	DET
cuesj-1047	99	38	-	-	PUNCT
cuesj-1047	99	39	counter	counter	NOUN
cuesj-1047	99	40	assays	assay	NOUN
cuesj-1047	99	41	,	,	PUNCT
cuesj-1047	99	42	despite	despite	SCONJ
cuesj-1047	99	43	the	the	DET
cuesj-1047	99	44	fact	fact	NOUN
cuesj-1047	99	45	that	that	SCONJ
cuesj-1047	99	46	they	they	PRON
cuesj-1047	99	47	should	should	AUX
cuesj-1047	99	48	only	only	ADV
cuesj-1047	99	49	be	be	AUX
cuesj-1047	99	50	utilized	utilize	VERB
cuesj-1047	99	51	by	by	ADP
cuesj-1047	99	52	qualified	qualified	ADJ
cuesj-1047	99	53	specialists	specialist	NOUN
cuesj-1047	99	54	.	.	PUNCT
cuesj-1047	100	1	self	self	NOUN
cuesj-1047	100	2	-	-	PUNCT
cuesj-1047	100	3	testing	testing	NOUN
cuesj-1047	100	4	reduces	reduce	VERB
cuesj-1047	100	5	the	the	DET
cuesj-1047	100	6	bar	bar	NOUN
cuesj-1047	100	7	for	for	ADP
cuesj-1047	100	8	testing	testing	NOUN
cuesj-1047	100	9	and	and	CCONJ
cuesj-1047	100	10	allows	allow	VERB
cuesj-1047	100	11	people	people	NOUN
cuesj-1047	100	12	to	to	PART
cuesj-1047	100	13	receive	receive	VERB
cuesj-1047	100	14	an	an	DET
cuesj-1047	100	15	outcome	outcome	NOUN
cuesj-1047	100	16	without	without	ADP
cuesj-1047	100	17	the	the	DET
cuesj-1047	100	18	guidance	guidance	NOUN
cuesj-1047	100	19	of	of	ADP
cuesj-1047	100	20	a	a	DET
cuesj-1047	100	21	certified	certified	ADJ
cuesj-1047	100	22	professional.[36	professional.[36	NOUN
cuesj-1047	100	23	]	]	X
cuesj-1047	100	24	hussein	hussein	PROPN
cuesj-1047	100	25	,	,	PUNCT
cuesj-1047	100	26	et	et	PROPN
cuesj-1047	100	27	al	al	PROPN
cuesj-1047	100	28	.	.	PUNCT
cuesj-1047	100	29	:	:	PUNCT
cuesj-1047	101	1	a	a	DET
cuesj-1047	101	2	review	review	NOUN
cuesj-1047	101	3	on	on	ADP
cuesj-1047	101	4	coronavirus	coronavirus	NOUN
cuesj-1047	101	5	and	and	CCONJ
cuesj-1047	101	6	omicron	omicron	PROPN
cuesj-1047	101	7	patients	patient	NOUN
cuesj-1047	101	8	12	12	NUM
cuesj-1047	101	9	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	101	10	cuesj	cuesj	ADJ
cuesj-1047	101	11	2024	2024	NUM
cuesj-1047	101	12	,	,	PUNCT
cuesj-1047	101	13	8	8	NUM
cuesj-1047	101	14	(	(	PUNCT
cuesj-1047	101	15	1	1	NUM
cuesj-1047	101	16	):	):	PUNCT
cuesj-1047	101	17	8	8	NUM
cuesj-1047	101	18	-	-	SYM
cuesj-1047	101	19	17	17	NUM
cuesj-1047	101	20	the	the	DET
cuesj-1047	101	21	correlation	correlation	NOUN
cuesj-1047	101	22	between	between	ADP
cuesj-1047	101	23	the	the	DET
cuesj-1047	101	24	covid-19	covid-19	PROPN
cuesj-1047	101	25	vaccine	vaccine	NOUN
cuesj-1047	101	26	and	and	CCONJ
cuesj-1047	101	27	hospitalization	hospitalization	NOUN
cuesj-1047	101	28	in	in	ADP
cuesj-1047	101	29	patients	patient	NOUN
cuesj-1047	101	30	taking	take	VERB
cuesj-1047	101	31	immunosuppressive	immunosuppressive	ADJ
cuesj-1047	101	32	drugs	drug	NOUN
cuesj-1047	101	33	patients	patient	NOUN
cuesj-1047	101	34	who	who	PRON
cuesj-1047	101	35	were	be	AUX
cuesj-1047	101	36	taking	take	VERB
cuesj-1047	101	37	immunosuppressive	immunosuppressive	ADJ
cuesj-1047	101	38	dmards	dmard	NOUN
cuesj-1047	101	39	or	or	CCONJ
cuesj-1047	101	40	glucocorticoids	glucocorticoid	NOUN
cuesj-1047	101	41	had	have	VERB
cuesj-1047	101	42	a	a	DET
cuesj-1047	101	43	greater	great	ADJ
cuesj-1047	101	44	incidence	incidence	NOUN
cuesj-1047	101	45	of	of	ADP
cuesj-1047	101	46	covid-19	covid-19	PROPN
cuesj-1047	101	47	-	-	PUNCT
cuesj-1047	101	48	associated	associate	VERB
cuesj-1047	101	49	hospitalization	hospitalization	NOUN
cuesj-1047	101	50	and	and	CCONJ
cuesj-1047	101	51	sars	sar	NOUN
cuesj-1047	101	52	-	-	PUNCT
cuesj-1047	101	53	cov-2	cov-2	NOUN
cuesj-1047	101	54	illness	illness	NOUN
cuesj-1047	101	55	than	than	ADP
cuesj-1047	101	56	those	those	PRON
cuesj-1047	101	57	who	who	PRON
cuesj-1047	101	58	were	be	AUX
cuesj-1047	101	59	not	not	PART
cuesj-1047	101	60	.	.	PUNCT
cuesj-1047	102	1	those	those	DET
cuesj-1047	102	2	patients	patient	NOUN
cuesj-1047	102	3	who	who	PRON
cuesj-1047	102	4	had	have	VERB
cuesj-1047	102	5	an	an	DET
cuesj-1047	102	6	organ	organ	NOUN
cuesj-1047	102	7	or	or	CCONJ
cuesj-1047	102	8	bone	bone	NOUN
cuesj-1047	102	9	marrow	marrow	NOUN
cuesj-1047	102	10	transplant	transplant	NOUN
cuesj-1047	102	11	were	be	AUX
cuesj-1047	102	12	more	more	ADV
cuesj-1047	102	13	likely	likely	ADJ
cuesj-1047	102	14	to	to	PART
cuesj-1047	102	15	become	become	VERB
cuesj-1047	102	16	ill	ill	ADJ
cuesj-1047	102	17	and	and	CCONJ
cuesj-1047	102	18	need	need	VERB
cuesj-1047	102	19	hospitalization	hospitalization	NOUN
cuesj-1047	102	20	,	,	PUNCT
cuesj-1047	102	21	despite	despite	SCONJ
cuesj-1047	102	22	receiving	receive	VERB
cuesj-1047	102	23	either	either	CCONJ
cuesj-1047	102	24	vaccination	vaccination	NOUN
cuesj-1047	102	25	they	they	PRON
cuesj-1047	102	26	were	be	AUX
cuesj-1047	102	27	still	still	ADV
cuesj-1047	102	28	at	at	ADP
cuesj-1047	102	29	high	high	ADJ
cuesj-1047	102	30	risk	risk	NOUN
cuesj-1047	102	31	.	.	PUNCT
cuesj-1047	103	1	the	the	DET
cuesj-1047	103	2	mrna1273	mrna1273	PROPN
cuesj-1047	103	3	and	and	CCONJ
cuesj-1047	103	4	bnt162b2	bnt162b2	NOUN
cuesj-1047	103	5	vaccines	vaccine	NOUN
cuesj-1047	103	6	had	have	VERB
cuesj-1047	103	7	an	an	DET
cuesj-1047	103	8	effect	effect	NOUN
cuesj-1047	103	9	on	on	ADP
cuesj-1047	103	10	covid-19	covid-19	PROPN
cuesj-1047	103	11	-	-	PUNCT
cuesj-1047	103	12	related	relate	VERB
cuesj-1047	103	13	hospitalization	hospitalization	NOUN
cuesj-1047	103	14	brought	bring	VERB
cuesj-1047	103	15	on	on	ADP
cuesj-1047	103	16	by	by	ADP
cuesj-1047	103	17	the	the	DET
cuesj-1047	103	18	omicron	omicron	PROPN
cuesj-1047	103	19	variant	variant	NOUN
cuesj-1047	103	20	in	in	ADP
cuesj-1047	103	21	individuals	individual	NOUN
cuesj-1047	103	22	using	use	VERB
cuesj-1047	103	23	immunosuppressants	immunosuppressant	NOUN
cuesj-1047	103	24	and	and	CCONJ
cuesj-1047	103	25	can	can	AUX
cuesj-1047	103	26	offer	offer	VERB
cuesj-1047	103	27	some	some	DET
cuesj-1047	103	28	protection	protection	NOUN
cuesj-1047	103	29	against	against	ADP
cuesj-1047	103	30	omicron	omicron	PROPN
cuesj-1047	103	31	infection	infection	NOUN
cuesj-1047	103	32	.	.	PUNCT
cuesj-1047	104	1	the	the	DET
cuesj-1047	104	2	mrna-1273	mrna-1273	ADJ
cuesj-1047	104	3	and	and	CCONJ
cuesj-1047	104	4	bnt162b2	bnt162b2	NOUN
cuesj-1047	104	5	vaccinations	vaccination	NOUN
cuesj-1047	104	6	offered	offer	VERB
cuesj-1047	104	7	superior	superior	ADJ
cuesj-1047	104	8	defense	defense	NOUN
cuesj-1047	104	9	against	against	ADP
cuesj-1047	104	10	covid-19	covid-19	PROPN
cuesj-1047	104	11	-	-	PUNCT
cuesj-1047	104	12	related	relate	VERB
cuesj-1047	104	13	hospitalization	hospitalization	NOUN
cuesj-1047	104	14	in	in	ADP
cuesj-1047	104	15	people	people	NOUN
cuesj-1047	104	16	whose	whose	DET
cuesj-1047	104	17	immune	immune	ADJ
cuesj-1047	104	18	systems	system	NOUN
cuesj-1047	104	19	were	be	AUX
cuesj-1047	104	20	inhibited	inhibit	VERB
cuesj-1047	104	21	throughout	throughout	ADP
cuesj-1047	104	22	the	the	DET
cuesj-1047	104	23	omicron	omicron	NOUN
cuesj-1047	104	24	-	-	PUNCT
cuesj-1047	104	25	dominant	dominant	PROPN
cuesj-1047	104	26	wave	wave	NOUN
cuesj-1047	104	27	sars	sar	NOUN
cuesj-1047	104	28	-	-	PUNCT
cuesj-1047	104	29	cov-2	cov-2	NOUN
cuesj-1047	104	30	.	.	PUNCT
cuesj-1047	105	1	in	in	ADP
cuesj-1047	105	2	addition	addition	NOUN
cuesj-1047	105	3	,	,	PUNCT
cuesj-1047	105	4	any	any	PRON
cuesj-1047	105	5	of	of	ADP
cuesj-1047	105	6	these	these	DET
cuesj-1047	105	7	two	two	NUM
cuesj-1047	105	8	vaccines	vaccine	NOUN
cuesj-1047	105	9	was	be	AUX
cuesj-1047	105	10	very	very	ADV
cuesj-1047	105	11	efficient	efficient	ADJ
cuesj-1047	105	12	in	in	ADP
cuesj-1047	105	13	lowering	lower	VERB
cuesj-1047	105	14	the	the	DET
cuesj-1047	105	15	likelihood	likelihood	NOUN
cuesj-1047	105	16	of	of	ADP
cuesj-1047	105	17	icu	icu	PROPN
cuesj-1047	105	18	admission	admission	NOUN
cuesj-1047	105	19	.	.	PUNCT
cuesj-1047	106	1	both	both	DET
cuesj-1047	106	2	three	three	NUM
cuesj-1047	106	3	and	and	CCONJ
cuesj-1047	106	4	two	two	NUM
cuesj-1047	106	5	doses	dose	NOUN
cuesj-1047	106	6	of	of	ADP
cuesj-1047	106	7	either	either	DET
cuesj-1047	106	8	vaccination	vaccination	NOUN
cuesj-1047	106	9	were	be	AUX
cuesj-1047	106	10	significantly	significantly	ADV
cuesj-1047	106	11	protective	protective	ADJ
cuesj-1047	106	12	against	against	ADP
cuesj-1047	106	13	covid-19	covid-19	PROPN
cuesj-1047	106	14	hospitalization	hospitalization	NOUN
cuesj-1047	106	15	in	in	ADP
cuesj-1047	106	16	both	both	CCONJ
cuesj-1047	106	17	immunocompetent	immunocompetent	ADJ
cuesj-1047	106	18	and	and	CCONJ
cuesj-1047	106	19	immunosuppressed	immunosuppressed	ADJ
cuesj-1047	106	20	individuals	individual	NOUN
cuesj-1047	106	21	.	.	PUNCT
cuesj-1047	107	1	all	all	DET
cuesj-1047	107	2	patients	patient	NOUN
cuesj-1047	107	3	on	on	ADP
cuesj-1047	107	4	immunosuppressive	immunosuppressive	ADJ
cuesj-1047	107	5	drugs	drug	NOUN
cuesj-1047	107	6	such	such	ADJ
cuesj-1047	107	7	as	as	ADP
cuesj-1047	107	8	dmards	dmard	NOUN
cuesj-1047	107	9	or	or	CCONJ
cuesj-1047	107	10	glucocorticoids	glucocorticoid	NOUN
cuesj-1047	107	11	,	,	PUNCT
cuesj-1047	107	12	as	as	ADV
cuesj-1047	107	13	well	well	ADV
cuesj-1047	107	14	as	as	ADP
cuesj-1047	107	15	those	those	PRON
cuesj-1047	107	16	who	who	PRON
cuesj-1047	107	17	have	have	AUX
cuesj-1047	107	18	had	have	VERB
cuesj-1047	107	19	organ	organ	NOUN
cuesj-1047	107	20	or	or	CCONJ
cuesj-1047	107	21	bone	bone	NOUN
cuesj-1047	107	22	marrow	marrow	NOUN
cuesj-1047	107	23	transplants	transplant	NOUN
cuesj-1047	107	24	,	,	PUNCT
cuesj-1047	107	25	significantly	significantly	ADV
cuesj-1047	107	26	had	have	VERB
cuesj-1047	107	27	a	a	DET
cuesj-1047	107	28	higher	high	ADJ
cuesj-1047	107	29	probability	probability	NOUN
cuesj-1047	107	30	of	of	ADP
cuesj-1047	107	31	hospitalization	hospitalization	NOUN
cuesj-1047	107	32	for	for	ADP
cuesj-1047	107	33	covid-19	covid-19	PROPN
cuesj-1047	107	34	,	,	PUNCT
cuesj-1047	107	35	therefore	therefore	ADV
cuesj-1047	107	36	a	a	DET
cuesj-1047	107	37	fourth	fourth	ADJ
cuesj-1047	107	38	dosage	dosage	NOUN
cuesj-1047	107	39	of	of	ADP
cuesj-1047	107	40	vaccination	vaccination	NOUN
cuesj-1047	107	41	would	would	AUX
cuesj-1047	107	42	be	be	AUX
cuesj-1047	107	43	justified.[37	justified.[37	PROPN
cuesj-1047	107	44	]	]	X
cuesj-1047	107	45	the	the	DET
cuesj-1047	107	46	variation	variation	NOUN
cuesj-1047	107	47	in	in	ADP
cuesj-1047	107	48	covid-19	covid-19	PROPN
cuesj-1047	107	49	mortality	mortality	NOUN
cuesj-1047	107	50	risk	risk	NOUN
cuesj-1047	107	51	,	,	PUNCT
cuesj-1047	107	52	as	as	ADV
cuesj-1047	107	53	well	well	ADV
cuesj-1047	107	54	as	as	ADP
cuesj-1047	107	55	immunization	immunization	NOUN
cuesj-1047	107	56	history	history	NOUN
cuesj-1047	107	57	,	,	PUNCT
cuesj-1047	107	58	comorbidities	comorbiditie	NOUN
cuesj-1047	107	59	,	,	PUNCT
cuesj-1047	107	60	and	and	CCONJ
cuesj-1047	107	61	other	other	ADJ
cuesj-1047	107	62	factors	factor	NOUN
cuesj-1047	107	63	there	there	PRON
cuesj-1047	107	64	were	be	VERB
cuesj-1047	107	65	53	53	NUM
cuesj-1047	107	66	deaths	death	NOUN
cuesj-1047	107	67	without	without	ADP
cuesj-1047	107	68	covid-19	covid-19	PROPN
cuesj-1047	107	69	and	and	CCONJ
cuesj-1047	107	70	128	128	NUM
cuesj-1047	107	71	deaths	death	NOUN
cuesj-1047	107	72	involving	involve	VERB
cuesj-1047	107	73	covid-19	covid-19	PROPN
cuesj-1047	107	74	among	among	ADP
cuesj-1047	107	75	those	those	PRON
cuesj-1047	107	76	who	who	PRON
cuesj-1047	107	77	have	have	VERB
cuesj-1047	107	78	omicron	omicron	PROPN
cuesj-1047	107	79	infection	infection	NOUN
cuesj-1047	107	80	,	,	PUNCT
cuesj-1047	107	81	meanwhile	meanwhile	ADV
cuesj-1047	107	82	,	,	PUNCT
cuesj-1047	107	83	in	in	ADP
cuesj-1047	107	84	those	those	PRON
cuesj-1047	107	85	infected	infect	VERB
cuesj-1047	107	86	with	with	ADP
cuesj-1047	107	87	the	the	DET
cuesj-1047	107	88	delta	delta	NOUN
cuesj-1047	107	89	,	,	PUNCT
cuesj-1047	107	90	there	there	PRON
cuesj-1047	107	91	were	be	VERB
cuesj-1047	107	92	189	189	NUM
cuesj-1047	107	93	and	and	CCONJ
cuesj-1047	107	94	28	28	NUM
cuesj-1047	107	95	,	,	PUNCT
cuesj-1047	107	96	respectively	respectively	ADV
cuesj-1047	107	97	.	.	PUNCT
cuesj-1047	108	1	the	the	DET
cuesj-1047	108	2	likelihood	likelihood	NOUN
cuesj-1047	108	3	of	of	ADP
cuesj-1047	108	4	dying	die	VERB
cuesj-1047	108	5	from	from	ADP
cuesj-1047	108	6	covid-19	covid-19	PROPN
cuesj-1047	108	7	was	be	AUX
cuesj-1047	108	8	67	67	NUM
cuesj-1047	108	9	%	%	NOUN
cuesj-1047	108	10	less	less	ADV
cuesj-1047	108	11	likely	likely	ADJ
cuesj-1047	108	12	to	to	PART
cuesj-1047	108	13	happen	happen	VERB
cuesj-1047	108	14	depending	depend	VERB
cuesj-1047	108	15	on	on	ADP
cuesj-1047	108	16	sociodemographic	sociodemographic	ADJ
cuesj-1047	108	17	characteristics	characteristic	NOUN
cuesj-1047	108	18	,	,	PUNCT
cuesj-1047	108	19	vaccination	vaccination	NOUN
cuesj-1047	108	20	status	status	NOUN
cuesj-1047	108	21	,	,	PUNCT
cuesj-1047	108	22	and	and	CCONJ
cuesj-1047	108	23	comorbidity	comorbidity	NOUN
cuesj-1047	108	24	differences	difference	NOUN
cuesj-1047	108	25	,	,	PUNCT
cuesj-1047	108	26	following	follow	VERB
cuesj-1047	108	27	infection	infection	NOUN
cuesj-1047	108	28	with	with	ADP
cuesj-1047	108	29	the	the	DET
cuesj-1047	108	30	omicron	omicron	PROPN
cuesj-1047	108	31	ba.1	ba.1	PROPN
cuesj-1047	108	32	variant	variant	NOUN
cuesj-1047	108	33	in	in	ADP
cuesj-1047	108	34	comparison	comparison	NOUN
cuesj-1047	108	35	to	to	ADP
cuesj-1047	108	36	the	the	DET
cuesj-1047	108	37	delta	delta	NOUN
cuesj-1047	108	38	variant	variant	NOUN
cuesj-1047	108	39	.	.	PUNCT
cuesj-1047	109	1	regarding	regard	VERB
cuesj-1047	109	2	all	all	DET
cuesj-1047	109	3	age	age	NOUN
cuesj-1047	109	4	groups	group	NOUN
cuesj-1047	109	5	,	,	PUNCT
cuesj-1047	109	6	the	the	DET
cuesj-1047	109	7	probability	probability	NOUN
cuesj-1047	109	8	of	of	ADP
cuesj-1047	109	9	dying	die	VERB
cuesj-1047	109	10	from	from	ADP
cuesj-1047	109	11	covid-19	covid-19	PROPN
cuesj-1047	109	12	infection	infection	NOUN
cuesj-1047	109	13	with	with	ADP
cuesj-1047	109	14	omicron	omicron	PROPN
cuesj-1047	109	15	infection	infection	NOUN
cuesj-1047	109	16	was	be	AUX
cuesj-1047	109	17	lower	low	ADJ
cuesj-1047	109	18	than	than	ADP
cuesj-1047	109	19	delta	delta	NOUN
cuesj-1047	109	20	.	.	PUNCT
cuesj-1047	110	1	the	the	DET
cuesj-1047	110	2	relative	relative	ADJ
cuesj-1047	110	3	risk	risk	NOUN
cuesj-1047	110	4	is	be	AUX
cuesj-1047	110	5	lower	low	ADJ
cuesj-1047	110	6	in	in	ADP
cuesj-1047	110	7	younger	young	ADJ
cuesj-1047	110	8	individuals	individual	NOUN
cuesj-1047	110	9	because	because	SCONJ
cuesj-1047	110	10	age	age	NOUN
cuesj-1047	110	11	has	have	VERB
cuesj-1047	110	12	a	a	DET
cuesj-1047	110	13	substantial	substantial	ADJ
cuesj-1047	110	14	impact	impact	NOUN
cuesj-1047	110	15	on	on	ADP
cuesj-1047	110	16	fatality	fatality	NOUN
cuesj-1047	110	17	risk	risk	NOUN
cuesj-1047	110	18	difference	difference	NOUN
cuesj-1047	110	19	,	,	PUNCT
cuesj-1047	110	20	with	with	ADP
cuesj-1047	110	21	omicron	omicron	PROPN
cuesj-1047	110	22	demonstrating	demonstrate	VERB
cuesj-1047	110	23	a	a	DET
cuesj-1047	110	24	greater	great	ADJ
cuesj-1047	110	25	decrease	decrease	NOUN
cuesj-1047	110	26	in	in	ADP
cuesj-1047	110	27	covid-19	covid-19	PROPN
cuesj-1047	110	28	mortality	mortality	NOUN
cuesj-1047	110	29	than	than	ADP
cuesj-1047	110	30	delta	delta	NOUN
cuesj-1047	110	31	for	for	ADP
cuesj-1047	110	32	individuals	individual	NOUN
cuesj-1047	110	33	between	between	ADP
cuesj-1047	110	34	the	the	DET
cuesj-1047	110	35	ages	age	NOUN
cuesj-1047	110	36	of	of	ADP
cuesj-1047	110	37	18	18	NUM
cuesj-1047	110	38	and	and	CCONJ
cuesj-1047	110	39	59	59	NUM
cuesj-1047	110	40	and	and	CCONJ
cuesj-1047	110	41	60	60	NUM
cuesj-1047	110	42	and	and	CCONJ
cuesj-1047	110	43	69	69	NUM
cuesj-1047	110	44	years	year	NOUN
cuesj-1047	110	45	than	than	ADP
cuesj-1047	110	46	for	for	ADP
cuesj-1047	110	47	those	those	PRON
cuesj-1047	110	48	who	who	PRON
cuesj-1047	110	49	are	be	AUX
cuesj-1047	110	50	70	70	NUM
cuesj-1047	110	51	or	or	CCONJ
cuesj-1047	110	52	beyond	beyond	ADP
cuesj-1047	110	53	.	.	PUNCT
cuesj-1047	111	1	in	in	ADP
cuesj-1047	111	2	terms	term	NOUN
cuesj-1047	111	3	of	of	ADP
cuesj-1047	111	4	gender	gender	NOUN
cuesj-1047	111	5	and	and	CCONJ
cuesj-1047	111	6	variant	variant	ADJ
cuesj-1047	111	7	interaction	interaction	NOUN
cuesj-1047	111	8	,	,	PUNCT
cuesj-1047	111	9	males	male	NOUN
cuesj-1047	111	10	exhibit	exhibit	VERB
cuesj-1047	111	11	a	a	DET
cuesj-1047	111	12	greater	great	ADJ
cuesj-1047	111	13	reduction	reduction	NOUN
cuesj-1047	111	14	than	than	ADP
cuesj-1047	111	15	females	female	NOUN
cuesj-1047	111	16	in	in	ADP
cuesj-1047	111	17	mortality	mortality	NOUN
cuesj-1047	111	18	risk	risk	NOUN
cuesj-1047	111	19	for	for	ADP
cuesj-1047	111	20	covid-19	covid-19	PROPN
cuesj-1047	111	21	.	.	PUNCT
cuesj-1047	112	1	the	the	DET
cuesj-1047	112	2	categories	category	NOUN
cuesj-1047	112	3	used	use	VERB
cuesj-1047	112	4	to	to	PART
cuesj-1047	112	5	categorize	categorize	VERB
cuesj-1047	112	6	vaccination	vaccination	NOUN
cuesj-1047	112	7	status	status	NOUN
cuesj-1047	112	8	were	be	AUX
cuesj-1047	112	9	one	one	NUM
cuesj-1047	112	10	dose	dose	NOUN
cuesj-1047	112	11	,	,	PUNCT
cuesj-1047	112	12	two	two	NUM
cuesj-1047	112	13	dosages	dosage	NOUN
cuesj-1047	112	14	of	of	ADP
cuesj-1047	112	15	the	the	DET
cuesj-1047	112	16	mrna	mrna	PROPN
cuesj-1047	112	17	vaccine	vaccine	NOUN
cuesj-1047	112	18	given	give	VERB
cuesj-1047	112	19	by	by	ADP
cuesj-1047	112	20	pfizer	pfizer	NOUN
cuesj-1047	112	21	or	or	CCONJ
cuesj-1047	112	22	moderna	moderna	NOUN
cuesj-1047	112	23	within	within	ADP
cuesj-1047	112	24	180	180	NUM
cuesj-1047	112	25	days	day	NOUN
cuesj-1047	112	26	,	,	PUNCT
cuesj-1047	112	27	two	two	NUM
cuesj-1047	112	28	dosages	dosage	NOUN
cuesj-1047	112	29	given	give	VERB
cuesj-1047	112	30	by	by	ADP
cuesj-1047	112	31	astrazeneca	astrazeneca	NOUN
cuesj-1047	112	32	within	within	ADP
cuesj-1047	112	33	180	180	NUM
cuesj-1047	112	34	days	day	NOUN
cuesj-1047	112	35	,	,	PUNCT
cuesj-1047	112	36	unvaccinated	unvaccinate	VERB
cuesj-1047	112	37	,	,	PUNCT
cuesj-1047	112	38	and	and	CCONJ
cuesj-1047	112	39	booster	booster	NOUN
cuesj-1047	112	40	.	.	PUNCT
cuesj-1047	113	1	regardless	regardless	ADV
cuesj-1047	113	2	of	of	ADP
cuesj-1047	113	3	age	age	NOUN
cuesj-1047	113	4	,	,	PUNCT
cuesj-1047	113	5	receiving	receive	VERB
cuesj-1047	113	6	a	a	DET
cuesj-1047	113	7	booster	booster	NOUN
cuesj-1047	113	8	lowered	lower	VERB
cuesj-1047	113	9	the	the	DET
cuesj-1047	113	10	death	death	NOUN
cuesj-1047	113	11	possibility	possibility	NOUN
cuesj-1047	113	12	from	from	ADP
cuesj-1047	113	13	omicron	omicron	PROPN
cuesj-1047	113	14	relative	relative	ADJ
cuesj-1047	113	15	to	to	ADP
cuesj-1047	113	16	delta	delta	NOUN
cuesj-1047	113	17	in	in	ADP
cuesj-1047	113	18	comparison	comparison	NOUN
cuesj-1047	113	19	to	to	ADP
cuesj-1047	113	20	receiving	receive	VERB
cuesj-1047	113	21	two	two	NUM
cuesj-1047	113	22	dosages	dosage	NOUN
cuesj-1047	113	23	only	only	ADV
cuesj-1047	113	24	.	.	PUNCT
cuesj-1047	114	1	in	in	ADP
cuesj-1047	114	2	south	south	PROPN
cuesj-1047	114	3	africa	africa	PROPN
cuesj-1047	114	4	,	,	PUNCT
cuesj-1047	114	5	california	california	PROPN
cuesj-1047	114	6	,	,	PUNCT
cuesj-1047	114	7	canada	canada	PROPN
cuesj-1047	114	8	,	,	PUNCT
cuesj-1047	114	9	and	and	CCONJ
cuesj-1047	114	10	the	the	DET
cuesj-1047	114	11	uk	uk	PROPN
cuesj-1047	114	12	,	,	PUNCT
cuesj-1047	114	13	the	the	DET
cuesj-1047	114	14	clinical	clinical	ADJ
cuesj-1047	114	15	seriousness	seriousness	NOUN
cuesj-1047	114	16	of	of	ADP
cuesj-1047	114	17	covid-19	covid-19	PROPN
cuesj-1047	114	18	omicron	omicron	PROPN
cuesj-1047	114	19	variation	variation	NOUN
cuesj-1047	114	20	was	be	AUX
cuesj-1047	114	21	way	way	ADV
cuesj-1047	114	22	less	less	ADV
cuesj-1047	114	23	severe	severe	ADJ
cuesj-1047	114	24	than	than	ADP
cuesj-1047	114	25	that	that	PRON
cuesj-1047	114	26	of	of	ADP
cuesj-1047	114	27	the	the	DET
cuesj-1047	114	28	delta	delta	NOUN
cuesj-1047	114	29	form	form	NOUN
cuesj-1047	114	30	.	.	PUNCT
cuesj-1047	115	1	for	for	ADP
cuesj-1047	115	2	all	all	DET
cuesj-1047	115	3	age	age	NOUN
cuesj-1047	115	4	categories	category	NOUN
cuesj-1047	115	5	,	,	PUNCT
cuesj-1047	115	6	the	the	DET
cuesj-1047	115	7	probability	probability	NOUN
cuesj-1047	115	8	of	of	ADP
cuesj-1047	115	9	covid-19	covid-19	PROPN
cuesj-1047	115	10	-	-	PUNCT
cuesj-1047	115	11	related	relate	VERB
cuesj-1047	115	12	mortality	mortality	NOUN
cuesj-1047	115	13	regardless	regardless	ADV
cuesj-1047	115	14	of	of	ADP
cuesj-1047	115	15	the	the	DET
cuesj-1047	115	16	number	number	NOUN
cuesj-1047	115	17	of	of	ADP
cuesj-1047	115	18	comorbidities	comorbiditie	NOUN
cuesj-1047	115	19	,	,	PUNCT
cuesj-1047	115	20	omicron	omicron	PROPN
cuesj-1047	115	21	infection	infection	NOUN
cuesj-1047	115	22	was	be	AUX
cuesj-1047	115	23	less	less	ADJ
cuesj-1047	115	24	than	than	ADP
cuesj-1047	115	25	delta	delta	NOUN
cuesj-1047	115	26	.	.	PUNCT
cuesj-1047	116	1	however	however	ADV
cuesj-1047	116	2	,	,	PUNCT
cuesj-1047	116	3	there	there	PRON
cuesj-1047	116	4	was	be	VERB
cuesj-1047	116	5	no	no	DET
cuesj-1047	116	6	proof	proof	NOUN
cuesj-1047	116	7	that	that	SCONJ
cuesj-1047	116	8	the	the	DET
cuesj-1047	116	9	number	number	NOUN
cuesj-1047	116	10	of	of	ADP
cuesj-1047	116	11	comorbidities	comorbiditie	NOUN
cuesj-1047	116	12	affected	affect	VERB
cuesj-1047	116	13	the	the	DET
cuesj-1047	116	14	relative	relative	ADJ
cuesj-1047	116	15	mortality	mortality	NOUN
cuesj-1047	116	16	risk	risk	NOUN
cuesj-1047	116	17	in	in	ADP
cuesj-1047	116	18	a	a	DET
cuesj-1047	116	19	different	different	ADJ
cuesj-1047	116	20	way.[38	way.[38	NOUN
cuesj-1047	116	21	]	]	X
cuesj-1047	116	22	parameters	parameter	NOUN
cuesj-1047	116	23	of	of	ADP
cuesj-1047	116	24	chronic	chronic	ADJ
cuesj-1047	116	25	illness	illness	NOUN
cuesj-1047	116	26	in	in	ADP
cuesj-1047	116	27	covid-19	covid-19	PROPN
cuesj-1047	116	28	patients	patient	NOUN
cuesj-1047	116	29	some	some	DET
cuesj-1047	116	30	people	people	NOUN
cuesj-1047	116	31	with	with	ADP
cuesj-1047	116	32	systemic	systemic	ADJ
cuesj-1047	116	33	autoimmune	autoimmune	ADJ
cuesj-1047	116	34	rheumatic	rheumatic	ADJ
cuesj-1047	116	35	diseases	disease	NOUN
cuesj-1047	116	36	(	(	PUNCT
cuesj-1047	116	37	sards	sard	NOUN
cuesj-1047	116	38	)	)	PUNCT
cuesj-1047	116	39	may	may	AUX
cuesj-1047	116	40	experience	experience	VERB
cuesj-1047	116	41	severe	severe	ADJ
cuesj-1047	116	42	covid-19	covid-19	PROPN
cuesj-1047	116	43	results	result	NOUN
cuesj-1047	116	44	,	,	PUNCT
cuesj-1047	116	45	such	such	ADJ
cuesj-1047	116	46	as	as	ADP
cuesj-1047	116	47	hospitalization	hospitalization	NOUN
cuesj-1047	116	48	and	and	CCONJ
cuesj-1047	116	49	mortality	mortality	NOUN
cuesj-1047	116	50	.	.	PUNCT
cuesj-1047	117	1	data	datum	NOUN
cuesj-1047	117	2	on	on	ADP
cuesj-1047	117	3	rheumatic	rheumatic	ADJ
cuesj-1047	117	4	disease	disease	NOUN
cuesj-1047	117	5	symptoms	symptom	NOUN
cuesj-1047	117	6	,	,	PUNCT
cuesj-1047	117	7	comorbidities	comorbiditie	NOUN
cuesj-1047	117	8	,	,	PUNCT
cuesj-1047	117	9	immunization	immunization	NOUN
cuesj-1047	117	10	status	status	NOUN
cuesj-1047	117	11	,	,	PUNCT
cuesj-1047	117	12	demographics	demographic	NOUN
cuesj-1047	117	13	,	,	PUNCT
cuesj-1047	117	14	and	and	CCONJ
cuesj-1047	117	15	medications	medication	NOUN
cuesj-1047	117	16	were	be	AUX
cuesj-1047	117	17	gathered	gather	VERB
cuesj-1047	117	18	.	.	PUNCT
cuesj-1047	118	1	the	the	DET
cuesj-1047	118	2	electronic	electronic	ADJ
cuesj-1047	118	3	inquiry	inquiry	NOUN
cuesj-1047	118	4	identified	identify	VERB
cuesj-1047	118	5	age	age	NOUN
cuesj-1047	118	6	,	,	PUNCT
cuesj-1047	118	7	gender	gender	NOUN
cuesj-1047	118	8	,	,	PUNCT
cuesj-1047	118	9	race	race	NOUN
cuesj-1047	118	10	(	(	PUNCT
cuesj-1047	118	11	asian	asian	ADJ
cuesj-1047	118	12	/	/	SYM
cuesj-1047	118	13	hawaiian	hawaiian	ADJ
cuesj-1047	118	14	/	/	SYM
cuesj-1047	118	15	pacific	pacific	PROPN
cuesj-1047	118	16	islander	islander	PROPN
cuesj-1047	118	17	,	,	PUNCT
cuesj-1047	118	18	black	black	ADJ
cuesj-1047	118	19	,	,	PUNCT
cuesj-1047	118	20	white	white	ADJ
cuesj-1047	118	21	,	,	PUNCT
cuesj-1047	118	22	or	or	CCONJ
cuesj-1047	118	23	other	other	ADJ
cuesj-1047	118	24	/	/	SYM
cuesj-1047	118	25	unknown	unknown	ADJ
cuesj-1047	118	26	)	)	PUNCT
cuesj-1047	118	27	,	,	PUNCT
cuesj-1047	118	28	and	and	CCONJ
cuesj-1047	118	29	hispanic	hispanic	ADJ
cuesj-1047	118	30	race	race	NOUN
cuesj-1047	118	31	.	.	PUNCT
cuesj-1047	119	1	medical	medical	ADJ
cuesj-1047	119	2	record	record	NOUN
cuesj-1047	119	3	review	review	NOUN
cuesj-1047	119	4	provided	provide	VERB
cuesj-1047	119	5	information	information	NOUN
cuesj-1047	119	6	on	on	ADP
cuesj-1047	119	7	comorbidities	comorbiditie	NOUN
cuesj-1047	119	8	such	such	ADJ
cuesj-1047	119	9	as	as	ADP
cuesj-1047	119	10	interstitial	interstitial	ADJ
cuesj-1047	119	11	lung	lung	NOUN
cuesj-1047	119	12	disease	disease	NOUN
cuesj-1047	119	13	,	,	PUNCT
cuesj-1047	119	14	high	high	ADJ
cuesj-1047	119	15	blood	blood	NOUN
cuesj-1047	119	16	pressure	pressure	NOUN
cuesj-1047	119	17	,	,	PUNCT
cuesj-1047	119	18	diabetes	diabetes	NOUN
cuesj-1047	119	19	,	,	PUNCT
cuesj-1047	119	20	obesity	obesity	NOUN
cuesj-1047	119	21	,	,	PUNCT
cuesj-1047	119	22	cardiovascular	cardiovascular	ADJ
cuesj-1047	119	23	disease	disease	NOUN
cuesj-1047	119	24	,	,	PUNCT
cuesj-1047	119	25	and	and	CCONJ
cuesj-1047	119	26	chronic	chronic	ADJ
cuesj-1047	119	27	bronchitis	bronchitis	NOUN
cuesj-1047	119	28	.	.	PUNCT
cuesj-1047	120	1	the	the	DET
cuesj-1047	120	2	overall	overall	ADJ
cuesj-1047	120	3	research	research	NOUN
cuesj-1047	120	4	samples	sample	NOUN
cuesj-1047	120	5	’	'	PUNCT
cuesj-1047	120	6	average	average	ADJ
cuesj-1047	120	7	age	age	NOUN
cuesj-1047	120	8	was	be	AUX
cuesj-1047	120	9	58.4	58.4	NUM
cuesj-1047	120	10	years	year	NOUN
cuesj-1047	120	11	(	(	PUNCT
cuesj-1047	120	12	standard	standard	ADJ
cuesj-1047	120	13	deviation	deviation	NOUN
cuesj-1047	120	14	[	[	X
cuesj-1047	120	15	sd	sd	X
cuesj-1047	120	16	]	]	X
cuesj-1047	120	17	17.5	17.5	NUM
cuesj-1047	120	18	)	)	PUNCT
cuesj-1047	120	19	.	.	PUNCT
cuesj-1047	121	1	overall	overall	ADV
cuesj-1047	121	2	,	,	PUNCT
cuesj-1047	121	3	the	the	DET
cuesj-1047	121	4	samples	sample	NOUN
cuesj-1047	121	5	were	be	AUX
cuesj-1047	121	6	comprised	comprise	VERB
cuesj-1047	121	7	71.4	71.4	NUM
cuesj-1047	121	8	%	%	NOUN
cuesj-1047	121	9	white	white	ADJ
cuesj-1047	121	10	,	,	PUNCT
cuesj-1047	121	11	11.2	11.2	NUM
cuesj-1047	121	12	%	%	NOUN
cuesj-1047	121	13	black	black	NOUN
cuesj-1047	121	14	,	,	PUNCT
cuesj-1047	121	15	and	and	CCONJ
cuesj-1047	121	16	3.6	3.6	NUM
cuesj-1047	121	17	%	%	NOUN
cuesj-1047	121	18	asian	asian	ADJ
cuesj-1047	121	19	/	/	SYM
cuesj-1047	121	20	hawaiian	hawaiian	ADJ
cuesj-1047	121	21	/	/	SYM
cuesj-1047	121	22	pacific	pacific	PROPN
cuesj-1047	121	23	islander	islander	PROPN
cuesj-1047	121	24	people	people	NOUN
cuesj-1047	121	25	.	.	PUNCT
cuesj-1047	122	1	the	the	DET
cuesj-1047	122	2	proportion	proportion	NOUN
cuesj-1047	122	3	of	of	ADP
cuesj-1047	122	4	black	black	ADJ
cuesj-1047	122	5	or	or	CCONJ
cuesj-1047	122	6	hispanic	hispanic	ADJ
cuesj-1047	122	7	sard	sard	NOUN
cuesj-1047	122	8	patients	patient	NOUN
cuesj-1047	122	9	who	who	PRON
cuesj-1047	122	10	tested	test	VERB
cuesj-1047	122	11	positive	positive	ADJ
cuesj-1047	122	12	for	for	ADP
cuesj-1047	122	13	covid-19	covid-19	PROPN
cuesj-1047	122	14	dropped	drop	VERB
cuesj-1047	122	15	.	.	PUNCT
cuesj-1047	123	1	high	high	ADJ
cuesj-1047	123	2	blood	blood	NOUN
cuesj-1047	123	3	pressure	pressure	NOUN
cuesj-1047	123	4	was	be	AUX
cuesj-1047	123	5	the	the	DET
cuesj-1047	123	6	most	most	ADV
cuesj-1047	123	7	prevalent	prevalent	ADJ
cuesj-1047	123	8	coexisting	coexist	VERB
cuesj-1047	123	9	condition	condition	NOUN
cuesj-1047	123	10	(	(	PUNCT
cuesj-1047	123	11	43.8	43.8	NUM
cuesj-1047	123	12	%	%	NOUN
cuesj-1047	123	13	)	)	PUNCT
cuesj-1047	123	14	.	.	PUNCT
cuesj-1047	124	1	at	at	ADP
cuesj-1047	124	2	the	the	DET
cuesj-1047	124	3	time	time	NOUN
cuesj-1047	124	4	of	of	ADP
cuesj-1047	124	5	infection	infection	NOUN
cuesj-1047	124	6	,	,	PUNCT
cuesj-1047	124	7	the	the	DET
cuesj-1047	124	8	vaccination	vaccination	NOUN
cuesj-1047	124	9	status	status	NOUN
cuesj-1047	124	10	of	of	ADP
cuesj-1047	124	11	the	the	DET
cuesj-1047	124	12	overall	overall	ADJ
cuesj-1047	124	13	sample	sample	NOUN
cuesj-1047	124	14	was	be	AUX
cuesj-1047	124	15	64.7	64.7	NUM
cuesj-1047	124	16	%	%	NOUN
cuesj-1047	124	17	pre	pre	NOUN
cuesj-1047	124	18	-	-	NOUN
cuesj-1047	124	19	vaccination	vaccination	NOUN
cuesj-1047	124	20	/	/	SYM
cuesj-1047	124	21	not	not	PART
cuesj-1047	124	22	vaccinated	vaccinate	VERB
cuesj-1047	124	23	,	,	PUNCT
cuesj-1047	124	24	3.5	3.5	NUM
cuesj-1047	124	25	%	%	NOUN
cuesj-1047	124	26	partly	partly	ADV
cuesj-1047	124	27	immunized	immunize	VERB
cuesj-1047	124	28	,	,	PUNCT
cuesj-1047	124	29	15.7	15.7	NUM
cuesj-1047	124	30	%	%	NOUN
cuesj-1047	124	31	two	two	NUM
cuesj-1047	124	32	-	-	PUNCT
cuesj-1047	124	33	dose	dose	NOUN
cuesj-1047	124	34	mrna	mrna	NOUN
cuesj-1047	124	35	or	or	CCONJ
cuesj-1047	124	36	one	one	NUM
cuesj-1047	124	37	-	-	PUNCT
cuesj-1047	124	38	dose	dose	NOUN
cuesj-1047	124	39	j&j	j&j	PROPN
cuesj-1047	124	40	,	,	PUNCT
cuesj-1047	124	41	and	and	CCONJ
cuesj-1047	124	42	16.1	16.1	NUM
cuesj-1047	124	43	%	%	NOUN
cuesj-1047	124	44	further	further	ADJ
cuesj-1047	124	45	dosage	dosage	NOUN
cuesj-1047	124	46	.	.	PUNCT
cuesj-1047	125	1	outcomes	outcome	NOUN
cuesj-1047	125	2	of	of	ADP
cuesj-1047	125	3	treatment	treatment	NOUN
cuesj-1047	125	4	and	and	CCONJ
cuesj-1047	125	5	severe	severe	ADJ
cuesj-1047	125	6	covid-19	covid-19	PROPN
cuesj-1047	125	7	neutralizing	neutralizing	ADJ
cuesj-1047	125	8	monoclonal	monoclonal	NOUN
cuesj-1047	125	9	antibodies	antibody	NOUN
cuesj-1047	125	10	(	(	PUNCT
cuesj-1047	125	11	12.6	12.6	NUM
cuesj-1047	125	12	%	%	NOUN
cuesj-1047	125	13	)	)	PUNCT
cuesj-1047	125	14	,	,	PUNCT
cuesj-1047	125	15	remdesivir	remdesivir	X
cuesj-1047	125	16	(	(	PUNCT
cuesj-1047	125	17	14.2	14.2	NUM
cuesj-1047	125	18	%	%	NOUN
cuesj-1047	125	19	)	)	PUNCT
cuesj-1047	125	20	,	,	PUNCT
cuesj-1047	125	21	and	and	CCONJ
cuesj-1047	125	22	dexamethasone	dexamethasone	NOUN
cuesj-1047	125	23	(	(	PUNCT
cuesj-1047	125	24	13.2	13.2	NUM
cuesj-1047	125	25	%	%	NOUN
cuesj-1047	125	26	)	)	PUNCT
cuesj-1047	125	27	were	be	AUX
cuesj-1047	125	28	the	the	DET
cuesj-1047	125	29	most	most	ADV
cuesj-1047	125	30	widely	widely	ADV
cuesj-1047	125	31	used	use	VERB
cuesj-1047	125	32	therapies	therapy	NOUN
cuesj-1047	125	33	for	for	ADP
cuesj-1047	125	34	covid-19	covid-19	PROPN
cuesj-1047	125	35	.	.	PUNCT
cuesj-1047	126	1	to	to	PART
cuesj-1047	126	2	treat	treat	VERB
cuesj-1047	126	3	covid-19	covid-19	PROPN
cuesj-1047	126	4	in	in	ADP
cuesj-1047	126	5	patients	patient	NOUN
cuesj-1047	126	6	with	with	ADP
cuesj-1047	126	7	sard	sard	NOUN
cuesj-1047	126	8	,	,	PUNCT
cuesj-1047	126	9	few	few	ADJ
cuesj-1047	126	10	were	be	AUX
cuesj-1047	126	11	given	give	VERB
cuesj-1047	126	12	tocilizumab	tocilizumab	NOUN
cuesj-1047	126	13	(	(	PUNCT
cuesj-1047	126	14	1.0	1.0	NUM
cuesj-1047	126	15	%	%	NOUN
cuesj-1047	126	16	)	)	PUNCT
cuesj-1047	126	17	,	,	PUNCT
cuesj-1047	126	18	baricitinib	baricitinib	NOUN
cuesj-1047	126	19	(	(	PUNCT
cuesj-1047	126	20	0.2	0.2	NUM
cuesj-1047	126	21	%	%	NOUN
cuesj-1047	126	22	)	)	PUNCT
cuesj-1047	126	23	,	,	PUNCT
cuesj-1047	126	24	or	or	CCONJ
cuesj-1047	126	25	regenerative	regenerative	ADJ
cuesj-1047	126	26	plasma	plasma	NOUN
cuesj-1047	126	27	(	(	PUNCT
cuesj-1047	126	28	0.5	0.5	NUM
cuesj-1047	126	29	%	%	NOUN
cuesj-1047	126	30	)	)	PUNCT
cuesj-1047	126	31	(	(	PUNCT
cuesj-1047	126	32	figure	figure	NOUN
cuesj-1047	126	33	8)	8)	NUM
cuesj-1047	126	34	.	.	PUNCT
cuesj-1047	127	1	three	three	NUM
cuesj-1047	127	2	hundred	hundred	NUM
cuesj-1047	127	3	ninety	ninety	NUM
cuesj-1047	127	4	-	-	PUNCT
cuesj-1047	127	5	nine	nine	NUM
cuesj-1047	127	6	individuals	individual	NOUN
cuesj-1047	127	7	(	(	PUNCT
cuesj-1047	127	8	or	or	CCONJ
cuesj-1047	127	9	27.5	27.5	NUM
cuesj-1047	127	10	%	%	NOUN
cuesj-1047	127	11	)	)	PUNCT
cuesj-1047	127	12	had	have	VERB
cuesj-1047	127	13	a	a	DET
cuesj-1047	127	14	severe	severe	ADJ
cuesj-1047	127	15	covid-19	covid-19	PROPN
cuesj-1047	127	16	composite	composite	ADJ
cuesj-1047	127	17	outcome	outcome	NOUN
cuesj-1047	127	18	,	,	PUNCT
cuesj-1047	127	19	which	which	PRON
cuesj-1047	127	20	included	include	VERB
cuesj-1047	127	21	hospitalization	hospitalization	NOUN
cuesj-1047	127	22	or	or	CCONJ
cuesj-1047	127	23	death	death	NOUN
cuesj-1047	127	24	.	.	PUNCT
cuesj-1047	128	1	there	there	PRON
cuesj-1047	128	2	were	be	AUX
cuesj-1047	128	3	recorded	record	VERB
cuesj-1047	128	4	60	60	NUM
cuesj-1047	128	5	(	(	PUNCT
cuesj-1047	128	6	4.1	4.1	NUM
cuesj-1047	128	7	%	%	NOUN
cuesj-1047	128	8	)	)	PUNCT
cuesj-1047	128	9	deaths	death	NOUN
cuesj-1047	128	10	and	and	CCONJ
cuesj-1047	128	11	391	391	NUM
cuesj-1047	128	12	(	(	PUNCT
cuesj-1047	128	13	27.0	27.0	NUM
cuesj-1047	128	14	%	%	NOUN
cuesj-1047	128	15	)	)	PUNCT
cuesj-1047	128	16	hospitalizations	hospitalization	NOUN
cuesj-1047	128	17	.	.	PUNCT
cuesj-1047	129	1	individuals	individual	NOUN
cuesj-1047	129	2	with	with	ADP
cuesj-1047	129	3	serious	serious	ADJ
cuesj-1047	129	4	covid19	covid19	NOUN
cuesj-1047	129	5	have	have	VERB
cuesj-1047	129	6	an	an	DET
cuesj-1047	129	7	age	age	NOUN
cuesj-1047	129	8	average	average	NOUN
cuesj-1047	129	9	of	of	ADP
cuesj-1047	129	10	66.9	66.9	NUM
cuesj-1047	129	11	years	year	NOUN
cuesj-1047	129	12	(	(	PUNCT
cuesj-1047	129	13	sd	sd	ADP
cuesj-1047	129	14	19.1	19.1	NUM
cuesj-1047	129	15	)	)	PUNCT
cuesj-1047	129	16	,	,	PUNCT
cuesj-1047	129	17	76.3	76.3	NUM
cuesj-1047	129	18	%	%	NOUN
cuesj-1047	129	19	being	be	AUX
cuesj-1047	129	20	female	female	ADJ
cuesj-1047	129	21	,	,	PUNCT
cuesj-1047	129	22	10.2	10.2	NUM
cuesj-1047	129	23	%	%	NOUN
cuesj-1047	129	24	having	have	VERB
cuesj-1047	129	25	interstitial	interstitial	ADJ
cuesj-1047	129	26	lung	lung	NOUN
cuesj-1047	129	27	disease	disease	NOUN
cuesj-1047	129	28	,	,	PUNCT
cuesj-1047	129	29	37.3	37.3	NUM
cuesj-1047	129	30	%	%	NOUN
cuesj-1047	129	31	having	having	AUX
cuesj-1047	129	32	rheumatoid	rheumatoid	VERB
cuesj-1047	129	33	arthritis	arthritis	NOUN
cuesj-1047	129	34	,	,	PUNCT
cuesj-1047	129	35	47.5	47.5	NUM
cuesj-1047	129	36	%	%	NOUN
cuesj-1047	129	37	using	use	VERB
cuesj-1047	129	38	glucocorticoids	glucocorticoid	NOUN
cuesj-1047	129	39	,	,	PUNCT
cuesj-1047	129	40	18.6	18.6	NUM
cuesj-1047	129	41	%	%	NOUN
cuesj-1047	129	42	on	on	ADP
cuesj-1047	129	43	methotrexate	methotrexate	NOUN
cuesj-1047	129	44	,	,	PUNCT
cuesj-1047	129	45	and	and	CCONJ
cuesj-1047	129	46	15.3	15.3	NUM
cuesj-1047	129	47	%	%	NOUN
cuesj-1047	129	48	taking	take	VERB
cuesj-1047	129	49	rituximab	rituximab	NOUN
cuesj-1047	129	50	.	.	PUNCT
cuesj-1047	130	1	several	several	ADJ
cuesj-1047	130	2	patients	patient	NOUN
cuesj-1047	130	3	had	have	VERB
cuesj-1047	130	4	significant	significant	ADJ
cuesj-1047	130	5	comorbidities	comorbiditie	NOUN
cuesj-1047	130	6	in	in	ADP
cuesj-1047	130	7	addition	addition	NOUN
cuesj-1047	130	8	to	to	ADP
cuesj-1047	130	9	sards	sard	NOUN
cuesj-1047	130	10	,	,	PUNCT
cuesj-1047	130	11	but	but	CCONJ
cuesj-1047	130	12	they	they	PRON
cuesj-1047	130	13	were	be	AUX
cuesj-1047	130	14	also	also	ADV
cuesj-1047	130	15	receiving	receive	VERB
cuesj-1047	130	16	therapies	therapy	NOUN
cuesj-1047	130	17	that	that	PRON
cuesj-1047	130	18	substantially	substantially	ADV
cuesj-1047	130	19	reduced	reduce	VERB
cuesj-1047	130	20	their	their	PRON
cuesj-1047	130	21	immune	immune	ADJ
cuesj-1047	130	22	response	response	NOUN
cuesj-1047	130	23	to	to	ADP
cuesj-1047	130	24	vaccines	vaccine	NOUN
cuesj-1047	130	25	and	and	CCONJ
cuesj-1047	130	26	infections	infection	NOUN
cuesj-1047	130	27	(	(	PUNCT
cuesj-1047	130	28	e.g.	e.g.	ADV
cuesj-1047	130	29	,	,	PUNCT
cuesj-1047	130	30	b	b	X
cuesj-1047	130	31	cell	cell	NOUN
cuesj-1047	130	32	depletion	depletion	NOUN
cuesj-1047	130	33	)	)	PUNCT
cuesj-1047	130	34	.	.	PUNCT
cuesj-1047	131	1	as	as	ADP
cuesj-1047	131	2	a	a	DET
cuesj-1047	131	3	result	result	NOUN
cuesj-1047	131	4	,	,	PUNCT
cuesj-1047	131	5	attributing	attribute	VERB
cuesj-1047	131	6	the	the	DET
cuesj-1047	131	7	impact	impact	NOUN
cuesj-1047	131	8	of	of	ADP
cuesj-1047	131	9	underlying	underlie	VERB
cuesj-1047	131	10	sard	sard	NOUN
cuesj-1047	131	11	and	and	CCONJ
cuesj-1047	131	12	immunosuppression	immunosuppression	NOUN
cuesj-1047	131	13	is	be	AUX
cuesj-1047	131	14	challenging	challenge	VERB
cuesj-1047	131	15	.	.	PUNCT
cuesj-1047	132	1	throughout	throughout	ADP
cuesj-1047	132	2	the	the	DET
cuesj-1047	132	3	calendar	calendar	NOUN
cuesj-1047	132	4	years	year	NOUN
cuesj-1047	132	5	,	,	PUNCT
cuesj-1047	132	6	sard	sard	NOUN
cuesj-1047	132	7	patients	patient	NOUN
cuesj-1047	132	8	who	who	PRON
cuesj-1047	132	9	had	have	VERB
cuesj-1047	132	10	severe	severe	ADJ
cuesj-1047	132	11	covid19	covid19	NOUN
cuesj-1047	132	12	made	make	VERB
cuesj-1047	132	13	up	up	ADP
cuesj-1047	132	14	less	less	ADJ
cuesj-1047	132	15	of	of	ADP
cuesj-1047	132	16	the	the	DET
cuesj-1047	132	17	total	total	ADJ
cuesj-1047	132	18	population	population	NOUN
cuesj-1047	132	19	.	.	PUNCT
cuesj-1047	133	1	each	each	DET
cuesj-1047	133	2	calendar	calendar	NOUN
cuesj-1047	133	3	period	period	NOUN
cuesj-1047	133	4	’s	’s	PART
cuesj-1047	133	5	overall	overall	ADJ
cuesj-1047	133	6	percentage	percentage	NOUN
cuesj-1047	133	7	of	of	ADP
cuesj-1047	133	8	serious	serious	ADJ
cuesj-1047	133	9	covid-19	covid-19	PROPN
cuesj-1047	133	10	cases	case	NOUN
cuesj-1047	133	11	was	be	AUX
cuesj-1047	133	12	119	119	NUM
cuesj-1047	133	13	(	(	PUNCT
cuesj-1047	133	14	45.6	45.6	NUM
cuesj-1047	133	15	%	%	NOUN
cuesj-1047	133	16	)	)	PUNCT
cuesj-1047	133	17	,	,	PUNCT
cuesj-1047	133	18	144	144	NUM
cuesj-1047	133	19	(	(	PUNCT
cuesj-1047	133	20	29.3	29.3	NUM
cuesj-1047	133	21	%	%	NOUN
cuesj-1047	133	22	)	)	PUNCT
cuesj-1047	133	23	,	,	PUNCT
cuesj-1047	133	24	41	41	NUM
cuesj-1047	133	25	(	(	PUNCT
cuesj-1047	133	26	33.3	33.3	NUM
cuesj-1047	133	27	%	%	NOUN
cuesj-1047	133	28	)	)	PUNCT
cuesj-1047	133	29	,	,	PUNCT
cuesj-1047	133	30	36	36	NUM
cuesj-1047	133	31	(	(	PUNCT
cuesj-1047	133	32	20.9	20.9	NUM
cuesj-1047	133	33	%	%	NOUN
cuesj-1047	133	34	)	)	PUNCT
cuesj-1047	133	35	,	,	PUNCT
cuesj-1047	133	36	and	and	CCONJ
cuesj-1047	133	37	59	59	NUM
cuesj-1047	133	38	(	(	PUNCT
cuesj-1047	133	39	14.7	14.7	NUM
cuesj-1047	133	40	%	%	NOUN
cuesj-1047	133	41	)	)	PUNCT
cuesj-1047	133	42	in	in	ADP
cuesj-1047	133	43	the	the	DET
cuesj-1047	133	44	early	early	ADJ
cuesj-1047	133	45	covid-19	covid-19	PROPN
cuesj-1047	133	46	,	,	PUNCT
cuesj-1047	133	47	early	early	ADJ
cuesj-1047	133	48	treatment	treatment	NOUN
cuesj-1047	133	49	,	,	PUNCT
cuesj-1047	133	50	fast	fast	ADJ
cuesj-1047	133	51	vaccination	vaccination	NOUN
cuesj-1047	133	52	,	,	PUNCT
cuesj-1047	133	53	further	further	ADJ
cuesj-1047	133	54	vaccination	vaccination	NOUN
cuesj-1047	133	55	,	,	PUNCT
cuesj-1047	133	56	delta	delta	NOUN
cuesj-1047	133	57	wave	wave	NOUN
cuesj-1047	133	58	,	,	PUNCT
cuesj-1047	133	59	and	and	CCONJ
cuesj-1047	133	60	omicron	omicron	PROPN
cuesj-1047	133	61	wave	wave	PROPN
cuesj-1047	133	62	times	times	PROPN
cuesj-1047	133	63	,	,	PUNCT
cuesj-1047	133	64	accordingly.[5	accordingly.[5	PUNCT
cuesj-1047	133	65	]	]	PUNCT
cuesj-1047	133	66	discussion	discussion	NOUN
cuesj-1047	133	67	in	in	ADP
cuesj-1047	133	68	shanghai	shanghai	PROPN
cuesj-1047	133	69	,	,	PUNCT
cuesj-1047	133	70	there	there	PRON
cuesj-1047	133	71	were	be	VERB
cuesj-1047	133	72	outbreaks	outbreak	NOUN
cuesj-1047	133	73	of	of	ADP
cuesj-1047	133	74	sars	sar	NOUN
cuesj-1047	133	75	-	-	PUNCT
cuesj-1047	133	76	cov-2	cov-2	NOUN
cuesj-1047	133	77	omicron	omicron	PROPN
cuesj-1047	133	78	ba.2	ba.2	PROPN
cuesj-1047	133	79	between	between	ADP
cuesj-1047	133	80	february	february	PROPN
cuesj-1047	133	81	26	26	NUM
cuesj-1047	133	82	and	and	CCONJ
cuesj-1047	133	83	june	june	PROPN
cuesj-1047	133	84	30	30	NUM
cuesj-1047	133	85	,	,	PUNCT
cuesj-1047	133	86	2022	2022	NUM
cuesj-1047	133	87	.	.	PUNCT
cuesj-1047	134	1	these	these	DET
cuesj-1047	134	2	outbreaks	outbreak	NOUN
cuesj-1047	134	3	’	'	PUNCT
cuesj-1047	134	4	clinical	clinical	ADJ
cuesj-1047	134	5	severity	severity	NOUN
cuesj-1047	134	6	and	and	CCONJ
cuesj-1047	134	7	disease	disease	NOUN
cuesj-1047	134	8	burden	burden	NOUN
cuesj-1047	134	9	were	be	AUX
cuesj-1047	134	10	estimated	estimate	VERB
cuesj-1047	134	11	.	.	PUNCT
cuesj-1047	135	1	in	in	ADP
cuesj-1047	135	2	comparison	comparison	NOUN
cuesj-1047	135	3	to	to	ADP
cuesj-1047	135	4	the	the	DET
cuesj-1047	135	5	general	general	ADJ
cuesj-1047	135	6	population	population	NOUN
cuesj-1047	135	7	,	,	PUNCT
cuesj-1047	135	8	the	the	DET
cuesj-1047	135	9	aged	aged	ADJ
cuesj-1047	135	10	people	people	NOUN
cuesj-1047	135	11	had	have	VERB
cuesj-1047	135	12	much	much	ADV
cuesj-1047	135	13	higher	high	ADJ
cuesj-1047	135	14	rates	rate	NOUN
cuesj-1047	135	15	of	of	ADP
cuesj-1047	135	16	severe	severe	ADJ
cuesj-1047	135	17	/	/	SYM
cuesj-1047	135	18	critical	critical	ADJ
cuesj-1047	135	19	infections	infection	NOUN
cuesj-1047	135	20	and	and	CCONJ
cuesj-1047	135	21	mortality	mortality	NOUN
cuesj-1047	135	22	.	.	PUNCT
cuesj-1047	136	1	through	through	ADP
cuesj-1047	136	2	a	a	DET
cuesj-1047	136	3	city	city	NOUN
cuesj-1047	136	4	-	-	PUNCT
cuesj-1047	136	5	wide	wide	ADJ
cuesj-1047	136	6	lockdown	lockdown	NOUN
cuesj-1047	136	7	,	,	PUNCT
cuesj-1047	136	8	transportation	transportation	NOUN
cuesj-1047	136	9	restrictions	restriction	NOUN
cuesj-1047	136	10	,	,	PUNCT
cuesj-1047	136	11	school	school	NOUN
cuesj-1047	136	12	closures	closure	NOUN
cuesj-1047	136	13	,	,	PUNCT
cuesj-1047	136	14	frequent	frequent	ADJ
cuesj-1047	136	15	and	and	CCONJ
cuesj-1047	136	16	thorough	thorough	ADJ
cuesj-1047	136	17	nucleic	nucleic	ADJ
cuesj-1047	136	18	testing	testing	NOUN
cuesj-1047	136	19	,	,	PUNCT
cuesj-1047	136	20	and	and	CCONJ
cuesj-1047	136	21	medical	medical	ADJ
cuesj-1047	136	22	aid	aid	NOUN
cuesj-1047	136	23	from	from	ADP
cuesj-1047	136	24	other	other	ADJ
cuesj-1047	136	25	provinces	province	NOUN
cuesj-1047	136	26	,	,	PUNCT
cuesj-1047	136	27	control	control	NOUN
cuesj-1047	136	28	of	of	ADP
cuesj-1047	136	29	the	the	DET
cuesj-1047	136	30	outbreak	outbreak	NOUN
cuesj-1047	136	31	was	be	AUX
cuesj-1047	136	32	hussein	hussein	PROPN
cuesj-1047	136	33	,	,	PUNCT
cuesj-1047	136	34	et	et	PROPN
cuesj-1047	136	35	al	al	PROPN
cuesj-1047	136	36	.	.	PUNCT
cuesj-1047	136	37	:	:	PUNCT
cuesj-1047	137	1	a	a	DET
cuesj-1047	137	2	review	review	NOUN
cuesj-1047	137	3	on	on	ADP
cuesj-1047	137	4	coronavirus	coronavirus	NOUN
cuesj-1047	137	5	and	and	CCONJ
cuesj-1047	137	6	omicron	omicron	PROPN
cuesj-1047	137	7	patients	patient	NOUN
cuesj-1047	137	8	13	13	NUM
cuesj-1047	137	9	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	137	10	cuesj	cuesj	NOUN
cuesj-1047	137	11	2024	2024	NUM
cuesj-1047	137	12	,	,	PUNCT
cuesj-1047	137	13	8	8	NUM
cuesj-1047	137	14	(	(	PUNCT
cuesj-1047	137	15	1	1	NUM
cuesj-1047	137	16	):	):	PUNCT
cuesj-1047	137	17	8	8	NUM
cuesj-1047	137	18	-	-	SYM
cuesj-1047	137	19	17	17	NUM
cuesj-1047	137	20	attained	attain	VERB
cuesj-1047	137	21	.	.	PUNCT
cuesj-1047	138	1	shanghai	shanghai	PROPN
cuesj-1047	138	2	has	have	VERB
cuesj-1047	138	3	a	a	DET
cuesj-1047	138	4	greater	great	ADJ
cuesj-1047	138	5	rate	rate	NOUN
cuesj-1047	138	6	of	of	ADP
cuesj-1047	138	7	primary	primary	ADJ
cuesj-1047	138	8	and	and	CCONJ
cuesj-1047	138	9	booster	booster	NOUN
cuesj-1047	138	10	vaccination	vaccination	NOUN
cuesj-1047	138	11	coverage	coverage	NOUN
cuesj-1047	138	12	than	than	ADP
cuesj-1047	138	13	hong	hong	PROPN
cuesj-1047	138	14	kong	kong	PROPN
cuesj-1047	138	15	,	,	PUNCT
cuesj-1047	138	16	particularly	particularly	ADV
cuesj-1047	138	17	among	among	ADP
cuesj-1047	138	18	those	those	DET
cuesj-1047	138	19	65	65	NUM
cuesj-1047	138	20	and	and	CCONJ
cuesj-1047	138	21	older	old	ADJ
cuesj-1047	138	22	.	.	PUNCT
cuesj-1047	139	1	to	to	PART
cuesj-1047	139	2	prepare	prepare	VERB
cuesj-1047	139	3	for	for	ADP
cuesj-1047	139	4	future	future	ADJ
cuesj-1047	139	5	covid-19	covid-19	PROPN
cuesj-1047	139	6	waves	wave	NOUN
cuesj-1047	139	7	that	that	PRON
cuesj-1047	139	8	may	may	AUX
cuesj-1047	139	9	occur	occur	VERB
cuesj-1047	139	10	,	,	PUNCT
cuesj-1047	139	11	shanghai	shanghai	PROPN
cuesj-1047	139	12	has	have	VERB
cuesj-1047	139	13	to	to	PART
cuesj-1047	139	14	increase	increase	VERB
cuesj-1047	139	15	immunization	immunization	NOUN
cuesj-1047	139	16	rates	rate	NOUN
cuesj-1047	139	17	,	,	PUNCT
cuesj-1047	139	18	especially	especially	ADV
cuesj-1047	139	19	among	among	ADP
cuesj-1047	139	20	older	old	ADJ
cuesj-1047	139	21	persons	person	NOUN
cuesj-1047	139	22	with	with	ADP
cuesj-1047	139	23	a	a	DET
cuesj-1047	139	24	history	history	NOUN
cuesj-1047	139	25	of	of	ADP
cuesj-1047	139	26	persistent	persistent	ADJ
cuesj-1047	139	27	underlying	underlie	VERB
cuesj-1047	139	28	illnesses	illness	NOUN
cuesj-1047	139	29	.	.	PUNCT
cuesj-1047	140	1	for	for	ADP
cuesj-1047	140	2	the	the	DET
cuesj-1047	140	3	omicron	omicron	PROPN
cuesj-1047	140	4	ba.2	ba.2	PROPN
cuesj-1047	140	5	epidemics	epidemic	NOUN
cuesj-1047	140	6	that	that	PRON
cuesj-1047	140	7	will	will	AUX
cuesj-1047	140	8	occur	occur	VERB
cuesj-1047	140	9	in	in	ADP
cuesj-1047	140	10	shanghai	shanghai	PROPN
cuesj-1047	140	11	between	between	ADP
cuesj-1047	140	12	february	february	PROPN
cuesj-1047	140	13	and	and	CCONJ
cuesj-1047	140	14	june	june	PROPN
cuesj-1047	140	15	of	of	ADP
cuesj-1047	140	16	2022	2022	NUM
cuesj-1047	140	17	,	,	PUNCT
cuesj-1047	140	18	sickness	sickness	NOUN
cuesj-1047	140	19	load	load	NOUN
cuesj-1047	140	20	and	and	CCONJ
cuesj-1047	140	21	severity	severity	NOUN
cuesj-1047	140	22	in	in	ADP
cuesj-1047	140	23	clinical	clinical	ADJ
cuesj-1047	140	24	terms	term	NOUN
cuesj-1047	140	25	were	be	AUX
cuesj-1047	140	26	estimated	estimate	VERB
cuesj-1047	140	27	.	.	PUNCT
cuesj-1047	141	1	when	when	SCONJ
cuesj-1047	141	2	compared	compare	VERB
cuesj-1047	141	3	to	to	ADP
cuesj-1047	141	4	other	other	ADJ
cuesj-1047	141	5	contexts	context	NOUN
cuesj-1047	141	6	and	and	CCONJ
cuesj-1047	141	7	countries	country	NOUN
cuesj-1047	141	8	,	,	PUNCT
cuesj-1047	141	9	we	we	PRON
cuesj-1047	141	10	found	find	VERB
cuesj-1047	141	11	lower	low	ADJ
cuesj-1047	141	12	outbreak	outbreak	NOUN
cuesj-1047	141	13	burden	burden	NOUN
cuesj-1047	141	14	and	and	CCONJ
cuesj-1047	141	15	death	death	NOUN
cuesj-1047	141	16	,	,	PUNCT
cuesj-1047	141	17	showing	show	VERB
cuesj-1047	141	18	the	the	DET
cuesj-1047	141	19	significance	significance	NOUN
cuesj-1047	141	20	of	of	ADP
cuesj-1047	141	21	shanghai	shanghai	PROPN
cuesj-1047	141	22	’s	’s	PART
cuesj-1047	141	23	effective	effective	ADJ
cuesj-1047	141	24	outbreak	outbreak	NOUN
cuesj-1047	141	25	containment	containment	NOUN
cuesj-1047	141	26	measures.[17	measures.[17	VERB
cuesj-1047	141	27	]	]	PUNCT
cuesj-1047	141	28	a	a	DET
cuesj-1047	141	29	substantial	substantial	ADJ
cuesj-1047	141	30	rise	rise	NOUN
cuesj-1047	141	31	in	in	ADP
cuesj-1047	141	32	sars	sar	NOUN
cuesj-1047	141	33	-	-	PUNCT
cuesj-1047	141	34	cov-2	cov-2	NOUN
cuesj-1047	141	35	positive	positive	ADJ
cuesj-1047	141	36	and	and	CCONJ
cuesj-1047	141	37	related	relate	VERB
cuesj-1047	141	38	covid-19	covid-19	PROPN
cuesj-1047	141	39	hospitalizations	hospitalization	NOUN
cuesj-1047	141	40	among	among	ADP
cuesj-1047	141	41	young	young	ADJ
cuesj-1047	141	42	people	people	NOUN
cuesj-1047	141	43	including	include	VERB
cuesj-1047	141	44	kids	kid	NOUN
cuesj-1047	141	45	and	and	CCONJ
cuesj-1047	141	46	adolescents	adolescent	NOUN
cuesj-1047	141	47	was	be	AUX
cuesj-1047	141	48	found	find	VERB
cuesj-1047	141	49	in	in	ADP
cuesj-1047	141	50	the	the	DET
cuesj-1047	141	51	south	south	ADJ
cuesj-1047	141	52	african	african	ADJ
cuesj-1047	141	53	district	district	NOUN
cuesj-1047	141	54	of	of	ADP
cuesj-1047	141	55	tshwane	tshwane	NOUN
cuesj-1047	141	56	.	.	PUNCT
cuesj-1047	142	1	this	this	DET
cuesj-1047	142	2	rise	rise	NOUN
cuesj-1047	142	3	resulted	result	VERB
cuesj-1047	142	4	from	from	ADP
cuesj-1047	142	5	the	the	DET
cuesj-1047	142	6	strong	strong	ADJ
cuesj-1047	142	7	communal	communal	ADJ
cuesj-1047	142	8	transmission	transmission	NOUN
cuesj-1047	142	9	and	and	CCONJ
cuesj-1047	142	10	the	the	DET
cuesj-1047	142	11	quick	quick	ADJ
cuesj-1047	142	12	relocation	relocation	NOUN
cuesj-1047	142	13	of	of	ADP
cuesj-1047	142	14	the	the	DET
cuesj-1047	142	15	delta	delta	NOUN
cuesj-1047	142	16	type	type	NOUN
cuesj-1047	142	17	by	by	ADP
cuesj-1047	142	18	the	the	DET
cuesj-1047	142	19	omicron	omicron	PROPN
cuesj-1047	142	20	type	type	NOUN
cuesj-1047	142	21	commencing	commencing	NOUN
cuesj-1047	142	22	in	in	ADP
cuesj-1047	142	23	mid	mid	PROPN
cuesj-1047	142	24	-	-	PROPN
cuesj-1047	142	25	november	november	PROPN
cuesj-1047	142	26	2021	2021	NUM
cuesj-1047	142	27	.	.	PUNCT
cuesj-1047	143	1	sars	sar	NOUN
cuesj-1047	143	2	-	-	PUNCT
cuesj-1047	143	3	cov-2s	cov-2s	PROPN
cuesj-1047	143	4	’	'	PUNCT
cuesj-1047	143	5	omicron	omicron	PROPN
cuesj-1047	143	6	variety	variety	NOUN
cuesj-1047	143	7	has	have	AUX
cuesj-1047	143	8	been	be	AUX
cuesj-1047	143	9	referenced	reference	VERB
cuesj-1047	143	10	with	with	ADP
cuesj-1047	143	11	•	•	NUM
cuesj-1047	143	12	screened	screen	VERB
cuesj-1047	143	13	data	datum	NOUN
cuesj-1047	143	14	(	(	PUNCT
cuesj-1047	143	15	n=155)•	n=155)•	X
cuesj-1047	143	16	discovered	discover	VERB
cuesj-1047	143	17	data	datum	NOUN
cuesj-1047	143	18	from	from	ADP
cuesj-1047	143	19	databases:(n=411	databases:(n=411	ADJ
cuesj-1047	143	20	)	)	PUNCT
cuesj-1047	143	21	•	•	NUM
cuesj-1047	143	22	evaluation	evaluation	NOUN
cuesj-1047	143	23	of	of	ADP
cuesj-1047	143	24	publications	publication	NOUN
cuesj-1047	143	25	(	(	PUNCT
cuesj-1047	143	26	n=117	n=117	NUM
cuesj-1047	143	27	)	)	PUNCT
cuesj-1047	143	28	•	•	ADV
cuesj-1047	143	29	duplicated	duplicate	VERB
cuesj-1047	143	30	(	(	PUNCT
cuesj-1047	143	31	n=23	n=23	PROPN
cuesj-1047	143	32	)	)	PUNCT
cuesj-1047	143	33	•	•	ADP
cuesj-1047	143	34	unclear	unclear	ADJ
cuesj-1047	143	35	data	datum	NOUN
cuesj-1047	143	36	(	(	PUNCT
cuesj-1047	143	37	n=15	n=15	ADV
cuesj-1047	143	38	)	)	PUNCT
cuesj-1047	143	39	discovering	discover	VERB
cuesj-1047	143	40	classification	classification	NOUN
cuesj-1047	143	41	controling	control	VERB
cuesj-1047	143	42	figure	figure	NOUN
cuesj-1047	143	43	1	1	NUM
cuesj-1047	143	44	:	:	PUNCT
cuesj-1047	143	45	study	study	NOUN
cuesj-1047	143	46	flowchart	flowchart	NOUN
cuesj-1047	143	47	.	.	PUNCT
cuesj-1047	144	1	this	this	DET
cuesj-1047	144	2	graph	graph	NOUN
cuesj-1047	144	3	displays	display	VERB
cuesj-1047	144	4	the	the	DET
cuesj-1047	144	5	various	various	ADJ
cuesj-1047	144	6	observations	observation	NOUN
cuesj-1047	144	7	used	use	VERB
cuesj-1047	144	8	in	in	ADP
cuesj-1047	144	9	analyzing	analyze	VERB
cuesj-1047	144	10	throughout	throughout	ADP
cuesj-1047	144	11	the	the	DET
cuesj-1047	144	12	various	various	ADJ
cuesj-1047	144	13	subsections	subsection	NOUN
cuesj-1047	144	14	of	of	ADP
cuesj-1047	144	15	the	the	DET
cuesj-1047	144	16	finding	find	VERB
cuesj-1047	144	17	part	part	NOUN
cuesj-1047	144	18	.	.	PUNCT
cuesj-1047	145	1	utilizing	utilize	VERB
cuesj-1047	145	2	the	the	DET
cuesj-1047	145	3	following	follow	VERB
cuesj-1047	145	4	mesh	mesh	NOUN
cuesj-1047	145	5	or	or	CCONJ
cuesj-1047	145	6	keywords	keyword	NOUN
cuesj-1047	145	7	,	,	PUNCT
cuesj-1047	145	8	studies	study	NOUN
cuesj-1047	145	9	were	be	AUX
cuesj-1047	145	10	discovered	discover	VERB
cuesj-1047	145	11	using	use	VERB
cuesj-1047	145	12	pubmed	pubmed	PROPN
cuesj-1047	145	13	,	,	PUNCT
cuesj-1047	145	14	scopus	scopus	PROPN
cuesj-1047	145	15	,	,	PUNCT
cuesj-1047	145	16	google	google	NOUN
cuesj-1047	145	17	scholar	scholar	NOUN
cuesj-1047	145	18	,	,	PUNCT
cuesj-1047	145	19	and	and	CCONJ
cuesj-1047	145	20	medrxiv	medrxiv	NOUN
cuesj-1047	145	21	.	.	PUNCT
cuesj-1047	145	22	transmission	transmission	NOUN
cuesj-1047	145	23	fever	fever	NOUN
cuesj-1047	145	24	,	,	PUNCT
cuesj-1047	145	25	61	61	NUM
cuesj-1047	145	26	%	%	NOUN
cuesj-1047	145	27	cough	cough	NOUN
cuesj-1047	145	28	,	,	PUNCT
cuesj-1047	145	29	57	57	NUM
cuesj-1047	145	30	%	%	NOUN
cuesj-1047	145	31	shortness	shortness	NOUN
cuesj-1047	145	32	of	of	ADP
cuesj-1047	145	33	breath	breath	NOUN
cuesj-1047	145	34	,	,	PUNCT
cuesj-1047	145	35	31	31	NUM
cuesj-1047	145	36	%	%	NOUN
cuesj-1047	145	37	vomiting	vomiting	NOUN
cuesj-1047	145	38	,	,	PUNCT
cuesj-1047	145	39	26	26	NUM
cuesj-1047	145	40	%	%	NOUN
cuesj-1047	145	41	diarrhea	diarrhea	NOUN
cuesj-1047	145	42	,	,	PUNCT
cuesj-1047	145	43	25	25	NUM
cuesj-1047	145	44	%	%	NOUN
cuesj-1047	145	45	symptoms	symptom	NOUN
cuesj-1047	145	46	figure	figure	VERB
cuesj-1047	145	47	2	2	NUM
cuesj-1047	145	48	:	:	PUNCT
cuesj-1047	145	49	hospitalization	hospitalization	NOUN
cuesj-1047	145	50	percentage	percentage	NOUN
cuesj-1047	145	51	of	of	ADP
cuesj-1047	145	52	children	child	NOUN
cuesj-1047	145	53	with	with	ADP
cuesj-1047	145	54	covid-19	covid-19	PROPN
cuesj-1047	145	55	0	0	NUM
cuesj-1047	145	56	%	%	NOUN
cuesj-1047	145	57	20	20	NUM
cuesj-1047	145	58	%	%	NOUN
cuesj-1047	145	59	40	40	NUM
cuesj-1047	145	60	%	%	NOUN
cuesj-1047	145	61	60	60	NUM
cuesj-1047	145	62	%	%	NOUN
cuesj-1047	145	63	80	80	NUM
cuesj-1047	145	64	%	%	NOUN
cuesj-1047	145	65	100	100	NUM
cuesj-1047	145	66	%	%	NOUN
cuesj-1047	145	67	required	require	VERB
cuesj-1047	145	68	routine	routine	ADJ
cuesj-1047	145	69	hospital	hospital	NOUN
cuesj-1047	145	70	care	care	NOUN
cuesj-1047	145	71	oxygen	oxygen	NOUN
cuesj-1047	145	72	treatment	treatment	NOUN
cuesj-1047	145	73	(	(	PUNCT
cuesj-1047	145	74	passed	pass	VERB
cuesj-1047	145	75	)	)	PUNCT
cuesj-1047	145	76	required	require	VERB
cuesj-1047	145	77	ventilation	ventilation	NOUN
cuesj-1047	145	78	due	due	ADP
cuesj-1047	145	79	to	to	ADP
cuesj-1047	145	80	complicated	complicated	ADJ
cuesj-1047	145	81	underlying	underlie	VERB
cuesj-1047	145	82	pathologies	pathology	NOUN
cuesj-1047	145	83	figure	figure	VERB
cuesj-1047	145	84	3	3	NUM
cuesj-1047	145	85	:	:	PUNCT
cuesj-1047	145	86	proportion	proportion	NOUN
cuesj-1047	145	87	of	of	ADP
cuesj-1047	145	88	patient	patient	ADJ
cuesj-1047	145	89	hospitality	hospitality	NOUN
cuesj-1047	145	90	status	status	NOUN
cuesj-1047	145	91	under	under	ADP
cuesj-1047	145	92	4	4	NUM
cuesj-1047	145	93	age	age	NOUN
cuesj-1047	145	94	(	(	PUNCT
cuesj-1047	145	95	kids	kid	NOUN
cuesj-1047	145	96	)	)	PUNCT
cuesj-1047	145	97	,	,	PUNCT
cuesj-1047	145	98	63	63	NUM
cuesj-1047	145	99	%	%	NOUN
cuesj-1047	145	100	under	under	ADP
cuesj-1047	145	101	19	19	NUM
cuesj-1047	145	102	age	age	NOUN
cuesj-1047	145	103	,	,	PUNCT
cuesj-1047	145	104	18	18	NUM
cuesj-1047	145	105	%	%	NOUN
cuesj-1047	145	106	(	(	PUNCT
cuesj-1047	145	107	100	100	NUM
cuesj-1047	145	108	%	%	NOUN
cuesj-1047	145	109	omicron	omicron	PROPN
cuesj-1047	145	110	)	)	PUNCT
cuesj-1047	145	111	unvaccinaed	unvaccinaed	NOUN
cuesj-1047	145	112	pateints	pateint	NOUN
cuesj-1047	145	113	figure	figure	VERB
cuesj-1047	145	114	4	4	NUM
cuesj-1047	145	115	:	:	PUNCT
cuesj-1047	145	116	unvaccinated	unvaccinated	ADJ
cuesj-1047	145	117	kids	kid	NOUN
cuesj-1047	145	118	and	and	CCONJ
cuesj-1047	145	119	teenagers	teenager	NOUN
cuesj-1047	145	120	’	'	PUNCT
cuesj-1047	145	121	percentage	percentage	NOUN
cuesj-1047	145	122	figure	figure	NOUN
cuesj-1047	145	123	5	5	NUM
cuesj-1047	145	124	:	:	PUNCT
cuesj-1047	145	125	severe	severe	ADJ
cuesj-1047	145	126	acute	acute	ADJ
cuesj-1047	145	127	respiratory	respiratory	ADJ
cuesj-1047	145	128	syndrome	syndrome	NOUN
cuesj-1047	145	129	coronavirus	coronavirus	NOUN
cuesj-1047	145	130	2	2	NUM
cuesj-1047	145	131	infections	infection	NOUN
cuesj-1047	145	132	and	and	CCONJ
cuesj-1047	145	133	hospitalizations	hospitalization	NOUN
cuesj-1047	145	134	percentage	percentage	NOUN
cuesj-1047	145	135	in	in	ADP
cuesj-1047	145	136	omicron	omicron	PROPN
cuesj-1047	145	137	ba.1	ba.1	PROPN
cuesj-1047	145	138	and	and	CCONJ
cuesj-1047	145	139	ba.2	ba.2	PROPN
cuesj-1047	145	140	hussein	hussein	PROPN
cuesj-1047	145	141	,	,	PUNCT
cuesj-1047	145	142	et	et	PROPN
cuesj-1047	145	143	al	al	PROPN
cuesj-1047	145	144	.	.	PUNCT
cuesj-1047	145	145	:	:	PUNCT
cuesj-1047	146	1	a	a	DET
cuesj-1047	146	2	review	review	NOUN
cuesj-1047	146	3	on	on	ADP
cuesj-1047	146	4	coronavirus	coronavirus	NOUN
cuesj-1047	146	5	and	and	CCONJ
cuesj-1047	146	6	omicron	omicron	PROPN
cuesj-1047	146	7	patients	patient	NOUN
cuesj-1047	146	8	14	14	NUM
cuesj-1047	146	9	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	146	10	cuesj	cuesj	ADJ
cuesj-1047	146	11	2024	2024	NUM
cuesj-1047	146	12	,	,	PUNCT
cuesj-1047	146	13	8	8	NUM
cuesj-1047	146	14	(	(	PUNCT
cuesj-1047	146	15	1	1	NUM
cuesj-1047	146	16	):	):	PUNCT
cuesj-1047	146	17	8	8	NUM
cuesj-1047	146	18	-	-	SYM
cuesj-1047	146	19	17	17	NUM
cuesj-1047	146	20	poorer	poor	ADJ
cuesj-1047	146	21	antibody	antibody	NOUN
cuesj-1047	146	22	neutralization	neutralization	NOUN
cuesj-1047	146	23	,	,	PUNCT
cuesj-1047	146	24	increased	increase	VERB
cuesj-1047	146	25	infectiousness	infectiousness	NOUN
cuesj-1047	146	26	,	,	PUNCT
cuesj-1047	146	27	decreased	decrease	VERB
cuesj-1047	146	28	vaccination	vaccination	NOUN
cuesj-1047	146	29	effect	effect	NOUN
cuesj-1047	146	30	,	,	PUNCT
cuesj-1047	146	31	and	and	CCONJ
cuesj-1047	146	32	a	a	DET
cuesj-1047	146	33	greater	great	ADJ
cuesj-1047	146	34	risk	risk	NOUN
cuesj-1047	146	35	for	for	ADP
cuesj-1047	146	36	recurrence	recurrence	NOUN
cuesj-1047	146	37	in	in	ADP
cuesj-1047	146	38	comparison	comparison	NOUN
cuesj-1047	146	39	to	to	ADP
cuesj-1047	146	40	the	the	DET
cuesj-1047	146	41	delta	delta	NOUN
cuesj-1047	146	42	form	form	NOUN
cuesj-1047	146	43	.	.	PUNCT
cuesj-1047	147	1	children	child	NOUN
cuesj-1047	147	2	hospitalized	hospitalize	VERB
cuesj-1047	147	3	with	with	ADP
cuesj-1047	147	4	covid-19	covid-19	PROPN
cuesj-1047	147	5	were	be	AUX
cuesj-1047	147	6	diagnosed	diagnose	VERB
cuesj-1047	147	7	as	as	ADP
cuesj-1047	147	8	36	36	NUM
cuesj-1047	147	9	%	%	NOUN
cuesj-1047	147	10	incidental	incidental	ADJ
cuesj-1047	147	11	cases	case	NOUN
cuesj-1047	147	12	,	,	PUNCT
cuesj-1047	147	13	and	and	CCONJ
cuesj-1047	147	14	another	another	DET
cuesj-1047	147	15	20	20	NUM
cuesj-1047	147	16	%	%	NOUN
cuesj-1047	147	17	were	be	AUX
cuesj-1047	147	18	contributory	contributory	NOUN
cuesj-1047	147	19	diagnoses	diagnosis	NOUN
cuesj-1047	147	20	(	(	PUNCT
cuesj-1047	147	21	not	not	PART
cuesj-1047	147	22	the	the	DET
cuesj-1047	147	23	major	major	ADJ
cuesj-1047	147	24	diagnosis	diagnosis	NOUN
cuesj-1047	147	25	)	)	PUNCT
cuesj-1047	147	26	,	,	PUNCT
cuesj-1047	147	27	showing	show	VERB
cuesj-1047	147	28	the	the	DET
cuesj-1047	147	29	virus	virus	NOUN
cuesj-1047	147	30	’s	’s	PART
cuesj-1047	147	31	quick	quick	ADJ
cuesj-1047	147	32	spread	spread	NOUN
cuesj-1047	147	33	throughout	throughout	ADP
cuesj-1047	147	34	the	the	DET
cuesj-1047	147	35	neighborhood	neighborhood	NOUN
cuesj-1047	147	36	.	.	PUNCT
cuesj-1047	148	1	a	a	DET
cuesj-1047	148	2	number	number	NOUN
cuesj-1047	148	3	of	of	ADP
cuesj-1047	148	4	factors	factor	NOUN
cuesj-1047	148	5	,	,	PUNCT
cuesj-1047	148	6	including	include	VERB
cuesj-1047	148	7	the	the	DET
cuesj-1047	148	8	unavailability	unavailability	NOUN
cuesj-1047	148	9	of	of	ADP
cuesj-1047	148	10	childhood	childhood	NOUN
cuesj-1047	148	11	immunization	immunization	NOUN
cuesj-1047	148	12	,	,	PUNCT
cuesj-1047	148	13	the	the	DET
cuesj-1047	148	14	greater	great	ADJ
cuesj-1047	148	15	percentage	percentage	NOUN
cuesj-1047	148	16	of	of	ADP
cuesj-1047	148	17	prior	prior	ADJ
cuesj-1047	148	18	exposure	exposure	NOUN
cuesj-1047	148	19	,	,	PUNCT
cuesj-1047	148	20	and	and	CCONJ
cuesj-1047	148	21	the	the	DET
cuesj-1047	148	22	innate	innate	ADJ
cuesj-1047	148	23	immunity	immunity	NOUN
cuesj-1047	148	24	of	of	ADP
cuesj-1047	148	25	adults	adult	NOUN
cuesj-1047	148	26	being	be	AUX
cuesj-1047	148	27	superior	superior	ADJ
cuesj-1047	148	28	to	to	ADP
cuesj-1047	148	29	that	that	PRON
cuesj-1047	148	30	of	of	ADP
cuesj-1047	148	31	infants	infant	NOUN
cuesj-1047	148	32	are	be	AUX
cuesj-1047	148	33	thought	think	VERB
cuesj-1047	148	34	to	to	PART
cuesj-1047	148	35	be	be	AUX
cuesj-1047	148	36	associated	associate	VERB
cuesj-1047	148	37	with	with	ADP
cuesj-1047	148	38	an	an	DET
cuesj-1047	148	39	excessive	excessive	ADJ
cuesj-1047	148	40	infection	infection	NOUN
cuesj-1047	148	41	of	of	ADP
cuesj-1047	148	42	the	the	DET
cuesj-1047	148	43	omicron	omicron	PROPN
cuesj-1047	148	44	variant	variant	NOUN
cuesj-1047	148	45	of	of	ADP
cuesj-1047	148	46	sars	sar	NOUN
cuesj-1047	148	47	-	-	PUNCT
cuesj-1047	148	48	cov-2	cov-2	NOUN
cuesj-1047	148	49	,	,	PUNCT
cuesj-1047	148	50	and	and	CCONJ
cuesj-1047	148	51	children	child	NOUN
cuesj-1047	148	52	usually	usually	ADV
cuesj-1047	148	53	do	do	AUX
cuesj-1047	148	54	not	not	PART
cuesj-1047	148	55	put	put	VERB
cuesj-1047	148	56	on	on	ADP
cuesj-1047	148	57	face	face	NOUN
cuesj-1047	148	58	masks	mask	NOUN
cuesj-1047	148	59	as	as	SCONJ
cuesj-1047	148	60	adults	adult	NOUN
cuesj-1047	148	61	frequently	frequently	ADV
cuesj-1047	148	62	do	do	VERB
cuesj-1047	148	63	.	.	PUNCT
cuesj-1047	149	1	viral	viral	ADJ
cuesj-1047	149	2	variations	variation	NOUN
cuesj-1047	149	3	with	with	ADP
cuesj-1047	149	4	high	high	ADJ
cuesj-1047	149	5	transmissibility	transmissibility	NOUN
cuesj-1047	149	6	spread	spread	VERB
cuesj-1047	149	7	more	more	ADV
cuesj-1047	149	8	readily	readily	ADV
cuesj-1047	149	9	when	when	SCONJ
cuesj-1047	149	10	total	total	ADJ
cuesj-1047	149	11	population	population	NOUN
cuesj-1047	149	12	immunity	immunity	NOUN
cuesj-1047	149	13	is	be	AUX
cuesj-1047	149	14	low	low	ADJ
cuesj-1047	149	15	,	,	PUNCT
cuesj-1047	149	16	but	but	CCONJ
cuesj-1047	149	17	immune	immune	ADJ
cuesj-1047	149	18	evasion	evasion	NOUN
cuesj-1047	149	19	features	feature	NOUN
cuesj-1047	149	20	of	of	ADP
cuesj-1047	149	21	a	a	DET
cuesj-1047	149	22	virus	virus	NOUN
cuesj-1047	149	23	play	play	VERB
cuesj-1047	149	24	a	a	DET
cuesj-1047	149	25	greater	great	ADJ
cuesj-1047	149	26	role	role	NOUN
cuesj-1047	149	27	in	in	ADP
cuesj-1047	149	28	populations	population	NOUN
cuesj-1047	149	29	with	with	ADP
cuesj-1047	149	30	a	a	DET
cuesj-1047	149	31	higher	high	ADJ
cuesj-1047	149	32	immunity	immunity	NOUN
cuesj-1047	149	33	.	.	PUNCT
cuesj-1047	150	1	the	the	DET
cuesj-1047	150	2	vast	vast	ADJ
cuesj-1047	150	3	majority	majority	NOUN
cuesj-1047	150	4	of	of	ADP
cuesj-1047	150	5	children	child	NOUN
cuesj-1047	150	6	with	with	ADP
cuesj-1047	150	7	covid-19	covid-19	PROPN
cuesj-1047	150	8	did	do	AUX
cuesj-1047	150	9	not	not	PART
cuesj-1047	150	10	develop	develop	VERB
cuesj-1047	150	11	serious	serious	ADJ
cuesj-1047	150	12	illnesses	illness	NOUN
cuesj-1047	150	13	,	,	PUNCT
cuesj-1047	150	14	which	which	PRON
cuesj-1047	150	15	was	be	AUX
cuesj-1047	150	16	encouraging	encouraging	ADJ
cuesj-1047	150	17	,	,	PUNCT
cuesj-1047	150	18	and	and	CCONJ
cuesj-1047	150	19	a	a	DET
cuesj-1047	150	20	substantial	substantial	ADJ
cuesj-1047	150	21	portion	portion	NOUN
cuesj-1047	150	22	of	of	ADP
cuesj-1047	150	23	diagnoses	diagnosis	NOUN
cuesj-1047	150	24	was	be	AUX
cuesj-1047	150	25	made	make	VERB
cuesj-1047	150	26	accidentally	accidentally	ADV
cuesj-1047	150	27	.	.	PUNCT
cuesj-1047	151	1	however	however	ADV
cuesj-1047	151	2	,	,	PUNCT
cuesj-1047	151	3	considering	consider	VERB
cuesj-1047	151	4	that	that	SCONJ
cuesj-1047	151	5	this	this	DET
cuesj-1047	151	6	population	population	NOUN
cuesj-1047	151	7	is	be	AUX
cuesj-1047	151	8	still	still	ADV
cuesj-1047	151	9	uninfected	uninfected	ADJ
cuesj-1047	151	10	in	in	ADP
cuesj-1047	151	11	many	many	ADJ
cuesj-1047	151	12	countries	country	NOUN
cuesj-1047	151	13	,	,	PUNCT
cuesj-1047	151	14	the	the	DET
cuesj-1047	151	15	quick	quick	ADJ
cuesj-1047	151	16	rise	rise	NOUN
cuesj-1047	151	17	in	in	ADP
cuesj-1047	151	18	pediatric	pediatric	ADJ
cuesj-1047	151	19	cases	case	NOUN
cuesj-1047	151	20	shows	show	VERB
cuesj-1047	151	21	that	that	SCONJ
cuesj-1047	151	22	hospitals	hospital	NOUN
cuesj-1047	151	23	should	should	AUX
cuesj-1047	151	24	be	be	AUX
cuesj-1047	151	25	ready	ready	ADJ
cuesj-1047	151	26	for	for	ADP
cuesj-1047	151	27	extremely	extremely	ADV
cuesj-1047	151	28	contagious	contagious	ADJ
cuesj-1047	151	29	variants	variant	NOUN
cuesj-1047	151	30	of	of	ADP
cuesj-1047	151	31	sars	sar	NOUN
cuesj-1047	151	32	-	-	PUNCT
cuesj-1047	151	33	cov-2	cov-2	NOUN
cuesj-1047	151	34	that	that	PRON
cuesj-1047	151	35	could	could	AUX
cuesj-1047	151	36	cause	cause	VERB
cuesj-1047	151	37	a	a	DET
cuesj-1047	151	38	sudden	sudden	ADJ
cuesj-1047	151	39	surge	surge	NOUN
cuesj-1047	151	40	in	in	ADP
cuesj-1047	151	41	pediatric	pediatric	ADJ
cuesj-1047	151	42	cases	case	NOUN
cuesj-1047	151	43	and	and	CCONJ
cuesj-1047	151	44	hospitalizations.[29	hospitalizations.[29	X
cuesj-1047	151	45	]	]	PUNCT
cuesj-1047	151	46	nineteen	nineteen	NUM
cuesj-1047	151	47	percent	percent	NOUN
cuesj-1047	151	48	of	of	ADP
cuesj-1047	151	49	our	our	PRON
cuesj-1047	151	50	pediatric	pediatric	ADJ
cuesj-1047	151	51	patients	patient	NOUN
cuesj-1047	151	52	and	and	CCONJ
cuesj-1047	151	53	only	only	ADV
cuesj-1047	151	54	45	45	NUM
cuesj-1047	151	55	%	%	NOUN
cuesj-1047	151	56	of	of	ADP
cuesj-1047	151	57	the	the	DET
cuesj-1047	151	58	adult	adult	NOUN
cuesj-1047	151	59	patients	patient	NOUN
cuesj-1047	151	60	who	who	PRON
cuesj-1047	151	61	were	be	AUX
cuesj-1047	151	62	hospitalized	hospitalize	VERB
cuesj-1047	151	63	with	with	ADP
cuesj-1047	151	64	ba.1	ba.1	NOUN
cuesj-1047	151	65	or	or	CCONJ
cuesj-1047	151	66	ba.2	ba.2	PROPN
cuesj-1047	151	67	were	be	AUX
cuesj-1047	151	68	identified	identify	VERB
cuesj-1047	151	69	to	to	PART
cuesj-1047	151	70	be	be	AUX
cuesj-1047	151	71	the	the	DET
cuesj-1047	151	72	predominant	predominant	ADJ
cuesj-1047	151	73	covid19	covid19	NOUN
cuesj-1047	151	74	cases	case	NOUN
cuesj-1047	151	75	.	.	PUNCT
cuesj-1047	152	1	compared	compare	VERB
cuesj-1047	152	2	to	to	ADP
cuesj-1047	152	3	individuals	individual	NOUN
cuesj-1047	152	4	with	with	ADP
cuesj-1047	152	5	accidental	accidental	ADJ
cuesj-1047	152	6	covid-19	covid-19	PROPN
cuesj-1047	152	7	,	,	PUNCT
cuesj-1047	152	8	those	those	PRON
cuesj-1047	152	9	with	with	ADP
cuesj-1047	152	10	the	the	DET
cuesj-1047	152	11	main	main	ADJ
cuesj-1047	152	12	covid-19	covid-19	PROPN
cuesj-1047	152	13	had	have	VERB
cuesj-1047	152	14	solid	solid	ADJ
cuesj-1047	152	15	organ	organ	NOUN
cuesj-1047	152	16	transplants	transplant	NOUN
cuesj-1047	152	17	considerably	considerably	ADV
cuesj-1047	152	18	more	more	ADV
cuesj-1047	152	19	frequently	frequently	ADV
cuesj-1047	152	20	and	and	CCONJ
cuesj-1047	152	21	showed	show	VERB
cuesj-1047	152	22	much	much	ADV
cuesj-1047	152	23	less	less	ADJ
cuesj-1047	152	24	ba.1	ba.1	NOUN
cuesj-1047	152	25	.	.	PUNCT
cuesj-1047	153	1	in	in	ADP
cuesj-1047	153	2	addition	addition	NOUN
cuesj-1047	153	3	,	,	PUNCT
cuesj-1047	153	4	they	they	PRON
cuesj-1047	153	5	appeared	appear	VERB
cuesj-1047	153	6	to	to	PART
cuesj-1047	153	7	be	be	AUX
cuesj-1047	153	8	older	old	ADJ
cuesj-1047	153	9	than	than	ADP
cuesj-1047	153	10	patients	patient	NOUN
cuesj-1047	153	11	who	who	PRON
cuesj-1047	153	12	simply	simply	ADV
cuesj-1047	153	13	had	have	VERB
cuesj-1047	153	14	covid-19	covid-19	PROPN
cuesj-1047	153	15	,	,	PUNCT
cuesj-1047	153	16	and	and	CCONJ
cuesj-1047	153	17	they	they	PRON
cuesj-1047	153	18	also	also	ADV
cuesj-1047	153	19	had	have	VERB
cuesj-1047	153	20	what	what	PRON
cuesj-1047	153	21	appeared	appear	VERB
cuesj-1047	153	22	to	to	PART
cuesj-1047	153	23	be	be	AUX
cuesj-1047	153	24	a	a	DET
cuesj-1047	153	25	greater	great	ADJ
cuesj-1047	153	26	28	28	NUM
cuesj-1047	153	27	-	-	PUNCT
cuesj-1047	153	28	day	day	NOUN
cuesj-1047	153	29	in	in	ADP
cuesj-1047	153	30	-	-	PUNCT
cuesj-1047	153	31	hospital	hospital	NOUN
cuesj-1047	153	32	death	death	NOUN
cuesj-1047	153	33	rate	rate	NOUN
cuesj-1047	153	34	.	.	PUNCT
cuesj-1047	154	1	they	they	PRON
cuesj-1047	154	2	had	have	VERB
cuesj-1047	154	3	higher	high	ADJ
cuesj-1047	154	4	rates	rate	NOUN
cuesj-1047	154	5	of	of	ADP
cuesj-1047	154	6	covid-19	covid-19	PROPN
cuesj-1047	154	7	vaccination	vaccination	NOUN
cuesj-1047	154	8	in	in	ADP
cuesj-1047	154	9	comparison	comparison	NOUN
cuesj-1047	154	10	to	to	ADP
cuesj-1047	154	11	those	those	PRON
cuesj-1047	154	12	who	who	PRON
cuesj-1047	154	13	had	have	VERB
cuesj-1047	154	14	accidental	accidental	ADJ
cuesj-1047	154	15	covid-19.[31	covid-19.[31	NOUN
cuesj-1047	154	16	]	]	X
cuesj-1047	154	17	a	a	DET
cuesj-1047	154	18	case	case	NOUN
cuesj-1047	154	19	–	–	PUNCT
cuesj-1047	154	20	case	case	NOUN
cuesj-1047	154	21	study	study	NOUN
cuesj-1047	154	22	revealed	reveal	VERB
cuesj-1047	154	23	that	that	SCONJ
cuesj-1047	154	24	pneumonia	pneumonia	NOUN
cuesj-1047	154	25	was	be	AUX
cuesj-1047	154	26	66	66	NUM
cuesj-1047	154	27	%	%	NOUN
cuesj-1047	154	28	less	less	ADV
cuesj-1047	154	29	probable	probable	ADJ
cuesj-1047	154	30	to	to	PART
cuesj-1047	154	31	arise	arise	VERB
cuesj-1047	154	32	from	from	ADP
cuesj-1047	154	33	omicron	omicron	PROPN
cuesj-1047	154	34	variant	variant	ADJ
cuesj-1047	154	35	infection	infection	NOUN
cuesj-1047	154	36	than	than	ADP
cuesj-1047	154	37	from	from	ADP
cuesj-1047	154	38	delta	delta	NOUN
cuesj-1047	154	39	variant	variant	ADJ
cuesj-1047	154	40	infection	infection	NOUN
cuesj-1047	154	41	.	.	PUNCT
cuesj-1047	155	1	within	within	ADP
cuesj-1047	155	2	6	6	NUM
cuesj-1047	155	3	months	month	NOUN
cuesj-1047	155	4	of	of	ADP
cuesj-1047	155	5	infection	infection	NOUN
cuesj-1047	155	6	,	,	PUNCT
cuesj-1047	155	7	the	the	DET
cuesj-1047	155	8	delta	delta	NOUN
cuesj-1047	155	9	variant	variant	NOUN
cuesj-1047	155	10	’s	’s	PART
cuesj-1047	155	11	full	full	ADJ
cuesj-1047	155	12	primary	primary	ADJ
cuesj-1047	155	13	immunization	immunization	NOUN
cuesj-1047	155	14	lowered	lower	VERB
cuesj-1047	155	15	the	the	DET
cuesj-1047	155	16	incidence	incidence	NOUN
cuesj-1047	155	17	of	of	ADP
cuesj-1047	155	18	pneumonia	pneumonia	NOUN
cuesj-1047	155	19	by	by	ADP
cuesj-1047	155	20	52	52	NUM
cuesj-1047	155	21	%	%	NOUN
cuesj-1047	155	22	.	.	PUNCT
cuesj-1047	156	1	international	international	ADJ
cuesj-1047	156	2	investigations	investigation	NOUN
cuesj-1047	156	3	have	have	AUX
cuesj-1047	156	4	shown	show	VERB
cuesj-1047	156	5	that	that	SCONJ
cuesj-1047	156	6	maximal	maximal	ADJ
cuesj-1047	156	7	viral	viral	ADJ
cuesj-1047	156	8	loads	load	NOUN
cuesj-1047	156	9	are	be	AUX
cuesj-1047	156	10	lower	low	ADJ
cuesj-1047	156	11	in	in	ADP
cuesj-1047	156	12	people	people	NOUN
cuesj-1047	156	13	with	with	ADP
cuesj-1047	156	14	omicron	omicron	PROPN
cuesj-1047	156	15	infections	infection	NOUN
cuesj-1047	156	16	than	than	ADP
cuesj-1047	156	17	in	in	ADP
cuesj-1047	156	18	patients	patient	NOUN
cuesj-1047	156	19	with	with	ADP
cuesj-1047	156	20	delta	delta	NOUN
cuesj-1047	156	21	infections	infection	NOUN
cuesj-1047	156	22	,	,	PUNCT
cuesj-1047	156	23	although	although	SCONJ
cuesj-1047	156	24	variations	variation	NOUN
cuesj-1047	156	25	did	do	AUX
cuesj-1047	156	26	not	not	PART
cuesj-1047	156	27	reveal	reveal	VERB
cuesj-1047	156	28	any	any	DET
cuesj-1047	156	29	differences	difference	NOUN
cuesj-1047	156	30	.	.	PUNCT
cuesj-1047	157	1	the	the	DET
cuesj-1047	157	2	co	co	ADJ
cuesj-1047	157	3	-	-	ADJ
cuesj-1047	157	4	occurring	occur	VERB
cuesj-1047	157	5	medical	medical	ADJ
cuesj-1047	157	6	conditions	condition	NOUN
cuesj-1047	157	7	among	among	ADP
cuesj-1047	157	8	this	this	DET
cuesj-1047	157	9	study	study	NOUN
cuesj-1047	157	10	participant	participant	NOUN
cuesj-1047	157	11	were	be	AUX
cuesj-1047	157	12	high	high	ADJ
cuesj-1047	157	13	blood	blood	NOUN
cuesj-1047	157	14	pressure	pressure	NOUN
cuesj-1047	157	15	,	,	PUNCT
cuesj-1047	157	16	diabetes	diabetes	NOUN
cuesj-1047	157	17	,	,	PUNCT
cuesj-1047	157	18	cerebral	cerebral	ADJ
cuesj-1047	157	19	vascular	vascular	ADJ
cuesj-1047	157	20	disease	disease	NOUN
cuesj-1047	157	21	,	,	PUNCT
cuesj-1047	157	22	coronary	coronary	ADJ
cuesj-1047	157	23	heart	heart	NOUN
cuesj-1047	157	24	disease	disease	NOUN
cuesj-1047	157	25	,	,	PUNCT
cuesj-1047	157	26	asthma	asthma	NOUN
cuesj-1047	157	27	,	,	PUNCT
cuesj-1047	157	28	and	and	CCONJ
cuesj-1047	157	29	so	so	ADV
cuesj-1047	157	30	forth	forth	ADV
cuesj-1047	157	31	.	.	PUNCT
cuesj-1047	158	1	in	in	ADP
cuesj-1047	158	2	comparison	comparison	NOUN
cuesj-1047	158	3	to	to	ADP
cuesj-1047	158	4	delta	delta	NOUN
cuesj-1047	158	5	infection	infection	NOUN
cuesj-1047	158	6	,	,	PUNCT
cuesj-1047	158	7	omicron	omicron	PROPN
cuesj-1047	158	8	infection	infection	NOUN
cuesj-1047	158	9	has	have	VERB
cuesj-1047	158	10	a	a	DET
cuesj-1047	158	11	lower	low	ADJ
cuesj-1047	158	12	chance	chance	NOUN
cuesj-1047	158	13	of	of	ADP
cuesj-1047	158	14	developing	develop	VERB
cuesj-1047	158	15	pneumonia.[14	pneumonia.[14	PROPN
cuesj-1047	158	16	]	]	PUNCT
cuesj-1047	158	17	comparing	compare	VERB
cuesj-1047	158	18	the	the	DET
cuesj-1047	158	19	fourth	fourth	ADJ
cuesj-1047	158	20	dosage	dosage	NOUN
cuesj-1047	158	21	with	with	ADP
cuesj-1047	158	22	the	the	DET
cuesj-1047	158	23	third	third	ADJ
cuesj-1047	158	24	dosage	dosage	NOUN
cuesj-1047	158	25	resulted	result	VERB
cuesj-1047	158	26	in	in	ADP
cuesj-1047	158	27	lower	low	ADJ
cuesj-1047	158	28	marginal	marginal	ADJ
cuesj-1047	158	29	efficacy	efficacy	NOUN
cuesj-1047	158	30	against	against	ADP
cuesj-1047	158	31	all	all	DET
cuesj-1047	158	32	outcomes	outcome	NOUN
cuesj-1047	158	33	and	and	CCONJ
cuesj-1047	158	34	it	it	PRON
cuesj-1047	158	35	was	be	AUX
cuesj-1047	158	36	discovered	discover	VERB
cuesj-1047	158	37	that	that	SCONJ
cuesj-1047	158	38	a	a	DET
cuesj-1047	158	39	fourth	fourth	ADJ
cuesj-1047	158	40	dose	dose	NOUN
cuesj-1047	158	41	provided	provide	VERB
cuesj-1047	158	42	more	more	ADJ
cuesj-1047	158	43	protection	protection	NOUN
cuesj-1047	158	44	than	than	ADP
cuesj-1047	158	45	a	a	DET
cuesj-1047	158	46	third	third	ADJ
cuesj-1047	158	47	dose	dose	NOUN
cuesj-1047	158	48	.	.	PUNCT
cuesj-1047	159	1	for	for	ADP
cuesj-1047	159	2	instance	instance	NOUN
cuesj-1047	159	3	,	,	PUNCT
cuesj-1047	159	4	if	if	SCONJ
cuesj-1047	159	5	long	long	ADJ
cuesj-1047	159	6	-	-	PUNCT
cuesj-1047	159	7	term	term	NOUN
cuesj-1047	159	8	care	care	NOUN
cuesj-1047	159	9	residents	resident	NOUN
cuesj-1047	159	10	who	who	PRON
cuesj-1047	159	11	lack	lack	VERB
cuesj-1047	159	12	vaccinations	vaccination	NOUN
cuesj-1047	159	13	experience	experience	VERB
cuesj-1047	159	14	catastrophic	catastrophic	ADJ
cuesj-1047	159	15	outcomes	outcome	NOUN
cuesj-1047	159	16	10	10	NUM
cuesj-1047	159	17	times	time	NOUN
cuesj-1047	159	18	every	every	DET
cuesj-1047	159	19	1000	1000	NUM
cuesj-1047	159	20	resident	resident	NOUN
cuesj-1047	159	21	weeks	week	NOUN
cuesj-1047	159	22	,	,	PUNCT
cuesj-1047	159	23	a	a	DET
cuesj-1047	159	24	fourth	fourth	ADJ
cuesj-1047	159	25	dose	dose	NOUN
cuesj-1047	159	26	of	of	ADP
cuesj-1047	159	27	the	the	DET
cuesj-1047	159	28	vaccine	vaccine	NOUN
cuesj-1047	159	29	is	be	AUX
cuesj-1047	159	30	86	86	NUM
cuesj-1047	159	31	%	%	NOUN
cuesj-1047	159	32	effective	effective	ADJ
cuesj-1047	159	33	,	,	PUNCT
cuesj-1047	159	34	and	and	CCONJ
cuesj-1047	159	35	a	a	DET
cuesj-1047	159	36	third	third	ADJ
cuesj-1047	159	37	dosage	dosage	NOUN
cuesj-1047	159	38	is	be	AUX
cuesj-1047	159	39	77	77	NUM
cuesj-1047	159	40	%	%	NOUN
cuesj-1047	159	41	successful	successful	ADJ
cuesj-1047	159	42	.	.	PUNCT
cuesj-1047	160	1	earlier	early	ADJ
cuesj-1047	160	2	research	research	NOUN
cuesj-1047	160	3	on	on	ADP
cuesj-1047	160	4	the	the	DET
cuesj-1047	160	5	efficacy	efficacy	NOUN
cuesj-1047	160	6	of	of	ADP
cuesj-1047	160	7	the	the	DET
cuesj-1047	160	8	two	two	NUM
cuesj-1047	160	9	injections	injection	NOUN
cuesj-1047	160	10	of	of	ADP
cuesj-1047	160	11	mrna	mrna	PROPN
cuesj-1047	160	12	vaccinations	vaccination	NOUN
cuesj-1047	160	13	in	in	ADP
cuesj-1047	160	14	long	long	ADJ
cuesj-1047	160	15	-	-	PUNCT
cuesj-1047	160	16	term	term	NOUN
cuesj-1047	160	17	care	care	NOUN
cuesj-1047	160	18	residents	resident	NOUN
cuesj-1047	160	19	undertaken	undertake	VERB
cuesj-1047	160	20	before	before	SCONJ
cuesj-1047	160	21	the	the	DET
cuesj-1047	160	22	pandemic	pandemic	NOUN
cuesj-1047	160	23	revealed	reveal	VERB
cuesj-1047	160	24	greater	great	ADJ
cuesj-1047	160	25	immunization	immunization	NOUN
cuesj-1047	160	26	efficiency	efficiency	NOUN
cuesj-1047	160	27	rates	rate	NOUN
cuesj-1047	160	28	(	(	PUNCT
cuesj-1047	160	29	71	71	NUM
cuesj-1047	160	30	–	–	SYM
cuesj-1047	160	31	82	82	NUM
cuesj-1047	160	32	%	%	NOUN
cuesj-1047	160	33	)	)	PUNCT
cuesj-1047	160	34	toward	toward	ADP
cuesj-1047	160	35	infection	infection	NOUN
cuesj-1047	160	36	in	in	ADP
cuesj-1047	160	37	comparison	comparison	NOUN
cuesj-1047	160	38	to	to	ADP
cuesj-1047	160	39	the	the	DET
cuesj-1047	160	40	fourth	fourth	ADJ
cuesj-1047	160	41	dose	dose	NOUN
cuesj-1047	160	42	.	.	PUNCT
cuesj-1047	161	1	our	our	PRON
cuesj-1047	161	2	research	research	NOUN
cuesj-1047	161	3	revealed	reveal	VERB
cuesj-1047	161	4	that	that	SCONJ
cuesj-1047	161	5	the	the	DET
cuesj-1047	161	6	covid-19	covid-19	PROPN
cuesj-1047	161	7	mrna	mrna	PROPN
cuesj-1047	161	8	vaccine	vaccine	NOUN
cuesj-1047	161	9	’s	’s	PART
cuesj-1047	161	10	fourth	fourth	ADJ
cuesj-1047	161	11	dosage	dosage	NOUN
cuesj-1047	161	12	dramatically	dramatically	ADV
cuesj-1047	161	13	improved	improve	VERB
cuesj-1047	161	14	protection	protection	NOUN
cuesj-1047	161	15	against	against	ADP
cuesj-1047	161	16	any	any	DET
cuesj-1047	161	17	sarscov-2	sarscov-2	NUM
cuesj-1047	161	18	infection	infection	NOUN
cuesj-1047	161	19	,	,	PUNCT
cuesj-1047	161	20	symptomatic	symptomatic	ADJ
cuesj-1047	161	21	illness	illness	NOUN
cuesj-1047	161	22	,	,	PUNCT
cuesj-1047	161	23	and	and	CCONJ
cuesj-1047	161	24	care	care	VERB
cuesj-1047	161	25	during	during	ADP
cuesj-1047	161	26	omicron	omicron	PROPN
cuesj-1047	161	27	duration.[32	duration.[32	PROPN
cuesj-1047	161	28	]	]	PUNCT
cuesj-1047	161	29	in	in	ADP
cuesj-1047	161	30	a	a	DET
cuesj-1047	161	31	cohort	cohort	NOUN
cuesj-1047	161	32	of	of	ADP
cuesj-1047	161	33	organ	organ	NOUN
cuesj-1047	161	34	transplant	transplant	NOUN
cuesj-1047	161	35	patients	patient	NOUN
cuesj-1047	161	36	,	,	PUNCT
cuesj-1047	161	37	a	a	DET
cuesj-1047	161	38	prospective	prospective	ADJ
cuesj-1047	161	39	observational	observational	ADJ
cuesj-1047	161	40	study	study	NOUN
cuesj-1047	161	41	was	be	AUX
cuesj-1047	161	42	conducted	conduct	VERB
cuesj-1047	161	43	during	during	ADP
cuesj-1047	161	44	the	the	DET
cuesj-1047	161	45	omicron	omicron	PROPN
cuesj-1047	161	46	wave	wave	NOUN
cuesj-1047	161	47	which	which	PRON
cuesj-1047	161	48	discovered	discover	VERB
cuesj-1047	161	49	late	late	ADJ
cuesj-1047	161	50	age	age	NOUN
cuesj-1047	161	51	and	and	CCONJ
cuesj-1047	161	52	several	several	ADJ
cuesj-1047	161	53	comorbidities	comorbiditie	NOUN
cuesj-1047	161	54	continue	continue	VERB
cuesj-1047	161	55	to	to	PART
cuesj-1047	161	56	be	be	AUX
cuesj-1047	161	57	significant	significant	ADJ
cuesj-1047	161	58	risk	risk	NOUN
cuesj-1047	161	59	factors	factor	NOUN
cuesj-1047	161	60	for	for	ADP
cuesj-1047	161	61	serious	serious	ADJ
cuesj-1047	161	62	illness	illness	NOUN
cuesj-1047	161	63	.	.	PUNCT
cuesj-1047	162	1	however	however	ADV
cuesj-1047	162	2	,	,	PUNCT
cuesj-1047	162	3	the	the	DET
cuesj-1047	162	4	reduced	reduce	VERB
cuesj-1047	162	5	chance	chance	NOUN
cuesj-1047	162	6	of	of	ADP
cuesj-1047	162	7	developing	develop	VERB
cuesj-1047	162	8	a	a	DET
cuesj-1047	162	9	major	major	ADJ
cuesj-1047	162	10	disease	disease	NOUN
cuesj-1047	162	11	in	in	ADP
cuesj-1047	162	12	liver	liver	NOUN
cuesj-1047	162	13	transplant	transplant	NOUN
cuesj-1047	162	14	recipients	recipient	NOUN
cuesj-1047	162	15	is	be	AUX
cuesj-1047	162	16	probably	probably	ADV
cuesj-1047	162	17	due	due	ADJ
cuesj-1047	162	18	to	to	ADP
cuesj-1047	162	19	low	low	ADJ
cuesj-1047	162	20	levels	level	NOUN
cuesj-1047	162	21	and	and	CCONJ
cuesj-1047	162	22	dosages	dosage	NOUN
cuesj-1047	162	23	of	of	ADP
cuesj-1047	162	24	maintenance	maintenance	NOUN
cuesj-1047	162	25	immunosuppression	immunosuppression	NOUN
cuesj-1047	162	26	.	.	PUNCT
cuesj-1047	163	1	over	over	ADP
cuesj-1047	163	2	the	the	DET
cuesj-1047	163	3	course	course	NOUN
cuesj-1047	163	4	of	of	ADP
cuesj-1047	163	5	their	their	PRON
cuesj-1047	163	6	illnesses	illness	NOUN
cuesj-1047	163	7	,	,	PUNCT
cuesj-1047	163	8	many	many	ADJ
cuesj-1047	163	9	patients	patient	NOUN
cuesj-1047	163	10	’	'	PUNCT
cuesj-1047	163	11	immunosuppression	immunosuppression	NOUN
cuesj-1047	163	12	levels	level	NOUN
cuesj-1047	163	13	decreased	decrease	VERB
cuesj-1047	163	14	,	,	PUNCT
cuesj-1047	163	15	1	1	NUM
cuesj-1047	163	16	2	2	NUM
cuesj-1047	163	17	0	0	NUM
cuesj-1047	163	18	%	%	NOUN
cuesj-1047	163	19	10	10	NUM
cuesj-1047	163	20	%	%	NOUN
cuesj-1047	163	21	20	20	NUM
cuesj-1047	163	22	%	%	NOUN
cuesj-1047	163	23	30	30	NUM
cuesj-1047	163	24	%	%	NOUN
cuesj-1047	163	25	40	40	NUM
cuesj-1047	163	26	%	%	NOUN
cuesj-1047	163	27	50	50	NUM
cuesj-1047	163	28	%	%	NOUN
cuesj-1047	163	29	60	60	NUM
cuesj-1047	163	30	%	%	NOUN
cuesj-1047	163	31	70	70	NUM
cuesj-1047	163	32	%	%	NOUN
cuesj-1047	163	33	80	80	NUM
cuesj-1047	163	34	%	%	NOUN
cuesj-1047	163	35	delta	delta	NOUN
cuesj-1047	163	36	omicron	omicron	PROPN
cuesj-1047	163	37	figure	figure	NOUN
cuesj-1047	163	38	6	6	NUM
cuesj-1047	163	39	:	:	PUNCT
cuesj-1047	163	40	pneumonia	pneumonia	NOUN
cuesj-1047	163	41	varieties	variety	NOUN
cuesj-1047	163	42	and	and	CCONJ
cuesj-1047	163	43	immunization	immunization	NOUN
cuesj-1047	163	44	status	status	NOUN
cuesj-1047	164	1	remdesivir	remdesivir	NOUN
cuesj-1047	164	2	16	16	NUM
cuesj-1047	164	3	%	%	NOUN
cuesj-1047	164	4	dexamethasone	dexamethasone	NOUN
cuesj-1047	164	5	14	14	NUM
cuesj-1047	164	6	%	%	NOUN
cuesj-1047	164	7	monoclonal	monoclonal	NOUN
cuesj-1047	164	8	antibodies	antibodie	VERB
cuesj-1047	164	9	14	14	NUM
cuesj-1047	164	10	%	%	NOUN
cuesj-1047	164	11	tocilizumab	tocilizumab	NOUN
cuesj-1047	164	12	1	1	NUM
cuesj-1047	164	13	%	%	NOUN
cuesj-1047	164	14	baricitinib	baricitinib	NOUN
cuesj-1047	164	15	0	0	NUM
cuesj-1047	164	16	%	%	NOUN
cuesj-1047	164	17	convalescent	convalescent	NOUN
cuesj-1047	164	18	plasma	plasma	NOUN
cuesj-1047	164	19	55	55	NUM
cuesj-1047	164	20	%	%	NOUN
cuesj-1047	164	21	other	other	ADJ
cuesj-1047	164	22	55	55	NUM
cuesj-1047	164	23	%	%	NOUN
cuesj-1047	164	24	effectiveness	effectiveness	NOUN
cuesj-1047	164	25	of	of	ADP
cuesj-1047	164	26	treatments	treatment	NOUN
cuesj-1047	164	27	figure	figure	VERB
cuesj-1047	164	28	8	8	NUM
cuesj-1047	164	29	:	:	PUNCT
cuesj-1047	164	30	treatment	treatment	NOUN
cuesj-1047	164	31	outcomes	outcome	NOUN
cuesj-1047	164	32	and	and	CCONJ
cuesj-1047	164	33	severe	severe	ADJ
cuesj-1047	164	34	covid-19	covid-19	PROPN
cuesj-1047	164	35	2	2	NUM
cuesj-1047	164	36	doses	dose	NOUN
cuesj-1047	164	37	3	3	NUM
cuesj-1047	164	38	doses	dose	NOUN
cuesj-1047	164	39	more	more	ADJ
cuesj-1047	164	40	than	than	ADP
cuesj-1047	164	41	3	3	NUM
cuesj-1047	164	42	doses	dose	NOUN
cuesj-1047	164	43	figure	figure	VERB
cuesj-1047	164	44	7	7	NUM
cuesj-1047	164	45	:	:	PUNCT
cuesj-1047	164	46	the	the	DET
cuesj-1047	164	47	influence	influence	NOUN
cuesj-1047	164	48	of	of	ADP
cuesj-1047	164	49	vaccination	vaccination	NOUN
cuesj-1047	164	50	on	on	ADP
cuesj-1047	164	51	clinical	clinical	ADJ
cuesj-1047	164	52	treatment	treatment	NOUN
cuesj-1047	164	53	outcomes	outcome	NOUN
cuesj-1047	164	54	during	during	ADP
cuesj-1047	164	55	the	the	DET
cuesj-1047	164	56	omicron	omicron	PROPN
cuesj-1047	164	57	hussein	hussein	PROPN
cuesj-1047	164	58	,	,	PUNCT
cuesj-1047	164	59	et	et	PROPN
cuesj-1047	164	60	al	al	PROPN
cuesj-1047	164	61	.	.	PUNCT
cuesj-1047	164	62	:	:	PUNCT
cuesj-1047	165	1	a	a	DET
cuesj-1047	165	2	review	review	NOUN
cuesj-1047	165	3	on	on	ADP
cuesj-1047	165	4	coronavirus	coronavirus	NOUN
cuesj-1047	165	5	and	and	CCONJ
cuesj-1047	165	6	omicron	omicron	PROPN
cuesj-1047	165	7	patients	patient	NOUN
cuesj-1047	165	8	15	15	NUM
cuesj-1047	165	9	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	165	10	cuesj	cuesj	NOUN
cuesj-1047	165	11	2024	2024	NUM
cuesj-1047	165	12	,	,	PUNCT
cuesj-1047	165	13	8	8	NUM
cuesj-1047	165	14	(	(	PUNCT
cuesj-1047	165	15	1	1	NUM
cuesj-1047	165	16	):	):	PUNCT
cuesj-1047	165	17	8	8	NUM
cuesj-1047	165	18	-	-	SYM
cuesj-1047	165	19	17	17	NUM
cuesj-1047	165	20	especially	especially	ADV
cuesj-1047	165	21	in	in	ADP
cuesj-1047	165	22	those	those	PRON
cuesj-1047	165	23	with	with	ADP
cuesj-1047	165	24	more	more	ADV
cuesj-1047	165	25	serious	serious	ADJ
cuesj-1047	165	26	illnesses	illness	NOUN
cuesj-1047	165	27	.	.	PUNCT
cuesj-1047	166	1	in	in	ADP
cuesj-1047	166	2	addition	addition	NOUN
cuesj-1047	166	3	,	,	PUNCT
cuesj-1047	166	4	we	we	PRON
cuesj-1047	166	5	discovered	discover	VERB
cuesj-1047	166	6	that	that	SCONJ
cuesj-1047	166	7	sotrovimab	sotrovimab	NOUN
cuesj-1047	166	8	was	be	AUX
cuesj-1047	166	9	effective	effective	ADJ
cuesj-1047	166	10	at	at	ADP
cuesj-1047	166	11	lowering	lower	VERB
cuesj-1047	166	12	the	the	DET
cuesj-1047	166	13	requirement	requirement	NOUN
cuesj-1047	166	14	for	for	ADP
cuesj-1047	166	15	extra	extra	ADJ
cuesj-1047	166	16	oxygen	oxygen	NOUN
cuesj-1047	166	17	and	and	CCONJ
cuesj-1047	166	18	hospitalization	hospitalization	NOUN
cuesj-1047	166	19	when	when	SCONJ
cuesj-1047	166	20	administered	administer	VERB
cuesj-1047	166	21	within	within	ADP
cuesj-1047	166	22	the	the	DET
cuesj-1047	166	23	1st	1st	ADJ
cuesj-1047	166	24	week	week	NOUN
cuesj-1047	166	25	of	of	ADP
cuesj-1047	166	26	symptom	symptom	NOUN
cuesj-1047	166	27	onset.[33	onset.[33	PROPN
cuesj-1047	166	28	]	]	PUNCT
cuesj-1047	166	29	in	in	ADP
cuesj-1047	166	30	comparison	comparison	NOUN
cuesj-1047	166	31	to	to	ADP
cuesj-1047	166	32	earlier	early	ADJ
cuesj-1047	166	33	versions	version	NOUN
cuesj-1047	166	34	,	,	PUNCT
cuesj-1047	166	35	the	the	DET
cuesj-1047	166	36	omicron	omicron	PROPN
cuesj-1047	166	37	form	form	NOUN
cuesj-1047	166	38	is	be	AUX
cuesj-1047	166	39	more	more	ADV
cuesj-1047	166	40	contagious	contagious	ADJ
cuesj-1047	166	41	and	and	CCONJ
cuesj-1047	166	42	immune	immune	ADJ
cuesj-1047	166	43	to	to	ADP
cuesj-1047	166	44	vaccination	vaccination	NOUN
cuesj-1047	166	45	neutralization	neutralization	NOUN
cuesj-1047	166	46	.	.	PUNCT
cuesj-1047	167	1	retrospective	retrospective	ADJ
cuesj-1047	167	2	extraction	extraction	NOUN
cuesj-1047	167	3	of	of	ADP
cuesj-1047	167	4	clinical	clinical	ADJ
cuesj-1047	167	5	features	feature	NOUN
cuesj-1047	167	6	and	and	CCONJ
cuesj-1047	167	7	outcomes	outcome	NOUN
cuesj-1047	167	8	from	from	ADP
cuesj-1047	167	9	electronic	electronic	ADJ
cuesj-1047	167	10	health	health	NOUN
cuesj-1047	167	11	records	record	NOUN
cuesj-1047	167	12	with	with	ADP
cuesj-1047	167	13	positive	positive	ADJ
cuesj-1047	167	14	rt	rt	ADJ
cuesj-1047	167	15	-	-	PUNCT
cuesj-1047	167	16	pcr	pcr	NOUN
cuesj-1047	167	17	sarscov-2	sarscov-2	NUM
cuesj-1047	167	18	test	test	NOUN
cuesj-1047	167	19	findings	finding	NOUN
cuesj-1047	167	20	was	be	AUX
cuesj-1047	167	21	performed	perform	VERB
cuesj-1047	167	22	.	.	PUNCT
cuesj-1047	168	1	covid-19	covid-19	PROPN
cuesj-1047	168	2	immunization	immunization	NOUN
cuesj-1047	168	3	,	,	PUNCT
cuesj-1047	168	4	particularly	particularly	ADV
cuesj-1047	168	5	obtaining	obtain	VERB
cuesj-1047	168	6	a	a	DET
cuesj-1047	168	7	booster	booster	NOUN
cuesj-1047	168	8	dosage	dosage	NOUN
cuesj-1047	168	9	,	,	PUNCT
cuesj-1047	168	10	correlated	correlate	VERB
cuesj-1047	168	11	with	with	ADP
cuesj-1047	168	12	a	a	DET
cuesj-1047	168	13	lower	low	ADJ
cuesj-1047	168	14	risk	risk	NOUN
cuesj-1047	168	15	of	of	ADP
cuesj-1047	168	16	icu	icu	PROPN
cuesj-1047	168	17	admission	admission	NOUN
cuesj-1047	168	18	and	and	CCONJ
cuesj-1047	168	19	lower	low	ADJ
cuesj-1047	168	20	chance	chance	NOUN
cuesj-1047	168	21	of	of	ADP
cuesj-1047	168	22	mortality	mortality	NOUN
cuesj-1047	168	23	while	while	SCONJ
cuesj-1047	168	24	at	at	ADP
cuesj-1047	168	25	the	the	DET
cuesj-1047	168	26	hospital	hospital	NOUN
cuesj-1047	168	27	among	among	ADP
cuesj-1047	168	28	individuals	individual	NOUN
cuesj-1047	168	29	who	who	PRON
cuesj-1047	168	30	are	be	AUX
cuesj-1047	168	31	65	65	NUM
cuesj-1047	168	32	years	year	NOUN
cuesj-1047	168	33	or	or	CCONJ
cuesj-1047	168	34	older	old	ADJ
cuesj-1047	168	35	and	and	CCONJ
cuesj-1047	168	36	who	who	PRON
cuesj-1047	168	37	are	be	AUX
cuesj-1047	168	38	more	more	ADV
cuesj-1047	168	39	likely	likely	ADJ
cuesj-1047	168	40	to	to	PART
cuesj-1047	168	41	experience	experience	VERB
cuesj-1047	168	42	major	major	ADJ
cuesj-1047	168	43	difficulties	difficulty	NOUN
cuesj-1047	168	44	while	while	SCONJ
cuesj-1047	168	45	hospitalized	hospitalize	VERB
cuesj-1047	168	46	.	.	PUNCT
cuesj-1047	169	1	hospitalizations	hospitalization	NOUN
cuesj-1047	169	2	during	during	ADP
cuesj-1047	169	3	the	the	DET
cuesj-1047	169	4	omicron	omicron	PROPN
cuesj-1047	169	5	period	period	NOUN
cuesj-1047	169	6	were	be	AUX
cuesj-1047	169	7	correlated	correlate	VERB
cuesj-1047	169	8	with	with	ADP
cuesj-1047	169	9	reduced	reduced	ADJ
cuesj-1047	169	10	imv	imv	NOUN
cuesj-1047	169	11	and	and	CCONJ
cuesj-1047	169	12	hospital	hospital	NOUN
cuesj-1047	169	13	fatalities	fatality	NOUN
cuesj-1047	169	14	as	as	ADP
cuesj-1047	169	15	compared	compare	VERB
cuesj-1047	169	16	to	to	ADP
cuesj-1047	169	17	hospitalizations	hospitalization	NOUN
cuesj-1047	169	18	during	during	ADP
cuesj-1047	169	19	the	the	DET
cuesj-1047	169	20	delta	delta	NOUN
cuesj-1047	169	21	era	era	NOUN
cuesj-1047	169	22	.	.	PUNCT
cuesj-1047	170	1	the	the	DET
cuesj-1047	170	2	higher	high	ADJ
cuesj-1047	170	3	population	population	NOUN
cuesj-1047	170	4	-	-	PUNCT
cuesj-1047	170	5	level	level	NOUN
cuesj-1047	170	6	immunity	immunity	NOUN
cuesj-1047	170	7	imparted	impart	VERB
cuesj-1047	170	8	by	by	ADP
cuesj-1047	170	9	vaccination	vaccination	NOUN
cuesj-1047	170	10	may	may	AUX
cuesj-1047	170	11	be	be	AUX
cuesj-1047	170	12	the	the	DET
cuesj-1047	170	13	cause	cause	NOUN
cuesj-1047	170	14	of	of	ADP
cuesj-1047	170	15	the	the	DET
cuesj-1047	170	16	reduced	reduce	VERB
cuesj-1047	170	17	illness	illness	NOUN
cuesj-1047	170	18	severity	severity	NOUN
cuesj-1047	170	19	seen	see	VERB
cuesj-1047	170	20	during	during	ADP
cuesj-1047	170	21	omicron	omicron	PROPN
cuesj-1047	170	22	predominance	predominance	NOUN
cuesj-1047	170	23	.	.	PUNCT
cuesj-1047	171	1	the	the	DET
cuesj-1047	171	2	severity	severity	NOUN
cuesj-1047	171	3	markers	marker	NOUN
cuesj-1047	171	4	were	be	AUX
cuesj-1047	171	5	contrasted	contrast	VERB
cuesj-1047	171	6	during	during	ADP
cuesj-1047	171	7	omicron	omicron	PROPN
cuesj-1047	171	8	-	-	PUNCT
cuesj-1047	171	9	period	period	NOUN
cuesj-1047	171	10	hospitalizations	hospitalization	NOUN
cuesj-1047	171	11	among	among	ADP
cuesj-1047	171	12	the	the	DET
cuesj-1047	171	13	four	four	NUM
cuesj-1047	171	14	vaccination	vaccination	NOUN
cuesj-1047	171	15	status	status	NOUN
cuesj-1047	171	16	categories	category	NOUN
cuesj-1047	171	17	including	include	VERB
cuesj-1047	171	18	unvaccinated	unvaccinate	VERB
cuesj-1047	171	19	,	,	PUNCT
cuesj-1047	171	20	partially	partially	ADV
cuesj-1047	171	21	immunized	immunize	VERB
cuesj-1047	171	22	,	,	PUNCT
cuesj-1047	171	23	totally	totally	ADV
cuesj-1047	171	24	immunized	immunize	VERB
cuesj-1047	171	25	without	without	ADP
cuesj-1047	171	26	a	a	DET
cuesj-1047	171	27	booster	booster	NOUN
cuesj-1047	171	28	injection	injection	NOUN
cuesj-1047	171	29	,	,	PUNCT
cuesj-1047	171	30	and	and	CCONJ
cuesj-1047	171	31	completely	completely	ADV
cuesj-1047	171	32	immunized	immunize	VERB
cuesj-1047	171	33	with	with	ADP
cuesj-1047	171	34	a	a	DET
cuesj-1047	171	35	booster	booster	NOUN
cuesj-1047	171	36	injection	injection	NOUN
cuesj-1047	171	37	.	.	PUNCT
cuesj-1047	172	1	increased	increase	VERB
cuesj-1047	172	2	infections	infection	NOUN
cuesj-1047	172	3	among	among	ADP
cuesj-1047	172	4	vaccination	vaccination	NOUN
cuesj-1047	172	5	recipients	recipient	NOUN
cuesj-1047	172	6	during	during	ADP
cuesj-1047	172	7	the	the	DET
cuesj-1047	172	8	omicron	omicron	PROPN
cuesj-1047	172	9	dominance	dominance	NOUN
cuesj-1047	172	10	period	period	NOUN
cuesj-1047	172	11	were	be	AUX
cuesj-1047	172	12	most	most	ADV
cuesj-1047	172	13	likely	likely	ADV
cuesj-1047	172	14	caused	cause	VERB
cuesj-1047	172	15	by	by	ADP
cuesj-1047	172	16	a	a	DET
cuesj-1047	172	17	combination	combination	NOUN
cuesj-1047	172	18	of	of	ADP
cuesj-1047	172	19	deteriorating	deteriorate	VERB
cuesj-1047	172	20	vaccination	vaccination	NOUN
cuesj-1047	172	21	-	-	PUNCT
cuesj-1047	172	22	derived	derive	VERB
cuesj-1047	172	23	immunity	immunity	NOUN
cuesj-1047	172	24	with	with	ADP
cuesj-1047	172	25	time	time	NOUN
cuesj-1047	172	26	and	and	CCONJ
cuesj-1047	172	27	the	the	DET
cuesj-1047	172	28	omicron	omicron	PROPN
cuesj-1047	172	29	variation	variation	NOUN
cuesj-1047	172	30	’s	’s	PART
cuesj-1047	172	31	increased	increase	VERB
cuesj-1047	172	32	vaccine	vaccine	NOUN
cuesj-1047	172	33	-	-	PUNCT
cuesj-1047	172	34	neutralization	neutralization	NOUN
cuesj-1047	172	35	resistance	resistance	NOUN
cuesj-1047	172	36	compared	compare	VERB
cuesj-1047	172	37	to	to	ADP
cuesj-1047	172	38	the	the	DET
cuesj-1047	172	39	delta	delta	NOUN
cuesj-1047	172	40	variant	variant	NOUN
cuesj-1047	172	41	.	.	PUNCT
cuesj-1047	173	1	hospitalized	hospitalize	VERB
cuesj-1047	173	2	patients	patient	NOUN
cuesj-1047	173	3	having	have	VERB
cuesj-1047	173	4	other	other	ADJ
cuesj-1047	173	5	illnesses	illness	NOUN
cuesj-1047	173	6	were	be	AUX
cuesj-1047	173	7	younger	young	ADJ
cuesj-1047	173	8	than	than	SCONJ
cuesj-1047	173	9	adults	adult	NOUN
cuesj-1047	173	10	hospitalized	hospitalize	VERB
cuesj-1047	173	11	for	for	ADP
cuesj-1047	173	12	covid-19	covid-19	PROPN
cuesj-1047	173	13	.	.	PUNCT
cuesj-1047	174	1	among	among	ADP
cuesj-1047	174	2	the	the	DET
cuesj-1047	174	3	105	105	NUM
cuesj-1047	174	4	hospitalized	hospitalize	VERB
cuesj-1047	174	5	patients	patient	NOUN
cuesj-1047	174	6	for	for	ADP
cuesj-1047	174	7	covid-19	covid-19	PROPN
cuesj-1047	174	8	,	,	PUNCT
cuesj-1047	174	9	39.0	39.0	NUM
cuesj-1047	174	10	%	%	NOUN
cuesj-1047	174	11	exhibited	exhibit	VERB
cuesj-1047	174	12	hypoxemia	hypoxemia	NOUN
cuesj-1047	174	13	,	,	PUNCT
cuesj-1047	174	14	51.4	51.4	NUM
cuesj-1047	174	15	%	%	NOUN
cuesj-1047	174	16	had	have	VERB
cuesj-1047	174	17	unusual	unusual	ADJ
cuesj-1047	174	18	chest	chest	NOUN
cuesj-1047	174	19	radiography	radiography	NOUN
cuesj-1047	174	20	,	,	PUNCT
cuesj-1047	174	21	and	and	CCONJ
cuesj-1047	174	22	63.8	63.8	NUM
cuesj-1047	174	23	%	%	NOUN
cuesj-1047	174	24	had	have	VERB
cuesj-1047	174	25	symptoms	symptom	NOUN
cuesj-1047	174	26	of	of	ADP
cuesj-1047	174	27	the	the	DET
cuesj-1047	174	28	lower	low	ADJ
cuesj-1047	174	29	respiratory	respiratory	ADJ
cuesj-1047	174	30	tract	tract	NOUN
cuesj-1047	174	31	.	.	PUNCT
cuesj-1047	175	1	omicron	omicron	PROPN
cuesj-1047	175	2	variant	variant	PROPN
cuesj-1047	175	3	illness	illness	NOUN
cuesj-1047	175	4	still	still	ADV
cuesj-1047	175	5	produces	produce	VERB
cuesj-1047	175	6	serious	serious	ADJ
cuesj-1047	175	7	lower	low	ADJ
cuesj-1047	175	8	respiratory	respiratory	ADJ
cuesj-1047	175	9	disease	disease	NOUN
cuesj-1047	175	10	despite	despite	SCONJ
cuesj-1047	175	11	reported	report	VERB
cuesj-1047	175	12	differences	difference	NOUN
cuesj-1047	175	13	from	from	ADP
cuesj-1047	175	14	the	the	DET
cuesj-1047	175	15	delta	delta	NOUN
cuesj-1047	175	16	.	.	PUNCT
cuesj-1047	176	1	less	less	ADJ
cuesj-1047	176	2	omicron	omicron	NOUN
cuesj-1047	176	3	-	-	PUNCT
cuesj-1047	176	4	period	period	NOUN
cuesj-1047	176	5	individuals	individual	NOUN
cuesj-1047	176	6	got	get	VERB
cuesj-1047	176	7	covid-19	covid-19	PROPN
cuesj-1047	176	8	therapy	therapy	NOUN
cuesj-1047	176	9	than	than	ADP
cuesj-1047	176	10	delta	delta	NOUN
cuesj-1047	176	11	-	-	PUNCT
cuesj-1047	176	12	period	period	NOUN
cuesj-1047	176	13	patients	patient	NOUN
cuesj-1047	176	14	,	,	PUNCT
cuesj-1047	176	15	which	which	PRON
cuesj-1047	176	16	may	may	AUX
cuesj-1047	176	17	indicate	indicate	VERB
cuesj-1047	176	18	a	a	DET
cuesj-1047	176	19	lower	low	ADJ
cuesj-1047	176	20	proportion	proportion	NOUN
cuesj-1047	176	21	of	of	ADP
cuesj-1047	176	22	hypoxemia.[34	hypoxemia.[34	NOUN
cuesj-1047	176	23	]	]	PUNCT
cuesj-1047	176	24	it	it	PRON
cuesj-1047	176	25	has	have	AUX
cuesj-1047	176	26	been	be	AUX
cuesj-1047	176	27	demonstrated	demonstrate	VERB
cuesj-1047	176	28	that	that	SCONJ
cuesj-1047	176	29	covid-19	covid-19	PROPN
cuesj-1047	176	30	vaccinations	vaccination	NOUN
cuesj-1047	176	31	are	be	AUX
cuesj-1047	176	32	more	more	ADV
cuesj-1047	176	33	effective	effective	ADJ
cuesj-1047	176	34	toward	toward	ADP
cuesj-1047	176	35	severe	severe	ADJ
cuesj-1047	176	36	omicron	omicron	PROPN
cuesj-1047	176	37	efficacy	efficacy	PROPN
cuesj-1047	176	38	estimates	estimate	NOUN
cuesj-1047	176	39	based	base	VERB
cuesj-1047	176	40	on	on	ADP
cuesj-1047	176	41	hospitalization	hospitalization	NOUN
cuesj-1047	176	42	in	in	ADP
cuesj-1047	176	43	omicron	omicron	PROPN
cuesj-1047	176	44	-	-	PUNCT
cuesj-1047	176	45	infected	infect	VERB
cuesj-1047	176	46	individuals	individual	NOUN
cuesj-1047	176	47	underestimate	underestimate	VERB
cuesj-1047	176	48	the	the	DET
cuesj-1047	176	49	covid-19	covid-19	PROPN
cuesj-1047	176	50	sickness	sickness	NOUN
cuesj-1047	176	51	.	.	PUNCT
cuesj-1047	177	1	the	the	DET
cuesj-1047	177	2	reason	reason	NOUN
cuesj-1047	177	3	for	for	ADP
cuesj-1047	177	4	this	this	PRON
cuesj-1047	177	5	is	be	AUX
cuesj-1047	177	6	due	due	ADJ
cuesj-1047	177	7	to	to	ADP
cuesj-1047	177	8	the	the	DET
cuesj-1047	177	9	less	less	ADJ
cuesj-1047	177	10	covid-19	covid-19	PROPN
cuesj-1047	177	11	vaccine	vaccine	NOUN
cuesj-1047	177	12	effectiveness	effectiveness	NOUN
cuesj-1047	177	13	which	which	PRON
cuesj-1047	177	14	is	be	AUX
cuesj-1047	177	15	responsible	responsible	ADJ
cuesj-1047	177	16	for	for	ADP
cuesj-1047	177	17	a	a	DET
cuesj-1047	177	18	higher	high	ADJ
cuesj-1047	177	19	percentage	percentage	NOUN
cuesj-1047	177	20	of	of	ADP
cuesj-1047	177	21	hospitalizations	hospitalization	NOUN
cuesj-1047	177	22	than	than	SCONJ
cuesj-1047	177	23	it	it	PRON
cuesj-1047	177	24	is	be	AUX
cuesj-1047	177	25	for	for	ADP
cuesj-1047	177	26	its	its	PRON
cuesj-1047	177	27	actual	actual	ADJ
cuesj-1047	177	28	induction	induction	NOUN
cuesj-1047	177	29	.	.	PUNCT
cuesj-1047	178	1	there	there	PRON
cuesj-1047	178	2	was	be	VERB
cuesj-1047	178	3	greater	great	ADJ
cuesj-1047	178	4	vaccination	vaccination	NOUN
cuesj-1047	178	5	protection	protection	NOUN
cuesj-1047	178	6	against	against	ADP
cuesj-1047	178	7	the	the	DET
cuesj-1047	178	8	development	development	NOUN
cuesj-1047	178	9	of	of	ADP
cuesj-1047	178	10	omicron	omicron	PROPN
cuesj-1047	178	11	infection	infection	NOUN
cuesj-1047	178	12	to	to	ADP
cuesj-1047	178	13	severe	severe	ADJ
cuesj-1047	178	14	illness	illness	NOUN
cuesj-1047	178	15	as	as	ADV
cuesj-1047	178	16	well	well	ADV
cuesj-1047	178	17	as	as	ADP
cuesj-1047	178	18	hospitalization	hospitalization	NOUN
cuesj-1047	178	19	.	.	PUNCT
cuesj-1047	179	1	when	when	SCONJ
cuesj-1047	179	2	more	more	ADV
cuesj-1047	179	3	exact	exact	ADJ
cuesj-1047	179	4	diagnostic	diagnostic	ADJ
cuesj-1047	179	5	criteria	criterion	NOUN
cuesj-1047	179	6	for	for	ADP
cuesj-1047	179	7	serious	serious	ADJ
cuesj-1047	179	8	covid-19	covid-19	PROPN
cuesj-1047	179	9	respiratory	respiratory	ADJ
cuesj-1047	179	10	sickness	sickness	NOUN
cuesj-1047	179	11	were	be	AUX
cuesj-1047	179	12	applied	apply	VERB
cuesj-1047	179	13	,	,	PUNCT
cuesj-1047	179	14	such	such	ADJ
cuesj-1047	179	15	as	as	ADP
cuesj-1047	179	16	respiratory	respiratory	ADJ
cuesj-1047	179	17	distress	distress	NOUN
cuesj-1047	179	18	signs	sign	NOUN
cuesj-1047	179	19	(	(	PUNCT
cuesj-1047	179	20	such	such	ADJ
cuesj-1047	179	21	as	as	ADP
cuesj-1047	179	22	the	the	DET
cuesj-1047	179	23	need	need	NOUN
cuesj-1047	179	24	for	for	ADP
cuesj-1047	179	25	oxygen	oxygen	NOUN
cuesj-1047	179	26	,	,	PUNCT
cuesj-1047	179	27	mechanical	mechanical	ADJ
cuesj-1047	179	28	ventilation	ventilation	NOUN
cuesj-1047	179	29	,	,	PUNCT
cuesj-1047	179	30	and	and	CCONJ
cuesj-1047	179	31	icu	icu	PROPN
cuesj-1047	179	32	hospitalization	hospitalization	NOUN
cuesj-1047	179	33	)	)	PUNCT
cuesj-1047	179	34	,	,	PUNCT
cuesj-1047	179	35	the	the	DET
cuesj-1047	179	36	efficacy	efficacy	NOUN
cuesj-1047	179	37	of	of	ADP
cuesj-1047	179	38	the	the	DET
cuesj-1047	179	39	vaccine	vaccine	NOUN
cuesj-1047	179	40	against	against	ADP
cuesj-1047	179	41	hospitalization	hospitalization	NOUN
cuesj-1047	179	42	improved	improve	VERB
cuesj-1047	179	43	.	.	PUNCT
cuesj-1047	180	1	the	the	DET
cuesj-1047	180	2	second	second	ADJ
cuesj-1047	180	3	method	method	NOUN
cuesj-1047	180	4	to	to	PART
cuesj-1047	180	5	evaluate	evaluate	VERB
cuesj-1047	180	6	vaccination	vaccination	NOUN
cuesj-1047	180	7	protection	protection	NOUN
cuesj-1047	180	8	against	against	ADP
cuesj-1047	180	9	serious	serious	ADJ
cuesj-1047	180	10	illness	illness	NOUN
cuesj-1047	180	11	included	include	VERB
cuesj-1047	180	12	observing	observe	VERB
cuesj-1047	180	13	the	the	DET
cuesj-1047	180	14	transition	transition	NOUN
cuesj-1047	180	15	from	from	ADP
cuesj-1047	180	16	an	an	DET
cuesj-1047	180	17	omicron	omicron	PROPN
cuesj-1047	180	18	infection	infection	NOUN
cuesj-1047	180	19	to	to	ADP
cuesj-1047	180	20	a	a	DET
cuesj-1047	180	21	more	more	ADV
cuesj-1047	180	22	serious	serious	ADJ
cuesj-1047	180	23	effect	effect	NOUN
cuesj-1047	180	24	,	,	PUNCT
cuesj-1047	180	25	such	such	ADJ
cuesj-1047	180	26	as	as	ADP
cuesj-1047	180	27	intensive	intensive	ADJ
cuesj-1047	180	28	care	care	NOUN
cuesj-1047	180	29	needing	need	VERB
cuesj-1047	180	30	hospitalization	hospitalization	NOUN
cuesj-1047	180	31	and	and	CCONJ
cuesj-1047	180	32	ventilation	ventilation	NOUN
cuesj-1047	180	33	support	support	NOUN
cuesj-1047	180	34	.	.	PUNCT
cuesj-1047	181	1	the	the	DET
cuesj-1047	181	2	efficacy	efficacy	NOUN
cuesj-1047	181	3	of	of	ADP
cuesj-1047	181	4	vaccination	vaccination	NOUN
cuesj-1047	181	5	against	against	ADP
cuesj-1047	181	6	severe	severe	ADJ
cuesj-1047	181	7	omicron	omicron	PROPN
cuesj-1047	181	8	illness	illness	NOUN
cuesj-1047	181	9	can	can	AUX
cuesj-1047	181	10	be	be	AUX
cuesj-1047	181	11	assessed	assess	VERB
cuesj-1047	181	12	using	use	VERB
cuesj-1047	181	13	fatal	fatal	ADJ
cuesj-1047	181	14	outcomes	outcome	NOUN
cuesj-1047	181	15	,	,	PUNCT
cuesj-1047	181	16	although	although	SCONJ
cuesj-1047	181	17	care	care	NOUN
cuesj-1047	181	18	should	should	AUX
cuesj-1047	181	19	be	be	AUX
cuesj-1047	181	20	considered	consider	VERB
cuesj-1047	181	21	to	to	PART
cuesj-1047	181	22	avoid	avoid	VERB
cuesj-1047	181	23	misclassifying	misclassifye	VERB
cuesj-1047	181	24	the	the	DET
cuesj-1047	181	25	result	result	NOUN
cuesj-1047	181	26	in	in	ADP
cuesj-1047	181	27	death	death	NOUN
cuesj-1047	181	28	.	.	PUNCT
cuesj-1047	182	1	ecological	ecological	ADJ
cuesj-1047	182	2	assessments	assessment	NOUN
cuesj-1047	182	3	might	might	AUX
cuesj-1047	182	4	also	also	ADV
cuesj-1047	182	5	be	be	AUX
cuesj-1047	182	6	beneficial	beneficial	ADJ
cuesj-1047	182	7	.	.	PUNCT
cuesj-1047	183	1	the	the	DET
cuesj-1047	183	2	present	present	ADJ
cuesj-1047	183	3	vaccine	vaccine	NOUN
cuesj-1047	183	4	formulations	formulation	NOUN
cuesj-1047	183	5	may	may	AUX
cuesj-1047	183	6	still	still	ADV
cuesj-1047	183	7	be	be	AUX
cuesj-1047	183	8	useful	useful	ADJ
cuesj-1047	183	9	in	in	ADP
cuesj-1047	183	10	avoiding	avoid	VERB
cuesj-1047	183	11	the	the	DET
cuesj-1047	183	12	most	most	ADV
cuesj-1047	183	13	severe	severe	ADJ
cuesj-1047	183	14	disease	disease	NOUN
cuesj-1047	183	15	forms	form	NOUN
cuesj-1047	183	16	,	,	PUNCT
cuesj-1047	183	17	as	as	SCONJ
cuesj-1047	183	18	evidenced	evidence	VERB
cuesj-1047	183	19	by	by	ADP
cuesj-1047	183	20	the	the	DET
cuesj-1047	183	21	vaccination	vaccination	NOUN
cuesj-1047	183	22	’s	’s	PART
cuesj-1047	183	23	high	high	ADJ
cuesj-1047	183	24	standard	standard	NOUN
cuesj-1047	183	25	of	of	ADP
cuesj-1047	183	26	safety	safety	NOUN
cuesj-1047	183	27	against	against	ADP
cuesj-1047	183	28	the	the	DET
cuesj-1047	183	29	severe	severe	ADJ
cuesj-1047	183	30	covid-19	covid-19	PROPN
cuesj-1047	183	31	illness	illness	NOUN
cuesj-1047	183	32	associated	associate	VERB
cuesj-1047	183	33	with	with	ADP
cuesj-1047	183	34	omicron	omicron	PROPN
cuesj-1047	183	35	.	.	PUNCT
cuesj-1047	184	1	however	however	ADV
cuesj-1047	184	2	,	,	PUNCT
cuesj-1047	184	3	because	because	SCONJ
cuesj-1047	184	4	omicron	omicron	PROPN
cuesj-1047	184	5	future	future	ADJ
cuesj-1047	184	6	emerging	emerge	VERB
cuesj-1047	184	7	variations	variation	NOUN
cuesj-1047	184	8	,	,	PUNCT
cuesj-1047	184	9	resist	resist	VERB
cuesj-1047	184	10	vaccine	vaccine	NOUN
cuesj-1047	184	11	-	-	PUNCT
cuesj-1047	184	12	induced	induce	VERB
cuesj-1047	184	13	immunity	immunity	NOUN
cuesj-1047	184	14	against	against	ADP
cuesj-1047	184	15	infection	infection	NOUN
cuesj-1047	184	16	,	,	PUNCT
cuesj-1047	184	17	and	and	CCONJ
cuesj-1047	184	18	exacerbations	exacerbation	NOUN
cuesj-1047	184	19	of	of	ADP
cuesj-1047	184	20	chronic	chronic	ADJ
cuesj-1047	184	21	conditions	condition	NOUN
cuesj-1047	184	22	caused	cause	VERB
cuesj-1047	184	23	by	by	ADP
cuesj-1047	184	24	infections	infection	NOUN
cuesj-1047	184	25	in	in	ADP
cuesj-1047	184	26	susceptible	susceptible	ADJ
cuesj-1047	184	27	individuals	individual	NOUN
cuesj-1047	184	28	,	,	PUNCT
cuesj-1047	184	29	it	it	PRON
cuesj-1047	184	30	may	may	AUX
cuesj-1047	184	31	result	result	VERB
cuesj-1047	184	32	in	in	ADP
cuesj-1047	184	33	a	a	DET
cuesj-1047	184	34	higher	high	ADJ
cuesj-1047	184	35	percentage	percentage	NOUN
cuesj-1047	184	36	of	of	ADP
cuesj-1047	184	37	hospitalizations	hospitalization	NOUN
cuesj-1047	184	38	and	and	CCONJ
cuesj-1047	184	39	mortality	mortality	NOUN
cuesj-1047	184	40	.	.	PUNCT
cuesj-1047	185	1	it	it	PRON
cuesj-1047	185	2	may	may	AUX
cuesj-1047	185	3	be	be	AUX
cuesj-1047	185	4	necessary	necessary	ADJ
cuesj-1047	185	5	to	to	PART
cuesj-1047	185	6	provide	provide	VERB
cuesj-1047	185	7	booster	booster	NOUN
cuesj-1047	185	8	shots	shot	VERB
cuesj-1047	185	9	more	more	ADV
cuesj-1047	185	10	often	often	ADV
cuesj-1047	185	11	or	or	CCONJ
cuesj-1047	185	12	to	to	PART
cuesj-1047	185	13	develop	develop	VERB
cuesj-1047	185	14	new	new	ADJ
cuesj-1047	185	15	vaccinations	vaccination	NOUN
cuesj-1047	185	16	that	that	PRON
cuesj-1047	185	17	will	will	AUX
cuesj-1047	185	18	more	more	ADV
cuesj-1047	185	19	effectively	effectively	ADV
cuesj-1047	185	20	and	and	CCONJ
cuesj-1047	185	21	long	long	ADV
cuesj-1047	185	22	-	-	PUNCT
cuesj-1047	185	23	lastingly	lastingly	ADV
cuesj-1047	185	24	prevent	prevent	ADJ
cuesj-1047	185	25	sars	sar	NOUN
cuesj-1047	185	26	-	-	PUNCT
cuesj-1047	185	27	cov-2	cov-2	NOUN
cuesj-1047	185	28	infection.[35	infection.[35	PROPN
cuesj-1047	185	29	]	]	PUNCT
cuesj-1047	185	30	for	for	ADP
cuesj-1047	185	31	the	the	DET
cuesj-1047	185	32	identification	identification	NOUN
cuesj-1047	185	33	of	of	ADP
cuesj-1047	185	34	sars	sar	NOUN
cuesj-1047	185	35	-	-	PUNCT
cuesj-1047	185	36	cov-2	cov-2	NOUN
cuesj-1047	185	37	,	,	PUNCT
cuesj-1047	185	38	rapid	rapid	ADJ
cuesj-1047	185	39	antigen	antigen	NOUN
cuesj-1047	185	40	assays	assay	NOUN
cuesj-1047	185	41	exhibit	exhibit	VERB
cuesj-1047	185	42	promising	promising	ADJ
cuesj-1047	185	43	performance	performance	NOUN
cuesj-1047	185	44	.	.	PUNCT
cuesj-1047	186	1	minimal	minimal	ADJ
cuesj-1047	186	2	equipment	equipment	NOUN
cuesj-1047	186	3	is	be	AUX
cuesj-1047	186	4	needed	need	VERB
cuesj-1047	186	5	for	for	ADP
cuesj-1047	186	6	the	the	DET
cuesj-1047	186	7	tests	test	NOUN
cuesj-1047	186	8	,	,	PUNCT
cuesj-1047	186	9	and	and	CCONJ
cuesj-1047	186	10	they	they	PRON
cuesj-1047	186	11	give	give	VERB
cuesj-1047	186	12	results	result	NOUN
cuesj-1047	186	13	in	in	ADP
cuesj-1047	186	14	15–30	15–30	NUM
cuesj-1047	186	15	min	min	NOUN
cuesj-1047	186	16	.	.	PROPN
cuesj-1047	186	17	selftesting	selfteste	VERB
cuesj-1047	186	18	without	without	ADP
cuesj-1047	186	19	the	the	DET
cuesj-1047	186	20	guidance	guidance	NOUN
cuesj-1047	186	21	of	of	ADP
cuesj-1047	186	22	a	a	DET
cuesj-1047	186	23	knowledgeable	knowledgeable	ADJ
cuesj-1047	186	24	specialist	specialist	NOUN
cuesj-1047	186	25	reduces	reduce	VERB
cuesj-1047	186	26	the	the	DET
cuesj-1047	186	27	bar	bar	NOUN
cuesj-1047	186	28	for	for	ADP
cuesj-1047	186	29	testing	testing	NOUN
cuesj-1047	186	30	and	and	CCONJ
cuesj-1047	186	31	enables	enable	VERB
cuesj-1047	186	32	anyone	anyone	PRON
cuesj-1047	186	33	to	to	PART
cuesj-1047	186	34	get	get	VERB
cuesj-1047	186	35	the	the	DET
cuesj-1047	186	36	results	result	NOUN
cuesj-1047	186	37	quickly	quickly	ADV
cuesj-1047	186	38	and	and	CCONJ
cuesj-1047	186	39	as	as	ADV
cuesj-1047	186	40	soon	soon	ADV
cuesj-1047	186	41	as	as	SCONJ
cuesj-1047	186	42	it	it	PRON
cuesj-1047	186	43	is	be	AUX
cuesj-1047	186	44	convenient	convenient	ADJ
cuesj-1047	186	45	for	for	ADP
cuesj-1047	186	46	them	they	PRON
cuesj-1047	186	47	.	.	PUNCT
cuesj-1047	187	1	this	this	PRON
cuesj-1047	187	2	,	,	PUNCT
cuesj-1047	187	3	in	in	ADP
cuesj-1047	187	4	turn	turn	NOUN
cuesj-1047	187	5	,	,	PUNCT
cuesj-1047	187	6	might	might	AUX
cuesj-1047	187	7	aid	aid	VERB
cuesj-1047	187	8	in	in	ADP
cuesj-1047	187	9	the	the	DET
cuesj-1047	187	10	early	early	ADJ
cuesj-1047	187	11	discovery	discovery	NOUN
cuesj-1047	187	12	and	and	CCONJ
cuesj-1047	187	13	self	self	NOUN
cuesj-1047	187	14	-	-	PUNCT
cuesj-1047	187	15	isolation	isolation	NOUN
cuesj-1047	187	16	of	of	ADP
cuesj-1047	187	17	infected	infected	ADJ
cuesj-1047	187	18	individuals	individual	NOUN
cuesj-1047	187	19	,	,	PUNCT
cuesj-1047	187	20	hence	hence	ADV
cuesj-1047	187	21	reducing	reduce	VERB
cuesj-1047	187	22	community	community	NOUN
cuesj-1047	187	23	transmission	transmission	NOUN
cuesj-1047	187	24	.	.	PUNCT
cuesj-1047	188	1	sensitivity	sensitivity	NOUN
cuesj-1047	188	2	of	of	ADP
cuesj-1047	188	3	three	three	NUM
cuesj-1047	188	4	readily	readily	ADV
cuesj-1047	188	5	accessible	accessible	ADJ
cuesj-1047	188	6	sars	sar	NOUN
cuesj-1047	188	7	-	-	PUNCT
cuesj-1047	188	8	cov-2	cov-2	PART
cuesj-1047	188	9	fast	fast	ADJ
cuesj-1047	188	10	antigen	antigen	NOUN
cuesj-1047	188	11	tests	test	NOUN
cuesj-1047	188	12	(	(	PUNCT
cuesj-1047	188	13	flowflex	flowflex	ADJ
cuesj-1047	188	14	,	,	PUNCT
cuesj-1047	188	15	mpbio	mpbio	NOUN
cuesj-1047	188	16	,	,	PUNCT
cuesj-1047	188	17	and	and	CCONJ
cuesj-1047	188	18	clinical	clinical	ADJ
cuesj-1047	188	19	test	test	NOUN
cuesj-1047	188	20	)	)	PUNCT
cuesj-1047	188	21	spontaneous	spontaneous	ADJ
cuesj-1047	188	22	nasal	nasal	NOUN
cuesj-1047	188	23	sampling	sample	VERB
cuesj-1047	188	24	by	by	ADP
cuesj-1047	188	25	oneself	oneself	PRON
cuesj-1047	188	26	by	by	ADP
cuesj-1047	188	27	symptomatic	symptomatic	ADJ
cuesj-1047	188	28	people	people	NOUN
cuesj-1047	188	29	reduced	reduce	VERB
cuesj-1047	188	30	the	the	DET
cuesj-1047	188	31	total	total	ADJ
cuesj-1047	188	32	omicron	omicron	PROPN
cuesj-1047	188	33	emergence	emergence	NOUN
cuesj-1047	188	34	.	.	PUNCT
cuesj-1047	189	1	however	however	ADV
cuesj-1047	189	2	,	,	PUNCT
cuesj-1047	189	3	the	the	DET
cuesj-1047	189	4	clinical	clinical	ADJ
cuesj-1047	189	5	test	test	NOUN
cuesj-1047	189	6	was	be	AUX
cuesj-1047	189	7	the	the	DET
cuesj-1047	189	8	only	only	ADJ
cuesj-1047	189	9	test	test	NOUN
cuesj-1047	189	10	that	that	PRON
cuesj-1047	189	11	showed	show	VERB
cuesj-1047	189	12	a	a	DET
cuesj-1047	189	13	significant	significant	ADJ
cuesj-1047	189	14	statistical	statistical	ADJ
cuesj-1047	189	15	decline	decline	NOUN
cuesj-1047	189	16	.	.	PUNCT
cuesj-1047	190	1	in	in	ADP
cuesj-1047	190	2	contrast	contrast	NOUN
cuesj-1047	190	3	to	to	ADP
cuesj-1047	190	4	individuals	individual	NOUN
cuesj-1047	190	5	who	who	PRON
cuesj-1047	190	6	visited	visit	VERB
cuesj-1047	190	7	testing	testing	NOUN
cuesj-1047	190	8	facilities	facility	NOUN
cuesj-1047	190	9	for	for	ADP
cuesj-1047	190	10	different	different	ADJ
cuesj-1047	190	11	reasons	reason	NOUN
cuesj-1047	190	12	,	,	PUNCT
cuesj-1047	190	13	confirmatory	confirmatory	NOUN
cuesj-1047	190	14	testers	tester	NOUN
cuesj-1047	190	15	(	(	PUNCT
cuesj-1047	190	16	those	those	PRON
cuesj-1047	190	17	tested	test	VERB
cuesj-1047	190	18	who	who	PRON
cuesj-1047	190	19	could	could	AUX
cuesj-1047	190	20	prove	prove	VERB
cuesj-1047	190	21	favorable	favorable	ADJ
cuesj-1047	190	22	self	self	NOUN
cuesj-1047	190	23	-	-	PUNCT
cuesj-1047	190	24	test	test	NOUN
cuesj-1047	190	25	results	result	NOUN
cuesj-1047	190	26	)	)	PUNCT
cuesj-1047	190	27	showed	show	VERB
cuesj-1047	190	28	much	much	ADV
cuesj-1047	190	29	greater	great	ADJ
cuesj-1047	190	30	sensitivities	sensitivity	NOUN
cuesj-1047	190	31	.	.	PUNCT
cuesj-1047	191	1	without	without	ADP
cuesj-1047	191	2	the	the	DET
cuesj-1047	191	3	requirement	requirement	NOUN
cuesj-1047	191	4	for	for	ADP
cuesj-1047	191	5	confirmation	confirmation	NOUN
cuesj-1047	191	6	testing	testing	NOUN
cuesj-1047	191	7	,	,	PUNCT
cuesj-1047	191	8	an	an	DET
cuesj-1047	191	9	immediate	immediate	ADJ
cuesj-1047	191	10	selfisolation	selfisolation	NOUN
cuesj-1047	191	11	can	can	AUX
cuesj-1047	191	12	be	be	AUX
cuesj-1047	191	13	justified	justify	VERB
cuesj-1047	191	14	by	by	ADP
cuesj-1047	191	15	a	a	DET
cuesj-1047	191	16	positive	positive	ADJ
cuesj-1047	191	17	self	self	NOUN
cuesj-1047	191	18	-	-	PUNCT
cuesj-1047	191	19	test	test	NOUN
cuesj-1047	191	20	result	result	NOUN
cuesj-1047	191	21	.	.	PUNCT
cuesj-1047	192	1	predictive	predictive	ADJ
cuesj-1047	192	2	values	value	NOUN
cuesj-1047	192	3	that	that	PRON
cuesj-1047	192	4	were	be	AUX
cuesj-1047	192	5	negative	negative	ADJ
cuesj-1047	192	6	were	be	AUX
cuesj-1047	192	7	significantly	significantly	ADV
cuesj-1047	192	8	lower	low	ADJ
cuesj-1047	192	9	.	.	PUNCT
cuesj-1047	193	1	those	those	PRON
cuesj-1047	193	2	with	with	ADP
cuesj-1047	193	3	a	a	DET
cuesj-1047	193	4	negative	negative	ADJ
cuesj-1047	193	5	self	self	NOUN
cuesj-1047	193	6	-	-	PUNCT
cuesj-1047	193	7	test	test	NOUN
cuesj-1047	193	8	result	result	NOUN
cuesj-1047	193	9	should	should	AUX
cuesj-1047	193	10	take	take	VERB
cuesj-1047	193	11	the	the	DET
cuesj-1047	193	12	usual	usual	ADJ
cuesj-1047	193	13	precautions	precaution	NOUN
cuesj-1047	193	14	because	because	SCONJ
cuesj-1047	193	15	it	it	PRON
cuesj-1047	193	16	is	be	AUX
cuesj-1047	193	17	impossible	impossible	ADJ
cuesj-1047	193	18	to	to	PART
cuesj-1047	193	19	rule	rule	VERB
cuesj-1047	193	20	out	out	ADP
cuesj-1047	193	21	a	a	DET
cuesj-1047	193	22	false	false	ADJ
cuesj-1047	193	23	negative	negative	ADJ
cuesj-1047	193	24	result.[36	result.[36	NOUN
cuesj-1047	193	25	]	]	PUNCT
cuesj-1047	193	26	many	many	ADJ
cuesj-1047	193	27	conditions	condition	NOUN
cuesj-1047	193	28	are	be	AUX
cuesj-1047	193	29	treated	treat	VERB
cuesj-1047	193	30	with	with	ADP
cuesj-1047	193	31	immunosuppressants	immunosuppressant	NOUN
cuesj-1047	193	32	,	,	PUNCT
cuesj-1047	193	33	and	and	CCONJ
cuesj-1047	193	34	it	it	PRON
cuesj-1047	193	35	has	have	AUX
cuesj-1047	193	36	been	be	AUX
cuesj-1047	193	37	demonstrated	demonstrate	VERB
cuesj-1047	193	38	that	that	SCONJ
cuesj-1047	193	39	individuals	individual	NOUN
cuesj-1047	193	40	taking	take	VERB
cuesj-1047	193	41	glucocorticoids	glucocorticoid	NOUN
cuesj-1047	193	42	or	or	CCONJ
cuesj-1047	193	43	immunosuppressive	immunosuppressive	ADJ
cuesj-1047	193	44	dmards	dmard	NOUN
cuesj-1047	193	45	were	be	AUX
cuesj-1047	193	46	more	more	ADV
cuesj-1047	193	47	likely	likely	ADJ
cuesj-1047	193	48	than	than	SCONJ
cuesj-1047	193	49	nonusers	nonuser	NOUN
cuesj-1047	193	50	to	to	PART
cuesj-1047	193	51	experience	experience	VERB
cuesj-1047	193	52	covid-19	covid-19	PROPN
cuesj-1047	193	53	-	-	PUNCT
cuesj-1047	193	54	linked	link	VERB
cuesj-1047	193	55	hospitalization	hospitalization	NOUN
cuesj-1047	193	56	and	and	CCONJ
cuesj-1047	193	57	sars	sar	NOUN
cuesj-1047	193	58	-	-	PUNCT
cuesj-1047	193	59	cov-2	cov-2	NOUN
cuesj-1047	193	60	illness	illness	NOUN
cuesj-1047	193	61	.	.	PUNCT
cuesj-1047	194	1	it	it	PRON
cuesj-1047	194	2	was	be	AUX
cuesj-1047	194	3	proven	prove	VERB
cuesj-1047	194	4	that	that	SCONJ
cuesj-1047	194	5	patients	patient	NOUN
cuesj-1047	194	6	with	with	ADP
cuesj-1047	194	7	an	an	DET
cuesj-1047	194	8	organ	organ	NOUN
cuesj-1047	194	9	,	,	PUNCT
cuesj-1047	194	10	or	or	CCONJ
cuesj-1047	194	11	bone	bone	NOUN
cuesj-1047	194	12	marrow	marrow	NOUN
cuesj-1047	194	13	transplant	transplant	NOUN
cuesj-1047	194	14	had	have	VERB
cuesj-1047	194	15	a	a	DET
cuesj-1047	194	16	considerably	considerably	ADV
cuesj-1047	194	17	higher	high	ADJ
cuesj-1047	194	18	chance	chance	NOUN
cuesj-1047	194	19	of	of	ADP
cuesj-1047	194	20	hospitalization	hospitalization	NOUN
cuesj-1047	194	21	for	for	ADP
cuesj-1047	194	22	covid-19	covid-19	PROPN
cuesj-1047	194	23	than	than	ADP
cuesj-1047	194	24	those	those	PRON
cuesj-1047	194	25	who	who	PRON
cuesj-1047	194	26	had	have	VERB
cuesj-1047	194	27	not	not	PART
cuesj-1047	194	28	,	,	PUNCT
cuesj-1047	194	29	and	and	CCONJ
cuesj-1047	194	30	suggested	suggest	VERB
cuesj-1047	194	31	that	that	SCONJ
cuesj-1047	194	32	all	all	PRON
cuesj-1047	194	33	of	of	ADP
cuesj-1047	194	34	the	the	DET
cuesj-1047	194	35	patients	patient	NOUN
cuesj-1047	194	36	on	on	ADP
cuesj-1047	194	37	glucocorticoids	glucocorticoid	NOUN
cuesj-1047	194	38	or	or	CCONJ
cuesj-1047	194	39	immunosuppressive	immunosuppressive	ADJ
cuesj-1047	194	40	dmards	dmard	NOUN
cuesj-1047	194	41	might	might	AUX
cuesj-1047	194	42	also	also	ADV
cuesj-1047	194	43	require	require	VERB
cuesj-1047	194	44	a	a	DET
cuesj-1047	194	45	similar	similar	ADJ
cuesj-1047	194	46	prioritization	prioritization	NOUN
cuesj-1047	194	47	for	for	ADP
cuesj-1047	194	48	a	a	DET
cuesj-1047	194	49	fourth	fourth	ADJ
cuesj-1047	194	50	dosage	dosage	NOUN
cuesj-1047	194	51	as	as	ADP
cuesj-1047	194	52	those	those	DET
cuesj-1047	194	53	patients	patient	NOUN
cuesj-1047	194	54	.	.	PUNCT
cuesj-1047	195	1	the	the	DET
cuesj-1047	195	2	mrna1273	mrna1273	PROPN
cuesj-1047	195	3	and	and	CCONJ
cuesj-1047	195	4	bnt162b2	bnt162b2	NOUN
cuesj-1047	195	5	vaccines	vaccine	NOUN
cuesj-1047	195	6	are	be	AUX
cuesj-1047	195	7	extremely	extremely	ADV
cuesj-1047	195	8	effective	effective	ADJ
cuesj-1047	195	9	toward	toward	ADP
cuesj-1047	195	10	covid-19	covid-19	PROPN
cuesj-1047	195	11	-	-	PUNCT
cuesj-1047	195	12	associated	associate	VERB
cuesj-1047	195	13	hospitalization	hospitalization	NOUN
cuesj-1047	195	14	brought	bring	VERB
cuesj-1047	195	15	on	on	ADP
cuesj-1047	195	16	by	by	ADP
cuesj-1047	195	17	the	the	DET
cuesj-1047	195	18	omicron	omicron	PROPN
cuesj-1047	195	19	variant	variant	NOUN
cuesj-1047	195	20	and	and	CCONJ
cuesj-1047	195	21	can	can	AUX
cuesj-1047	195	22	offer	offer	VERB
cuesj-1047	195	23	some	some	DET
cuesj-1047	195	24	protection	protection	NOUN
cuesj-1047	195	25	against	against	ADP
cuesj-1047	195	26	omicron	omicron	PROPN
cuesj-1047	195	27	infection	infection	NOUN
cuesj-1047	195	28	in	in	ADP
cuesj-1047	195	29	individuals	individual	NOUN
cuesj-1047	195	30	utilizing	utilize	VERB
cuesj-1047	195	31	immunosuppressants	immunosuppressant	NOUN
cuesj-1047	195	32	.	.	PUNCT
cuesj-1047	196	1	prioritizing	prioritize	VERB
cuesj-1047	196	2	and	and	CCONJ
cuesj-1047	196	3	maintaining	maintain	VERB
cuesj-1047	196	4	immunization	immunization	NOUN
cuesj-1047	196	5	records	record	NOUN
cuesj-1047	196	6	for	for	ADP
cuesj-1047	196	7	immunosuppressant	immunosuppressant	ADJ
cuesj-1047	196	8	–	–	PUNCT
cuesj-1047	196	9	using	use	VERB
cuesj-1047	196	10	individuals	individual	NOUN
cuesj-1047	196	11	are	be	AUX
cuesj-1047	196	12	vital.[37	vital.[37	PROPN
cuesj-1047	196	13	]	]	X
cuesj-1047	196	14	omicron	omicron	PROPN
cuesj-1047	196	15	has	have	AUX
cuesj-1047	196	16	been	be	AUX
cuesj-1047	196	17	shown	show	VERB
cuesj-1047	196	18	to	to	PART
cuesj-1047	196	19	be	be	AUX
cuesj-1047	196	20	less	less	ADV
cuesj-1047	196	21	severe	severe	ADJ
cuesj-1047	196	22	than	than	ADP
cuesj-1047	196	23	delta	delta	NOUN
cuesj-1047	196	24	in	in	ADP
cuesj-1047	196	25	terms	term	NOUN
cuesj-1047	196	26	of	of	ADP
cuesj-1047	196	27	hospitalization	hospitalization	NOUN
cuesj-1047	196	28	and	and	CCONJ
cuesj-1047	196	29	mortality	mortality	NOUN
cuesj-1047	196	30	.	.	PUNCT
cuesj-1047	197	1	the	the	DET
cuesj-1047	197	2	chance	chance	NOUN
cuesj-1047	197	3	of	of	ADP
cuesj-1047	197	4	mortality	mortality	NOUN
cuesj-1047	197	5	from	from	ADP
cuesj-1047	197	6	covid-19	covid-19	PROPN
cuesj-1047	197	7	was	be	AUX
cuesj-1047	197	8	67	67	NUM
cuesj-1047	197	9	%	%	NOUN
cuesj-1047	197	10	less	less	ADJ
cuesj-1047	197	11	for	for	ADP
cuesj-1047	197	12	omicron	omicron	PROPN
cuesj-1047	197	13	than	than	ADP
cuesj-1047	197	14	for	for	ADP
cuesj-1047	197	15	delta	delta	NOUN
cuesj-1047	197	16	after	after	ADP
cuesj-1047	197	17	accounting	account	VERB
cuesj-1047	197	18	for	for	ADP
cuesj-1047	197	19	several	several	ADJ
cuesj-1047	197	20	possible	possible	ADJ
cuesj-1047	197	21	confounding	confound	VERB
cuesj-1047	197	22	factors	factor	NOUN
cuesj-1047	197	23	such	such	ADJ
cuesj-1047	197	24	as	as	ADP
cuesj-1047	197	25	vaccination	vaccination	NOUN
cuesj-1047	197	26	status	status	NOUN
cuesj-1047	197	27	and	and	CCONJ
cuesj-1047	197	28	health	health	NOUN
cuesj-1047	197	29	conditions	condition	NOUN
cuesj-1047	197	30	which	which	PRON
cuesj-1047	197	31	was	be	AUX
cuesj-1047	197	32	more	more	ADV
cuesj-1047	197	33	evident	evident	ADJ
cuesj-1047	197	34	in	in	ADP
cuesj-1047	197	35	youthful	youthful	ADJ
cuesj-1047	197	36	people	people	NOUN
cuesj-1047	197	37	and	and	CCONJ
cuesj-1047	197	38	men	man	NOUN
cuesj-1047	197	39	than	than	ADP
cuesj-1047	197	40	females	female	NOUN
cuesj-1047	197	41	.	.	PUNCT
cuesj-1047	198	1	for	for	ADP
cuesj-1047	198	2	those	those	DET
cuesj-1047	198	3	individuals	individual	NOUN
cuesj-1047	198	4	who	who	PRON
cuesj-1047	198	5	received	receive	VERB
cuesj-1047	198	6	a	a	DET
cuesj-1047	198	7	booster	booster	NOUN
cuesj-1047	198	8	,	,	PUNCT
cuesj-1047	198	9	their	their	PRON
cuesj-1047	198	10	chance	chance	NOUN
cuesj-1047	198	11	of	of	ADP
cuesj-1047	198	12	dying	die	VERB
cuesj-1047	198	13	was	be	AUX
cuesj-1047	198	14	much	much	ADJ
cuesj-1047	198	15	lower.[38	lower.[38	NOUN
cuesj-1047	198	16	]	]	PUNCT
cuesj-1047	198	17	serious	serious	ADJ
cuesj-1047	198	18	covid-19	covid-19	PROPN
cuesj-1047	198	19	,	,	PUNCT
cuesj-1047	198	20	which	which	PRON
cuesj-1047	198	21	is	be	AUX
cuesj-1047	198	22	marked	mark	VERB
cuesj-1047	198	23	by	by	ADP
cuesj-1047	198	24	hospitalization	hospitalization	NOUN
cuesj-1047	198	25	or	or	CCONJ
cuesj-1047	198	26	death	death	NOUN
cuesj-1047	198	27	,	,	PUNCT
cuesj-1047	198	28	is	be	AUX
cuesj-1047	198	29	more	more	ADV
cuesj-1047	198	30	likely	likely	ADJ
cuesj-1047	198	31	to	to	PART
cuesj-1047	198	32	occur	occur	VERB
cuesj-1047	198	33	in	in	ADP
cuesj-1047	198	34	patients	patient	NOUN
cuesj-1047	198	35	with	with	ADP
cuesj-1047	198	36	sards	sard	NOUN
cuesj-1047	198	37	.	.	PUNCT
cuesj-1047	199	1	in	in	ADP
cuesj-1047	199	2	comparison	comparison	NOUN
cuesj-1047	199	3	to	to	ADP
cuesj-1047	199	4	sard	sard	NOUN
cuesj-1047	199	5	individuals	individual	NOUN
cuesj-1047	199	6	who	who	PRON
cuesj-1047	199	7	had	have	VERB
cuesj-1047	199	8	mild	mild	ADJ
cuesj-1047	199	9	covid-19	covid-19	PROPN
cuesj-1047	199	10	,	,	PUNCT
cuesj-1047	199	11	those	those	PRON
cuesj-1047	199	12	who	who	PRON
cuesj-1047	199	13	had	have	VERB
cuesj-1047	199	14	severe	severe	ADJ
cuesj-1047	199	15	covid-19	covid-19	PROPN
cuesj-1047	199	16	tended	tend	VERB
cuesj-1047	199	17	to	to	PART
cuesj-1047	199	18	be	be	AUX
cuesj-1047	199	19	unvaccinated	unvaccinate	VERB
cuesj-1047	199	20	.	.	PUNCT
cuesj-1047	200	1	the	the	DET
cuesj-1047	200	2	initial	initial	ADJ
cuesj-1047	200	3	omicron	omicron	PROPN
cuesj-1047	200	4	wave	wave	NOUN
cuesj-1047	200	5	,	,	PUNCT
cuesj-1047	200	6	which	which	PRON
cuesj-1047	200	7	contributed	contribute	VERB
cuesj-1047	200	8	to	to	ADP
cuesj-1047	200	9	the	the	DET
cuesj-1047	200	10	most	most	ADV
cuesj-1047	200	11	significant	significant	ADJ
cuesj-1047	200	12	hussein	hussein	NOUN
cuesj-1047	200	13	,	,	PUNCT
cuesj-1047	200	14	et	et	PROPN
cuesj-1047	200	15	al	al	PROPN
cuesj-1047	200	16	.	.	PUNCT
cuesj-1047	200	17	:	:	PUNCT
cuesj-1047	201	1	a	a	DET
cuesj-1047	201	2	review	review	NOUN
cuesj-1047	201	3	on	on	ADP
cuesj-1047	201	4	coronavirus	coronavirus	NOUN
cuesj-1047	201	5	and	and	CCONJ
cuesj-1047	201	6	omicron	omicron	PROPN
cuesj-1047	201	7	patients	patient	NOUN
cuesj-1047	201	8	16	16	NUM
cuesj-1047	201	9	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	201	10	cuesj	cuesj	NOUN
cuesj-1047	201	11	2024	2024	NUM
cuesj-1047	201	12	,	,	PUNCT
cuesj-1047	201	13	8	8	NUM
cuesj-1047	201	14	(	(	PUNCT
cuesj-1047	201	15	1	1	NUM
cuesj-1047	201	16	):	):	PUNCT
cuesj-1047	201	17	8	8	NUM
cuesj-1047	201	18	-	-	SYM
cuesj-1047	201	19	17	17	NUM
cuesj-1047	201	20	number	number	NOUN
cuesj-1047	201	21	of	of	ADP
cuesj-1047	201	22	instances	instance	NOUN
cuesj-1047	201	23	but	but	CCONJ
cuesj-1047	201	24	the	the	DET
cuesj-1047	201	25	minimal	minimal	ADJ
cuesj-1047	201	26	chance	chance	NOUN
cuesj-1047	201	27	of	of	ADP
cuesj-1047	201	28	severe	severe	ADJ
cuesj-1047	201	29	illness	illness	NOUN
cuesj-1047	201	30	,	,	PUNCT
cuesj-1047	201	31	the	the	DET
cuesj-1047	201	32	percentage	percentage	NOUN
cuesj-1047	201	33	of	of	ADP
cuesj-1047	201	34	sard	sard	NOUN
cuesj-1047	201	35	individuals	individual	NOUN
cuesj-1047	201	36	with	with	ADP
cuesj-1047	201	37	serious	serious	ADJ
cuesj-1047	201	38	covid-19	covid-19	PROPN
cuesj-1047	201	39	has	have	AUX
cuesj-1047	201	40	reduced	reduce	VERB
cuesj-1047	201	41	.	.	PUNCT
cuesj-1047	202	1	the	the	DET
cuesj-1047	202	2	findings	finding	NOUN
cuesj-1047	202	3	revealed	reveal	VERB
cuesj-1047	202	4	that	that	SCONJ
cuesj-1047	202	5	,	,	PUNCT
cuesj-1047	202	6	although	although	SCONJ
cuesj-1047	202	7	certain	certain	ADJ
cuesj-1047	202	8	sard	sard	NOUN
cuesj-1047	202	9	individuals	individual	NOUN
cuesj-1047	202	10	on	on	ADP
cuesj-1047	202	11	immunosuppressive	immunosuppressive	ADJ
cuesj-1047	202	12	drugs	drug	NOUN
cuesj-1047	202	13	may	may	AUX
cuesj-1047	202	14	be	be	AUX
cuesj-1047	202	15	more	more	ADV
cuesj-1047	202	16	likely	likely	ADJ
cuesj-1047	202	17	to	to	PART
cuesj-1047	202	18	contract	contract	VERB
cuesj-1047	202	19	a	a	DET
cuesj-1047	202	20	new	new	ADJ
cuesj-1047	202	21	infection	infection	NOUN
cuesj-1047	202	22	.	.	PUNCT
cuesj-1047	203	1	vaccination	vaccination	NOUN
cuesj-1047	203	2	showed	show	VERB
cuesj-1047	203	3	notable	notable	ADJ
cuesj-1047	203	4	advantages	advantage	NOUN
cuesj-1047	203	5	for	for	ADP
cuesj-1047	203	6	several	several	ADJ
cuesj-1047	203	7	of	of	ADP
cuesj-1047	203	8	these	these	DET
cuesj-1047	203	9	sars	sar	NOUN
cuesj-1047	203	10	-	-	PUNCT
cuesj-1047	203	11	cov-2	cov-2	ADV
cuesj-1047	203	12	-	-	PUNCT
cuesj-1047	203	13	infected	infect	VERB
cuesj-1047	203	14	individuals	individual	NOUN
cuesj-1047	203	15	.	.	PUNCT
cuesj-1047	204	1	regardless	regardless	ADV
cuesj-1047	204	2	of	of	ADP
cuesj-1047	204	3	these	these	DET
cuesj-1047	204	4	results	result	NOUN
cuesj-1047	204	5	,	,	PUNCT
cuesj-1047	204	6	some	some	DET
cuesj-1047	204	7	individuals	individual	NOUN
cuesj-1047	204	8	with	with	ADP
cuesj-1047	204	9	sards	sard	NOUN
cuesj-1047	204	10	continue	continue	VERB
cuesj-1047	204	11	to	to	PART
cuesj-1047	204	12	encounter	encounter	VERB
cuesj-1047	204	13	serious	serious	ADJ
cuesj-1047	204	14	diseases	disease	NOUN
cuesj-1047	204	15	,	,	PUNCT
cuesj-1047	204	16	particularly	particularly	ADV
cuesj-1047	204	17	those	those	PRON
cuesj-1047	204	18	who	who	PRON
cuesj-1047	204	19	are	be	AUX
cuesj-1047	204	20	using	use	VERB
cuesj-1047	204	21	immunosuppressive	immunosuppressive	ADJ
cuesj-1047	204	22	medications	medication	NOUN
cuesj-1047	204	23	known	know	VERB
cuesj-1047	204	24	to	to	PART
cuesj-1047	204	25	impair	impair	VERB
cuesj-1047	204	26	the	the	DET
cuesj-1047	204	27	body	body	NOUN
cuesj-1047	204	28	’s	’s	PART
cuesj-1047	204	29	response	response	NOUN
cuesj-1047	204	30	to	to	ADP
cuesj-1047	204	31	infection	infection	NOUN
cuesj-1047	204	32	and	and	CCONJ
cuesj-1047	204	33	vaccination	vaccination	NOUN
cuesj-1047	204	34	as	as	ADV
cuesj-1047	204	35	well	well	ADV
cuesj-1047	204	36	as	as	ADP
cuesj-1047	204	37	those	those	PRON
cuesj-1047	204	38	who	who	PRON
cuesj-1047	204	39	have	have	VERB
cuesj-1047	204	40	other	other	ADJ
cuesj-1047	204	41	significant	significant	ADJ
cuesj-1047	204	42	comorbidities	comorbiditie	NOUN
cuesj-1047	204	43	.	.	PUNCT
cuesj-1047	205	1	however	however	ADV
cuesj-1047	205	2	,	,	PUNCT
cuesj-1047	205	3	advancements	advancement	NOUN
cuesj-1047	205	4	in	in	ADP
cuesj-1047	205	5	covid-19	covid-19	PROPN
cuesj-1047	205	6	treatment	treatment	NOUN
cuesj-1047	205	7	,	,	PUNCT
cuesj-1047	205	8	diagnosis	diagnosis	NOUN
cuesj-1047	205	9	,	,	PUNCT
cuesj-1047	205	10	and	and	CCONJ
cuesj-1047	205	11	prevention	prevention	NOUN
cuesj-1047	205	12	may	may	AUX
cuesj-1047	205	13	have	have	AUX
cuesj-1047	205	14	enhanced	enhance	VERB
cuesj-1047	205	15	patient	patient	ADJ
cuesj-1047	205	16	outcomes	outcome	NOUN
cuesj-1047	205	17	in	in	ADP
cuesj-1047	205	18	sard	sard	NOUN
cuesj-1047	205	19	cases.[5	cases.[5	NOUN
cuesj-1047	205	20	]	]	PUNCT
cuesj-1047	205	21	conclusion	conclusion	NOUN
cuesj-1047	205	22	the	the	DET
cuesj-1047	205	23	most	most	ADV
cuesj-1047	205	24	commonly	commonly	ADV
cuesj-1047	205	25	reported	report	VERB
cuesj-1047	205	26	symptoms	symptom	NOUN
cuesj-1047	205	27	of	of	ADP
cuesj-1047	205	28	covid-19	covid-19	PROPN
cuesj-1047	205	29	included	include	VERB
cuesj-1047	205	30	mood	mood	NOUN
cuesj-1047	205	31	fluctuations	fluctuation	NOUN
cuesj-1047	205	32	,	,	PUNCT
cuesj-1047	205	33	rashes	rash	NOUN
cuesj-1047	205	34	,	,	PUNCT
cuesj-1047	205	35	gastrointestinal	gastrointestinal	ADJ
cuesj-1047	205	36	problems	problem	NOUN
cuesj-1047	205	37	,	,	PUNCT
cuesj-1047	205	38	coughing	cough	VERB
cuesj-1047	205	39	,	,	PUNCT
cuesj-1047	205	40	and	and	CCONJ
cuesj-1047	205	41	lack	lack	NOUN
cuesj-1047	205	42	of	of	ADP
cuesj-1047	205	43	appetite	appetite	NOUN
cuesj-1047	205	44	among	among	ADP
cuesj-1047	205	45	children	child	NOUN
cuesj-1047	205	46	aged	age	VERB
cuesj-1047	205	47	0–3	0–3	NUM
cuesj-1047	205	48	years	year	NOUN
cuesj-1047	205	49	old	old	ADJ
cuesj-1047	205	50	whereas	whereas	SCONJ
cuesj-1047	205	51	children	child	NOUN
cuesj-1047	205	52	between	between	ADP
cuesj-1047	205	53	the	the	DET
cuesj-1047	205	54	ages	age	NOUN
cuesj-1047	205	55	of	of	ADP
cuesj-1047	205	56	4	4	NUM
cuesj-1047	205	57	and	and	CCONJ
cuesj-1047	205	58	11	11	NUM
cuesj-1047	205	59	years	year	NOUN
cuesj-1047	205	60	most	most	ADV
cuesj-1047	205	61	frequently	frequently	ADV
cuesj-1047	205	62	had	have	VERB
cuesj-1047	205	63	mood	mood	NOUN
cuesj-1047	205	64	fluctuations	fluctuation	NOUN
cuesj-1047	205	65	,	,	PUNCT
cuesj-1047	205	66	memory	memory	NOUN
cuesj-1047	205	67	loss	loss	NOUN
cuesj-1047	205	68	,	,	PUNCT
cuesj-1047	205	69	attention	attention	NOUN
cuesj-1047	205	70	issues	issue	NOUN
cuesj-1047	205	71	,	,	PUNCT
cuesj-1047	205	72	and	and	CCONJ
cuesj-1047	205	73	rashes	rash	NOUN
cuesj-1047	205	74	.	.	PUNCT
cuesj-1047	206	1	two	two	NUM
cuesj-1047	206	2	days	day	NOUN
cuesj-1047	206	3	on	on	ADP
cuesj-1047	206	4	average	average	ADJ
cuesj-1047	206	5	were	be	AUX
cuesj-1047	206	6	spent	spend	VERB
cuesj-1047	206	7	in	in	ADP
cuesj-1047	206	8	the	the	DET
cuesj-1047	206	9	hospital	hospital	NOUN
cuesj-1047	206	10	(	(	PUNCT
cuesj-1047	206	11	range	range	NOUN
cuesj-1047	206	12	,	,	PUNCT
cuesj-1047	206	13	1–3	1–3	NOUN
cuesj-1047	206	14	)	)	PUNCT
cuesj-1047	206	15	.	.	PUNCT
cuesj-1047	207	1	pneumonia	pneumonia	NOUN
cuesj-1047	207	2	is	be	AUX
cuesj-1047	207	3	less	less	ADV
cuesj-1047	207	4	likely	likely	ADJ
cuesj-1047	207	5	to	to	PART
cuesj-1047	207	6	develop	develop	VERB
cuesj-1047	207	7	from	from	ADP
cuesj-1047	207	8	an	an	DET
cuesj-1047	207	9	omicron	omicron	NOUN
cuesj-1047	207	10	infection	infection	NOUN
cuesj-1047	207	11	than	than	ADP
cuesj-1047	207	12	a	a	DET
cuesj-1047	207	13	delta	delta	NOUN
cuesj-1047	207	14	infection	infection	NOUN
cuesj-1047	207	15	.	.	PUNCT
cuesj-1047	208	1	both	both	CCONJ
cuesj-1047	208	2	the	the	DET
cuesj-1047	208	3	administration	administration	NOUN
cuesj-1047	208	4	of	of	ADP
cuesj-1047	208	5	booster	booster	NOUN
cuesj-1047	208	6	doses	dose	NOUN
cuesj-1047	208	7	6	6	NUM
cuesj-1047	208	8	months	month	NOUN
cuesj-1047	208	9	after	after	ADP
cuesj-1047	208	10	receiving	receive	VERB
cuesj-1047	208	11	the	the	DET
cuesj-1047	208	12	initial	initial	ADJ
cuesj-1047	208	13	vaccines	vaccine	NOUN
cuesj-1047	208	14	and	and	CCONJ
cuesj-1047	208	15	the	the	DET
cuesj-1047	208	16	first	first	ADJ
cuesj-1047	208	17	6	6	NUM
cuesj-1047	208	18	months	month	NOUN
cuesj-1047	208	19	afterward	afterward	ADV
cuesj-1047	208	20	were	be	AUX
cuesj-1047	208	21	linked	link	VERB
cuesj-1047	208	22	to	to	ADP
cuesj-1047	208	23	a	a	DET
cuesj-1047	208	24	significantly	significantly	ADV
cuesj-1047	208	25	decreased	decrease	VERB
cuesj-1047	208	26	incidence	incidence	NOUN
cuesj-1047	208	27	of	of	ADP
cuesj-1047	208	28	pneumonia	pneumonia	NOUN
cuesj-1047	208	29	.	.	PUNCT
cuesj-1047	209	1	less	less	ADJ
cuesj-1047	209	2	omicron	omicron	NOUN
cuesj-1047	209	3	-	-	PUNCT
cuesj-1047	209	4	period	period	NOUN
cuesj-1047	209	5	patients	patient	NOUN
cuesj-1047	209	6	needed	need	VERB
cuesj-1047	209	7	to	to	PART
cuesj-1047	209	8	be	be	AUX
cuesj-1047	209	9	admitted	admit	VERB
cuesj-1047	209	10	to	to	ADP
cuesj-1047	209	11	the	the	DET
cuesj-1047	209	12	icu	icu	PROPN
cuesj-1047	209	13	than	than	SCONJ
cuesj-1047	209	14	delta	delta	NOUN
cuesj-1047	209	15	-	-	PUNCT
cuesj-1047	209	16	period	period	NOUN
cuesj-1047	209	17	patients	patient	NOUN
cuesj-1047	209	18	did	do	VERB
cuesj-1047	209	19	.	.	PUNCT
cuesj-1047	210	1	in	in	ADP
cuesj-1047	210	2	comparison	comparison	NOUN
cuesj-1047	210	3	to	to	ADP
cuesj-1047	210	4	the	the	DET
cuesj-1047	210	5	delta	delta	NOUN
cuesj-1047	210	6	,	,	PUNCT
cuesj-1047	210	7	the	the	DET
cuesj-1047	210	8	omicron	omicron	NOUN
cuesj-1047	210	9	showed	show	VERB
cuesj-1047	210	10	a	a	DET
cuesj-1047	210	11	larger	large	ADJ
cuesj-1047	210	12	variation	variation	NOUN
cuesj-1047	210	13	in	in	ADP
cuesj-1047	210	14	vaccination	vaccination	NOUN
cuesj-1047	210	15	efficacy	efficacy	NOUN
cuesj-1047	210	16	among	among	ADP
cuesj-1047	210	17	hospitalized	hospitalize	VERB
cuesj-1047	210	18	cases	case	NOUN
cuesj-1047	210	19	.	.	PUNCT
cuesj-1047	211	1	both	both	DET
cuesj-1047	211	2	three	three	NUM
cuesj-1047	211	3	and	and	CCONJ
cuesj-1047	211	4	two	two	NUM
cuesj-1047	211	5	doses	dose	NOUN
cuesj-1047	211	6	of	of	ADP
cuesj-1047	211	7	either	either	DET
cuesj-1047	211	8	vaccination	vaccination	NOUN
cuesj-1047	211	9	were	be	AUX
cuesj-1047	211	10	significantly	significantly	ADV
cuesj-1047	211	11	protective	protective	ADJ
cuesj-1047	211	12	against	against	ADP
cuesj-1047	211	13	covid-19	covid-19	PROPN
cuesj-1047	211	14	hospitalization	hospitalization	NOUN
cuesj-1047	211	15	in	in	ADP
cuesj-1047	211	16	both	both	CCONJ
cuesj-1047	211	17	immunocompetent	immunocompetent	ADJ
cuesj-1047	211	18	and	and	CCONJ
cuesj-1047	211	19	immunosuppressed	immunosuppressed	ADJ
cuesj-1047	211	20	individuals	individual	NOUN
cuesj-1047	211	21	.	.	PUNCT
cuesj-1047	212	1	for	for	ADP
cuesj-1047	212	2	all	all	DET
cuesj-1047	212	3	age	age	NOUN
cuesj-1047	212	4	categories	category	NOUN
cuesj-1047	212	5	,	,	PUNCT
cuesj-1047	212	6	the	the	DET
cuesj-1047	212	7	probability	probability	NOUN
cuesj-1047	212	8	of	of	ADP
cuesj-1047	212	9	covid-19	covid-19	PROPN
cuesj-1047	212	10	-	-	PUNCT
cuesj-1047	212	11	related	relate	VERB
cuesj-1047	212	12	mortality	mortality	NOUN
cuesj-1047	212	13	regardless	regardless	ADV
cuesj-1047	212	14	of	of	ADP
cuesj-1047	212	15	the	the	DET
cuesj-1047	212	16	number	number	NOUN
cuesj-1047	212	17	of	of	ADP
cuesj-1047	212	18	comorbidities	comorbiditie	NOUN
cuesj-1047	212	19	,	,	PUNCT
cuesj-1047	212	20	omicron	omicron	PROPN
cuesj-1047	212	21	infection	infection	NOUN
cuesj-1047	212	22	was	be	AUX
cuesj-1047	212	23	less	less	ADJ
cuesj-1047	212	24	than	than	ADP
cuesj-1047	212	25	delta	delta	NOUN
cuesj-1047	212	26	.	.	PUNCT
cuesj-1047	213	1	overall	overall	ADJ
cuesj-1047	213	2	,	,	PUNCT
cuesj-1047	213	3	throughout	throughout	ADP
cuesj-1047	213	4	the	the	DET
cuesj-1047	213	5	calendar	calendar	NOUN
cuesj-1047	213	6	year	year	NOUN
cuesj-1047	213	7	,	,	PUNCT
cuesj-1047	213	8	sard	sard	NOUN
cuesj-1047	213	9	patients	patient	NOUN
cuesj-1047	213	10	who	who	PRON
cuesj-1047	213	11	had	have	VERB
cuesj-1047	213	12	severe	severe	ADJ
cuesj-1047	213	13	covid-19	covid-19	PROPN
cuesj-1047	213	14	made	make	VERB
cuesj-1047	213	15	up	up	ADP
cuesj-1047	213	16	less	less	ADJ
cuesj-1047	213	17	of	of	ADP
cuesj-1047	213	18	the	the	DET
cuesj-1047	213	19	total	total	ADJ
cuesj-1047	213	20	population	population	NOUN
cuesj-1047	213	21	.	.	PUNCT
cuesj-1047	214	1	acknowledgment	acknowledgment	NOUN
cuesj-1047	214	2	we	we	PRON
cuesj-1047	214	3	would	would	AUX
cuesj-1047	214	4	like	like	VERB
cuesj-1047	214	5	to	to	PART
cuesj-1047	214	6	thank	thank	VERB
cuesj-1047	214	7	cihan	cihan	VERB
cuesj-1047	214	8	university	university	NOUN
cuesj-1047	214	9	-	-	PUNCT
cuesj-1047	214	10	erbil	erbil	PROPN
cuesj-1047	214	11	for	for	ADP
cuesj-1047	214	12	its	its	PRON
cuesj-1047	214	13	support	support	NOUN
cuesj-1047	214	14	and	and	CCONJ
cuesj-1047	214	15	for	for	ADP
cuesj-1047	214	16	giving	give	VERB
cuesj-1047	214	17	us	we	PRON
cuesj-1047	214	18	opportunities	opportunity	NOUN
cuesj-1047	214	19	to	to	PART
cuesj-1047	214	20	prepare	prepare	VERB
cuesj-1047	214	21	this	this	DET
cuesj-1047	214	22	review	review	NOUN
cuesj-1047	214	23	article	article	NOUN
cuesj-1047	214	24	.	.	PUNCT
cuesj-1047	215	1	references	reference	NOUN
cuesj-1047	215	2	1	1	NUM
cuesj-1047	215	3	.	.	PUNCT
cuesj-1047	215	4	f.	f.	PROPN
cuesj-1047	215	5	abdullah	abdullah	PROPN
cuesj-1047	215	6	,	,	PUNCT
cuesj-1047	215	7	j.	j.	PROPN
cuesj-1047	215	8	myers	myers	PROPN
cuesj-1047	215	9	,	,	PUNCT
cuesj-1047	215	10	d.	d.	PROPN
cuesj-1047	215	11	basu	basu	PROPN
cuesj-1047	215	12	,	,	PUNCT
cuesj-1047	215	13	g.	g.	PROPN
cuesj-1047	215	14	tintinger	tintinger	PROPN
cuesj-1047	215	15	,	,	PUNCT
cuesj-1047	215	16	v.	v.	ADP
cuesj-1047	215	17	ueckermann	ueckermann	NOUN
cuesj-1047	215	18	,	,	PUNCT
cuesj-1047	215	19	m.	m.	NOUN
cuesj-1047	215	20	mathebula	mathebula	PROPN
cuesj-1047	215	21	,	,	PUNCT
cuesj-1047	215	22	r.	r.	PROPN
cuesj-1047	215	23	ramlall	ramlall	PROPN
cuesj-1047	215	24	,	,	PUNCT
cuesj-1047	215	25	s.	s.	PROPN
cuesj-1047	215	26	spoor	spoor	PROPN
cuesj-1047	215	27	,	,	PUNCT
cuesj-1047	215	28	t.	t.	PROPN
cuesj-1047	215	29	de	de	PROPN
cuesj-1047	215	30	villiers	villiers	PROPN
cuesj-1047	215	31	,	,	PUNCT
cuesj-1047	215	32	z.	z.	PROPN
cuesj-1047	215	33	van	van	PROPN
cuesj-1047	215	34	der	der	PROPN
cuesj-1047	215	35	walt	walt	PROPN
cuesj-1047	215	36	,	,	PUNCT
cuesj-1047	215	37	j.	j.	PROPN
cuesj-1047	215	38	cloete	cloete	PROPN
cuesj-1047	215	39	,	,	PUNCT
cuesj-1047	215	40	p.	p.	PROPN
cuesj-1047	215	41	soma	soma	PROPN
cuesj-1047	215	42	-	-	PUNCT
cuesj-1047	215	43	pillay	pillay	PROPN
cuesj-1047	215	44	,	,	PUNCT
cuesj-1047	215	45	p.	p.	PROPN
cuesj-1047	215	46	rheeder	rheeder	NOUN
cuesj-1047	215	47	,	,	PUNCT
cuesj-1047	215	48	f.	f.	PROPN
cuesj-1047	215	49	paruk	paruk	PROPN
cuesj-1047	215	50	,	,	PUNCT
cuesj-1047	215	51	a.	a.	NOUN
cuesj-1047	215	52	engelbrecht	engelbrecht	NOUN
cuesj-1047	215	53	,	,	PUNCT
cuesj-1047	215	54	v.	v.	CCONJ
cuesj-1047	215	55	lalloo	lalloo	NOUN
cuesj-1047	215	56	,	,	PUNCT
cuesj-1047	215	57	m.	m.	NOUN
cuesj-1047	215	58	myburg	myburg	NOUN
cuesj-1047	215	59	,	,	PUNCT
cuesj-1047	215	60	j.	j.	PROPN
cuesj-1047	215	61	kistan	kistan	PROPN
cuesj-1047	215	62	,	,	PUNCT
cuesj-1047	215	63	w.	w.	PROPN
cuesj-1047	215	64	van	van	PROPN
cuesj-1047	215	65	hougenhouck	hougenhouck	NOUN
cuesj-1047	215	66	-	-	PUNCT
cuesj-1047	215	67	tulleken	tulleken	VERB
cuesj-1047	215	68	,	,	PUNCT
cuesj-1047	215	69	m.	m.	NOUN
cuesj-1047	215	70	t.	t.	PROPN
cuesj-1047	215	71	boswell	boswell	PROPN
cuesj-1047	215	72	,	,	PUNCT
cuesj-1047	215	73	g.	g.	PROPN
cuesj-1047	215	74	gray	gray	PROPN
cuesj-1047	215	75	,	,	PUNCT
cuesj-1047	215	76	r.	r.	PROPN
cuesj-1047	215	77	welch	welch	PROPN
cuesj-1047	215	78	,	,	PUNCT
cuesj-1047	215	79	l.	l.	PROPN
cuesj-1047	215	80	blumberg	blumberg	PROPN
cuesj-1047	215	81	and	and	CCONJ
cuesj-1047	215	82	w.	w.	PROPN
cuesj-1047	215	83	jassat	jassat	PROPN
cuesj-1047	215	84	.	.	PUNCT
cuesj-1047	216	1	decreased	decrease	VERB
cuesj-1047	216	2	severity	severity	NOUN
cuesj-1047	216	3	of	of	ADP
cuesj-1047	216	4	disease	disease	NOUN
cuesj-1047	216	5	during	during	ADP
cuesj-1047	216	6	the	the	DET
cuesj-1047	216	7	first	first	ADJ
cuesj-1047	216	8	global	global	ADJ
cuesj-1047	216	9	omicron	omicron	PROPN
cuesj-1047	216	10	variant	variant	NOUN
cuesj-1047	216	11	covid-19	covid-19	PROPN
cuesj-1047	216	12	outbreak	outbreak	NOUN
cuesj-1047	216	13	in	in	ADP
cuesj-1047	216	14	a	a	DET
cuesj-1047	216	15	large	large	ADJ
cuesj-1047	216	16	hospital	hospital	NOUN
cuesj-1047	216	17	in	in	ADP
cuesj-1047	216	18	tshwane	tshwane	NOUN
cuesj-1047	216	19	,	,	PUNCT
cuesj-1047	216	20	south	south	PROPN
cuesj-1047	216	21	africa	africa	PROPN
cuesj-1047	216	22	.	.	PUNCT
cuesj-1047	217	1	international	international	ADJ
cuesj-1047	217	2	journal	journal	PROPN
cuesj-1047	217	3	of	of	ADP
cuesj-1047	217	4	infectious	infectious	ADJ
cuesj-1047	217	5	diseases	disease	NOUN
cuesj-1047	217	6	,	,	PUNCT
cuesj-1047	217	7	vol	vol	NOUN
cuesj-1047	217	8	.	.	PROPN
cuesj-1047	217	9	116	116	NUM
cuesj-1047	217	10	,	,	PUNCT
cuesj-1047	217	11	pp	pp	ADJ
cuesj-1047	217	12	.	.	PUNCT
cuesj-1047	218	1	38	38	NUM
cuesj-1047	218	2	-	-	SYM
cuesj-1047	218	3	42	42	NUM
cuesj-1047	218	4	,	,	PUNCT
cuesj-1047	218	5	2022	2022	NUM
cuesj-1047	218	6	.	.	PUNCT
cuesj-1047	219	1	2	2	NUM
cuesj-1047	219	2	.	.	X
cuesj-1047	219	3	s.	s.	PROPN
cuesj-1047	219	4	evans	evans	PROPN
cuesj-1047	219	5	,	,	PUNCT
cuesj-1047	219	6	d.	d.	PROPN
cuesj-1047	219	7	holt	holt	PROPN
cuesj-1047	219	8	,	,	PUNCT
cuesj-1047	219	9	c.	c.	PROPN
cuesj-1047	219	10	weil	weil	PROPN
cuesj-1047	219	11	-	-	PUNCT
cuesj-1047	219	12	olivier	olivier	PROPN
cuesj-1047	219	13	,	,	PUNCT
cuesj-1047	219	14	g.	g.	PROPN
cuesj-1047	219	15	finnegan	finnegan	PROPN
cuesj-1047	219	16	and	and	CCONJ
cuesj-1047	219	17	v.	v.	ADP
cuesj-1047	219	18	usonis	usonis	PROPN
cuesj-1047	219	19	.	.	PUNCT
cuesj-1047	220	1	building	build	VERB
cuesj-1047	220	2	population	population	NOUN
cuesj-1047	220	3	and	and	CCONJ
cuesj-1047	220	4	health	health	NOUN
cuesj-1047	220	5	system	system	NOUN
cuesj-1047	220	6	resilience	resilience	NOUN
cuesj-1047	220	7	:	:	PUNCT
cuesj-1047	220	8	using	use	VERB
cuesj-1047	220	9	lessons	lesson	NOUN
cuesj-1047	220	10	learned	learn	VERB
cuesj-1047	220	11	during	during	ADP
cuesj-1047	220	12	the	the	DET
cuesj-1047	220	13	covid	covid	PROPN
cuesj-1047	220	14	pandemic	pandemic	ADJ
cuesj-1047	220	15	to	to	PART
cuesj-1047	220	16	implement	implement	VERB
cuesj-1047	220	17	life	life	NOUN
cuesj-1047	220	18	-	-	PUNCT
cuesj-1047	220	19	course	course	NOUN
cuesj-1047	220	20	immunisation	immunisation	NOUN
cuesj-1047	220	21	policy	policy	NOUN
cuesj-1047	220	22	.	.	PUNCT
cuesj-1047	221	1	vaccine	vaccine	NOUN
cuesj-1047	221	2	,	,	PUNCT
cuesj-1047	221	3	vol	vol	NOUN
cuesj-1047	221	4	.	.	PROPN
cuesj-1047	221	5	40	40	NUM
cuesj-1047	221	6	,	,	PUNCT
cuesj-1047	221	7	no	no	INTJ
cuesj-1047	221	8	.	.	NOUN
cuesj-1047	221	9	26	26	NUM
cuesj-1047	221	10	,	,	PUNCT
cuesj-1047	221	11	pp	pp	ADJ
cuesj-1047	221	12	.	.	PUNCT
cuesj-1047	222	1	3511	3511	NUM
cuesj-1047	222	2	-	-	PUNCT
cuesj-1047	222	3	3513	3513	NUM
cuesj-1047	222	4	,	,	PUNCT
cuesj-1047	222	5	2022	2022	NUM
cuesj-1047	222	6	.	.	PUNCT
cuesj-1047	223	1	3	3	X
cuesj-1047	223	2	.	.	X
cuesj-1047	223	3	n.	n.	PROPN
cuesj-1047	223	4	van	van	PROPN
cuesj-1047	223	5	goethem	goethem	PROPN
cuesj-1047	223	6	,	,	PUNCT
cuesj-1047	223	7	p.	p.	PROPN
cuesj-1047	223	8	y.	y.	PROPN
cuesj-1047	223	9	j.	j.	PROPN
cuesj-1047	223	10	chung	chung	PROPN
cuesj-1047	223	11	,	,	PUNCT
cuesj-1047	223	12	m.	m.	NOUN
cuesj-1047	223	13	meurisse	meurisse	PROPN
cuesj-1047	223	14	,	,	PUNCT
cuesj-1047	223	15	m.	m.	NOUN
cuesj-1047	223	16	vandromme	vandromme	PROPN
cuesj-1047	223	17	,	,	PUNCT
cuesj-1047	223	18	l.	l.	PROPN
cuesj-1047	223	19	de	de	PROPN
cuesj-1047	223	20	mot	mot	PROPN
cuesj-1047	223	21	,	,	PUNCT
cuesj-1047	223	22	r.	r.	PROPN
cuesj-1047	223	23	brondeel	brondeel	PROPN
cuesj-1047	223	24	,	,	PUNCT
cuesj-1047	223	25	v.	v.	PROPN
cuesj-1047	223	26	stouten	stouten	PROPN
cuesj-1047	223	27	,	,	PUNCT
cuesj-1047	223	28	s.	s.	PROPN
cuesj-1047	223	29	klamer	klamer	PROPN
cuesj-1047	223	30	,	,	PUNCT
cuesj-1047	223	31	l.	l.	PROPN
cuesj-1047	223	32	cuypers	cuypers	PROPN
cuesj-1047	223	33	,	,	PUNCT
cuesj-1047	223	34	t.	t.	PROPN
cuesj-1047	223	35	braeye	braeye	PROPN
cuesj-1047	223	36	,	,	PUNCT
cuesj-1047	223	37	l.	l.	PROPN
cuesj-1047	223	38	catteau	catteau	PROPN
cuesj-1047	223	39	,	,	PUNCT
cuesj-1047	223	40	l.	l.	PROPN
cuesj-1047	223	41	nevejan	nevejan	PROPN
cuesj-1047	223	42	,	,	PUNCT
cuesj-1047	223	43	j.	j.	PROPN
cuesj-1047	223	44	a.	a.	PROPN
cuesj-1047	223	45	f.	f.	PROPN
cuesj-1047	223	46	van	van	PROPN
cuesj-1047	223	47	loenhout	loenhout	PROPN
cuesj-1047	223	48	and	and	CCONJ
cuesj-1047	223	49	k.	k.	PROPN
cuesj-1047	223	50	blot	blot	PROPN
cuesj-1047	223	51	.	.	PUNCT
cuesj-1047	224	1	clinical	clinical	ADJ
cuesj-1047	224	2	severity	severity	NOUN
cuesj-1047	224	3	of	of	ADP
cuesj-1047	224	4	sars	sar	NOUN
cuesj-1047	224	5	-	-	PUNCT
cuesj-1047	224	6	cov-2	cov-2	NOUN
cuesj-1047	224	7	omicron	omicron	NOUN
cuesj-1047	224	8	variant	variant	NOUN
cuesj-1047	224	9	compared	compare	VERB
cuesj-1047	224	10	with	with	ADP
cuesj-1047	224	11	delta	delta	NOUN
cuesj-1047	224	12	among	among	ADP
cuesj-1047	224	13	hospitalized	hospitalize	VERB
cuesj-1047	224	14	covid-19	covid-19	PROPN
cuesj-1047	224	15	patients	patient	NOUN
cuesj-1047	224	16	in	in	ADP
cuesj-1047	224	17	belgium	belgium	NOUN
cuesj-1047	224	18	during	during	ADP
cuesj-1047	224	19	autumn	autumn	NOUN
cuesj-1047	224	20	and	and	CCONJ
cuesj-1047	224	21	winter	winter	NOUN
cuesj-1047	224	22	season	season	NOUN
cuesj-1047	224	23	2021	2021	NUM
cuesj-1047	224	24	-	-	SYM
cuesj-1047	224	25	2022	2022	NUM
cuesj-1047	224	26	.	.	PUNCT
cuesj-1047	225	1	viruses	virus	NOUN
cuesj-1047	225	2	,	,	PUNCT
cuesj-1047	225	3	vol	vol	NOUN
cuesj-1047	225	4	.	.	PROPN
cuesj-1047	225	5	14	14	NUM
cuesj-1047	225	6	,	,	PUNCT
cuesj-1047	225	7	no	no	INTJ
cuesj-1047	225	8	.	.	NOUN
cuesj-1047	225	9	6	6	NUM
cuesj-1047	225	10	,	,	PUNCT
cuesj-1047	225	11	p.	p.	NOUN
cuesj-1047	225	12	1297	1297	NUM
cuesj-1047	225	13	,	,	PUNCT
cuesj-1047	225	14	2022	2022	NUM
cuesj-1047	225	15	.	.	PUNCT
cuesj-1047	226	1	4	4	X
cuesj-1047	226	2	.	.	X
cuesj-1047	226	3	v.	v.	PROPN
cuesj-1047	226	4	jordan	jordan	PROPN
cuesj-1047	226	5	.	.	PUNCT
cuesj-1047	227	1	coronavirus	coronavirus	PROPN
cuesj-1047	227	2	(	(	PUNCT
cuesj-1047	227	3	covid-19	covid-19	PROPN
cuesj-1047	227	4	):	):	PUNCT
cuesj-1047	227	5	using	use	VERB
cuesj-1047	227	6	signs	sign	NOUN
cuesj-1047	227	7	and	and	CCONJ
cuesj-1047	227	8	symptoms	symptom	NOUN
cuesj-1047	227	9	to	to	PART
cuesj-1047	227	10	diagnose	diagnose	VERB
cuesj-1047	227	11	covid-19	covid-19	PROPN
cuesj-1047	227	12	in	in	ADP
cuesj-1047	227	13	primary	primary	ADJ
cuesj-1047	227	14	care	care	NOUN
cuesj-1047	227	15	.	.	PUNCT
cuesj-1047	228	1	journal	journal	PROPN
cuesj-1047	228	2	of	of	ADP
cuesj-1047	228	3	primary	primary	ADJ
cuesj-1047	228	4	health	health	NOUN
cuesj-1047	228	5	care	care	NOUN
cuesj-1047	228	6	,	,	PUNCT
cuesj-1047	228	7	vol	vol	NOUN
cuesj-1047	228	8	.	.	PROPN
cuesj-1047	228	9	14	14	NUM
cuesj-1047	228	10	,	,	PUNCT
cuesj-1047	228	11	no	no	INTJ
cuesj-1047	228	12	.	.	NOUN
cuesj-1047	228	13	2	2	NUM
cuesj-1047	228	14	,	,	PUNCT
cuesj-1047	228	15	pp	pp	ADJ
cuesj-1047	228	16	.	.	PUNCT
cuesj-1047	229	1	187	187	NUM
cuesj-1047	229	2	-	-	SYM
cuesj-1047	229	3	188	188	NUM
cuesj-1047	229	4	,	,	PUNCT
cuesj-1047	229	5	2022	2022	NUM
cuesj-1047	229	6	.	.	PUNCT
cuesj-1047	230	1	5	5	NUM
cuesj-1047	230	2	.	.	PUNCT
cuesj-1047	230	3	y.	y.	PROPN
cuesj-1047	230	4	kawano	kawano	PROPN
cuesj-1047	230	5	,	,	PUNCT
cuesj-1047	230	6	n.	n.	PROPN
cuesj-1047	230	7	j.	j.	PROPN
cuesj-1047	230	8	patel	patel	PROPN
cuesj-1047	230	9	,	,	PUNCT
cuesj-1047	230	10	x.	x.	PROPN
cuesj-1047	230	11	wang	wang	PROPN
cuesj-1047	230	12	,	,	PUNCT
cuesj-1047	230	13	c.	c.	PROPN
cuesj-1047	230	14	e.	e.	PROPN
cuesj-1047	230	15	cook	cook	PROPN
cuesj-1047	230	16	,	,	PUNCT
cuesj-1047	230	17	k.	k.	PROPN
cuesj-1047	230	18	m.	m.	PROPN
cuesj-1047	230	19	vanni	vanni	PROPN
cuesj-1047	230	20	,	,	PUNCT
cuesj-1047	230	21	e.	e.	PROPN
cuesj-1047	230	22	n.	n.	PROPN
cuesj-1047	230	23	kowalski	kowalski	PROPN
cuesj-1047	230	24	,	,	PUNCT
cuesj-1047	230	25	e.	e.	PROPN
cuesj-1047	230	26	p.	p.	PROPN
cuesj-1047	230	27	banasiak	banasiak	PROPN
cuesj-1047	230	28	,	,	PUNCT
cuesj-1047	230	29	g.	g.	PROPN
cuesj-1047	230	30	qian	qian	PROPN
cuesj-1047	230	31	,	,	PUNCT
cuesj-1047	230	32	m.	m.	NOUN
cuesj-1047	230	33	diiorio	diiorio	PROPN
cuesj-1047	230	34	,	,	PUNCT
cuesj-1047	230	35	t.	t.	PROPN
cuesj-1047	230	36	y.	y.	PROPN
cuesj-1047	230	37	t.	t.	PROPN
cuesj-1047	230	38	hsu	hsu	PROPN
cuesj-1047	230	39	,	,	PUNCT
cuesj-1047	230	40	m.	m.	PROPN
cuesj-1047	230	41	e.	e.	PROPN
cuesj-1047	230	42	weinblatt	weinblatt	PROPN
cuesj-1047	230	43	,	,	PUNCT
cuesj-1047	230	44	d.	d.	PROPN
cuesj-1047	230	45	j.	j.	PROPN
cuesj-1047	230	46	todd	todd	PROPN
cuesj-1047	230	47	,	,	PUNCT
cuesj-1047	230	48	z.	z.	PROPN
cuesj-1047	230	49	s.	s.	PROPN
cuesj-1047	230	50	wallace	wallace	PROPN
cuesj-1047	230	51	and	and	CCONJ
cuesj-1047	230	52	j.	j.	PROPN
cuesj-1047	230	53	a.	a.	PROPN
cuesj-1047	230	54	sparks	spark	VERB
cuesj-1047	230	55	.	.	PUNCT
cuesj-1047	231	1	temporal	temporal	ADJ
cuesj-1047	231	2	trends	trend	NOUN
cuesj-1047	231	3	in	in	ADP
cuesj-1047	231	4	covid-19	covid-19	PROPN
cuesj-1047	231	5	outcomes	outcome	NOUN
cuesj-1047	231	6	among	among	ADP
cuesj-1047	231	7	patients	patient	NOUN
cuesj-1047	231	8	with	with	ADP
cuesj-1047	231	9	systemic	systemic	ADJ
cuesj-1047	231	10	autoimmune	autoimmune	ADJ
cuesj-1047	231	11	rheumatic	rheumatic	ADJ
cuesj-1047	231	12	diseases	disease	NOUN
cuesj-1047	231	13	:	:	PUNCT
cuesj-1047	231	14	from	from	ADP
cuesj-1047	231	15	the	the	DET
cuesj-1047	231	16	first	first	ADJ
cuesj-1047	231	17	wave	wave	NOUN
cuesj-1047	231	18	through	through	ADP
cuesj-1047	231	19	the	the	DET
cuesj-1047	231	20	initial	initial	ADJ
cuesj-1047	231	21	omicron	omicron	PROPN
cuesj-1047	231	22	wave	wave	NOUN
cuesj-1047	231	23	.	.	PUNCT
cuesj-1047	232	1	annals	annal	NOUN
cuesj-1047	232	2	of	of	ADP
cuesj-1047	232	3	the	the	DET
cuesj-1047	232	4	rheumatic	rheumatic	ADJ
cuesj-1047	232	5	diseases	disease	NOUN
cuesj-1047	232	6	,	,	PUNCT
cuesj-1047	232	7	vol	vol	NOUN
cuesj-1047	232	8	.	.	PROPN
cuesj-1047	232	9	81	81	NUM
cuesj-1047	232	10	,	,	PUNCT
cuesj-1047	232	11	no	no	INTJ
cuesj-1047	232	12	.	.	NOUN
cuesj-1047	232	13	12	12	NUM
cuesj-1047	232	14	,	,	PUNCT
cuesj-1047	232	15	pp	pp	ADJ
cuesj-1047	232	16	.	.	PUNCT
cuesj-1047	233	1	1742	1742	NUM
cuesj-1047	233	2	-	-	SYM
cuesj-1047	233	3	1749	1749	NUM
cuesj-1047	233	4	,	,	PUNCT
cuesj-1047	233	5	2022	2022	NUM
cuesj-1047	233	6	.	.	PUNCT
cuesj-1047	234	1	6	6	NUM
cuesj-1047	234	2	.	.	PUNCT
cuesj-1047	234	3	s.	s.	PROPN
cuesj-1047	234	4	k.	k.	PROPN
cuesj-1047	234	5	berg	berg	PROPN
cuesj-1047	234	6	,	,	PUNCT
cuesj-1047	234	7	p.	p.	PROPN
cuesj-1047	234	8	palm	palm	PROPN
cuesj-1047	234	9	,	,	PUNCT
cuesj-1047	234	10	u.	u.	PROPN
cuesj-1047	234	11	nygaard	nygaard	PROPN
cuesj-1047	234	12	,	,	PUNCT
cuesj-1047	234	13	h.	h.	PROPN
cuesj-1047	234	14	bundgaard	bundgaard	PROPN
cuesj-1047	234	15	,	,	PUNCT
cuesj-1047	234	16	m.	m.	PROPN
cuesj-1047	234	17	n.	n.	PROPN
cuesj-1047	234	18	s.	s.	PROPN
cuesj-1047	234	19	petersen	petersen	PROPN
cuesj-1047	234	20	,	,	PUNCT
cuesj-1047	234	21	s.	s.	PROPN
cuesj-1047	234	22	rosenkilde	rosenkilde	PROPN
cuesj-1047	234	23	,	,	PUNCT
cuesj-1047	234	24	a.	a.	PROPN
cuesj-1047	234	25	b.	b.	PROPN
cuesj-1047	234	26	thorsted	thorste	VERB
cuesj-1047	234	27	,	,	PUNCT
cuesj-1047	234	28	a.	a.	PROPN
cuesj-1047	234	29	k.	k.	PROPN
cuesj-1047	234	30	ersbøll	ersbøll	PROPN
cuesj-1047	234	31	,	,	PUNCT
cuesj-1047	234	32	l.	l.	PROPN
cuesj-1047	234	33	c.	c.	PROPN
cuesj-1047	234	34	thygesen	thygesen	PROPN
cuesj-1047	234	35	,	,	PUNCT
cuesj-1047	234	36	s.	s.	PROPN
cuesj-1047	234	37	d.	d.	PROPN
cuesj-1047	234	38	nielsen	nielsen	PROPN
cuesj-1047	234	39	and	and	CCONJ
cuesj-1047	234	40	a.	a.	PROPN
cuesj-1047	234	41	v.	v.	PROPN
cuesj-1047	234	42	christensen	christensen	PROPN
cuesj-1047	234	43	.	.	PUNCT
cuesj-1047	235	1	long	long	PROPN
cuesj-1047	235	2	covid	covid	PROPN
cuesj-1047	235	3	symptoms	symptom	NOUN
cuesj-1047	235	4	in	in	ADP
cuesj-1047	235	5	sars	sar	NOUN
cuesj-1047	235	6	-	-	PUNCT
cuesj-1047	235	7	cov-2	cov-2	ADP
cuesj-1047	235	8	-	-	ADJ
cuesj-1047	235	9	positive	positive	ADJ
cuesj-1047	235	10	children	child	NOUN
cuesj-1047	235	11	aged	age	VERB
cuesj-1047	235	12	0	0	NUM
cuesj-1047	235	13	-	-	SYM
cuesj-1047	235	14	14	14	NUM
cuesj-1047	235	15	years	year	NOUN
cuesj-1047	235	16	and	and	CCONJ
cuesj-1047	235	17	matched	match	VERB
cuesj-1047	235	18	controls	control	NOUN
cuesj-1047	235	19	in	in	ADP
cuesj-1047	235	20	denmark	denmark	NOUN
cuesj-1047	235	21	(	(	PUNCT
cuesj-1047	235	22	longcovidkidsdk	longcovidkidsdk	NOUN
cuesj-1047	235	23	):	):	PUNCT
cuesj-1047	235	24	a	a	DET
cuesj-1047	235	25	national	national	ADJ
cuesj-1047	235	26	,	,	PUNCT
cuesj-1047	235	27	crosssectional	crosssectional	ADJ
cuesj-1047	235	28	study	study	NOUN
cuesj-1047	235	29	.	.	PUNCT
cuesj-1047	236	1	the	the	DET
cuesj-1047	236	2	lancet	lancet	PROPN
cuesj-1047	236	3	child	child	NOUN
cuesj-1047	236	4	and	and	CCONJ
cuesj-1047	236	5	adolescent	adolescent	ADJ
cuesj-1047	236	6	health	health	NOUN
cuesj-1047	236	7	,	,	PUNCT
cuesj-1047	236	8	vol	vol	NOUN
cuesj-1047	236	9	.	.	PROPN
cuesj-1047	236	10	6	6	NUM
cuesj-1047	236	11	,	,	PUNCT
cuesj-1047	236	12	no	no	INTJ
cuesj-1047	236	13	.	.	NOUN
cuesj-1047	236	14	9	9	NUM
cuesj-1047	236	15	,	,	PUNCT
cuesj-1047	236	16	pp	pp	ADJ
cuesj-1047	236	17	.	.	PUNCT
cuesj-1047	237	1	614	614	NUM
cuesj-1047	237	2	-	-	SYM
cuesj-1047	237	3	623	623	NUM
cuesj-1047	237	4	,	,	PUNCT
cuesj-1047	237	5	2022	2022	NUM
cuesj-1047	237	6	.	.	PUNCT
cuesj-1047	238	1	7	7	X
cuesj-1047	238	2	.	.	PUNCT
cuesj-1047	238	3	t.	t.	PROPN
cuesj-1047	238	4	k.	k.	PROPN
cuesj-1047	238	5	burki	burki	PROPN
cuesj-1047	238	6	.	.	PUNCT
cuesj-1047	239	1	omicron	omicron	PROPN
cuesj-1047	239	2	variant	variant	NOUN
cuesj-1047	239	3	and	and	CCONJ
cuesj-1047	239	4	booster	booster	NOUN
cuesj-1047	239	5	covid-19	covid-19	PROPN
cuesj-1047	239	6	vaccines	vaccine	NOUN
cuesj-1047	239	7	.	.	PUNCT
cuesj-1047	240	1	the	the	DET
cuesj-1047	240	2	lancet	lancet	ADJ
cuesj-1047	240	3	respiratory	respiratory	ADJ
cuesj-1047	240	4	medicine	medicine	NOUN
cuesj-1047	240	5	,	,	PUNCT
cuesj-1047	240	6	vol	vol	NOUN
cuesj-1047	240	7	.	.	PROPN
cuesj-1047	240	8	10	10	NUM
cuesj-1047	240	9	,	,	PUNCT
cuesj-1047	240	10	no	no	INTJ
cuesj-1047	240	11	.	.	NOUN
cuesj-1047	240	12	2	2	NUM
cuesj-1047	240	13	,	,	PUNCT
cuesj-1047	240	14	p.	p.	NOUN
cuesj-1047	240	15	e17	e17	NOUN
cuesj-1047	240	16	,	,	PUNCT
cuesj-1047	240	17	2022	2022	NUM
cuesj-1047	240	18	.	.	PUNCT
cuesj-1047	241	1	8	8	NUM
cuesj-1047	241	2	.	.	PUNCT
cuesj-1047	241	3	y.	y.	PROPN
cuesj-1047	241	4	du	du	PROPN
cuesj-1047	241	5	,	,	PUNCT
cuesj-1047	241	6	l.	l.	PROPN
cuesj-1047	241	7	chen	chen	PROPN
cuesj-1047	241	8	and	and	CCONJ
cuesj-1047	241	9	y.	y.	PROPN
cuesj-1047	241	10	shi	shi	PROPN
cuesj-1047	241	11	.	.	PUNCT
cuesj-1047	242	1	booster	booster	NOUN
cuesj-1047	242	2	covid-19	covid-19	PROPN
cuesj-1047	242	3	vaccination	vaccination	NOUN
cuesj-1047	242	4	against	against	ADP
cuesj-1047	242	5	the	the	DET
cuesj-1047	242	6	sars	sar	NOUN
cuesj-1047	242	7	-	-	PUNCT
cuesj-1047	242	8	cov-2	cov-2	NOUN
cuesj-1047	242	9	omicron	omicron	PROPN
cuesj-1047	242	10	variant	variant	NOUN
cuesj-1047	242	11	:	:	PUNCT
cuesj-1047	242	12	a	a	DET
cuesj-1047	242	13	systematic	systematic	ADJ
cuesj-1047	242	14	review	review	NOUN
cuesj-1047	242	15	.	.	PUNCT
cuesj-1047	243	1	human	human	ADJ
cuesj-1047	243	2	vaccines	vaccine	NOUN
cuesj-1047	243	3	and	and	CCONJ
cuesj-1047	243	4	immunotherapeutics	immunotherapeutic	NOUN
cuesj-1047	243	5	,	,	PUNCT
cuesj-1047	243	6	vol	vol	NOUN
cuesj-1047	243	7	.	.	PROPN
cuesj-1047	243	8	18	18	NUM
cuesj-1047	243	9	,	,	PUNCT
cuesj-1047	243	10	no	no	INTJ
cuesj-1047	243	11	.	.	NOUN
cuesj-1047	243	12	5	5	NUM
cuesj-1047	243	13	,	,	PUNCT
cuesj-1047	243	14	p.	p.	NOUN
cuesj-1047	243	15	2062983	2062983	NUM
cuesj-1047	243	16	,	,	PUNCT
cuesj-1047	243	17	2022	2022	NUM
cuesj-1047	243	18	.	.	PUNCT
cuesj-1047	244	1	9	9	NUM
cuesj-1047	244	2	.	.	X
cuesj-1047	244	3	c.	c.	PROPN
cuesj-1047	244	4	a.	a.	PROPN
cuesj-1047	244	5	taylor	taylor	PROPN
cuesj-1047	244	6	,	,	PUNCT
cuesj-1047	244	7	m.	m.	NOUN
cuesj-1047	244	8	whitaker	whitaker	PROPN
cuesj-1047	244	9	,	,	PUNCT
cuesj-1047	244	10	o.	o.	PROPN
cuesj-1047	244	11	anglin	anglin	PROPN
cuesj-1047	244	12	,	,	PUNCT
cuesj-1047	244	13	j.	j.	PROPN
cuesj-1047	244	14	milucky	milucky	PROPN
cuesj-1047	244	15	,	,	PUNCT
cuesj-1047	244	16	k.	k.	PROPN
cuesj-1047	244	17	patel	patel	PROPN
cuesj-1047	244	18	,	,	PUNCT
cuesj-1047	244	19	h.	h.	PROPN
cuesj-1047	244	20	pham	pham	PROPN
cuesj-1047	244	21	,	,	PUNCT
cuesj-1047	244	22	s.	s.	PROPN
cuesj-1047	244	23	j.	j.	PROPN
cuesj-1047	244	24	chai	chai	PROPN
cuesj-1047	244	25	,	,	PUNCT
cuesj-1047	244	26	n.	n.	PROPN
cuesj-1047	244	27	b.	b.	PROPN
cuesj-1047	244	28	alden	alden	PROPN
cuesj-1047	244	29	,	,	PUNCT
cuesj-1047	244	30	k.	k.	PROPN
cuesj-1047	244	31	yousey	yousey	ADJ
cuesj-1047	244	32	-	-	PUNCT
cuesj-1047	244	33	hindes	hinde	NOUN
cuesj-1047	244	34	,	,	PUNCT
cuesj-1047	244	35	e.	e.	PROPN
cuesj-1047	244	36	j.	j.	PROPN
cuesj-1047	244	37	anderson	anderson	PROPN
cuesj-1047	244	38	,	,	PUNCT
cuesj-1047	244	39	k.	k.	PROPN
cuesj-1047	244	40	teno	teno	PROPN
cuesj-1047	244	41	,	,	PUNCT
cuesj-1047	244	42	l.	l.	PROPN
cuesj-1047	244	43	reeg	reeg	PROPN
cuesj-1047	244	44	,	,	PUNCT
cuesj-1047	244	45	k.	k.	PROPN
cuesj-1047	244	46	como	como	PROPN
cuesj-1047	244	47	-	-	PUNCT
cuesj-1047	244	48	sabetti	sabetti	PROPN
cuesj-1047	244	49	,	,	PUNCT
cuesj-1047	244	50	m.	m.	NOUN
cuesj-1047	244	51	bleecker	bleecker	PROPN
cuesj-1047	244	52	,	,	PUNCT
cuesj-1047	244	53	g.	g.	PROPN
cuesj-1047	244	54	barney	barney	PROPN
cuesj-1047	244	55	,	,	PUNCT
cuesj-1047	244	56	n.	n.	PROPN
cuesj-1047	244	57	m.	m.	PROPN
cuesj-1047	244	58	bennett	bennett	PROPN
cuesj-1047	244	59	,	,	PUNCT
cuesj-1047	244	60	l.	l.	PROPN
cuesj-1047	244	61	m.	m.	PROPN
cuesj-1047	244	62	billing	billing	PROPN
cuesj-1047	244	63	,	,	PUNCT
cuesj-1047	244	64	m.	m.	NOUN
cuesj-1047	244	65	sutton	sutton	PROPN
cuesj-1047	244	66	,	,	PUNCT
cuesj-1047	244	67	h.	h.	PROPN
cuesj-1047	244	68	k.	k.	PROPN
cuesj-1047	244	69	talbot	talbot	PROPN
cuesj-1047	244	70	,	,	PUNCT
cuesj-1047	244	71	k.	k.	PROPN
cuesj-1047	244	72	mccaffrey	mccaffrey	PROPN
cuesj-1047	244	73	,	,	PUNCT
cuesj-1047	244	74	f.	f.	PROPN
cuesj-1047	244	75	p.	p.	PROPN
cuesj-1047	244	76	havers	haver	NOUN
cuesj-1047	244	77	and	and	CCONJ
cuesj-1047	244	78	covid	covid	PROPN
cuesj-1047	244	79	-	-	ADJ
cuesj-1047	244	80	net	net	ADJ
cuesj-1047	244	81	surveillance	surveillance	NOUN
cuesj-1047	244	82	team	team	NOUN
cuesj-1047	244	83	.	.	PUNCT
cuesj-1047	245	1	covid-19	covid-19	PROPN
cuesj-1047	245	2	-	-	PUNCT
cuesj-1047	245	3	associated	associate	VERB
cuesj-1047	245	4	hospitalizations	hospitalization	NOUN
cuesj-1047	245	5	among	among	ADP
cuesj-1047	245	6	adults	adult	NOUN
cuesj-1047	245	7	during	during	ADP
cuesj-1047	245	8	sars	sar	NOUN
cuesj-1047	245	9	-	-	PUNCT
cuesj-1047	245	10	cov-2	cov-2	PART
cuesj-1047	245	11	delta	delta	NOUN
cuesj-1047	245	12	and	and	CCONJ
cuesj-1047	245	13	omicron	omicron	PROPN
cuesj-1047	245	14	variant	variant	ADJ
cuesj-1047	245	15	predominance	predominance	NOUN
cuesj-1047	245	16	,	,	PUNCT
cuesj-1047	245	17	by	by	ADP
cuesj-1047	245	18	race	race	NOUN
cuesj-1047	245	19	/	/	SYM
cuesj-1047	245	20	ethnicity	ethnicity	NOUN
cuesj-1047	245	21	and	and	CCONJ
cuesj-1047	245	22	vaccination	vaccination	NOUN
cuesj-1047	245	23	status	status	NOUN
cuesj-1047	245	24	-	-	PUNCT
cuesj-1047	245	25	covid	covid	NOUN
cuesj-1047	245	26	-	-	PUNCT
cuesj-1047	245	27	net	net	NOUN
cuesj-1047	245	28	,	,	PUNCT
cuesj-1047	245	29	14	14	NUM
cuesj-1047	245	30	states	state	NOUN
cuesj-1047	245	31	,	,	PUNCT
cuesj-1047	245	32	july	july	PROPN
cuesj-1047	245	33	2021	2021	NUM
cuesj-1047	245	34	-	-	SYM
cuesj-1047	245	35	january	january	PROPN
cuesj-1047	245	36	2022	2022	NUM
cuesj-1047	245	37	.	.	PUNCT
cuesj-1047	246	1	morbidity	morbidity	NOUN
cuesj-1047	246	2	and	and	CCONJ
cuesj-1047	246	3	mortality	mortality	NOUN
cuesj-1047	246	4	weekly	weekly	ADJ
cuesj-1047	246	5	report	report	NOUN
cuesj-1047	246	6	,	,	PUNCT
cuesj-1047	246	7	vol	vol	NOUN
cuesj-1047	246	8	.	.	PROPN
cuesj-1047	246	9	71	71	NUM
cuesj-1047	246	10	,	,	PUNCT
cuesj-1047	246	11	no	no	INTJ
cuesj-1047	246	12	.	.	NOUN
cuesj-1047	246	13	12	12	NUM
cuesj-1047	246	14	,	,	PUNCT
cuesj-1047	246	15	pp	pp	ADJ
cuesj-1047	246	16	.	.	PUNCT
cuesj-1047	247	1	466	466	NUM
cuesj-1047	247	2	-	-	SYM
cuesj-1047	247	3	473	473	NUM
cuesj-1047	247	4	,	,	PUNCT
cuesj-1047	247	5	2022	2022	NUM
cuesj-1047	247	6	.	.	PUNCT
cuesj-1047	248	1	10	10	NUM
cuesj-1047	248	2	.	.	PUNCT
cuesj-1047	248	3	k.	k.	PROPN
cuesj-1047	248	4	adams	adams	PROPN
cuesj-1047	248	5	,	,	PUNCT
cuesj-1047	248	6	j.	j.	PROPN
cuesj-1047	248	7	p.	p.	PROPN
cuesj-1047	248	8	rhoads	rhoads	PROPN
cuesj-1047	248	9	,	,	PUNCT
cuesj-1047	248	10	d.	d.	PROPN
cuesj-1047	248	11	surie	surie	PROPN
cuesj-1047	248	12	,	,	PUNCT
cuesj-1047	248	13	m.	m.	NOUN
cuesj-1047	248	14	gaglani	gaglani	PROPN
cuesj-1047	248	15	,	,	PUNCT
cuesj-1047	248	16	a.	a.	NOUN
cuesj-1047	248	17	a.	a.	NOUN
cuesj-1047	248	18	ginde	ginde	PROPN
cuesj-1047	248	19	,	,	PUNCT
cuesj-1047	248	20	t.	t.	PROPN
cuesj-1047	248	21	mcneal	mcneal	PROPN
cuesj-1047	248	22	,	,	PUNCT
cuesj-1047	248	23	h.	h.	PROPN
cuesj-1047	248	24	k.	k.	PROPN
cuesj-1047	248	25	talbot	talbot	PROPN
cuesj-1047	248	26	,	,	PUNCT
cuesj-1047	248	27	j.	j.	PROPN
cuesj-1047	248	28	d.	d.	PROPN
cuesj-1047	248	29	casey	casey	PROPN
cuesj-1047	248	30	,	,	PUNCT
cuesj-1047	248	31	a.	a.	NOUN
cuesj-1047	248	32	zepeski	zepeski	PROPN
cuesj-1047	248	33	,	,	PUNCT
cuesj-1047	248	34	n.	n.	PROPN
cuesj-1047	248	35	i.	i.	PROPN
cuesj-1047	248	36	shapiro	shapiro	PROPN
cuesj-1047	248	37	,	,	PUNCT
cuesj-1047	248	38	k.	k.	PROPN
cuesj-1047	248	39	w.	w.	PROPN
cuesj-1047	248	40	gibbs	gibbs	PROPN
cuesj-1047	248	41	,	,	PUNCT
cuesj-1047	248	42	d.	d.	PROPN
cuesj-1047	248	43	c.	c.	PROPN
cuesj-1047	248	44	files	files	PROPN
cuesj-1047	248	45	,	,	PUNCT
cuesj-1047	248	46	d.	d.	PROPN
cuesj-1047	248	47	n.	n.	PROPN
cuesj-1047	248	48	hager	hager	PROPN
cuesj-1047	248	49	,	,	PUNCT
cuesj-1047	248	50	…	…	PUNCT
cuesj-1047	248	51	and	and	CCONJ
cuesj-1047	248	52	a.	a.	PROPN
cuesj-1047	248	53	e.	e.	PROPN
cuesj-1047	248	54	forsch	forsch	PROPN
cuesj-1047	248	55	.	.	PUNCT
cuesj-1047	249	1	vaccine	vaccine	NOUN
cuesj-1047	249	2	effectiveness	effectiveness	NOUN
cuesj-1047	249	3	of	of	ADP
cuesj-1047	249	4	primary	primary	ADJ
cuesj-1047	249	5	series	series	NOUN
cuesj-1047	249	6	and	and	CCONJ
cuesj-1047	249	7	booster	booster	NOUN
cuesj-1047	249	8	doses	dose	NOUN
cuesj-1047	249	9	against	against	ADP
cuesj-1047	249	10	covid-19	covid-19	PROPN
cuesj-1047	249	11	associated	associated	ADJ
cuesj-1047	249	12	hospital	hospital	NOUN
cuesj-1047	249	13	admissions	admission	NOUN
cuesj-1047	249	14	in	in	ADP
cuesj-1047	249	15	the	the	DET
cuesj-1047	249	16	united	united	PROPN
cuesj-1047	249	17	states	states	PROPN
cuesj-1047	249	18	:	:	PUNCT
cuesj-1047	249	19	living	live	VERB
cuesj-1047	249	20	test	test	NOUN
cuesj-1047	249	21	negative	negative	ADJ
cuesj-1047	249	22	design	design	NOUN
cuesj-1047	249	23	study	study	NOUN
cuesj-1047	249	24	.	.	PUNCT
cuesj-1047	250	1	bmj	bmj	PROPN
cuesj-1047	250	2	,	,	PUNCT
cuesj-1047	250	3	vol	vol	NOUN
cuesj-1047	250	4	.	.	PROPN
cuesj-1047	250	5	379	379	NUM
cuesj-1047	250	6	,	,	PUNCT
cuesj-1047	250	7	p.	p.	NOUN
cuesj-1047	250	8	e072065	e072065	NOUN
cuesj-1047	250	9	,	,	PUNCT
cuesj-1047	250	10	2022	2022	NUM
cuesj-1047	250	11	.	.	PUNCT
cuesj-1047	251	1	11	11	NUM
cuesj-1047	251	2	.	.	PUNCT
cuesj-1047	251	3	m.	m.	PROPN
cuesj-1047	251	4	antonelli	antonelli	PROPN
cuesj-1047	251	5	,	,	PUNCT
cuesj-1047	251	6	j.	j.	PROPN
cuesj-1047	251	7	c.	c.	PROPN
cuesj-1047	251	8	pujol	pujol	PROPN
cuesj-1047	251	9	,	,	PUNCT
cuesj-1047	251	10	t.	t.	PROPN
cuesj-1047	251	11	d.	d.	PROPN
cuesj-1047	251	12	spector	spector	PROPN
cuesj-1047	251	13	,	,	PUNCT
cuesj-1047	251	14	s.	s.	PROPN
cuesj-1047	251	15	ourselin	ourselin	PROPN
cuesj-1047	251	16	and	and	CCONJ
cuesj-1047	251	17	c.	c.	PROPN
cuesj-1047	251	18	j.	j.	PROPN
cuesj-1047	251	19	steves	steves	PROPN
cuesj-1047	251	20	.	.	PUNCT
cuesj-1047	252	1	risk	risk	NOUN
cuesj-1047	252	2	of	of	ADP
cuesj-1047	252	3	long	long	ADJ
cuesj-1047	252	4	covid	covid	NOUN
cuesj-1047	252	5	associated	associate	VERB
cuesj-1047	252	6	with	with	ADP
cuesj-1047	252	7	delta	delta	PROPN
cuesj-1047	252	8	versus	versus	ADP
cuesj-1047	252	9	omicron	omicron	PROPN
cuesj-1047	252	10	variants	variant	NOUN
cuesj-1047	252	11	of	of	ADP
cuesj-1047	252	12	sars	sar	NOUN
cuesj-1047	252	13	-	-	PUNCT
cuesj-1047	252	14	cov-2	cov-2	NOUN
cuesj-1047	252	15	.	.	PUNCT
cuesj-1047	253	1	the	the	DET
cuesj-1047	253	2	lancet	lancet	PROPN
cuesj-1047	253	3	,	,	PUNCT
cuesj-1047	253	4	vol	vol	NOUN
cuesj-1047	253	5	.	.	PROPN
cuesj-1047	254	1	399	399	NUM
cuesj-1047	254	2	,	,	PUNCT
cuesj-1047	254	3	no	no	INTJ
cuesj-1047	254	4	.	.	NOUN
cuesj-1047	254	5	10343	10343	NUM
cuesj-1047	254	6	,	,	PUNCT
cuesj-1047	254	7	pp	pp	ADJ
cuesj-1047	254	8	.	.	PUNCT
cuesj-1047	255	1	2263	2263	NUM
cuesj-1047	255	2	-	-	SYM
cuesj-1047	255	3	2264	2264	NUM
cuesj-1047	255	4	,	,	PUNCT
cuesj-1047	255	5	2022	2022	NUM
cuesj-1047	255	6	.	.	PUNCT
cuesj-1047	256	1	12	12	NUM
cuesj-1047	256	2	.	.	PUNCT
cuesj-1047	257	1	s.	s.	PROPN
cuesj-1047	257	2	chenchula	chenchula	PROPN
cuesj-1047	257	3	,	,	PUNCT
cuesj-1047	257	4	p.	p.	PROPN
cuesj-1047	257	5	karunakaran	karunakaran	PROPN
cuesj-1047	257	6	,	,	PUNCT
cuesj-1047	257	7	s.	s.	PROPN
cuesj-1047	257	8	sharma	sharma	PROPN
cuesj-1047	257	9	and	and	CCONJ
cuesj-1047	257	10	m.	m.	NOUN
cuesj-1047	257	11	chavan	chavan	PROPN
cuesj-1047	257	12	.	.	PUNCT
cuesj-1047	258	1	current	current	ADJ
cuesj-1047	258	2	evidence	evidence	NOUN
cuesj-1047	258	3	on	on	ADP
cuesj-1047	258	4	efficacy	efficacy	NOUN
cuesj-1047	258	5	of	of	ADP
cuesj-1047	258	6	covid-19	covid-19	PROPN
cuesj-1047	258	7	booster	booster	NOUN
cuesj-1047	258	8	dose	dose	NOUN
cuesj-1047	258	9	vaccination	vaccination	NOUN
cuesj-1047	258	10	against	against	ADP
cuesj-1047	258	11	the	the	DET
cuesj-1047	258	12	omicron	omicron	PROPN
cuesj-1047	258	13	variant	variant	NOUN
cuesj-1047	258	14	:	:	PUNCT
cuesj-1047	258	15	a	a	DET
cuesj-1047	258	16	systematic	systematic	ADJ
cuesj-1047	258	17	review	review	NOUN
cuesj-1047	258	18	.	.	PUNCT
cuesj-1047	259	1	journal	journal	PROPN
cuesj-1047	259	2	of	of	ADP
cuesj-1047	259	3	medical	medical	ADJ
cuesj-1047	259	4	virology	virology	NOUN
cuesj-1047	259	5	,	,	PUNCT
cuesj-1047	259	6	vol	vol	NOUN
cuesj-1047	259	7	.	.	PROPN
cuesj-1047	259	8	94	94	NUM
cuesj-1047	259	9	,	,	PUNCT
cuesj-1047	259	10	no	no	INTJ
cuesj-1047	259	11	.	.	NOUN
cuesj-1047	259	12	7	7	NUM
cuesj-1047	259	13	,	,	PUNCT
cuesj-1047	259	14	pp	pp	ADJ
cuesj-1047	259	15	.	.	PUNCT
cuesj-1047	260	1	2969	2969	NUM
cuesj-1047	260	2	-	-	SYM
cuesj-1047	260	3	2976	2976	NUM
cuesj-1047	260	4	,	,	PUNCT
cuesj-1047	260	5	2022	2022	NUM
cuesj-1047	260	6	.	.	PUNCT
cuesj-1047	261	1	13	13	NUM
cuesj-1047	261	2	.	.	X
cuesj-1047	261	3	d.	d.	PROPN
cuesj-1047	261	4	eggink	eggink	PROPN
cuesj-1047	261	5	,	,	PUNCT
cuesj-1047	261	6	s.	s.	PROPN
cuesj-1047	261	7	p.	p.	PROPN
cuesj-1047	261	8	andeweg	andeweg	PROPN
cuesj-1047	261	9	,	,	PUNCT
cuesj-1047	261	10	h.	h.	PROPN
cuesj-1047	261	11	vennema	vennema	PROPN
cuesj-1047	261	12	,	,	PUNCT
cuesj-1047	261	13	n.	n.	PROPN
cuesj-1047	261	14	van	van	PROPN
cuesj-1047	261	15	maarseveen	maarseveen	PROPN
cuesj-1047	261	16	,	,	PUNCT
cuesj-1047	261	17	k.	k.	PROPN
cuesj-1047	261	18	vermaas	vermaas	PROPN
cuesj-1047	261	19	,	,	PUNCT
cuesj-1047	261	20	b.	b.	PROPN
cuesj-1047	261	21	vlaemynck	vlaemynck	PROPN
cuesj-1047	261	22	,	,	PUNCT
cuesj-1047	261	23	r.	r.	PROPN
cuesj-1047	261	24	schepers	schepers	PROPN
cuesj-1047	261	25	,	,	PUNCT
cuesj-1047	261	26	a.	a.	PROPN
cuesj-1047	261	27	b.	b.	PROPN
cuesj-1047	261	28	van	van	PROPN
cuesj-1047	261	29	gageldonklafeber	gageldonklafeber	PROPN
cuesj-1047	261	30	,	,	PUNCT
cuesj-1047	261	31	s.	s.	PROPN
cuesj-1047	261	32	van	van	PROPN
cuesj-1047	261	33	den	den	PROPN
cuesj-1047	261	34	hof	hof	PROPN
cuesj-1047	261	35	,	,	PUNCT
cuesj-1047	261	36	c.	c.	PROPN
cuesj-1047	261	37	b.	b.	PROPN
cuesj-1047	261	38	reusken	reusken	PROPN
cuesj-1047	261	39	and	and	CCONJ
cuesj-1047	261	40	m.	m.	NOUN
cuesj-1047	261	41	knol	knol	NOUN
cuesj-1047	261	42	.	.	PUNCT
cuesj-1047	262	1	increased	increase	VERB
cuesj-1047	262	2	risk	risk	NOUN
cuesj-1047	262	3	of	of	ADP
cuesj-1047	262	4	infection	infection	NOUN
cuesj-1047	262	5	with	with	ADP
cuesj-1047	262	6	sars	sar	NOUN
cuesj-1047	262	7	-	-	PUNCT
cuesj-1047	262	8	cov-2	cov-2	NOUN
cuesj-1047	262	9	omicron	omicron	PROPN
cuesj-1047	262	10	ba.1	ba.1	PROPN
cuesj-1047	262	11	compared	compare	VERB
cuesj-1047	262	12	with	with	ADP
cuesj-1047	262	13	delta	delta	NOUN
cuesj-1047	262	14	in	in	ADP
cuesj-1047	262	15	vaccinated	vaccinate	VERB
cuesj-1047	262	16	and	and	CCONJ
cuesj-1047	262	17	previously	previously	ADV
cuesj-1047	262	18	infected	infect	VERB
cuesj-1047	262	19	individuals	individual	NOUN
cuesj-1047	262	20	,	,	PUNCT
cuesj-1047	262	21	the	the	DET
cuesj-1047	262	22	netherlands	netherlands	PROPN
cuesj-1047	262	23	,	,	PUNCT
cuesj-1047	262	24	22	22	NUM
cuesj-1047	262	25	november	november	NOUN
cuesj-1047	262	26	2021	2021	NUM
cuesj-1047	262	27	to	to	ADP
cuesj-1047	262	28	19	19	NUM
cuesj-1047	262	29	january	january	PROPN
cuesj-1047	262	30	2022	2022	NUM
cuesj-1047	262	31	.	.	PUNCT
cuesj-1047	263	1	eurosurveillance	eurosurveillance	NOUN
cuesj-1047	263	2	,	,	PUNCT
cuesj-1047	263	3	vol	vol	NOUN
cuesj-1047	263	4	.	.	PROPN
cuesj-1047	263	5	27	27	NUM
cuesj-1047	263	6	,	,	PUNCT
cuesj-1047	263	7	no	no	INTJ
cuesj-1047	263	8	.	.	NOUN
cuesj-1047	263	9	4	4	NUM
cuesj-1047	263	10	,	,	PUNCT
cuesj-1047	263	11	p.	p.	NOUN
cuesj-1047	263	12	2101196	2101196	NUM
cuesj-1047	263	13	,	,	PUNCT
cuesj-1047	263	14	2022	2022	NUM
cuesj-1047	263	15	.	.	PUNCT
cuesj-1047	264	1	14	14	NUM
cuesj-1047	264	2	.	.	PUNCT
cuesj-1047	264	3	d.	d.	PROPN
cuesj-1047	264	4	wu	wu	PROPN
cuesj-1047	264	5	,	,	PUNCT
cuesj-1047	264	6	y.	y.	PROPN
cuesj-1047	264	7	ye	ye	PROPN
cuesj-1047	264	8	,	,	PUNCT
cuesj-1047	264	9	l.	l.	PROPN
cuesj-1047	264	10	tang	tang	PROPN
cuesj-1047	264	11	,	,	PUNCT
cuesj-1047	264	12	a.	a.	PROPN
cuesj-1047	264	13	b.	b.	PROPN
cuesj-1047	264	14	wang	wang	PROPN
cuesj-1047	264	15	,	,	PUNCT
cuesj-1047	264	16	r.	r.	PROPN
cuesj-1047	264	17	zhang	zhang	PROPN
cuesj-1047	264	18	,	,	PUNCT
cuesj-1047	264	19	z.	z.	PROPN
cuesj-1047	264	20	h.	h.	PROPN
cuesj-1047	264	21	qian	qian	PROPN
cuesj-1047	264	22	,	,	PUNCT
cuesj-1047	264	23	f.	f.	PROPN
cuesj-1047	264	24	z.	z.	PROPN
cuesj-1047	264	25	wang	wang	PROPN
cuesj-1047	264	26	,	,	PUNCT
cuesj-1047	264	27	h.	h.	PROPN
cuesj-1047	264	28	zheng	zheng	PROPN
cuesj-1047	264	29	,	,	PUNCT
cuesj-1047	264	30	c.	c.	PROPN
cuesj-1047	264	31	huang	huang	PROPN
cuesj-1047	264	32	,	,	PUNCT
cuesj-1047	264	33	x.	x.	PROPN
cuesj-1047	264	34	y.	y.	PROPN
cuesj-1047	264	35	lv	lv	PROPN
cuesj-1047	264	36	,	,	PUNCT
cuesj-1047	264	37	h.	h.	PROPN
cuesj-1047	264	38	f.	f.	PROPN
cuesj-1047	264	39	wang	wang	PROPN
cuesj-1047	264	40	,	,	PUNCT
cuesj-1047	264	41	y.	y.	PROPN
cuesj-1047	264	42	y.	y.	PROPN
cuesj-1047	264	43	zhang	zhang	PROPN
cuesj-1047	264	44	,	,	PUNCT
cuesj-1047	264	45	j.	j.	PROPN
cuesj-1047	264	46	j.	j.	PROPN
cuesj-1047	264	47	pan	pan	PROPN
cuesj-1047	264	48	,	,	PUNCT
cuesj-1047	264	49	y.	y.	PROPN
cuesj-1047	264	50	f.	f.	PROPN
cuesj-1047	264	51	li	li	PROPN
cuesj-1047	264	52	,	,	PUNCT
cuesj-1047	264	53	…	…	PUNCT
cuesj-1047	264	54	and	and	CCONJ
cuesj-1047	264	55	m.	m.	NOUN
cuesj-1047	264	56	x.	x.	NOUN
cuesj-1047	264	57	lu	lu	PROPN
cuesj-1047	264	58	.	.	PUNCT
cuesj-1047	265	1	a	a	DET
cuesj-1047	265	2	case	case	NOUN
cuesj-1047	265	3	-	-	PUNCT
cuesj-1047	265	4	case	case	NOUN
cuesj-1047	265	5	study	study	NOUN
cuesj-1047	265	6	on	on	ADP
cuesj-1047	265	7	the	the	DET
cuesj-1047	265	8	effect	effect	NOUN
cuesj-1047	265	9	of	of	ADP
cuesj-1047	265	10	primary	primary	ADJ
cuesj-1047	265	11	and	and	CCONJ
cuesj-1047	265	12	booster	booster	NOUN
cuesj-1047	265	13	immunization	immunization	NOUN
cuesj-1047	265	14	with	with	ADP
cuesj-1047	265	15	china	china	PROPN
cuesj-1047	265	16	-	-	PUNCT
cuesj-1047	265	17	produced	produce	VERB
cuesj-1047	265	18	covid-19	covid-19	PROPN
cuesj-1047	265	19	vaccines	vaccine	NOUN
cuesj-1047	265	20	on	on	ADP
cuesj-1047	265	21	prevention	prevention	NOUN
cuesj-1047	265	22	of	of	ADP
cuesj-1047	265	23	pneumonia	pneumonia	NOUN
cuesj-1047	265	24	and	and	CCONJ
cuesj-1047	265	25	viral	viral	ADJ
cuesj-1047	265	26	load	load	NOUN
cuesj-1047	265	27	among	among	ADP
cuesj-1047	265	28	vaccinated	vaccinated	ADJ
cuesj-1047	265	29	persons	person	NOUN
cuesj-1047	265	30	infected	infect	VERB
cuesj-1047	265	31	by	by	ADP
cuesj-1047	265	32	delta	delta	NOUN
cuesj-1047	265	33	and	and	CCONJ
cuesj-1047	265	34	omicron	omicron	PROPN
cuesj-1047	265	35	variants	variant	NOUN
cuesj-1047	265	36	.	.	PUNCT
cuesj-1047	266	1	emerging	emerge	VERB
cuesj-1047	266	2	microbes	microbe	NOUN
cuesj-1047	266	3	and	and	CCONJ
cuesj-1047	266	4	infections	infection	NOUN
cuesj-1047	266	5	,	,	PUNCT
cuesj-1047	266	6	vol	vol	NOUN
cuesj-1047	266	7	.	.	PROPN
cuesj-1047	266	8	11	11	NUM
cuesj-1047	266	9	,	,	PUNCT
cuesj-1047	266	10	no	no	INTJ
cuesj-1047	266	11	.	.	NOUN
cuesj-1047	266	12	1	1	NUM
cuesj-1047	266	13	,	,	PUNCT
cuesj-1047	266	14	pp	pp	ADJ
cuesj-1047	266	15	.	.	PUNCT
cuesj-1047	266	16	1950	1950	NUM
cuesj-1047	266	17	-	-	SYM
cuesj-1047	266	18	1958	1958	NUM
cuesj-1047	266	19	,	,	PUNCT
cuesj-1047	266	20	2022	2022	NUM
cuesj-1047	266	21	.	.	PUNCT
cuesj-1047	266	22	15	15	NUM
cuesj-1047	266	23	.	.	PUNCT
cuesj-1047	267	1	s.	s.	PROPN
cuesj-1047	267	2	swed	swed	PROPN
cuesj-1047	267	3	,	,	PUNCT
cuesj-1047	267	4	f.	f.	PROPN
cuesj-1047	267	5	kashkash	kashkash	PROPN
cuesj-1047	267	6	,	,	PUNCT
cuesj-1047	267	7	s.	s.	PROPN
cuesj-1047	267	8	shoib	shoib	PROPN
cuesj-1047	267	9	,	,	PUNCT
cuesj-1047	267	10	n.	n.	PROPN
cuesj-1047	267	11	shaheen	shaheen	PROPN
cuesj-1047	267	12	,	,	PUNCT
cuesj-1047	267	13	m.	m.	PROPN
cuesj-1047	267	14	n.	n.	PROPN
cuesj-1047	267	15	nasif	nasif	PROPN
cuesj-1047	267	16	,	,	PUNCT
cuesj-1047	267	17	hussein	hussein	PROPN
cuesj-1047	267	18	,	,	PUNCT
cuesj-1047	267	19	et	et	PROPN
cuesj-1047	267	20	al	al	PROPN
cuesj-1047	267	21	.	.	PUNCT
cuesj-1047	267	22	:	:	PUNCT
cuesj-1047	268	1	a	a	DET
cuesj-1047	268	2	review	review	NOUN
cuesj-1047	268	3	on	on	ADP
cuesj-1047	268	4	coronavirus	coronavirus	NOUN
cuesj-1047	268	5	and	and	CCONJ
cuesj-1047	268	6	omicron	omicron	PROPN
cuesj-1047	268	7	patients	patient	NOUN
cuesj-1047	268	8	17	17	NUM
cuesj-1047	268	9	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1047	268	10	cuesj	cuesj	ADJ
cuesj-1047	268	11	2024	2024	NUM
cuesj-1047	268	12	,	,	PUNCT
cuesj-1047	268	13	8	8	NUM
cuesj-1047	268	14	(	(	PUNCT
cuesj-1047	268	15	1	1	NUM
cuesj-1047	268	16	):	):	PUNCT
cuesj-1047	268	17	8	8	NUM
cuesj-1047	268	18	-	-	SYM
cuesj-1047	268	19	17	17	NUM
cuesj-1047	268	20	k.	k.	PROPN
cuesj-1047	268	21	r.	r.	PROPN
cuesj-1047	268	22	motawea	motawea	PROPN
cuesj-1047	268	23	,	,	PUNCT
cuesj-1047	268	24	a.	a.	PROPN
cuesj-1047	268	25	s.	s.	PROPN
cuesj-1047	268	26	elhawary	elhawary	PROPN
cuesj-1047	268	27	,	,	PUNCT
cuesj-1047	268	28	y.	y.	PROPN
cuesj-1047	268	29	h.	h.	PROPN
cuesj-1047	268	30	abdelqadir	abdelqadir	PROPN
cuesj-1047	268	31	,	,	PUNCT
cuesj-1047	268	32	m.	m.	NOUN
cuesj-1047	268	33	m.	m.	PROPN
cuesj-1047	268	34	patwary	patwary	PROPN
cuesj-1047	268	35	,	,	PUNCT
cuesj-1047	268	36	h.	h.	PROPN
cuesj-1047	268	37	alibrahim	alibrahim	PROPN
cuesj-1047	268	38	,	,	PUNCT
cuesj-1047	268	39	b.	b.	PROPN
cuesj-1047	268	40	sawaf	sawaf	PROPN
cuesj-1047	268	41	,	,	PUNCT
cuesj-1047	268	42	…	…	PUNCT
cuesj-1047	268	43	and	and	CCONJ
cuesj-1047	268	44	l.	l.	PROPN
cuesj-1047	268	45	t.	t.	PROPN
cuesj-1047	268	46	khairy	khairy	PROPN
cuesj-1047	268	47	.	.	PUNCT
cuesj-1047	269	1	anxiety	anxiety	NOUN
cuesj-1047	269	2	and	and	CCONJ
cuesj-1047	269	3	depression	depression	NOUN
cuesj-1047	269	4	among	among	ADP
cuesj-1047	269	5	patient	patient	NOUN
cuesj-1047	269	6	’s	’s	PART
cuesj-1047	269	7	companions	companion	NOUN
cuesj-1047	269	8	during	during	ADP
cuesj-1047	269	9	admission	admission	NOUN
cuesj-1047	269	10	to	to	ADP
cuesj-1047	269	11	the	the	DET
cuesj-1047	269	12	icu	icu	PROPN
cuesj-1047	269	13	in	in	ADP
cuesj-1047	269	14	the	the	DET
cuesj-1047	269	15	omicron	omicron	PROPN
cuesj-1047	269	16	wave	wave	NOUN
cuesj-1047	269	17	of	of	ADP
cuesj-1047	269	18	covid-19	covid-19	PROPN
cuesj-1047	269	19	:	:	PUNCT
cuesj-1047	269	20	a	a	DET
cuesj-1047	269	21	cross	cross	ADJ
cuesj-1047	269	22	-	-	ADJ
cuesj-1047	269	23	sectional	sectional	ADJ
cuesj-1047	269	24	study	study	NOUN
cuesj-1047	269	25	in	in	ADP
cuesj-1047	269	26	aleppo	aleppo	PROPN
cuesj-1047	269	27	university	university	NOUN
cuesj-1047	269	28	hospital	hospital	NOUN
cuesj-1047	269	29	.	.	PUNCT
cuesj-1047	270	1	plos	plos	PROPN
cuesj-1047	270	2	one	one	NUM
cuesj-1047	270	3	,	,	PUNCT
cuesj-1047	270	4	vol	vol	NOUN
cuesj-1047	270	5	.	.	PROPN
cuesj-1047	270	6	17	17	NUM
cuesj-1047	270	7	,	,	PUNCT
cuesj-1047	270	8	no	no	INTJ
cuesj-1047	270	9	.	.	NOUN
cuesj-1047	270	10	10	10	NUM
cuesj-1047	270	11	,	,	PUNCT
cuesj-1047	270	12	p.	p.	NOUN
cuesj-1047	270	13	e0273900	e0273900	ADJ
cuesj-1047	270	14	,	,	PUNCT
cuesj-1047	270	15	2022	2022	NUM
cuesj-1047	270	16	.	.	PUNCT
cuesj-1047	271	1	16	16	NUM
cuesj-1047	271	2	.	.	PUNCT
cuesj-1047	272	1	f.	f.	PROPN
cuesj-1047	272	2	b.	b.	PROPN
cuesj-1047	272	3	mayr	mayr	PROPN
cuesj-1047	272	4	,	,	PUNCT
cuesj-1047	272	5	v.	v.	PROPN
cuesj-1047	272	6	b.	b.	PROPN
cuesj-1047	272	7	talisa	talisa	PROPN
cuesj-1047	272	8	,	,	PUNCT
cuesj-1047	272	9	a.	a.	PROPN
cuesj-1047	272	10	d.	d.	PROPN
cuesj-1047	272	11	castro	castro	PROPN
cuesj-1047	272	12	,	,	PUNCT
cuesj-1047	272	13	o.	o.	PROPN
cuesj-1047	272	14	s.	s.	PROPN
cuesj-1047	272	15	shaikh	shaikh	PROPN
cuesj-1047	272	16	,	,	PUNCT
cuesj-1047	272	17	s.	s.	PROPN
cuesj-1047	272	18	b.	b.	PROPN
cuesj-1047	272	19	omer	omer	PROPN
cuesj-1047	272	20	and	and	CCONJ
cuesj-1047	272	21	a.	a.	NOUN
cuesj-1047	272	22	a.	a.	NOUN
cuesj-1047	272	23	butt	butt	PROPN
cuesj-1047	272	24	.	.	PUNCT
cuesj-1047	273	1	covid-19	covid-19	PROPN
cuesj-1047	273	2	disease	disease	NOUN
cuesj-1047	273	3	severity	severity	NOUN
cuesj-1047	273	4	in	in	ADP
cuesj-1047	273	5	us	us	PROPN
cuesj-1047	273	6	veterans	veteran	NOUN
cuesj-1047	273	7	infected	infect	VERB
cuesj-1047	273	8	during	during	ADP
cuesj-1047	273	9	omicron	omicron	PROPN
cuesj-1047	273	10	and	and	CCONJ
cuesj-1047	273	11	delta	delta	PROPN
cuesj-1047	273	12	variant	variant	NOUN
cuesj-1047	273	13	predominant	predominant	ADJ
cuesj-1047	273	14	periods	period	NOUN
cuesj-1047	273	15	.	.	PUNCT
cuesj-1047	274	1	nature	nature	NOUN
cuesj-1047	274	2	communications	communication	NOUN
cuesj-1047	274	3	,	,	PUNCT
cuesj-1047	274	4	vol	vol	NOUN
cuesj-1047	274	5	.	.	PROPN
cuesj-1047	274	6	13	13	NUM
cuesj-1047	274	7	,	,	PUNCT
cuesj-1047	274	8	no	no	INTJ
cuesj-1047	274	9	.	.	NOUN
cuesj-1047	274	10	1	1	NUM
cuesj-1047	274	11	,	,	PUNCT
cuesj-1047	274	12	p.	p.	NOUN
cuesj-1047	274	13	3647	3647	NUM
cuesj-1047	274	14	,	,	PUNCT
cuesj-1047	274	15	2022	2022	NUM
cuesj-1047	274	16	.	.	PUNCT
cuesj-1047	275	1	17	17	NUM
cuesj-1047	275	2	.	.	PUNCT
cuesj-1047	275	3	x.	x.	PROPN
cuesj-1047	275	4	chen	chen	PROPN
cuesj-1047	275	5	,	,	PUNCT
cuesj-1047	275	6	x.	x.	PROPN
cuesj-1047	275	7	yan	yan	PROPN
cuesj-1047	275	8	,	,	PUNCT
cuesj-1047	275	9	k.	k.	PROPN
cuesj-1047	275	10	sun	sun	PROPN
cuesj-1047	275	11	,	,	PUNCT
cuesj-1047	275	12	n.	n.	PROPN
cuesj-1047	275	13	zheng	zheng	PROPN
cuesj-1047	275	14	,	,	PUNCT
cuesj-1047	275	15	r.	r.	PROPN
cuesj-1047	275	16	sun	sun	PROPN
cuesj-1047	275	17	,	,	PUNCT
cuesj-1047	275	18	j.	j.	PROPN
cuesj-1047	275	19	zhou	zhou	PROPN
cuesj-1047	275	20	,	,	PUNCT
cuesj-1047	275	21	x.	x.	PROPN
cuesj-1047	275	22	deng	deng	PROPN
cuesj-1047	275	23	,	,	PUNCT
cuesj-1047	275	24	t.	t.	PROPN
cuesj-1047	275	25	zhuang	zhuang	PROPN
cuesj-1047	275	26	,	,	PUNCT
cuesj-1047	275	27	j.	j.	PROPN
cuesj-1047	275	28	cai	cai	PROPN
cuesj-1047	275	29	,	,	PUNCT
cuesj-1047	275	30	j.	j.	PROPN
cuesj-1047	275	31	zhang	zhang	PROPN
cuesj-1047	275	32	,	,	PUNCT
cuesj-1047	275	33	m.	m.	NOUN
cuesj-1047	275	34	ajelli	ajelli	PROPN
cuesj-1047	275	35	and	and	CCONJ
cuesj-1047	275	36	h.	h.	PROPN
cuesj-1047	275	37	yu	yu	PROPN
cuesj-1047	275	38	.	.	PROPN
cuesj-1047	275	39	estimation	estimation	NOUN
cuesj-1047	275	40	of	of	ADP
cuesj-1047	275	41	disease	disease	NOUN
cuesj-1047	275	42	burden	burden	NOUN
cuesj-1047	275	43	and	and	CCONJ
cuesj-1047	275	44	clinical	clinical	ADJ
cuesj-1047	275	45	severity	severity	NOUN
cuesj-1047	275	46	of	of	ADP
cuesj-1047	275	47	covid-19	covid-19	PROPN
cuesj-1047	275	48	caused	cause	VERB
cuesj-1047	275	49	by	by	ADP
cuesj-1047	275	50	omicron	omicron	PROPN
cuesj-1047	275	51	ba.2	ba.2	PROPN
cuesj-1047	275	52	in	in	ADP
cuesj-1047	275	53	shanghai	shanghai	PROPN
cuesj-1047	275	54	,	,	PUNCT
cuesj-1047	275	55	february	february	PROPN
cuesj-1047	275	56	-	-	SYM
cuesj-1047	275	57	june	june	PROPN
cuesj-1047	275	58	2022	2022	NUM
cuesj-1047	275	59	.	.	PUNCT
cuesj-1047	276	1	emerging	emerge	VERB
cuesj-1047	276	2	microbes	microbe	NOUN
cuesj-1047	276	3	and	and	CCONJ
cuesj-1047	276	4	infections	infection	NOUN
cuesj-1047	276	5	,	,	PUNCT
cuesj-1047	276	6	vol	vol	NOUN
cuesj-1047	276	7	.	.	PROPN
cuesj-1047	276	8	11	11	NUM
cuesj-1047	276	9	,	,	PUNCT
cuesj-1047	276	10	no	no	INTJ
cuesj-1047	276	11	.	.	NOUN
cuesj-1047	276	12	1	1	NUM
cuesj-1047	276	13	,	,	PUNCT
cuesj-1047	276	14	pp	pp	ADJ
cuesj-1047	276	15	.	.	PUNCT
cuesj-1047	276	16	2800	2800	NUM
cuesj-1047	276	17	-	-	SYM
cuesj-1047	276	18	2807	2807	NUM
cuesj-1047	276	19	,	,	PUNCT
cuesj-1047	276	20	2022	2022	NUM
cuesj-1047	276	21	.	.	PUNCT
cuesj-1047	277	1	18	18	NUM
cuesj-1047	277	2	.	.	PUNCT
cuesj-1047	277	3	a.	a.	PROPN
cuesj-1047	277	4	dinh	dinh	PROPN
cuesj-1047	277	5	,	,	PUNCT
cuesj-1047	277	6	l.	l.	PROPN
cuesj-1047	277	7	dahmane	dahmane	PROPN
cuesj-1047	277	8	,	,	PUNCT
cuesj-1047	277	9	m.	m.	NOUN
cuesj-1047	277	10	dahoumane	dahoumane	NOUN
cuesj-1047	277	11	,	,	PUNCT
cuesj-1047	277	12	x.	x.	NOUN
cuesj-1047	277	13	masingue	masingue	PROPN
cuesj-1047	277	14	,	,	PUNCT
cuesj-1047	277	15	p.	p.	NOUN
cuesj-1047	277	16	jourdain	jourdain	PROPN
cuesj-1047	277	17	and	and	CCONJ
cuesj-1047	277	18	f.	f.	PROPN
cuesj-1047	277	19	x.	x.	PROPN
cuesj-1047	277	20	lescure	lescure	PROPN
cuesj-1047	277	21	.	.	PUNCT
cuesj-1047	278	1	impact	impact	NOUN
cuesj-1047	278	2	of	of	ADP
cuesj-1047	278	3	omicron	omicron	PROPN
cuesj-1047	278	4	surge	surge	NOUN
cuesj-1047	278	5	in	in	ADP
cuesj-1047	278	6	community	community	NOUN
cuesj-1047	278	7	setting	set	VERB
cuesj-1047	278	8	in	in	ADP
cuesj-1047	278	9	greater	great	ADJ
cuesj-1047	278	10	paris	paris	PROPN
cuesj-1047	278	11	area	area	NOUN
cuesj-1047	278	12	.	.	PUNCT
cuesj-1047	279	1	clinical	clinical	ADJ
cuesj-1047	279	2	microbiology	microbiology	NOUN
cuesj-1047	279	3	and	and	CCONJ
cuesj-1047	279	4	infection	infection	NOUN
cuesj-1047	279	5	,	,	PUNCT
cuesj-1047	279	6	vol	vol	NOUN
cuesj-1047	279	7	.	.	PROPN
cuesj-1047	279	8	28	28	NUM
cuesj-1047	279	9	,	,	PUNCT
cuesj-1047	279	10	no	no	INTJ
cuesj-1047	279	11	.	.	NOUN
cuesj-1047	279	12	6	6	NUM
cuesj-1047	279	13	,	,	PUNCT
cuesj-1047	279	14	pp	pp	ADJ
cuesj-1047	279	15	.	.	PUNCT
cuesj-1047	280	1	897	897	NUM
cuesj-1047	280	2	-	-	SYM
cuesj-1047	280	3	899	899	NUM
cuesj-1047	280	4	,	,	PUNCT
cuesj-1047	280	5	2022	2022	NUM
cuesj-1047	280	6	.	.	PUNCT
cuesj-1047	281	1	19	19	NUM
cuesj-1047	281	2	.	.	PUNCT
cuesj-1047	281	3	j.	j.	PROPN
cuesj-1047	281	4	a.	a.	PROPN
cuesj-1047	281	5	otter	otter	PROPN
cuesj-1047	281	6	,	,	PUNCT
cuesj-1047	281	7	w.	w.	PROPN
cuesj-1047	281	8	newsholme	newsholme	PROPN
cuesj-1047	281	9	,	,	PUNCT
cuesj-1047	281	10	l.	l.	PROPN
cuesj-1047	281	11	b.	b.	PROPN
cuesj-1047	281	12	snell	snell	PROPN
cuesj-1047	281	13	,	,	PUNCT
cuesj-1047	281	14	b.	b.	PROPN
cuesj-1047	281	15	merrick	merrick	PROPN
cuesj-1047	281	16	,	,	PUNCT
cuesj-1047	281	17	n.	n.	PROPN
cuesj-1047	281	18	okeke	okeke	PROPN
cuesj-1047	281	19	d.	d.	PROPN
cuesj-1047	281	20	j.	j.	PROPN
cuesj-1047	281	21	f.	f.	PROPN
cuesj-1047	281	22	mack	mack	PROPN
cuesj-1047	281	23	,	,	PUNCT
cuesj-1047	281	24	a.	a.	PROPN
cuesj-1047	281	25	s.	s.	PROPN
cuesj-1047	281	26	breathnach	breathnach	PROPN
cuesj-1047	281	27	and	and	CCONJ
cuesj-1047	281	28	n.	n.	PROPN
cuesj-1047	281	29	m.	m.	NOUN
cuesj-1047	281	30	price	price	NOUN
cuesj-1047	281	31	.	.	PUNCT
cuesj-1047	282	1	evaluation	evaluation	NOUN
cuesj-1047	282	2	of	of	ADP
cuesj-1047	282	3	clinical	clinical	ADJ
cuesj-1047	282	4	harm	harm	NOUN
cuesj-1047	282	5	associated	associate	VERB
cuesj-1047	282	6	with	with	ADP
cuesj-1047	282	7	omicron	omicron	PROPN
cuesj-1047	282	8	hospital	hospital	NOUN
cuesj-1047	282	9	-	-	PUNCT
cuesj-1047	282	10	onset	onset	NOUN
cuesj-1047	282	11	covid-19	covid-19	PROPN
cuesj-1047	282	12	infection	infection	NOUN
cuesj-1047	282	13	.	.	PUNCT
cuesj-1047	283	1	journal	journal	NOUN
cuesj-1047	283	2	of	of	ADP
cuesj-1047	283	3	infection	infection	NOUN
cuesj-1047	283	4	,	,	PUNCT
cuesj-1047	283	5	vol	vol	NOUN
cuesj-1047	283	6	.	.	PROPN
cuesj-1047	283	7	86	86	NUM
cuesj-1047	283	8	,	,	PUNCT
cuesj-1047	283	9	no	no	INTJ
cuesj-1047	283	10	.	.	NOUN
cuesj-1047	283	11	1	1	NUM
cuesj-1047	283	12	,	,	PUNCT
cuesj-1047	283	13	pp	pp	ADJ
cuesj-1047	283	14	.	.	PUNCT
cuesj-1047	284	1	66	66	NUM
cuesj-1047	284	2	-	-	SYM
cuesj-1047	284	3	117	117	NUM
cuesj-1047	284	4	,	,	PUNCT
cuesj-1047	284	5	2023	2023	NUM
cuesj-1047	284	6	.	.	PUNCT
cuesj-1047	285	1	20	20	NUM
cuesj-1047	285	2	.	.	PUNCT
cuesj-1047	285	3	m.	m.	NOUN
cuesj-1047	285	4	g.	g.	PROPN
cuesj-1047	285	5	chibwana	chibwana	PROPN
cuesj-1047	285	6	,	,	PUNCT
cuesj-1047	285	7	h.	h.	PROPN
cuesj-1047	285	8	w.	w.	PROPN
cuesj-1047	285	9	thole	thole	PROPN
cuesj-1047	285	10	,	,	PUNCT
cuesj-1047	285	11	c.	c.	PROPN
cuesj-1047	285	12	anscombe	anscombe	PROPN
cuesj-1047	285	13	,	,	PUNCT
cuesj-1047	285	14	p.	p.	PROPN
cuesj-1047	285	15	m.	m.	PROPN
cuesj-1047	285	16	ashton	ashton	PROPN
cuesj-1047	285	17	,	,	PUNCT
cuesj-1047	285	18	e.	e.	PROPN
cuesj-1047	285	19	green	green	PROPN
cuesj-1047	285	20	,	,	PUNCT
cuesj-1047	285	21	k.	k.	PROPN
cuesj-1047	285	22	g.	g.	PROPN
cuesj-1047	285	23	barnes	barnes	PROPN
cuesj-1047	285	24	,	,	PUNCT
cuesj-1047	285	25	j.	j.	PROPN
cuesj-1047	285	26	cornick	cornick	PROPN
cuesj-1047	285	27	,	,	PUNCT
cuesj-1047	285	28	a.	a.	NOUN
cuesj-1047	285	29	turner	turner	PROPN
cuesj-1047	285	30	,	,	PUNCT
cuesj-1047	285	31	d.	d.	PROPN
cuesj-1047	285	32	witte	witte	PROPN
cuesj-1047	285	33	,	,	PUNCT
cuesj-1047	285	34	s.	s.	PROPN
cuesj-1047	285	35	nthala	nthala	PROPN
cuesj-1047	285	36	,	,	PUNCT
cuesj-1047	285	37	c.	c.	PROPN
cuesj-1047	285	38	thom	thom	PROPN
cuesj-1047	285	39	,	,	PUNCT
cuesj-1047	285	40	f.	f.	PROPN
cuesj-1047	285	41	kanyandula	kanyandula	PROPN
cuesj-1047	285	42	,	,	PUNCT
cuesj-1047	285	43	a.	a.	NOUN
cuesj-1047	285	44	ainani	ainani	PROPN
cuesj-1047	285	45	,	,	PUNCT
cuesj-1047	285	46	n.	n.	PROPN
cuesj-1047	285	47	mtike	mtike	PROPN
cuesj-1047	285	48	,	,	PUNCT
cuesj-1047	285	49	h.	h.	PROPN
cuesj-1047	285	50	tambala	tambala	PROPN
cuesj-1047	285	51	,	,	PUNCT
cuesj-1047	285	52	…	…	PUNCT
cuesj-1047	285	53	and	and	CCONJ
cuesj-1047	286	1	v.	v.	ADP
cuesj-1047	286	2	n’goma	n’goma	NOUN
cuesj-1047	286	3	.	.	PUNCT
cuesj-1047	287	1	differential	differential	ADJ
cuesj-1047	287	2	symptoms	symptom	NOUN
cuesj-1047	287	3	among	among	ADP
cuesj-1047	287	4	covid-19	covid-19	PROPN
cuesj-1047	287	5	outpatients	outpatient	NOUN
cuesj-1047	287	6	before	before	ADP
cuesj-1047	287	7	and	and	CCONJ
cuesj-1047	287	8	during	during	ADP
cuesj-1047	287	9	periods	period	NOUN
cuesj-1047	287	10	of	of	ADP
cuesj-1047	287	11	sars	sar	NOUN
cuesj-1047	287	12	-	-	PUNCT
cuesj-1047	287	13	cov-2	cov-2	NOUN
cuesj-1047	287	14	omicron	omicron	NOUN
cuesj-1047	287	15	variant	variant	NOUN
cuesj-1047	287	16	dominance	dominance	NOUN
cuesj-1047	287	17	in	in	ADP
cuesj-1047	287	18	blantyre	blantyre	PROPN
cuesj-1047	287	19	,	,	PUNCT
cuesj-1047	287	20	malawi	malawi	PROPN
cuesj-1047	287	21	:	:	PUNCT
cuesj-1047	287	22	a	a	DET
cuesj-1047	287	23	prospective	prospective	ADJ
cuesj-1047	287	24	observational	observational	ADJ
cuesj-1047	287	25	study	study	NOUN
cuesj-1047	287	26	.	.	PUNCT
cuesj-1047	288	1	medrxiv	medrxiv	PROPN
cuesj-1047	288	2	,	,	PUNCT
cuesj-1047	288	3	2022	2022	NUM
cuesj-1047	288	4	.	.	PUNCT
cuesj-1047	289	1	https://doi.org/10.1101/2022.07.15.22277665	https://doi.org/10.1101/2022.07.15.22277665	PROPN
cuesj-1047	289	2	21	21	NUM
cuesj-1047	289	3	.	.	PUNCT
cuesj-1047	290	1	m.	m.	PROPN
cuesj-1047	290	2	h.	h.	PROPN
cuesj-1047	290	3	ebell	ebell	PROPN
cuesj-1047	290	4	,	,	PUNCT
cuesj-1047	290	5	r.	r.	PROPN
cuesj-1047	290	6	hamadani	hamadani	PROPN
cuesj-1047	290	7	and	and	CCONJ
cuesj-1047	290	8	a.	a.	PROPN
cuesj-1047	290	9	kieber	kieber	PROPN
cuesj-1047	290	10	-	-	PUNCT
cuesj-1047	290	11	emmons	emmons	PROPN
cuesj-1047	290	12	.	.	PUNCT
cuesj-1047	291	1	development	development	NOUN
cuesj-1047	291	2	and	and	CCONJ
cuesj-1047	291	3	validation	validation	NOUN
cuesj-1047	291	4	of	of	ADP
cuesj-1047	291	5	simple	simple	ADJ
cuesj-1047	291	6	risk	risk	NOUN
cuesj-1047	291	7	scores	score	NOUN
cuesj-1047	291	8	to	to	PART
cuesj-1047	291	9	predict	predict	VERB
cuesj-1047	291	10	hospitalization	hospitalization	NOUN
cuesj-1047	291	11	in	in	ADP
cuesj-1047	291	12	outpatients	outpatient	NOUN
cuesj-1047	291	13	with	with	ADP
cuesj-1047	291	14	covid-19	covid-19	PROPN
cuesj-1047	291	15	including	include	VERB
cuesj-1047	291	16	the	the	DET
cuesj-1047	291	17	omicron	omicron	PROPN
cuesj-1047	291	18	variant	variant	NOUN
cuesj-1047	291	19	.	.	PUNCT
cuesj-1047	292	1	the	the	DET
cuesj-1047	292	2	journal	journal	NOUN
cuesj-1047	292	3	of	of	ADP
cuesj-1047	292	4	the	the	DET
cuesj-1047	292	5	american	american	PROPN
cuesj-1047	292	6	board	board	PROPN
cuesj-1047	292	7	of	of	ADP
cuesj-1047	292	8	family	family	NOUN
cuesj-1047	292	9	medicine	medicine	NOUN
cuesj-1047	292	10	,	,	PUNCT
cuesj-1047	292	11	vol	vol	NOUN
cuesj-1047	292	12	.	.	PROPN
cuesj-1047	292	13	35	35	NUM
cuesj-1047	292	14	,	,	PUNCT
cuesj-1047	292	15	no	no	INTJ
cuesj-1047	292	16	.	.	NOUN
cuesj-1047	292	17	6	6	NUM
cuesj-1047	292	18	,	,	PUNCT
cuesj-1047	292	19	pp	pp	ADJ
cuesj-1047	292	20	.	.	PUNCT
cuesj-1047	292	21	1058	1058	NUM
cuesj-1047	292	22	-	-	SYM
cuesj-1047	292	23	1064	1064	NUM
cuesj-1047	292	24	,	,	PUNCT
cuesj-1047	292	25	2022	2022	NUM
cuesj-1047	292	26	.	.	PUNCT
cuesj-1047	293	1	22	22	NUM
cuesj-1047	293	2	.	.	PUNCT
cuesj-1047	294	1	s.	s.	PROPN
cuesj-1047	294	2	k.	k.	PROPN
cuesj-1047	294	3	greene	greene	PROPN
cuesj-1047	294	4	,	,	PUNCT
cuesj-1047	294	5	a.	a.	PROPN
cuesj-1047	294	6	levin	levin	PROPN
cuesj-1047	294	7	-	-	PUNCT
cuesj-1047	294	8	rector	rector	NOUN
cuesj-1047	294	9	,	,	PUNCT
cuesj-1047	294	10	e.	e.	PROPN
cuesj-1047	294	11	luoma	luoma	PROPN
cuesj-1047	294	12	,	,	PUNCT
cuesj-1047	294	13	h.	h.	PROPN
cuesj-1047	294	14	amin	amin	PROPN
cuesj-1047	294	15	,	,	PUNCT
cuesj-1047	294	16	e.	e.	PROPN
cuesj-1047	294	17	mcgibbon	mcgibbon	PROPN
cuesj-1047	294	18	,	,	PUNCT
cuesj-1047	294	19	r.	r.	PROPN
cuesj-1047	294	20	w.	w.	PROPN
cuesj-1047	294	21	mathes	mathes	PROPN
cuesj-1047	294	22	and	and	CCONJ
cuesj-1047	294	23	s.	s.	PROPN
cuesj-1047	294	24	d.	d.	PROPN
cuesj-1047	294	25	ahuja	ahuja	PROPN
cuesj-1047	294	26	.	.	PROPN
cuesj-1047	295	1	assessment	assessment	NOUN
cuesj-1047	295	2	of	of	ADP
cuesj-1047	295	3	covid-19	covid-19	PROPN
cuesj-1047	295	4	hospitalization	hospitalization	NOUN
cuesj-1047	295	5	risk	risk	NOUN
cuesj-1047	295	6	during	during	ADP
cuesj-1047	295	7	sars	sar	NOUN
cuesj-1047	295	8	-	-	PUNCT
cuesj-1047	295	9	cov-2	cov-2	NOUN
cuesj-1047	295	10	omicron	omicron	PROPN
cuesj-1047	295	11	relative	relative	NOUN
cuesj-1047	295	12	to	to	ADP
cuesj-1047	295	13	delta	delta	PROPN
cuesj-1047	295	14	variant	variant	ADJ
cuesj-1047	295	15	predominance	predominance	NOUN
cuesj-1047	295	16	,	,	PUNCT
cuesj-1047	295	17	new	new	PROPN
cuesj-1047	295	18	york	york	PROPN
cuesj-1047	295	19	city	city	PROPN
cuesj-1047	295	20	,	,	PUNCT
cuesj-1047	295	21	august	august	PROPN
cuesj-1047	295	22	2021	2021	NUM
cuesj-1047	295	23	-	-	SYM
cuesj-1047	295	24	january	january	PROPN
cuesj-1047	295	25	2022	2022	NUM
cuesj-1047	295	26	.	.	PUNCT
cuesj-1047	296	1	medrxiv	medrxiv	PROPN
cuesj-1047	296	2	,	,	PUNCT
cuesj-1047	296	3	2022	2022	NUM
cuesj-1047	296	4	.	.	PUNCT
cuesj-1047	297	1	https://doi.org/10.1101/2022.07.15.22276814	https://doi.org/10.1101/2022.07.15.22276814	PROPN
cuesj-1047	297	2	23	23	NUM
cuesj-1047	297	3	.	.	PUNCT
cuesj-1047	298	1	g.	g.	PROPN
cuesj-1047	298	2	lu	lu	PROPN
cuesj-1047	298	3	,	,	PUNCT
cuesj-1047	298	4	y.	y.	PROPN
cuesj-1047	298	5	zhang	zhang	PROPN
cuesj-1047	298	6	,	,	PUNCT
cuesj-1047	298	7	h.	h.	PROPN
cuesj-1047	298	8	zhang	zhang	PROPN
cuesj-1047	298	9	,	,	PUNCT
cuesj-1047	298	10	j.	j.	PROPN
cuesj-1047	298	11	ai	ai	PROPN
cuesj-1047	298	12	,	,	PUNCT
cuesj-1047	298	13	l.	l.	PROPN
cuesj-1047	298	14	he	he	PRON
cuesj-1047	298	15	,	,	PUNCT
cuesj-1047	298	16	x.	x.	PROPN
cuesj-1047	298	17	yuan	yuan	PROPN
cuesj-1047	298	18	,	,	PUNCT
cuesj-1047	298	19	s.	s.	PROPN
cuesj-1047	298	20	bao	bao	PROPN
cuesj-1047	298	21	,	,	PUNCT
cuesj-1047	298	22	x.	x.	PROPN
cuesj-1047	298	23	chen	chen	PROPN
cuesj-1047	298	24	,	,	PUNCT
cuesj-1047	298	25	h.	h.	PROPN
cuesj-1047	298	26	wang	wang	PROPN
cuesj-1047	298	27	,	,	PUNCT
cuesj-1047	298	28	j.	j.	PROPN
cuesj-1047	298	29	cai	cai	PROPN
cuesj-1047	298	30	,	,	PUNCT
cuesj-1047	298	31	s.	s.	PROPN
cuesj-1047	298	32	wang	wang	PROPN
cuesj-1047	298	33	,	,	PUNCT
cuesj-1047	298	34	w.	w.	PROPN
cuesj-1047	298	35	zhang	zhang	PROPN
cuesj-1047	298	36	and	and	CCONJ
cuesj-1047	298	37	j.	j.	PROPN
cuesj-1047	298	38	xu	xu	PROPN
cuesj-1047	298	39	.	.	PUNCT
cuesj-1047	299	1	geriatric	geriatric	ADJ
cuesj-1047	299	2	risk	risk	NOUN
cuesj-1047	299	3	and	and	CCONJ
cuesj-1047	299	4	protective	protective	ADJ
cuesj-1047	299	5	factors	factor	NOUN
cuesj-1047	299	6	for	for	ADP
cuesj-1047	299	7	serious	serious	ADJ
cuesj-1047	299	8	covid-19	covid-19	PROPN
cuesj-1047	299	9	outcomes	outcome	NOUN
cuesj-1047	299	10	among	among	ADP
cuesj-1047	299	11	older	old	ADJ
cuesj-1047	299	12	adults	adult	NOUN
cuesj-1047	299	13	in	in	ADP
cuesj-1047	299	14	shanghai	shanghai	PROPN
cuesj-1047	299	15	omicron	omicron	PROPN
cuesj-1047	299	16	wave	wave	PROPN
cuesj-1047	299	17	.	.	PUNCT
cuesj-1047	300	1	emerging	emerge	VERB
cuesj-1047	300	2	microbes	microbe	NOUN
cuesj-1047	300	3	and	and	CCONJ
cuesj-1047	300	4	infections	infection	NOUN
cuesj-1047	300	5	,	,	PUNCT
cuesj-1047	300	6	vol	vol	NOUN
cuesj-1047	300	7	.	.	PROPN
cuesj-1047	300	8	11	11	NUM
cuesj-1047	300	9	,	,	PUNCT
cuesj-1047	300	10	no	no	INTJ
cuesj-1047	300	11	.	.	NOUN
cuesj-1047	300	12	1	1	NUM
cuesj-1047	300	13	,	,	PUNCT
cuesj-1047	300	14	pp	pp	ADJ
cuesj-1047	300	15	.	.	PUNCT
cuesj-1047	300	16	2045	2045	NUM
cuesj-1047	300	17	-	-	SYM
cuesj-1047	300	18	2054	2054	NUM
cuesj-1047	300	19	,	,	PUNCT
cuesj-1047	300	20	2022	2022	NUM
cuesj-1047	300	21	.	.	PUNCT
cuesj-1047	301	1	24	24	NUM
cuesj-1047	301	2	.	.	PUNCT
cuesj-1047	301	3	e.	e.	PROPN
cuesj-1047	301	4	k.	k.	PROPN
cuesj-1047	301	5	accorsi	accorsi	PROPN
cuesj-1047	301	6	,	,	PUNCT
cuesj-1047	301	7	a.	a.	PROPN
cuesj-1047	301	8	britton	britton	PROPN
cuesj-1047	301	9	,	,	PUNCT
cuesj-1047	301	10	k.	k.	PROPN
cuesj-1047	301	11	e.	e.	PROPN
cuesj-1047	301	12	fleming	fleming	PROPN
cuesj-1047	301	13	-	-	PUNCT
cuesj-1047	301	14	dutra	dutra	PROPN
cuesj-1047	301	15	,	,	PUNCT
cuesj-1047	301	16	z.	z.	PROPN
cuesj-1047	301	17	r.	r.	PROPN
cuesj-1047	301	18	smith	smith	PROPN
cuesj-1047	301	19	,	,	PUNCT
cuesj-1047	301	20	n.	n.	PROPN
cuesj-1047	301	21	shang	shang	PROPN
cuesj-1047	301	22	,	,	PUNCT
cuesj-1047	301	23	g.	g.	PROPN
cuesj-1047	301	24	derado	derado	PROPN
cuesj-1047	301	25	,	,	PUNCT
cuesj-1047	301	26	j.	j.	PROPN
cuesj-1047	301	27	miller	miller	PROPN
cuesj-1047	301	28	,	,	PUNCT
cuesj-1047	301	29	s.	s.	PROPN
cuesj-1047	301	30	j.	j.	PROPN
cuesj-1047	301	31	schrag	schrag	PROPN
cuesj-1047	301	32	and	and	CCONJ
cuesj-1047	301	33	j.	j.	PROPN
cuesj-1047	301	34	r.	r.	PROPN
cuesj-1047	301	35	verani	verani	PROPN
cuesj-1047	301	36	.	.	PUNCT
cuesj-1047	302	1	association	association	NOUN
cuesj-1047	302	2	between	between	ADP
cuesj-1047	302	3	3	3	NUM
cuesj-1047	302	4	doses	dose	NOUN
cuesj-1047	302	5	of	of	ADP
cuesj-1047	302	6	mrna	mrna	PROPN
cuesj-1047	302	7	covid-19	covid-19	PROPN
cuesj-1047	302	8	vaccine	vaccine	NOUN
cuesj-1047	302	9	and	and	CCONJ
cuesj-1047	302	10	symptomatic	symptomatic	ADJ
cuesj-1047	302	11	infection	infection	NOUN
cuesj-1047	302	12	caused	cause	VERB
cuesj-1047	302	13	by	by	ADP
cuesj-1047	302	14	the	the	DET
cuesj-1047	302	15	sars	sar	NOUN
cuesj-1047	302	16	-	-	PUNCT
cuesj-1047	302	17	cov-2	cov-2	NOUN
cuesj-1047	302	18	omicron	omicron	NOUN
cuesj-1047	302	19	and	and	CCONJ
cuesj-1047	302	20	delta	delta	NOUN
cuesj-1047	302	21	variants	variant	NOUN
cuesj-1047	302	22	.	.	PUNCT
cuesj-1047	303	1	jama	jama	PROPN
cuesj-1047	303	2	,	,	PUNCT
cuesj-1047	303	3	vol	vol	NOUN
cuesj-1047	303	4	.	.	PROPN
cuesj-1047	303	5	327	327	NUM
cuesj-1047	303	6	,	,	PUNCT
cuesj-1047	303	7	no	no	INTJ
cuesj-1047	303	8	.	.	NOUN
cuesj-1047	303	9	7	7	NUM
cuesj-1047	303	10	,	,	PUNCT
cuesj-1047	303	11	pp	pp	ADJ
cuesj-1047	303	12	.	.	PUNCT
cuesj-1047	304	1	639	639	NUM
cuesj-1047	304	2	-	-	SYM
cuesj-1047	304	3	651	651	NUM
cuesj-1047	304	4	,	,	PUNCT
cuesj-1047	304	5	2022	2022	NUM
cuesj-1047	304	6	.	.	PUNCT
cuesj-1047	305	1	25	25	NUM
cuesj-1047	305	2	.	.	PUNCT
cuesj-1047	305	3	r.	r.	PROPN
cuesj-1047	305	4	cohen	cohen	PROPN
cuesj-1047	305	5	,	,	PUNCT
cuesj-1047	305	6	a.	a.	PROPN
cuesj-1047	305	7	rybak	rybak	PROPN
cuesj-1047	305	8	,	,	PUNCT
cuesj-1047	305	9	n.	n.	PROPN
cuesj-1047	305	10	ouldali	ouldali	PROPN
cuesj-1047	305	11	,	,	PUNCT
cuesj-1047	305	12	f.	f.	PROPN
cuesj-1047	305	13	angoulvant	angoulvant	PROPN
cuesj-1047	305	14	,	,	PUNCT
cuesj-1047	305	15	s.	s.	PROPN
cuesj-1047	305	16	béchet	béchet	PROPN
cuesj-1047	305	17	,	,	PUNCT
cuesj-1047	305	18	v.	v.	ADP
cuesj-1047	305	19	gajdos	gajdos	PROPN
cuesj-1047	305	20	,	,	PUNCT
cuesj-1047	305	21	i.	i.	PROPN
cuesj-1047	305	22	hau	hau	PROPN
cuesj-1047	305	23	,	,	PUNCT
cuesj-1047	305	24	a.	a.	PROPN
cuesj-1047	305	25	sellam	sellam	PROPN
cuesj-1047	305	26	,	,	PUNCT
cuesj-1047	305	27	i.	i.	PROPN
cuesj-1047	305	28	e.	e.	PROPN
cuesj-1047	305	29	a.	a.	PROPN
cuesj-1047	305	30	el	el	PROPN
cuesj-1047	305	31	ghomari	ghomari	PROPN
cuesj-1047	305	32	,	,	PUNCT
cuesj-1047	305	33	f.	f.	PROPN
cuesj-1047	305	34	elmerich	elmerich	PROPN
cuesj-1047	305	35	,	,	PUNCT
cuesj-1047	305	36	c.	c.	PROPN
cuesj-1047	305	37	batard	batard	PROPN
cuesj-1047	305	38	,	,	PUNCT
cuesj-1047	305	39	a.	a.	PROPN
cuesj-1047	305	40	auvrignon	auvrignon	PROPN
cuesj-1047	305	41	,	,	PUNCT
cuesj-1047	305	42	e.	e.	PROPN
cuesj-1047	305	43	grimprel	grimprel	PROPN
cuesj-1047	305	44	,	,	PUNCT
cuesj-1047	305	45	m.	m.	NOUN
cuesj-1047	305	46	favier	favier	NOUN
cuesj-1047	305	47	,	,	PUNCT
cuesj-1047	305	48	c.	c.	PROPN
cuesj-1047	305	49	jung	jung	PROPN
cuesj-1047	305	50	and	and	CCONJ
cuesj-1047	305	51	c.	c.	PROPN
cuesj-1047	305	52	levy	levy	NOUN
cuesj-1047	305	53	.	.	PUNCT
cuesj-1047	306	1	from	from	ADP
cuesj-1047	306	2	the	the	DET
cuesj-1047	306	3	original	original	ADJ
cuesj-1047	306	4	sars	sar	NOUN
cuesj-1047	306	5	-	-	PUNCT
cuesj-1047	306	6	cov-2	cov-2	NOUN
cuesj-1047	306	7	strain	strain	NOUN
cuesj-1047	306	8	to	to	ADP
cuesj-1047	306	9	the	the	DET
cuesj-1047	306	10	omicron	omicron	PROPN
cuesj-1047	306	11	variant	variant	NOUN
cuesj-1047	306	12	:	:	PUNCT
cuesj-1047	306	13	predictors	predictor	NOUN
cuesj-1047	306	14	of	of	ADP
cuesj-1047	306	15	covid-19	covid-19	PROPN
cuesj-1047	306	16	in	in	ADP
cuesj-1047	306	17	ambulatory	ambulatory	ADJ
cuesj-1047	306	18	symptomatic	symptomatic	ADJ
cuesj-1047	306	19	children	child	NOUN
cuesj-1047	306	20	.	.	PUNCT
cuesj-1047	307	1	infectious	infectious	ADJ
cuesj-1047	307	2	diseases	disease	NOUN
cuesj-1047	307	3	now	now	ADV
cuesj-1047	307	4	,	,	PUNCT
cuesj-1047	307	5	vol	vol	NOUN
cuesj-1047	307	6	.	.	PROPN
cuesj-1047	307	7	52	52	NUM
cuesj-1047	307	8	,	,	PUNCT
cuesj-1047	307	9	no	no	INTJ
cuesj-1047	307	10	.	.	NOUN
cuesj-1047	307	11	8	8	NUM
cuesj-1047	307	12	,	,	PUNCT
cuesj-1047	307	13	pp	pp	ADJ
cuesj-1047	307	14	.	.	PUNCT
cuesj-1047	308	1	432	432	NUM
cuesj-1047	308	2	-	-	SYM
cuesj-1047	308	3	440	440	NUM
cuesj-1047	308	4	,	,	PUNCT
cuesj-1047	308	5	2022	2022	NUM
cuesj-1047	308	6	.	.	PUNCT
cuesj-1047	309	1	26	26	NUM
cuesj-1047	309	2	.	.	PUNCT
cuesj-1047	310	1	h.	h.	PROPN
cuesj-1047	310	2	n.	n.	PROPN
cuesj-1047	310	3	altarawneh	altarawneh	PROPN
cuesj-1047	310	4	,	,	PUNCT
cuesj-1047	310	5	h.	h.	PROPN
cuesj-1047	310	6	chemaitelly	chemaitelly	PROPN
cuesj-1047	310	7	,	,	PUNCT
cuesj-1047	310	8	h.	h.	PROPN
cuesj-1047	310	9	h.	h.	PROPN
cuesj-1047	310	10	ayoub	ayoub	PROPN
cuesj-1047	310	11	,	,	PUNCT
cuesj-1047	310	12	p.	p.	PROPN
cuesj-1047	310	13	tang	tang	PROPN
cuesj-1047	310	14	,	,	PUNCT
cuesj-1047	310	15	m.	m.	PROPN
cuesj-1047	310	16	r.	r.	PROPN
cuesj-1047	310	17	hasan	hasan	PROPN
cuesj-1047	310	18	,	,	PUNCT
cuesj-1047	310	19	h.	h.	PROPN
cuesj-1047	310	20	m.	m.	PROPN
cuesj-1047	310	21	yassine	yassine	PROPN
cuesj-1047	310	22	,	,	PUNCT
cuesj-1047	310	23	h.	h.	PROPN
cuesj-1047	310	24	a.	a.	PROPN
cuesj-1047	310	25	al	al	PROPN
cuesj-1047	310	26	-	-	PUNCT
cuesj-1047	310	27	khatib	khatib	PROPN
cuesj-1047	310	28	,	,	PUNCT
cuesj-1047	310	29	m.	m.	PROPN
cuesj-1047	310	30	k.	k.	PROPN
cuesj-1047	310	31	smatti	smatti	PROPN
cuesj-1047	310	32	,	,	PUNCT
cuesj-1047	310	33	p.	p.	NOUN
cuesj-1047	310	34	coyle	coyle	PROPN
cuesj-1047	310	35	,	,	PUNCT
cuesj-1047	310	36	z.	z.	PROPN
cuesj-1047	310	37	al	al	PROPN
cuesj-1047	310	38	-	-	PUNCT
cuesj-1047	310	39	kanaani	kanaani	PROPN
cuesj-1047	310	40	,	,	PUNCT
cuesj-1047	310	41	e.	e.	PROPN
cuesj-1047	310	42	al	al	PROPN
cuesj-1047	310	43	-	-	PUNCT
cuesj-1047	310	44	kuwari	kuwari	PROPN
cuesj-1047	310	45	,	,	PUNCT
cuesj-1047	310	46	a.	a.	NOUN
cuesj-1047	310	47	jeremijenko	jeremijenko	PROPN
cuesj-1047	310	48	,	,	PUNCT
cuesj-1047	310	49	a.	a.	PROPN
cuesj-1047	310	50	h.	h.	PROPN
cuesj-1047	310	51	kaleeckal	kaleeckal	PROPN
cuesj-1047	310	52	,	,	PUNCT
cuesj-1047	310	53	a.	a.	PROPN
cuesj-1047	310	54	n.	n.	PROPN
cuesj-1047	310	55	latif	latif	PROPN
cuesj-1047	310	56	and	and	CCONJ
cuesj-1047	310	57	r.	r.	PROPN
cuesj-1047	310	58	m.	m.	PROPN
cuesj-1047	310	59	shaik	shaik	PROPN
cuesj-1047	310	60	.	.	PUNCT
cuesj-1047	311	1	effect	effect	NOUN
cuesj-1047	311	2	of	of	ADP
cuesj-1047	311	3	prior	prior	ADJ
cuesj-1047	311	4	infection	infection	NOUN
cuesj-1047	311	5	,	,	PUNCT
cuesj-1047	311	6	vaccination	vaccination	NOUN
cuesj-1047	311	7	,	,	PUNCT
cuesj-1047	311	8	and	and	CCONJ
cuesj-1047	311	9	hybrid	hybrid	ADJ
cuesj-1047	311	10	immunity	immunity	NOUN
cuesj-1047	311	11	against	against	ADP
cuesj-1047	311	12	symptomatic	symptomatic	ADJ
cuesj-1047	311	13	ba.1	ba.1	NOUN
cuesj-1047	311	14	and	and	CCONJ
cuesj-1047	311	15	ba.2	ba.2	PROPN
cuesj-1047	311	16	omicron	omicron	PROPN
cuesj-1047	311	17	infections	infection	NOUN
cuesj-1047	311	18	and	and	CCONJ
cuesj-1047	311	19	severe	severe	ADJ
cuesj-1047	311	20	covid-19	covid-19	PROPN
cuesj-1047	311	21	in	in	ADP
cuesj-1047	311	22	qatar	qatar	PROPN
cuesj-1047	311	23	.	.	PUNCT
cuesj-1047	312	1	medrxiv	medrxiv	PROPN
cuesj-1047	312	2	,	,	PUNCT
cuesj-1047	312	3	2022	2022	NUM
cuesj-1047	312	4	.	.	PUNCT
cuesj-1047	313	1	https://doi.org/10.1101/2022.03.22.22272745	https://doi.org/10.1101/2022.03.22.22272745	PROPN
cuesj-1047	313	2	27	27	NUM
cuesj-1047	313	3	.	.	PUNCT
cuesj-1047	314	1	j.	j.	PROPN
cuesj-1047	314	2	cloete	cloete	PROPN
cuesj-1047	314	3	,	,	PUNCT
cuesj-1047	314	4	a.	a.	PROPN
cuesj-1047	314	5	kruger	kruger	PROPN
cuesj-1047	314	6	,	,	PUNCT
cuesj-1047	314	7	m.	m.	PROPN
cuesj-1047	314	8	masha	masha	PROPN
cuesj-1047	314	9	,	,	PUNCT
cuesj-1047	314	10	n.	n.	PROPN
cuesj-1047	314	11	m.	m.	NOUN
cuesj-1047	314	12	du	du	PROPN
cuesj-1047	314	13	plessis	plessis	PROPN
cuesj-1047	314	14	,	,	PUNCT
cuesj-1047	314	15	d.	d.	PROPN
cuesj-1047	314	16	mawela	mawela	PROPN
cuesj-1047	314	17	,	,	PUNCT
cuesj-1047	314	18	m.	m.	NOUN
cuesj-1047	314	19	tshukudu	tshukudu	PROPN
cuesj-1047	314	20	,	,	PUNCT
cuesj-1047	314	21	t.	t.	NOUN
cuesj-1047	314	22	manyane	manyane	NOUN
cuesj-1047	314	23	,	,	PUNCT
cuesj-1047	314	24	l.	l.	PROPN
cuesj-1047	314	25	komane	komane	PROPN
cuesj-1047	314	26	,	,	PUNCT
cuesj-1047	314	27	m.	m.	NOUN
cuesj-1047	314	28	venter	venter	PROPN
cuesj-1047	314	29	,	,	PUNCT
cuesj-1047	314	30	w.	w.	PROPN
cuesj-1047	314	31	jassat	jassat	PROPN
cuesj-1047	314	32	,	,	PUNCT
cuesj-1047	314	33	a.	a.	NOUN
cuesj-1047	314	34	goga	goga	PROPN
cuesj-1047	314	35	and	and	CCONJ
cuesj-1047	314	36	u.	u.	PROPN
cuesj-1047	314	37	feucht	feucht	PROPN
cuesj-1047	314	38	.	.	PUNCT
cuesj-1047	315	1	rapid	rapid	ADJ
cuesj-1047	315	2	rise	rise	NOUN
cuesj-1047	315	3	in	in	ADP
cuesj-1047	315	4	paediatric	paediatric	ADJ
cuesj-1047	315	5	covid-19	covid-19	PROPN
cuesj-1047	315	6	hospitalisations	hospitalisation	NOUN
cuesj-1047	315	7	during	during	ADP
cuesj-1047	315	8	the	the	DET
cuesj-1047	315	9	early	early	ADJ
cuesj-1047	315	10	stages	stage	NOUN
cuesj-1047	315	11	of	of	ADP
cuesj-1047	315	12	the	the	DET
cuesj-1047	315	13	omicron	omicron	PROPN
cuesj-1047	315	14	wave	wave	NOUN
cuesj-1047	315	15	,	,	PUNCT
cuesj-1047	315	16	tshwane	tshwane	NOUN
cuesj-1047	315	17	district	district	NOUN
cuesj-1047	315	18	,	,	PUNCT
cuesj-1047	315	19	south	south	PROPN
cuesj-1047	315	20	africa	africa	PROPN
cuesj-1047	315	21	.	.	PUNCT
cuesj-1047	316	1	medrxiv	medrxiv	PROPN
cuesj-1047	316	2	,	,	PUNCT
cuesj-1047	316	3	2021	2021	NUM
cuesj-1047	316	4	.	.	PUNCT
cuesj-1047	317	1	https://doi	https://doi	PROPN
cuesj-1047	317	2	.	.	PROPN
cuesj-1047	317	3	org/10.1101/2021.12.21.21268108	org/10.1101/2021.12.21.21268108	PROPN
cuesj-1047	317	4	28	28	NUM
cuesj-1047	317	5	.	.	PUNCT
cuesj-1047	318	1	c.	c.	PROPN
cuesj-1047	318	2	d.	d.	PROPN
cuesj-1047	318	3	de	de	PROPN
cuesj-1047	318	4	luca	luca	PROPN
cuesj-1047	318	5	,	,	PUNCT
cuesj-1047	318	6	e.	e.	PROPN
cuesj-1047	318	7	esposito	esposito	PROPN
cuesj-1047	318	8	,	,	PUNCT
cuesj-1047	318	9	l.	l.	PROPN
cuesj-1047	318	10	cristiani	cristiani	PROPN
cuesj-1047	318	11	,	,	PUNCT
cuesj-1047	318	12	e.	e.	PROPN
cuesj-1047	318	13	mancino	mancino	PROPN
cuesj-1047	318	14	,	,	PUNCT
cuesj-1047	318	15	r.	r.	NOUN
cuesj-1047	318	16	nenna	nenna	NOUN
cuesj-1047	318	17	,	,	PUNCT
cuesj-1047	318	18	e.	e.	PROPN
cuesj-1047	318	19	cortis	cortis	PROPN
cuesj-1047	318	20	and	and	CCONJ
cuesj-1047	318	21	f.	f.	PROPN
cuesj-1047	318	22	midulla	midulla	PROPN
cuesj-1047	318	23	.	.	PUNCT
cuesj-1047	319	1	covid-19	covid-19	PROPN
cuesj-1047	319	2	in	in	ADP
cuesj-1047	319	3	children	child	NOUN
cuesj-1047	319	4	:	:	PUNCT
cuesj-1047	319	5	a	a	DET
cuesj-1047	319	6	brief	brief	ADJ
cuesj-1047	319	7	overview	overview	NOUN
cuesj-1047	319	8	after	after	ADP
cuesj-1047	319	9	three	three	NUM
cuesj-1047	319	10	months	month	NOUN
cuesj-1047	319	11	experience	experience	NOUN
cuesj-1047	319	12	.	.	PUNCT
cuesj-1047	320	1	paediatric	paediatric	ADJ
cuesj-1047	320	2	respiratory	respiratory	ADJ
cuesj-1047	320	3	reviews	review	NOUN
cuesj-1047	320	4	,	,	PUNCT
cuesj-1047	320	5	vol	vol	NOUN
cuesj-1047	320	6	.	.	PROPN
cuesj-1047	320	7	35	35	NUM
cuesj-1047	320	8	,	,	PUNCT
cuesj-1047	320	9	pp	pp	ADJ
cuesj-1047	320	10	.	.	PUNCT
cuesj-1047	321	1	9	9	NUM
cuesj-1047	321	2	-	-	SYM
cuesj-1047	321	3	14	14	NUM
cuesj-1047	321	4	,	,	PUNCT
cuesj-1047	321	5	2020	2020	NUM
cuesj-1047	321	6	.	.	PUNCT
cuesj-1047	322	1	29	29	NUM
cuesj-1047	322	2	.	.	PUNCT
cuesj-1047	323	1	j.	j.	PROPN
cuesj-1047	323	2	cloete	cloete	PROPN
cuesj-1047	323	3	,	,	PUNCT
cuesj-1047	323	4	a.	a.	PROPN
cuesj-1047	323	5	kruger	kruger	PROPN
cuesj-1047	323	6	,	,	PUNCT
cuesj-1047	323	7	m.	m.	PROPN
cuesj-1047	323	8	masha	masha	PROPN
cuesj-1047	323	9	,	,	PUNCT
cuesj-1047	323	10	n.	n.	PROPN
cuesj-1047	323	11	m.	m.	NOUN
cuesj-1047	323	12	du	du	PROPN
cuesj-1047	323	13	plessis	plessis	PROPN
cuesj-1047	323	14	,	,	PUNCT
cuesj-1047	323	15	d.	d.	PROPN
cuesj-1047	323	16	mawela	mawela	PROPN
cuesj-1047	323	17	,	,	PUNCT
cuesj-1047	323	18	m.	m.	NOUN
cuesj-1047	323	19	tshukudu	tshukudu	PROPN
cuesj-1047	323	20	,	,	PUNCT
cuesj-1047	323	21	t.	t.	NOUN
cuesj-1047	323	22	manyane	manyane	NOUN
cuesj-1047	323	23	,	,	PUNCT
cuesj-1047	323	24	l.	l.	PROPN
cuesj-1047	323	25	komane	komane	PROPN
cuesj-1047	323	26	,	,	PUNCT
cuesj-1047	323	27	m.	m.	NOUN
cuesj-1047	323	28	venter	venter	PROPN
cuesj-1047	323	29	,	,	PUNCT
cuesj-1047	323	30	w.	w.	PROPN
cuesj-1047	323	31	jassat	jassat	PROPN
cuesj-1047	323	32	,	,	PUNCT
cuesj-1047	323	33	a.	a.	NOUN
cuesj-1047	323	34	goga	goga	PROPN
cuesj-1047	323	35	and	and	CCONJ
cuesj-1047	323	36	u.	u.	PROPN
cuesj-1047	323	37	feucht	feucht	PROPN
cuesj-1047	323	38	.	.	PUNCT
cuesj-1047	324	1	paediatric	paediatric	ADJ
cuesj-1047	324	2	hospitalisations	hospitalisation	NOUN
cuesj-1047	324	3	due	due	ADP
cuesj-1047	324	4	to	to	ADP
cuesj-1047	324	5	covid-19	covid-19	PROPN
cuesj-1047	324	6	during	during	ADP
cuesj-1047	324	7	the	the	DET
cuesj-1047	324	8	first	first	ADJ
cuesj-1047	324	9	sars	sar	NOUN
cuesj-1047	324	10	-	-	PUNCT
cuesj-1047	324	11	cov-2	cov-2	NOUN
cuesj-1047	324	12	omicron	omicron	NOUN
cuesj-1047	324	13	(	(	PUNCT
cuesj-1047	324	14	b.1.1.529	b.1.1.529	ADV
cuesj-1047	324	15	)	)	PUNCT
cuesj-1047	324	16	variant	variant	ADJ
cuesj-1047	324	17	wave	wave	NOUN
cuesj-1047	324	18	in	in	ADP
cuesj-1047	324	19	south	south	PROPN
cuesj-1047	324	20	africa	africa	PROPN
cuesj-1047	324	21	:	:	PUNCT
cuesj-1047	324	22	a	a	DET
cuesj-1047	324	23	multicentre	multicentre	ADJ
cuesj-1047	324	24	observational	observational	ADJ
cuesj-1047	324	25	study	study	NOUN
cuesj-1047	324	26	.	.	PUNCT
cuesj-1047	325	1	the	the	DET
cuesj-1047	325	2	lancet	lancet	PROPN
cuesj-1047	325	3	child	child	NOUN
cuesj-1047	325	4	and	and	CCONJ
cuesj-1047	325	5	adolescent	adolescent	ADJ
cuesj-1047	325	6	health	health	NOUN
cuesj-1047	325	7	,	,	PUNCT
cuesj-1047	325	8	vol	vol	NOUN
cuesj-1047	325	9	.	.	PROPN
cuesj-1047	325	10	6	6	NUM
cuesj-1047	325	11	,	,	PUNCT
cuesj-1047	325	12	no	no	INTJ
cuesj-1047	325	13	.	.	NOUN
cuesj-1047	325	14	5	5	NUM
cuesj-1047	325	15	,	,	PUNCT
cuesj-1047	325	16	pp	pp	ADJ
cuesj-1047	325	17	.	.	PUNCT
cuesj-1047	326	1	294	294	NUM
cuesj-1047	326	2	-	-	SYM
cuesj-1047	326	3	302	302	NUM
cuesj-1047	326	4	,	,	PUNCT
cuesj-1047	326	5	2022	2022	NUM
cuesj-1047	326	6	.	.	PUNCT
cuesj-1047	327	1	30	30	NUM
cuesj-1047	327	2	.	.	PUNCT
cuesj-1047	328	1	f.	f.	PROPN
cuesj-1047	328	2	grabowski	grabowski	PROPN
cuesj-1047	328	3	,	,	PUNCT
cuesj-1047	328	4	m.	m.	NOUN
cuesj-1047	328	5	kochańczyk	kochańczyk	PROPN
cuesj-1047	328	6	and	and	CCONJ
cuesj-1047	328	7	t.	t.	PROPN
cuesj-1047	328	8	lipniacki	lipniacki	PROPN
cuesj-1047	328	9	.	.	PUNCT
cuesj-1047	329	1	omicron	omicron	PROPN
cuesj-1047	329	2	strain	strain	NOUN
cuesj-1047	329	3	spreads	spread	VERB
cuesj-1047	329	4	with	with	ADP
cuesj-1047	329	5	the	the	DET
cuesj-1047	329	6	doubling	double	VERB
cuesj-1047	329	7	time	time	NOUN
cuesj-1047	329	8	of	of	ADP
cuesj-1047	329	9	3.2	3.2	NUM
cuesj-1047	329	10	-	-	SYM
cuesj-1047	329	11	3.6	3.6	NUM
cuesj-1047	329	12	days	day	NOUN
cuesj-1047	329	13	in	in	ADP
cuesj-1047	329	14	south	south	PROPN
cuesj-1047	329	15	africa	africa	PROPN
cuesj-1047	329	16	province	province	PROPN
cuesj-1047	329	17	of	of	ADP
cuesj-1047	329	18	gauteng	gauteng	PROPN
cuesj-1047	329	19	that	that	PRON
cuesj-1047	329	20	achieved	achieve	VERB
cuesj-1047	329	21	herd	herd	NOUN
cuesj-1047	329	22	immunity	immunity	NOUN
cuesj-1047	329	23	to	to	ADP
cuesj-1047	329	24	delta	delta	PROPN
cuesj-1047	329	25	variant	variant	NOUN
cuesj-1047	329	26	.	.	PUNCT
cuesj-1047	330	1	medrxiv	medrxiv	NOUN
cuesj-1047	330	2	,	,	PUNCT
cuesj-1047	330	3	2021	2021	NUM
cuesj-1047	330	4	.	.	PUNCT
cuesj-1047	331	1	https://doi.org/10.1101/2021.12.08.21267494	https://doi.org/10.1101/2021.12.08.21267494	PROPN
cuesj-1047	331	2	31	31	NUM
cuesj-1047	331	3	.	.	PUNCT
cuesj-1047	331	4	a.	a.	PROPN
cuesj-1047	331	5	f.	f.	PROPN
cuesj-1047	331	6	voor	voor	PROPN
cuesj-1047	331	7	in	in	ADP
cuesj-1047	331	8	‘	'	PUNCT
cuesj-1047	331	9	t	t	PROPN
cuesj-1047	331	10	holt	holt	PROPN
cuesj-1047	331	11	,	,	PUNCT
cuesj-1047	331	12	c.	c.	PROPN
cuesj-1047	331	13	p.	p.	PROPN
cuesj-1047	331	14	haanappel	haanappel	NOUN
cuesj-1047	331	15	,	,	PUNCT
cuesj-1047	331	16	j.	j.	PROPN
cuesj-1047	331	17	rahamat	rahamat	PROPN
cuesj-1047	331	18	-	-	PUNCT
cuesj-1047	331	19	langendoen	langendoen	NOUN
cuesj-1047	331	20	,	,	PUNCT
cuesj-1047	331	21	r.	r.	PROPN
cuesj-1047	331	22	molenkamp	molenkamp	PROPN
cuesj-1047	331	23	,	,	PUNCT
cuesj-1047	331	24	e.	e.	PROPN
cuesj-1047	331	25	van	van	PROPN
cuesj-1047	331	26	nood	nood	PROPN
cuesj-1047	331	27	,	,	PUNCT
cuesj-1047	331	28	l.	l.	PROPN
cuesj-1047	331	29	m.	m.	PROPN
cuesj-1047	331	30	van	van	PROPN
cuesj-1047	331	31	den	den	PROPN
cuesj-1047	331	32	toorn	toorn	PROPN
cuesj-1047	331	33	,	,	PUNCT
cuesj-1047	331	34	r.	r.	PROPN
cuesj-1047	331	35	p.	p.	PROPN
cuesj-1047	331	36	peeters	peeters	PROPN
cuesj-1047	331	37	,	,	PUNCT
cuesj-1047	331	38	a.	a.	PROPN
cuesj-1047	331	39	m.	m.	PROPN
cuesj-1047	331	40	c.	c.	PROPN
cuesj-1047	331	41	van	van	PROPN
cuesj-1047	331	42	rossum	rossum	PROPN
cuesj-1047	331	43	and	and	CCONJ
cuesj-1047	331	44	j.	j.	PROPN
cuesj-1047	331	45	a.	a.	PROPN
cuesj-1047	331	46	severin	severin	PROPN
cuesj-1047	331	47	.	.	PUNCT
cuesj-1047	332	1	admissions	admission	NOUN
cuesj-1047	332	2	to	to	ADP
cuesj-1047	332	3	a	a	DET
cuesj-1047	332	4	large	large	ADJ
cuesj-1047	332	5	tertiary	tertiary	ADJ
cuesj-1047	332	6	care	care	NOUN
cuesj-1047	332	7	hospital	hospital	NOUN
cuesj-1047	332	8	and	and	CCONJ
cuesj-1047	332	9	omicron	omicron	PROPN
cuesj-1047	332	10	ba.1	ba.1	PROPN
cuesj-1047	332	11	and	and	CCONJ
cuesj-1047	332	12	ba.2	ba.2	PROPN
cuesj-1047	332	13	sars	sar	NOUN
cuesj-1047	332	14	-	-	PUNCT
cuesj-1047	332	15	cov-2	cov-2	NOUN
cuesj-1047	332	16	polymerase	polymerase	NOUN
cuesj-1047	332	17	chain	chain	NOUN
cuesj-1047	332	18	reaction	reaction	NOUN
cuesj-1047	332	19	positivity	positivity	NOUN
cuesj-1047	332	20	:	:	PUNCT
cuesj-1047	332	21	primary	primary	ADJ
cuesj-1047	332	22	,	,	PUNCT
cuesj-1047	332	23	contributing	contributing	NOUN
cuesj-1047	332	24	,	,	PUNCT
cuesj-1047	332	25	or	or	CCONJ
cuesj-1047	332	26	incidental	incidental	ADJ
cuesj-1047	332	27	covid-19	covid-19	PROPN
cuesj-1047	332	28	.	.	PUNCT
cuesj-1047	332	29	international	international	PROPN
cuesj-1047	332	30	journal	journal	NOUN
cuesj-1047	332	31	of	of	ADP
cuesj-1047	332	32	infectious	infectious	ADJ
cuesj-1047	332	33	diseases	disease	NOUN
cuesj-1047	332	34	,	,	PUNCT
cuesj-1047	332	35	vol	vol	NOUN
cuesj-1047	332	36	.	.	PROPN
cuesj-1047	332	37	122	122	NUM
cuesj-1047	332	38	,	,	PUNCT
cuesj-1047	332	39	pp	pp	ADJ
cuesj-1047	332	40	.	.	PUNCT
cuesj-1047	333	1	665	665	NUM
cuesj-1047	333	2	-	-	SYM
cuesj-1047	333	3	668	668	NUM
cuesj-1047	333	4	,	,	PUNCT
cuesj-1047	333	5	2022	2022	NUM
cuesj-1047	333	6	.	.	PUNCT
cuesj-1047	334	1	32	32	NUM
cuesj-1047	334	2	.	.	PUNCT
cuesj-1047	334	3	r.	r.	PROPN
cuesj-1047	334	4	grewal	grewal	PROPN
cuesj-1047	334	5	,	,	PUNCT
cuesj-1047	334	6	s.	s.	PROPN
cuesj-1047	334	7	a.	a.	PROPN
cuesj-1047	334	8	kitchen	kitchen	PROPN
cuesj-1047	334	9	,	,	PUNCT
cuesj-1047	334	10	l.	l.	PROPN
cuesj-1047	334	11	nguyen	nguyen	PROPN
cuesj-1047	334	12	,	,	PUNCT
cuesj-1047	334	13	s.	s.	PROPN
cuesj-1047	334	14	a.	a.	PROPN
cuesj-1047	334	15	buchan	buchan	PROPN
cuesj-1047	334	16	,	,	PUNCT
cuesj-1047	334	17	s.	s.	PROPN
cuesj-1047	334	18	e.	e.	PROPN
cuesj-1047	334	19	wilson	wilson	PROPN
cuesj-1047	334	20	,	,	PUNCT
cuesj-1047	334	21	a.	a.	PROPN
cuesj-1047	334	22	p.	p.	PROPN
cuesj-1047	334	23	costa	costa	PROPN
cuesj-1047	334	24	and	and	CCONJ
cuesj-1047	334	25	j.	j.	PROPN
cuesj-1047	334	26	c.	c.	PROPN
cuesj-1047	334	27	kwong	kwong	PROPN
cuesj-1047	334	28	.	.	PUNCT
cuesj-1047	335	1	effectiveness	effectiveness	NOUN
cuesj-1047	335	2	of	of	ADP
cuesj-1047	335	3	a	a	DET
cuesj-1047	335	4	fourth	fourth	ADJ
cuesj-1047	335	5	dose	dose	NOUN
cuesj-1047	335	6	of	of	ADP
cuesj-1047	335	7	covid-19	covid-19	PROPN
cuesj-1047	335	8	mrna	mrna	PROPN
cuesj-1047	335	9	vaccine	vaccine	NOUN
cuesj-1047	335	10	against	against	ADP
cuesj-1047	335	11	the	the	DET
cuesj-1047	335	12	omicron	omicron	PROPN
cuesj-1047	335	13	variant	variant	NOUN
cuesj-1047	335	14	among	among	ADP
cuesj-1047	335	15	long	long	ADJ
cuesj-1047	335	16	term	term	NOUN
cuesj-1047	335	17	care	care	NOUN
cuesj-1047	335	18	residents	resident	NOUN
cuesj-1047	335	19	in	in	ADP
cuesj-1047	335	20	ontario	ontario	PROPN
cuesj-1047	335	21	,	,	PUNCT
cuesj-1047	335	22	canada	canada	PROPN
cuesj-1047	335	23	:	:	PUNCT
cuesj-1047	335	24	test	test	NOUN
cuesj-1047	335	25	negative	negative	ADJ
cuesj-1047	335	26	design	design	NOUN
cuesj-1047	335	27	study	study	NOUN
cuesj-1047	335	28	.	.	PUNCT
cuesj-1047	336	1	bmj	bmj	PROPN
cuesj-1047	336	2	,	,	PUNCT
cuesj-1047	336	3	vol	vol	NOUN
cuesj-1047	336	4	.	.	PROPN
cuesj-1047	336	5	378	378	NUM
cuesj-1047	336	6	,	,	PUNCT
cuesj-1047	336	7	p.	p.	NOUN
cuesj-1047	336	8	e071502	e071502	PROPN
cuesj-1047	336	9	,	,	PUNCT
cuesj-1047	336	10	2022	2022	NUM
cuesj-1047	336	11	.	.	PUNCT
cuesj-1047	337	1	33	33	NUM
cuesj-1047	337	2	.	.	PUNCT
cuesj-1047	338	1	j.	j.	PROPN
cuesj-1047	338	2	t.	t.	PROPN
cuesj-1047	338	3	solera	solera	PROPN
cuesj-1047	338	4	,	,	PUNCT
cuesj-1047	338	5	b.	b.	PROPN
cuesj-1047	338	6	g.	g.	PROPN
cuesj-1047	338	7	árbol	árbol	PROPN
cuesj-1047	338	8	,	,	PUNCT
cuesj-1047	338	9	a.	a.	NOUN
cuesj-1047	338	10	alshahrani	alshahrani	PROPN
cuesj-1047	338	11	,	,	PUNCT
cuesj-1047	338	12	i.	i.	PROPN
cuesj-1047	338	13	bahinskaya	bahinskaya	PROPN
cuesj-1047	338	14	,	,	PUNCT
cuesj-1047	338	15	n.	n.	PROPN
cuesj-1047	338	16	marks	marks	PROPN
cuesj-1047	338	17	,	,	PUNCT
cuesj-1047	338	18	a.	a.	PROPN
cuesj-1047	338	19	humar	humar	PROPN
cuesj-1047	338	20	and	and	CCONJ
cuesj-1047	338	21	d.	d.	PROPN
cuesj-1047	338	22	kumar	kumar	PROPN
cuesj-1047	338	23	.	.	PROPN
cuesj-1047	339	1	impact	impact	NOUN
cuesj-1047	339	2	of	of	ADP
cuesj-1047	339	3	vaccination	vaccination	NOUN
cuesj-1047	339	4	and	and	CCONJ
cuesj-1047	339	5	early	early	ADJ
cuesj-1047	339	6	monoclonal	monoclonal	NOUN
cuesj-1047	339	7	antibody	antibody	NOUN
cuesj-1047	339	8	therapy	therapy	NOUN
cuesj-1047	339	9	on	on	ADP
cuesj-1047	339	10	coronavirus	coronavirus	NOUN
cuesj-1047	339	11	disease	disease	NOUN
cuesj-1047	339	12	2019	2019	NUM
cuesj-1047	339	13	outcomes	outcome	NOUN
cuesj-1047	339	14	in	in	ADP
cuesj-1047	339	15	organ	organ	NOUN
cuesj-1047	339	16	transplant	transplant	NOUN
cuesj-1047	339	17	recipients	recipient	NOUN
cuesj-1047	339	18	during	during	ADP
cuesj-1047	339	19	the	the	DET
cuesj-1047	339	20	omicron	omicron	PROPN
cuesj-1047	339	21	wave	wave	NOUN
cuesj-1047	339	22	.	.	PUNCT
cuesj-1047	340	1	clinical	clinical	ADJ
cuesj-1047	340	2	infectious	infectious	ADJ
cuesj-1047	340	3	diseases	disease	NOUN
cuesj-1047	340	4	,	,	PUNCT
cuesj-1047	340	5	vol	vol	NOUN
cuesj-1047	340	6	.	.	PROPN
cuesj-1047	341	1	75	75	NUM
cuesj-1047	341	2	,	,	PUNCT
cuesj-1047	341	3	no	no	INTJ
cuesj-1047	341	4	.	.	NOUN
cuesj-1047	341	5	12	12	NUM
cuesj-1047	341	6	,	,	PUNCT
cuesj-1047	341	7	pp	pp	ADJ
cuesj-1047	341	8	.	.	PUNCT
cuesj-1047	341	9	2193	2193	NUM
cuesj-1047	341	10	-	-	SYM
cuesj-1047	341	11	2200	2200	NUM
cuesj-1047	341	12	,	,	PUNCT
cuesj-1047	341	13	2022	2022	NUM
cuesj-1047	341	14	.	.	PUNCT
cuesj-1047	342	1	34	34	NUM
cuesj-1047	342	2	.	.	PUNCT
cuesj-1047	342	3	m.	m.	PROPN
cuesj-1047	342	4	e.	e.	PROPN
cuesj-1047	342	5	modes	modes	PROPN
cuesj-1047	342	6	,	,	PUNCT
cuesj-1047	342	7	m.	m.	NOUN
cuesj-1047	342	8	p.	p.	PROPN
cuesj-1047	342	9	directo	directo	PROPN
cuesj-1047	342	10	,	,	PUNCT
cuesj-1047	342	11	m.	m.	NOUN
cuesj-1047	342	12	melgar	melgar	PROPN
cuesj-1047	342	13	,	,	PUNCT
cuesj-1047	342	14	l.	l.	PROPN
cuesj-1047	342	15	r.	r.	PROPN
cuesj-1047	342	16	johnson	johnson	PROPN
cuesj-1047	342	17	,	,	PUNCT
cuesj-1047	342	18	h.	h.	PROPN
cuesj-1047	342	19	yang	yang	PROPN
cuesj-1047	342	20	,	,	PUNCT
cuesj-1047	342	21	p.	p.	PROPN
cuesj-1047	342	22	chaudhary	chaudhary	PROPN
cuesj-1047	342	23	,	,	PUNCT
cuesj-1047	342	24	s.	s.	PROPN
cuesj-1047	342	25	bartolini	bartolini	PROPN
cuesj-1047	342	26	,	,	PUNCT
cuesj-1047	342	27	n.	n.	PROPN
cuesj-1047	342	28	kho	kho	PROPN
cuesj-1047	342	29	,	,	PUNCT
cuesj-1047	342	30	p.	p.	PROPN
cuesj-1047	342	31	w.	w.	PROPN
cuesj-1047	342	32	noble	noble	PROPN
cuesj-1047	342	33	,	,	PUNCT
cuesj-1047	342	34	s.	s.	PROPN
cuesj-1047	342	35	isonaka	isonaka	PROPN
cuesj-1047	342	36	and	and	CCONJ
cuesj-1047	342	37	p.	p.	PROPN
cuesj-1047	342	38	chen	chen	PROPN
cuesj-1047	342	39	.	.	PUNCT
cuesj-1047	343	1	clinical	clinical	ADJ
cuesj-1047	343	2	characteristics	characteristic	NOUN
cuesj-1047	343	3	and	and	CCONJ
cuesj-1047	343	4	outcomes	outcome	NOUN
cuesj-1047	343	5	among	among	ADP
cuesj-1047	343	6	adults	adult	NOUN
cuesj-1047	343	7	hospitalized	hospitalize	VERB
cuesj-1047	343	8	with	with	ADP
cuesj-1047	343	9	laboratory	laboratory	NOUN
cuesj-1047	343	10	-	-	PUNCT
cuesj-1047	343	11	confirmed	confirm	VERB
cuesj-1047	343	12	sars	sar	NOUN
cuesj-1047	343	13	-	-	PUNCT
cuesj-1047	343	14	cov-2	cov-2	PART
cuesj-1047	343	15	infection	infection	NOUN
cuesj-1047	343	16	during	during	ADP
cuesj-1047	343	17	periods	period	NOUN
cuesj-1047	343	18	of	of	ADP
cuesj-1047	343	19	b.1.617.2	b.1.617.2	PROPN
cuesj-1047	343	20	(	(	PUNCT
cuesj-1047	343	21	delta	delta	NOUN
cuesj-1047	343	22	)	)	PUNCT
cuesj-1047	343	23	and	and	CCONJ
cuesj-1047	343	24	b.1.1.529	b.1.1.529	ADV
cuesj-1047	343	25	(	(	PUNCT
cuesj-1047	343	26	omicron	omicron	PROPN
cuesj-1047	343	27	)	)	PUNCT
cuesj-1047	343	28	variant	variant	ADJ
cuesj-1047	343	29	predominance	predominance	NOUN
cuesj-1047	343	30	-	-	PUNCT
cuesj-1047	343	31	one	one	NUM
cuesj-1047	343	32	hospital	hospital	NOUN
cuesj-1047	343	33	,	,	PUNCT
cuesj-1047	343	34	california	california	PROPN
cuesj-1047	343	35	,	,	PUNCT
cuesj-1047	343	36	july	july	PROPN
cuesj-1047	343	37	15	15	NUM
cuesj-1047	343	38	-	-	SYM
cuesj-1047	343	39	september	september	PROPN
cuesj-1047	343	40	23	23	NUM
cuesj-1047	343	41	,	,	PUNCT
cuesj-1047	343	42	2021	2021	NUM
cuesj-1047	343	43	,	,	PUNCT
cuesj-1047	343	44	and	and	CCONJ
cuesj-1047	343	45	december	december	PROPN
cuesj-1047	343	46	21	21	NUM
cuesj-1047	343	47	,	,	PUNCT
cuesj-1047	343	48	2021	2021	NUM
cuesj-1047	343	49	-	-	SYM
cuesj-1047	343	50	january	january	PROPN
cuesj-1047	343	51	27	27	NUM
cuesj-1047	343	52	,	,	PUNCT
cuesj-1047	343	53	2022	2022	NUM
cuesj-1047	343	54	.	.	PUNCT
cuesj-1047	344	1	morbidity	morbidity	NOUN
cuesj-1047	344	2	and	and	CCONJ
cuesj-1047	344	3	mortality	mortality	NOUN
cuesj-1047	344	4	weekly	weekly	ADJ
cuesj-1047	344	5	report	report	NOUN
cuesj-1047	344	6	,	,	PUNCT
cuesj-1047	344	7	vol	vol	NOUN
cuesj-1047	344	8	.	.	PROPN
cuesj-1047	344	9	71	71	NUM
cuesj-1047	344	10	,	,	PUNCT
cuesj-1047	344	11	no	no	INTJ
cuesj-1047	344	12	.	.	NOUN
cuesj-1047	344	13	6	6	NUM
cuesj-1047	344	14	,	,	PUNCT
cuesj-1047	344	15	pp	pp	ADJ
cuesj-1047	344	16	.	.	PUNCT
cuesj-1047	345	1	217	217	NUM
cuesj-1047	345	2	-	-	SYM
cuesj-1047	345	3	223	223	NUM
cuesj-1047	345	4	,	,	PUNCT
cuesj-1047	345	5	2022	2022	NUM
cuesj-1047	345	6	.	.	PUNCT
cuesj-1047	346	1	35	35	NUM
cuesj-1047	346	2	.	.	PUNCT
cuesj-1047	347	1	d.	d.	PROPN
cuesj-1047	347	2	r.	r.	PROPN
cuesj-1047	347	3	feikin	feikin	PROPN
cuesj-1047	347	4	,	,	PUNCT
cuesj-1047	347	5	l.	l.	PROPN
cuesj-1047	347	6	j.	j.	PROPN
cuesj-1047	347	7	abu	abu	PROPN
cuesj-1047	347	8	-	-	PUNCT
cuesj-1047	347	9	raddad	raddad	PROPN
cuesj-1047	347	10	,	,	PUNCT
cuesj-1047	347	11	n.	n.	PROPN
cuesj-1047	347	12	andrews	andrews	PROPN
cuesj-1047	347	13	,	,	PUNCT
cuesj-1047	347	14	m.	m.	NOUN
cuesj-1047	347	15	a.	a.	NOUN
cuesj-1047	347	16	davies	davy	NOUN
cuesj-1047	347	17	,	,	PUNCT
cuesj-1047	347	18	m.	m.	NOUN
cuesj-1047	347	19	m.	m.	PROPN
cuesj-1047	347	20	higdon	higdon	PROPN
cuesj-1047	347	21	,	,	PUNCT
cuesj-1047	347	22	w.	w.	PROPN
cuesj-1047	347	23	a.	a.	PROPN
cuesj-1047	347	24	orenstein	orenstein	PROPN
cuesj-1047	347	25	and	and	CCONJ
cuesj-1047	347	26	m.	m.	PROPN
cuesj-1047	347	27	k.	k.	PROPN
cuesj-1047	347	28	patel	patel	PROPN
cuesj-1047	347	29	.	.	PUNCT
cuesj-1047	348	1	assessing	assess	VERB
cuesj-1047	348	2	vaccine	vaccine	NOUN
cuesj-1047	348	3	effectiveness	effectiveness	NOUN
cuesj-1047	348	4	against	against	ADP
cuesj-1047	348	5	severe	severe	ADJ
cuesj-1047	348	6	covid-19	covid-19	PROPN
cuesj-1047	348	7	disease	disease	NOUN
cuesj-1047	348	8	caused	cause	VERB
cuesj-1047	348	9	by	by	ADP
cuesj-1047	348	10	omicron	omicron	PROPN
cuesj-1047	348	11	variant	variant	NOUN
cuesj-1047	348	12	.	.	PUNCT
cuesj-1047	349	1	report	report	NOUN
cuesj-1047	349	2	from	from	ADP
cuesj-1047	349	3	a	a	DET
cuesj-1047	349	4	meeting	meeting	NOUN
cuesj-1047	349	5	of	of	ADP
cuesj-1047	349	6	the	the	DET
cuesj-1047	349	7	world	world	PROPN
cuesj-1047	349	8	health	health	PROPN
cuesj-1047	349	9	organization	organization	PROPN
cuesj-1047	349	10	.	.	PUNCT
cuesj-1047	350	1	vaccine	vaccine	NOUN
cuesj-1047	350	2	,	,	PUNCT
cuesj-1047	350	3	vol	vol	NOUN
cuesj-1047	350	4	.	.	PROPN
cuesj-1047	350	5	40	40	NUM
cuesj-1047	350	6	,	,	PUNCT
cuesj-1047	350	7	no	no	INTJ
cuesj-1047	350	8	.	.	NOUN
cuesj-1047	350	9	26	26	NUM
cuesj-1047	350	10	,	,	PUNCT
cuesj-1047	350	11	pp	pp	ADJ
cuesj-1047	350	12	.	.	PUNCT
cuesj-1047	351	1	3516	3516	NUM
cuesj-1047	351	2	-	-	SYM
cuesj-1047	351	3	3527	3527	NUM
cuesj-1047	351	4	,	,	PUNCT
cuesj-1047	351	5	2022	2022	NUM
cuesj-1047	351	6	.	.	PUNCT
cuesj-1047	352	1	36	36	NUM
cuesj-1047	352	2	.	.	PUNCT
cuesj-1047	352	3	e.	e.	PROPN
cuesj-1047	352	4	schuit	schuit	PROPN
cuesj-1047	352	5	,	,	PUNCT
cuesj-1047	352	6	r.	r.	PROPN
cuesj-1047	352	7	p.	p.	PROPN
cuesj-1047	352	8	venekamp	venekamp	PROPN
cuesj-1047	352	9	,	,	PUNCT
cuesj-1047	352	10	l.	l.	PROPN
cuesj-1047	352	11	hooft	hooft	PROPN
cuesj-1047	352	12	,	,	PUNCT
cuesj-1047	352	13	i.	i.	PROPN
cuesj-1047	352	14	k.	k.	PROPN
cuesj-1047	352	15	veldhuijzen	veldhuijzen	PROPN
cuesj-1047	352	16	,	,	PUNCT
cuesj-1047	352	17	w.	w.	PROPN
cuesj-1047	352	18	van	van	PROPN
cuesj-1047	352	19	den	den	PROPN
cuesj-1047	352	20	bijllaardt	bijllaardt	PROPN
cuesj-1047	352	21	,	,	PUNCT
cuesj-1047	352	22	s.	s.	PROPN
cuesj-1047	352	23	d.	d.	PROPN
cuesj-1047	352	24	pas	pas	PROPN
cuesj-1047	352	25	,	,	PUNCT
cuesj-1047	352	26	v.	v.	PROPN
cuesj-1047	352	27	f.	f.	PROPN
cuesj-1047	352	28	zwart	zwart	PROPN
cuesj-1047	352	29	,	,	PUNCT
cuesj-1047	352	30	e.	e.	PROPN
cuesj-1047	352	31	b.	b.	PROPN
cuesj-1047	352	32	lodder	lodder	PROPN
cuesj-1047	352	33	,	,	PUNCT
cuesj-1047	352	34	m.	m.	NOUN
cuesj-1047	352	35	hellwich	hellwich	PROPN
cuesj-1047	352	36	,	,	PUNCT
cuesj-1047	352	37	m.	m.	NOUN
cuesj-1047	352	38	koppelman	koppelman	PROPN
cuesj-1047	352	39	,	,	PUNCT
cuesj-1047	352	40	r.	r.	PROPN
cuesj-1047	352	41	molenkamp	molenkamp	PROPN
cuesj-1047	352	42	,	,	PUNCT
cuesj-1047	352	43	c.	c.	PROPN
cuesj-1047	352	44	j.	j.	PROPN
cuesj-1047	352	45	h.	h.	PROPN
cuesj-1047	352	46	wijers	wijers	PROPN
cuesj-1047	352	47	,	,	PUNCT
cuesj-1047	352	48	i.	i.	PROPN
cuesj-1047	352	49	h.	h.	PROPN
cuesj-1047	352	50	vroom	vroom	PROPN
cuesj-1047	352	51	,	,	PUNCT
cuesj-1047	352	52	l.	l.	PROPN
cuesj-1047	352	53	c.	c.	PROPN
cuesj-1047	352	54	smeets	smeet	NOUN
cuesj-1047	352	55	,	,	PUNCT
cuesj-1047	352	56	c.	c.	PROPN
cuesj-1047	352	57	r.	r.	PROPN
cuesj-1047	352	58	s.	s.	PROPN
cuesj-1047	352	59	nagel	nagel	PROPN
cuesj-1047	352	60	-	-	PUNCT
cuesj-1047	352	61	imming	imming	PROPN
cuesj-1047	352	62	,	,	PUNCT
cuesj-1047	352	63	w.	w.	PROPN
cuesj-1047	352	64	g.	g.	PROPN
cuesj-1047	352	65	h.	h.	PROPN
cuesj-1047	352	66	han	han	PROPN
cuesj-1047	352	67	,	,	PUNCT
cuesj-1047	352	68	s.	s.	PROPN
cuesj-1047	352	69	van	van	PROPN
cuesj-1047	352	70	den	den	PROPN
cuesj-1047	352	71	hof	hof	PROPN
cuesj-1047	352	72	,	,	PUNCT
cuesj-1047	352	73	j.	j.	PROPN
cuesj-1047	352	74	a.	a.	PROPN
cuesj-1047	352	75	j.	j.	PROPN
cuesj-1047	352	76	w.	w.	PROPN
cuesj-1047	352	77	kluytmans	kluytmans	PROPN
cuesj-1047	352	78	,	,	PUNCT
cuesj-1047	352	79	j.	j.	PROPN
cuesj-1047	352	80	h.	h.	PROPN
cuesj-1047	352	81	h.	h.	PROPN
cuesj-1047	352	82	m.	m.	PROPN
cuesj-1047	352	83	van	van	PROPN
cuesj-1047	352	84	de	de	X
cuesj-1047	352	85	wijgert	wijgert	PROPN
cuesj-1047	352	86	and	and	CCONJ
cuesj-1047	352	87	k.	k.	PROPN
cuesj-1047	352	88	g.	g.	PROPN
cuesj-1047	352	89	m.	m.	PROPN
cuesj-1047	352	90	moons	moon	NOUN
cuesj-1047	352	91	.	.	PUNCT
cuesj-1047	353	1	diagnostic	diagnostic	ADJ
cuesj-1047	353	2	accuracy	accuracy	NOUN
cuesj-1047	353	3	of	of	ADP
cuesj-1047	353	4	covid-19	covid-19	PROPN
cuesj-1047	353	5	rapid	rapid	ADJ
cuesj-1047	353	6	antigen	antigen	NOUN
cuesj-1047	353	7	tests	test	NOUN
cuesj-1047	353	8	with	with	ADP
cuesj-1047	353	9	unsupervised	unsupervised	ADJ
cuesj-1047	353	10	self	self	NOUN
cuesj-1047	353	11	-	-	PUNCT
cuesj-1047	353	12	sampling	sampling	NOUN
cuesj-1047	353	13	in	in	ADP
cuesj-1047	353	14	people	people	NOUN
cuesj-1047	353	15	with	with	ADP
cuesj-1047	353	16	symptoms	symptom	NOUN
cuesj-1047	353	17	in	in	ADP
cuesj-1047	353	18	the	the	DET
cuesj-1047	353	19	omicron	omicron	PROPN
cuesj-1047	353	20	period	period	NOUN
cuesj-1047	353	21	:	:	PUNCT
cuesj-1047	353	22	cross	cross	VERB
cuesj-1047	353	23	sectional	sectional	ADJ
cuesj-1047	353	24	study	study	NOUN
cuesj-1047	353	25	.	.	PUNCT
cuesj-1047	354	1	bmj	bmj	PROPN
cuesj-1047	354	2	,	,	PUNCT
cuesj-1047	354	3	vol	vol	NOUN
cuesj-1047	354	4	.	.	PROPN
cuesj-1047	354	5	378	378	NUM
cuesj-1047	354	6	,	,	PUNCT
cuesj-1047	354	7	p.	p.	NOUN
cuesj-1047	354	8	e071215	e071215	NOUN
cuesj-1047	354	9	,	,	PUNCT
cuesj-1047	354	10	2022	2022	NUM
cuesj-1047	354	11	.	.	PUNCT
cuesj-1047	355	1	37	37	NUM
cuesj-1047	355	2	.	.	PUNCT
cuesj-1047	355	3	m.	m.	NOUN
cuesj-1047	355	4	risk	risk	NOUN
cuesj-1047	355	5	,	,	PUNCT
cuesj-1047	355	6	s.	s.	PROPN
cuesj-1047	355	7	s.	s.	PROPN
cuesj-1047	355	8	hayek	hayek	PROPN
cuesj-1047	355	9	,	,	PUNCT
cuesj-1047	355	10	e.	e.	PROPN
cuesj-1047	355	11	schiopu	schiopu	PROPN
cuesj-1047	355	12	,	,	PUNCT
cuesj-1047	355	13	l.	l.	PROPN
cuesj-1047	355	14	yuan	yuan	PROPN
cuesj-1047	355	15	,	,	PUNCT
cuesj-1047	355	16	c.	c.	PROPN
cuesj-1047	355	17	shen	shen	PROPN
cuesj-1047	355	18	,	,	PUNCT
cuesj-1047	355	19	x.	x.	PROPN
cuesj-1047	355	20	shi	shi	PROPN
cuesj-1047	355	21	,	,	PUNCT
cuesj-1047	355	22	g.	g.	PROPN
cuesj-1047	355	23	freed	free	VERB
cuesj-1047	355	24	and	and	CCONJ
cuesj-1047	355	25	l.	l.	PROPN
cuesj-1047	355	26	zhao	zhao	PROPN
cuesj-1047	355	27	.	.	PUNCT
cuesj-1047	356	1	covid-19	covid-19	PROPN
cuesj-1047	356	2	vaccine	vaccine	NOUN
cuesj-1047	356	3	effectiveness	effectiveness	NOUN
cuesj-1047	356	4	against	against	ADP
cuesj-1047	356	5	omicron	omicron	PROPN
cuesj-1047	356	6	(	(	PUNCT
cuesj-1047	356	7	b.1.1.529	b.1.1.529	ADV
cuesj-1047	356	8	)	)	PUNCT
cuesj-1047	356	9	variant	variant	ADJ
cuesj-1047	356	10	infection	infection	NOUN
cuesj-1047	356	11	and	and	CCONJ
cuesj-1047	356	12	hospitalisation	hospitalisation	NOUN
cuesj-1047	356	13	in	in	ADP
cuesj-1047	356	14	patients	patient	NOUN
cuesj-1047	356	15	taking	take	VERB
cuesj-1047	356	16	immunosuppressive	immunosuppressive	ADJ
cuesj-1047	356	17	medications	medication	NOUN
cuesj-1047	356	18	:	:	PUNCT
cuesj-1047	356	19	a	a	DET
cuesj-1047	356	20	retrospective	retrospective	ADJ
cuesj-1047	356	21	cohort	cohort	NOUN
cuesj-1047	356	22	study	study	NOUN
cuesj-1047	356	23	.	.	PUNCT
cuesj-1047	357	1	the	the	DET
cuesj-1047	357	2	lancet	lancet	PROPN
cuesj-1047	357	3	rheumatology	rheumatology	NOUN
cuesj-1047	357	4	,	,	PUNCT
cuesj-1047	357	5	vol	vol	NOUN
cuesj-1047	357	6	.	.	PROPN
cuesj-1047	357	7	4	4	NUM
cuesj-1047	357	8	,	,	PUNCT
cuesj-1047	357	9	no	no	INTJ
cuesj-1047	357	10	.	.	NOUN
cuesj-1047	357	11	11	11	NUM
cuesj-1047	357	12	,	,	PUNCT
cuesj-1047	357	13	pp	pp	ADJ
cuesj-1047	357	14	.	.	PUNCT
cuesj-1047	358	1	e775	e775	PROPN
cuesj-1047	358	2	-	-	PUNCT
cuesj-1047	358	3	e784	e784	PROPN
cuesj-1047	358	4	,	,	PUNCT
cuesj-1047	358	5	2022	2022	NUM
cuesj-1047	358	6	.	.	PUNCT
cuesj-1047	359	1	38	38	NUM
cuesj-1047	359	2	.	.	PUNCT
cuesj-1047	359	3	i.	i.	PROPN
cuesj-1047	359	4	l.	l.	PROPN
cuesj-1047	359	5	ward	ward	PROPN
cuesj-1047	359	6	,	,	PUNCT
cuesj-1047	359	7	c.	c.	PROPN
cuesj-1047	359	8	bermingham	bermingham	PROPN
cuesj-1047	359	9	,	,	PUNCT
cuesj-1047	359	10	d.	d.	PROPN
cuesj-1047	359	11	ayoubkhani	ayoubkhani	PROPN
cuesj-1047	359	12	,	,	PUNCT
cuesj-1047	359	13	o.	o.	PROPN
cuesj-1047	359	14	j.	j.	PROPN
cuesj-1047	359	15	gethings	gethings	PROPN
cuesj-1047	359	16	,	,	PUNCT
cuesj-1047	359	17	k.	k.	PROPN
cuesj-1047	359	18	b.	b.	PROPN
cuesj-1047	359	19	pouwels	pouwels	PROPN
cuesj-1047	359	20	,	,	PUNCT
cuesj-1047	359	21	t.	t.	PROPN
cuesj-1047	359	22	yates	yates	PROPN
cuesj-1047	359	23	,	,	PUNCT
cuesj-1047	359	24	k.	k.	PROPN
cuesj-1047	359	25	khunti	khunti	PROPN
cuesj-1047	359	26	,	,	PUNCT
cuesj-1047	359	27	j.	j.	PROPN
cuesj-1047	359	28	hippisley	hippisley	PROPN
cuesj-1047	359	29	-	-	PUNCT
cuesj-1047	359	30	cox	cox	PROPN
cuesj-1047	359	31	,	,	PUNCT
cuesj-1047	359	32	a.	a.	NOUN
cuesj-1047	359	33	banerjee	banerjee	PROPN
cuesj-1047	359	34	,	,	PUNCT
cuesj-1047	359	35	a.	a.	PROPN
cuesj-1047	359	36	s.	s.	PROPN
cuesj-1047	359	37	walker	walker	PROPN
cuesj-1047	359	38	and	and	CCONJ
cuesj-1047	359	39	v.	v.	ADP
cuesj-1047	359	40	nafilyan	nafilyan	ADJ
cuesj-1047	359	41	.	.	PUNCT
cuesj-1047	360	1	risk	risk	NOUN
cuesj-1047	360	2	of	of	ADP
cuesj-1047	360	3	covid-19	covid-19	PROPN
cuesj-1047	360	4	related	related	ADJ
cuesj-1047	360	5	deaths	death	NOUN
cuesj-1047	360	6	for	for	ADP
cuesj-1047	360	7	sarscov-2	sarscov-2	NUM
cuesj-1047	360	8	omicron	omicron	PROPN
cuesj-1047	360	9	(	(	PUNCT
cuesj-1047	360	10	b.1.1.529	b.1.1.529	ADV
cuesj-1047	360	11	)	)	PUNCT
cuesj-1047	360	12	compared	compare	VERB
cuesj-1047	360	13	with	with	ADP
cuesj-1047	360	14	delta	delta	NOUN
cuesj-1047	360	15	(	(	PUNCT
cuesj-1047	360	16	b.1.617.2	b.1.617.2	PROPN
cuesj-1047	360	17	):	):	PUNCT
cuesj-1047	360	18	retrospective	retrospective	ADJ
cuesj-1047	360	19	cohort	cohort	NOUN
cuesj-1047	360	20	study	study	NOUN
cuesj-1047	360	21	.	.	PUNCT
cuesj-1047	361	1	bmj	bmj	PROPN
cuesj-1047	361	2	,	,	PUNCT
cuesj-1047	361	3	vol	vol	NOUN
cuesj-1047	361	4	.	.	PROPN
cuesj-1047	361	5	378	378	NUM
cuesj-1047	361	6	,	,	PUNCT
cuesj-1047	361	7	p.	p.	NOUN
cuesj-1047	361	8	e070695	e070695	NOUN
cuesj-1047	361	9	,	,	PUNCT
cuesj-1047	361	10	2022	2022	NUM
cuesj-1047	361	11	.	.	PUNCT